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Bacterial infections remain a major cause of morbidity and mortality for mankind. In 
particular, the WHO Global Tuberculosis report (2015) estimated that one third of the 
world population is infected with Mycobacterium tuberculosis and that 9.6 million people 
have contracted tuberculosis (TB) in 2014 alone. An emergent problem is the prominence 
of multidrug and extensively drug-resistant strains. The evolution of antibiotic resistance is 
inevitable and requires continuous development of alternative therapeutic strategies. 
Therefore, a deeper understanding of the host-pathogen interface is needed. If the 
molecular mechanisms underlying host-pathogen interactions will be better understood, it 
may become possible to treat intracellular infections by targeting host cell functions that 
support bacterial growth, rather than targeting the pathogen itself. An important advantage 
of this approach is that it is more difficult for the pathogen to develop resistance to a host-
targeted therapy. In this thesis, we investigated the host-pathogen dynamics during 
mycobacterial infection and we focused on the mechanisms by which mycobacteria can 
hijack chemokine signalling. Chemokines are small secreted signalling proteins that play 
multiple functions in a vast range of diseases. Chemokine receptors are highly expressed 
by immune cells and chemokine ligands are largely induced by inflammatory processes, 
including mycobacterial infections. However, since chemokine ligands and receptors are 
largely redundant in function and expression patterns, it has been difficult to address the 
relevance of different chemokine signalling axes for the onset and the progression of 
inflammatory diseases. Research on chemokine functions in TB has been particularly 
complicated in the most widely studied murine model. In this thesis, we alternatively 
applied the zebrafish (Danio rerio)-Mycobacterium marinum model to dissect how 
chemokines orchestrate the response of immune cells to mycobacterial infection. Several 
chemokine axes are conserved from fish to mammals and the similarities between human-
M. tuberculosis and zebrafish-M. marinum pathology are remarkable. In this introduction, 
we briefly describe these aspects, which, together with the suitability of the zebrafish for 
microscopic analysis and genetic manipulations, have made us choose this model to 


















The	 human	 chemokine	 network	 as	 currently	 known	 consists	 of	 25	 receptors	 and	 45	 ligands.	 Ligand-
receptor	connecting	 lines	 indicate	binding	specificity.	The	AKCR	family	comprises	atypical	receptors	that	
lack	 the	 motif	 for	 signalling	 through	 G-proteins	 and	 can	 antagonise	 the	 activities	 of	 other	 chemokine	
receptors	(connected	with	orange	lines)	by	binding	one	or	more	of	their	ligands.	The	chemokine	receptor	
families	 include	CXCR	 (green),	 XCR	 (cyan),	 CCR	 (blue),	 CX3CR	 (violet),	ACKR	 (orange).	 Chemokine	 ligand	
families	 include	CXCL	(ELR+	chemokines	 in	shades	of	green,	homoeostatic	chemokines	 in	shades	of	red,	




The zebrafish model system for biomedical research 
Zebrafish initially emerged as a powerful vertebrate model organism to study embryonic 
development and morphogenesis1,2,3,4,5 and this model species is now used to study the 
mechanisms of a wide variety of human diseases5. Due to their optical accessibility, the 
early embryonic and larval stages are ideally suited for non-invasive intravital imaging and 
longitudinal in vivo studies1. The short generation time (3-4 months) together with the 
external fertilisation and the possibility to daily obtain a large number of fertilised eggs 
from a zebrafish adult colony has permitted the efficient application of genetic tools, 
thereby providing the zebrafish field with transgenic lines that fluorescently label distinct 
tissues, organs, cell types, but also the cellular ultrastructural components, such as the 
nucleus, autophagosomes and the cytoskeleton6. 
 
The genome of zebrafish has been sequenced and forward genetics approaches have been 
successfully applied to mutate a vast array of genes3,4. Additionally, reverse genetic 
approaches, including morpholino knockdown and mRNA injection-based overexpression, 
are widely used in zebrafish embryos and have permitted rapid screening of gene functions. 
The zebrafish model also keeps up with state-of-the-art technologies, such as novel genome 
editing techniques (e.g. TALENS and CRISPR/Cas9)7,8,9 and the application of cell/tissue-
specific RNA-sequencing analysis10, which are contributing to exponentially increase the 
availability of tools and data for this model system. 
 
Due to their continuous exchanges with the surrounding water, embryos and larvae are 
easily penetrated by a variety of drugs and vital dyes and are therefore chemically and 
pharmacologically tractable. With the increase of tools and successes in using zebrafish, 
we have gained a grounded knowledge on how to exploit this model to study diverse 
biological processes. Therefore, not surprisingly, the zebrafish field has promptly expanded 
from the initial niche in developmental research to other scientific branches, spanning from 
eco/toxicology to neuronal physiology, behavioural studies and immunology. The potential 
of zebrafish research and its translational value to develop new treatments for human 
diseases is also underscored by new therapeutics that emerged from initial studies in 
zebrafish. In particular, a milestone for the zebrafish translational research was achieved 
when the first drug developed through the use of zebrafish has passed phase 1 trial and 
advanced to phase 2 clinical studies11,12. 
 
Despite the many advantages of using the zebrafish as a model for human diseases, there 
are also several limitations that should be taken into account when extrapolating 
conclusions from experiments in this animal model. The first important aspect to consider 
is the evolutionary divergence. There are about 445 millions of years of evolutionary 
divergence between the zebrafish and the human species, which is approximately 5-fold 
higher than the rodents-human divergence (93 millions of years). While key aspects of the 
immune signalling architecture are maintained between human and zebrafish, some 
significant differences exist between fish and mammalian immunology. An example is the 
fact that the Toll-like receptor Tlr4, differently than in mammals, is not involved in 
bacterial lipopolysaccharide sensing in zebrafish and many other fish species, which 
explains also the high tolerance of fish to this compound13. Another difficulty when 
working with zebrafish, resides in the fact that the teleost genome has undergone genome 
duplication, which means that a variety of genes are present in two copies in these species. 
Some gene families have also experienced species-specific expansions in zebrafish per se 
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(e.g. the chemokine ligand families14). Adding to this, the different gene copies have 
sometimes undergone functional specialisation and have diverged to assume slightly 
different roles15. 
 
Oftentimes regarded as an advantage, the small size of the zebrafish can be, in some 
circumstances, a limiting factor. In fact, the reduced dimension of zebrafish makes it 
difficult (in juveniles and adults) or nearly impossible (in embryos and larvae) to collect 
body fluids or organs, and therefore to precisely quantify bioactive molecules and 
chemicals in the blood or specific tissues. This has been a relevant limit, especially for the 
application of zebrafish larvae for high-throughput screening of drugs via bath exposure, 
including anti-tubercular therapeuticals16,17. In fact, not all the drugs can infiltrate through 
the skin and the impossibility of blood and tissue sampling made it impossible to 
distinguish inactive compounds from non-permeable false negatives. However, protocols 
for sampling the yolk sac have been described and it has been shown that dosage of 
compounds from these specimens can be used as an indication for the compound uptake, 
enabling therefore, to discriminate ineffective compounds from those that could not cross 
the skin barrier18. 
 
The zebrafish community additionally suffers from the poor availability of immunological 
reagents, and from the inefficiency of site-directed genome manipulation strategies, which 
effectively apply to the murine model. However, the lack of antibodies is well compensated 
by the expanding availability of transgenic reporter lines and the possibility to apply whole 
mount RNA in situ hybridisation. Additionally, the recent advances in genome editing 
technology (e.g. CRISPR/Cas9 editing) has enabled precise gene disruptions and 
generation of conditional knockout, at par of those available in mice19,20. 
 
Finally, another limit of the zebrafish model consists in the fact that, differently from 
rodents, strict breeding and husbandry protocols are not widely applied in the zebrafish 
community and true inbred zebrafish lines are not adopted in the majority of studies. 
However, generation of clonal zebrafish lines is possible, either by conventional repeated 
sibling incrosses or even directly via gynogenesis21. Therefore, it is expected that the 
zebrafish community will increasingly adopt these lines and more standardised culturing 
protocols for future research. 
 
Taken together, despite some drawbacks, the zebrafish model holds great promise for 
translational biomedical research as it concentrates in a single vertebrate system several 
useful features, including remarkable homology to mammals in biological processes, 
optical transparency, availability of genetic tools, chemical tractability, adaptability to 
high-throughput research methods and finally, suitability to address research questions at 
multiple levels, from the molecular level to the whole organism level. 
 
Tuberculosis and mycobacterial infection in the zebrafish-M. marinum surrogate 
model 
Mycobacterium tuberculosis (Mtb) is a respiratory pathogen responsible for tuberculosis 
(TB). The main pathologic feature of mycobacterial infection is the formation of 
granulomas, which are inflammatory collections of immune cells that contain the infection 
and that are often chronically maintained22. TB is a life threatening and global disease, with 
high prevalence in all human populations23. Although many organs and tissues can be 
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infected with M. tuberculosis, the disease most often affects the lungs, with 75-80% of TB 
cases where the infection is exclusively pulmonary24. Approximately 1.5 million people die 
of tuberculosis each year, and there are over nine million new cases annually23. Although 
drug treatments are available, the therapeutic regimen is long and requires a combination of 
several pharmaceuticals. In addition, drug-resistant strains have evolved that do not 
respond to the currently available treatments. One third of the world population is 
estimated to be infected with Mtb. Only about 10% of infected individuals will manifest 
active TB disease while, in the vast majority of cases, the pathology is contained although 
not eliminated (latent TB). In case of latency, people are generally not contagious, and may 
never develop active TB. However, the infection can reactivate even many years later, 
especially in immune-suppressed/compromised patients, for example people subjected to 
chemotherapies or carrying HIV infection. 
 
The granuloma, the histopathological hallmark of TB disease, is composed mostly of 
infected and non-infected immune cells that have migrated to the infectious focus. The 
signals responsible for granuloma formation and maintenance are only partly elucidated 
and it is clear that both host and pathogen signals integrate together to initiate the cellular 
and molecular programme that leads to granuloma formation22. As further elaborated on in 
Chapter 2, M. marinum (Mm) is a closely related species to Mtb that is a natural pathogen 
of zebrafish and other ectothermic animals. Mm causes necrotic granulomatous lesion 
formation in host tissues and these lesions are histologically very similar to those generated 
by Mtb in TB patients25,26,27. Additionally, the Mm-zebrafish surrogate model has been 
proven to recapitulate key aspects of TB, including bacterial dormancy/reactivation, the 
coordination of host and pathogen components in the formation of granulomas, the 
dynamicity of these structures and the key role of the inflammatory status in controlling the 
infection28,29,30,31. The striking conservation of molecular mechanisms, cellular dynamics 
and histopathological features between human and fish tuberculosis, together with the 
unique accessibility of the early stages of granuloma formation in zebrafish larvae, made 
the zebrafish-Mm host-pathogen pair a valuable platform to unravel the core pathogenic 
processes of mycobacterial infections. However, it must be taken into account that 
experimental fish embryo infections are generally performed using non-natural infection 
routes. Most commonly, the bacteria are delivered directly into the blood and generate a 
systemic infection that anatomically poorly represents the lung disease that is evoked in M. 
tuberculosis-infected patients. While use of a fish model makes it obviously impossible to 
model the organ-specific effects of TB pathology, a variety of alternative routes can be 
used to mimic and study specific aspects of the disease. For example, the importance of the 
epithelium for the initial steps of macrophage recruitment and granuloma formation has 
been addressed by delivering the bacteria into the hindbrain cavity32, which is delimited by 
an epithelial barrier that resembles the alveolar lumen. Similarly, the relevance of the 
vasculature response could be addressed by delivering the pathogens in the poorly 
vascularised trunk tissue, where progression of the infection substantially depends on the 
induction of local angiogenesis33. 
 
Human infections with Mm are rare and generally limited to granulomatous nodules in the 
tissues of the skin, owing to the optimal growth of this pathogen at lower temperatures than 
that of the human body. Hence, Mm does not represent a serious risk for health, when 
compared to Mtb. The limited safety concern and the possibility to handle Mm under 
biosafety level 2 instead of level 3 conditions greatly expands the research opportunities 




Chemokines and chemokine receptors, the portrait of an “extended” family 
Chemokines are chordate-specific signalling molecules. Their primary function is to 
control cell movements by activating specific heterotrimeric G-protein coupled receptors 
(GPCRs), a class of 7 transmembrane (7TM) receptors (Figure 1, Table 1). Chemokines 
and chemokine receptors play critical roles in a wide context of biological processes, both 
in physiological and pathological conditions, which include development34, ontogenesis 
and homing of immune cells35, angiogenesis36, organogenesis37, autoimmune reactions38, 
infectious diseases39 and cancer40,41. These activities are not exclusively related to 
chemokine function in chemotaxis and cell migration, since multiple signal transduction 
pathways can be activated by GPCRs, including cell proliferation and differentiation42. 
 
GPCRs are the largest and most diverse group of membrane receptors in eukaryotes43 and 
their pleiotropic functions, despite similar protein and signalling architecture, have greatly 
influenced modern medical research. In fact, GPCRs mainly signal via well-described 
pathways, which has facilitated drug discovery and testing. Additionally, they are involved 
in a variety of biological processes and therefore therapeutic targeting of GPCRs is relevant 
for many diseases. It has been recently estimated that between 1/3 and 1/2 of all the drugs 
available on the market target GPCRs44,45. 
 
At the intracellular side of the plasma membrane, inactive GPCR/chemokine receptors 
constitutively interact with a three subunit G-protein complex, also known as 
heterotrimeric G-proteins. G-proteins are able to bind and exchange guanosine triphosphate 
(GTP) with guanosine diphosphate (GDP). Specifically, it is the Gα subunit of the 
heterotrimer that exchanges GDP/GTP in response to conformational changes of the 
receptor46. Receptor conformational switches are evoked by binding of cognate chemokine 
ligands to their receptors. In the inactive form, Gα is bound to GDP. Activation of the 
receptor evokes physical replacement of GDP with GTP. This affects the conformation of 
the Gα subunit, which in turn dissociates from both the receptor and the Gβ-γ heterodimer. 
Both Gα-GTP and Gβ-γ possess lipid anchors and therefore diffuse laterally on the plasma 
membrane, where they interact with their downstream signalling partners46. This 
phenomenon is transient and, as soon as Gα-GTP decays to Gα-GDP, it re-associates to the 
GPCR receptor and to Gβγ. Despite this highly conserved signalling mechanism, vertebrate 
genomes encode multiple variants of G-proteins, which therefore can transduce diverse 
downstream signalling47. Some chemokine receptors have also shown selectivity for 
coupling with G-protein complexes containing specific G isoforms47. 
 
The cascade initiated by GPCR/chemokines receptors commonly includes the activation of 
phosphoinositide 3-kinase (PI3K), which leads to changes in intracellular 
phosphatidylinositol-3,4,5-triphosphate, and mediates the recruitment of pleckstrin 
homology (PH) domain–containing proteins to the cell membrane48. Several components of 
the Rho family of small GTPases, as well as their GTP/GDP exchange factors (GEFs) and 
kinases, also contain PH domains. Activation of the small GTPases (e.g. RAC1, CDC42, 
RHOA) is critical to link chemoattractant receptors to cytoskeletal changes and the 





Figure	 1.	 Downstream	 pathways	 activated	 by	 chemokine	 signalling.	 Most	 of	 the	 downstream	 signals	
evoked	 by	 chemokine	 ligand/receptor	 binding	 depend	 on	 receptor	 dissociation	 from	 heterotrimeric	 G-
proteins	 (Gα-β-γ)	 and	 on	 the	 GDP-GTP	 (guanosine	 diphosphate	 and	 triphosphate)	 exchange	 in	 the	 Gα	
subunit.	Different	families	of	Gα-proteins	exist	(Gs,	Gi,	and	Gq),	which	can	activate	RHOA	(RAS	homologue	
A),	 PLC	 or	 PLA2	 (phospholipase	 C	 or	 A2)	 and	 PTK	 (protein	 tyrosine	 kinase).	 Gi	 (shown	 in	 figure)	 can	
additionally	 inhibit	 AC	 (adenylyl	 cyclase),	 while	 Gs	 can	 stimulate	 this	 enzyme	 and	 production	 of	 cAMP	
(cyclic	adenosine	monophosphate).	PLA2	controls	AA	(arachidonic	acid)	release	and	affects	the	synthesis	
of	pro/anti-inflammatory	derivatives.	PTK	activates	the	MAPK	(mitogen-activated	protein	kinases),	while	
RHOA	 evokes	 actin	 polymerisation	 and	 sustains	 cell	 migration.	 Gβ-γ	 modulates	 GRB2	 (growth	 factor	
receptor-bound	protein	2),	which	via	activation	of	RAS	proteins,	 leads	to	downstream	effects	synergistic	
with	 the	 MAPK.	 Gβ-γ	 also	 activates	 PI3K	 (phosphoinositide	 3-kinase)	 and	 production	 of	 PIP3	
(phosphatidylinositol-3,4,5-triphosphate).	 PIP3	 is	 key	 to	 maintain	 cell	 asymmetry	 by	mediating	 cortical	
recruitment	 and	 activation	 of	 PH	 (pleckstrin	 homology)	 domain-containing	 proteins,	 including	 small	
GTPases	and	their	regulators	(e.g.	TIAM1/RAC1,	GEFs,	ROCK,	CDC42).	PIP3	also	activates	AKT	and	PLC.	AKT	
controls	 a	 phosphorylation	 cascade	 while	 PLC	 leads	 to	 IP3	 (inositol-1,	 4,	 5-triphosphate)	 and	 DAG	
(diacylglycerol)	production.	IP3	mobilises	Ca2+	from	the	ER	(endoplasmic	reticulum)	and	evokes	profound	
changes	 in	 the	 cell,	 as	Ca2+	 controls	 cytoskeleton	dynamics	 and	modulates	 a	 variety	of	 targets,	 such	as	
PLA2	and	PKC	(protein	kinase	C).	Calmodulin	and	MLCK	(myosin	light	chain	kinase)	control	contractility	of	
actin	fibres	in	a	Ca2+-dependent	manner.	Additionally,	microtubule	elongation	depends	on	Ca2+	gradients.	
As	 a	 consequence,	 lysosomes	 and	 secretion	 granules	 that	 are	 trafficked	 on	microtubule	 tracks	 via	 the	
motor	protein	kinesin	accumulate	towards	the	cell	periphery.	Ca2+	also	controls	the	activity	of	RABs	and	




to	 immune	defence	and	metabolism.	Chemokines	can	also	 induce	G-protein	 independent	 signalling,	 for	
example	 via	 direct	 activation	 of	 JAK2/STAT5	 (Janus	 kinase	 2/signal	 transducer	 and	 activator	 of	
transcription	 5)	 or	 via	 β-arrestin.	 The	 latter	 is	 also	 involved	 in	 clathrin-dependent	 internalisation	 of	




Chemokine sensing also activates phospholipase C (PLC)47, which hydrolyses 
phosphatidylinositol-(4,5)-bisphosphate to produce inositol-1,4,5-triphosphate (IP3) and 
diacylglycerol (DAG). IP3 induces the mobilisation of intracellular calcium stores, which 
in turn has effects on calmodulin and myosin light-chain kinase (MLCK). Increased 
intracellular calcium is a hallmark of chemoattractant stimulation as this mediates, for 
example, cytoskeleton redistribution and relocation of focal adhesions50. Ca2+ also controls 
microtubule stability and their directional elongation in the direction of the cell movement. 
Secretion granules and lysosomes, which are trafficked in the cells via kinesin (a 
microtubule-associated motor protein), follow microtubule tracks and tend to accumulate at 
the cortex of the leading edge. Here the coordinated activity of Ca2+, RABs and 
synaptotagmins – the main components of the SNARE (Soluble NSF attachment protein 
receptor) complex – will mediate fusion and exocytosis51. This process will, in turn, deliver 
phospholipids to the plasma membrane to sustain emission of protrusions and will 
determine secretion of enzymes and signalling mediators into the extracellular space, to 
facilitate locomotion and to transmit signals to neighbouring cells. 
 
Another target of G-proteins is adenylyl cyclase (AC), which catalyses synthesis of cyclic 
adenosine monophosphate (cAMP). Some versions of Gα can activate this signalling while 
others (called inhibitory Gα or Gi) can instead negatively control this enzyme. Most 
chemokine receptors seem to associate with Gi complexes and therefore tend to antagonise 
this signalling pathway52. The activated G-proteins can also have a variety of other effects. 
These include activation of RAS/mitogen-activated protein kinase (MAPK) pathways53,54 
and modulation of phospholipase A2 (PLA2)55, with downstream effects as diverse as 
apoptosis and cell proliferation54, immune responses56,57, arachidonic acid (AA) 
signalling55 and metabolic control58 (Figure 1). 
 
Chemokine receptors were originally thought to act entirely through G-protein-mediated 
processes. However, we now know that some chemokine receptors can also initiate 
alternative signalling pathways, that do not require G-protein-coupling. For example, some 
chemokines can directly activate the JAK-STAT (Janus kinase-signal transducer and 
activator of transcription) signalling59 or β-arrestin signalling60,61, with the latter being 
associated with clathrin-mediated ligand/receptor complex internalisation and 
desensitisation. There is also a class of these receptors that are completely incapable of 
transmitting any G-signalling, known as atypical chemokine receptors which are further 
discussed below. Notably, their ligand-mediated internalisation/recycling remains intact (or 
even enhanced), since this requires only direct β-arrestin coupling. This aberrant signalling 
mechanism is responsible for the role of these receptors as ligand scavengers, as the 
internalisation of the ligand/receptor complex mediates degradation of the cargo and 
recycling of the empty receptor to the plasma membrane, where new cycles of scavenging 
can take place62,63. 
 
Chemokine ligands are classified into the CXC, CC, XC (or C) and CX3C subfamilies, 
according to the arrangement of four conserved cysteine residues, which are important for 
maintenance of their tridimensional structure64,65. In mammals as in teleost fish, the CXC 
and the CC families are the two largest subfamilies, whereas the CX3C and C families 
only contain few members (Table 1). In zebrafish, another fish-specific chemokine 
subfamily was also identified, namely CX chemokines. These CX chemokines lack one 
of the two conserved cysteine residues in the N-terminus but retain the third and the 
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fourth. This distinguishes them from the XC subfamily chemokines, which only retain 
the second and fourth of the signature cysteine residues14.  
 














Controversial.	 Recruitment	 of	 M(φ)	




from	 wt	 when	 exposed	 to	 lower	











recruitment/priming	 of	 T	 cells	 and	
iNKT	 evoked	 increased	 susceptibility	
of	 CCR4	 KO	 mice	 to	 M.	 bovis-BCG.	









Controversial.	 Pathology	 of	 CCR5	 KO	
mice	was	 indistinguishable	 from	 that	
of	 wt,	 most	 likely	 due	 to	
compensation	 by	 CCR1.	 However,	




CCR6	 CCL20-21	 Dual	 DC,	B,	T,	NKT	
Impaired	 recruitment	 of	 iNKT	 and	 T	
cells	 in	 CCR6	 KO	 mice	 increased	
susceptibility	 to	 M.	 bovis-BCG.	
Follow-up	 experiments	with	Mtb	 still	
necessary.	
CCR7	 CCL19-21	 Homoeostatic	 DC,	B,	T	
Beneficial.	 Reverse	 migration	 of	 DCs	
to	 the	 draining	 lymph	 nodes	 is	
delayed	 in	 CCR7	 KO	 animals,	 which	
delays	 activation	 of	 T	 cell-mediated	
response	against	Mtb.	
CCR8	 CCL1-4-16-18	 Dual	 DC,	B,	T,	NK	 -	
CCR9	 CCL25	 Homoeostatic	 T	 -	
CCR10	 CCL27-28	 Homoeostatic	 B,	T,	eosinophils	 -	
	
Table	1.	Mammalian	chemokine	axes,	and	their	roles	in	tuberculosis	as	emerging	from	murine	knockout	
(KO)	 studies	 (continued	 on	 the	 next	 page).	 B:	 B-lymphocytes;	 T:	 T-lymphocytes;	 M(Φ):	
monocyte/macrophages;	NΦ:	neutrophils;	DC:	dendritic	cells,	NK:	natural	killers;	NKT:	natural	killer	T	cells.	




CXCR	 CXCL	 Function	 Specificity	 Significance	of	the	axis	in	TB	





Detrimental.	 CXCR2	 KO	 animals	
presented	 reduced	 lung	pathology,	 due	









Detrimental.	 CXCR3	 KO	 mice	 displayed	
attenuated	 lung	 pathology,	 attributed	
to	differential	T	cell	priming.	
CXCR4	 CXCL12-14	 Homoeostatic	 M(Φ),	B,	T	
KO	 not	 available,	 since	 embryonic	
lethal.	
CXCR5	 CXCL13	 Homoeostatic	 B,	T	
Beneficial.	 Aberrant	 recruitment	 of	
lymphocytes	 limited	 Mtb	 control	 in	
CXCR5	KO	mice.	
CXCR6	 CXCL16	 Dual	 B,	NKT	 -	
-	 CXCL15*	 Inflammatory	 NΦ	 -	
CXCR8	
(GPR35)	
CXCL17	 Homoeostatic	 M(Φ),	DC	 -	
	 	 	 	 	






challenge	 with	 Mtb,	 CX3CR1	 KO	 mice	
were	indistinguishable	from	wt	in	terms	
of	survival	and	infection	burden.	
XCR1	 XCL1-2	 Dual	 T	 -	
	 	 	 	 	





















Beneficial.	 D6	 KO	 mice	 are	 highly	
susceptible	 to	 low	 doses	 of	 Mtb.	 The	
phenotype	 is	 linked	 to	 an	 increased	



































In mammals, CXC chemokines can be further divided into ELR and non-ELR chemokines, 
based on the presence of the ELR (Glu-Leu-Arg) motif upstream of their CXC motif64. In 
these species, the presence of the ELR motif distinguishes neutrophil-competent 
chemokines (ELR-positive) from non-neutrophil-competent chemokines (ELR-negative), 
which attract other myeloid and lymphoid cells (monocyte/macrophages, lymphocytes, 
dendritic cells and natural killer cells)66,67 (Table 1). Mammalian ELR+ chemokines are 
CXCL1-2-3-5-6-7-8-15. These act mostly through receptors CXCR1-2. ELR− chemokines 
include CXCL4-9-10-11-12-13-14-16-17 and interact with receptors CXCR3-4-5-6-8. In 
fish, the ELR motif is not conserved and is not essential for the attraction of neutrophils by 
fish neutrophil-chemotactic chemokines68. 
 
The chemokine receptors are also classified in subgroups, namely CXCR, CCR, XCR or 
CX3CR, depending on the ligands that they can bind (Table 1)64,65. A CXR family 
(which should bind the zebrafish-specific CX chemokines) has not been identified and 
the interacting partners of CXL ligands remain unknown14. In addition to classical 
chemokine receptors, a new group of receptors (or more precisely, interceptors) has 
been introduced to include non-classical chemokine receptors. This group 
phylogenetically belongs to the same protein family, but differs functionally, due to the 
inability to mediate classical GPCR signal transduction by coupling with G-proteins. 
This heterogeneous group of “decoy” receptors mostly act as broad spectrum ligand 
scavengers and are designated as atypical chemokine receptors or ACKR69. Most 
atypical receptors lack or display an altered E/DRY (Glu/Asp-Arg-Tyr) motif, which is 
key to couple 7TM receptors with G-proteins and mediate classical signalling (Figure 
1). 
 
Chemokines can be functionally classified as homoeostatic (or constitutive) or 
inflammatory according to the regulation and pattern of their expression65. The 
homoeostatic chemokines are generally expressed by a variety of tissues in physiological 
situations, while the expression of inflammatory chemokines requires 
inflammation/exposure to pathogens. However, this classification is not strict and many 
chemokines (e.g. CXCL9-10-11) exert a dual function, by controlling both physiological 
and pathological responses (Table 1). 
 
The number of chemokines identified and characterised has expanded rapidly in the past 
decades, both for human and animal models65. In humans, 25 chemokine receptors 
(including ACKRs, Table 1) and 45 chemokine ligands have been identified, while in 
zebrafish at least 36 putative chemokine receptors and 75 putative chemokine ligands have 
been mapped65. Studies have revealed high levels of redundancy in the function and 
expression patterns of both chemokines and chemokine receptors41. Several receptors bind 
multiple chemokines and several chemokines can also bind to more than one receptor 
(Table 1). During infection/inflammation and development, a variety of chemokine ligands 
can be expressed at a specific site and multiple chemokine receptors can be expressed by 
the chemoattracted cells. Taken together, chemokine ligands and receptors can be highly 
synergistic, complementary or, in some cases, even antagonistic41,42. Due to this 
complexity, it is very difficult to accurately assess to what extent the chemokine axes are 
really redundant. Current understanding of the roles and dynamics of each chemokine in 
the complexity of an in vivo system is also incomplete. Therefore, the evolutionary, 
functional and regulative forces, that permitted expansion and radiation of diverse 




Homologies between the chemokine signalling axes of human and zebrafish 
While most of the ligand-receptor interacting partners have been identified in human and 
mammalian models, functional roles in zebrafish are only beginning to be examined70. At 
transcriptional level, several zebrafish chemokines have been found to be expressed in 
discrete areas/organs and tissues (homoeostatic) and others were found to be highly 
responsive to inflammation (inflammatory), like in humans14,71,72,73,74. In a recent review on 
the translational value of zebrafish and other teleosts to study chemokine functions70, it was 
reported that only one CCL chemokine axis has been currently shown to have clear in vivo 
functional homologies with the human and mammalian system. In this study, the zebrafish 
Ccl25a gene was found essential for normal T cell lymphotaxis to the thymus73. 
 
While the CCL ligand family is more divergent between mammals and teleosts, the CXCL 
family is much better conserved. For example, 11 canonical CXCRs and 20 CXCLs can be 
currently identified in zebrafish, versus 7 CXCRs and 17 CXCLs described in humans14. 
Several true homologies between zebrafish and mammals (corroborated by sequence 
alignments, synteny studies and functional analyses) have been demonstrated for CXC 
axes. As described in this thesis (Chapter 3), the CXCR3/CXCL9-10-11 axis exists in 
zebrafish. On the ligand side, a cluster of seven CXCL11-like tandem-duplicated genes 
have been identified. Some of these genes are infection-inducible, similar to their 
mammalian counterpart, and we showed that two of the CXCL11-like chemokines encoded 
by these infection-inducible genes signal via an orthologue of CXCR3, the zebrafish 
receptor Cxcr3.2 (Chapter 3-4). The CXCR3 gene is also duplicated in zebrafish and two 
paralogues of cxcr3.2 exist, namely cxcr3.1 and cxcr3.3. In zebrafish embryos and larvae 
the cxcr3.2 and cxcr3.3 genes are expressed by macrophages and neutrophils (Chapter 3), 
while the expression of cxcr3.1 is very low in these cells. Preliminary data suggest that 
cxcr3.1 is detectable at higher levels than the other two orthologues in lck+ cells (immature 
T cells)75. Therefore, it is possible that the three isoforms regulate chemotaxis of different 
cell types and represent sub-functionalisation of the mammalian CXCR3 that is expressed 
by both myeloid and lymphoid leukocytes (T cells, natural killer cells, dendritic cells, 
macrophages and microglial cells). However, this remains speculative, since the expression 
patterns remain to be further examined in adult zebrafish. The function of Cxcr3.3 has not 
been yet elucidated. However, as described in Chapter 5, cxcr3.3 genes exist exclusively 
in fish and in most cases they present peculiar sequence adaptations, including disruption 
of the E/DRY-motif consensus, that suggest atypical functions. 
 
Two clear orthologous CXCL12/CXCR4 axes have also been reported in zebrafish and 
extensive functional studies have been performed for both systems72,76,77,78,79 (Chapter 
6). Both CXCL12 and CXCR4 are in fact duplicated in fish (Cxcl12a/b and Cxcr4a/b). 
Cxcr4a and Cxcr4b are mostly expressed in separate tissues and cell types, which 
corroborates the hypothesis that after gene duplication the two receptors have divided 
functions between the two copies80. It appears that Cxcr4a evokes more potent 
responses via Cxcl12b while Cxcr4b predominantly signals via Cxcl12a, however, 
cross-reactivity has also been described81. Importantly, it has been demonstrated that 
cross-communication between the zebrafish and human ligands and receptors takes 
place, supporting the translational value of the zebrafish model40. The mammalian 
CXCL12 and either one or both of the zebrafish counterparts, Cxcl12a/b, are 
chemotactic for endothelial cells, haematopoietic progenitor cells, lymphocytes and several 
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other types of leukocytes. In agreement with their more homoeostatic function, these axes 
were implicated in the development of morphogenetic/organogenetic programs, such as the 
formation of blood and lymphatic vessels, the migration of germ cells and of the lateral line 
primordium, the organisation and patterning of the nervous system and the homing of 
haematopoietic stem cells72,76,79,82,83. The axis (mostly the Cxcr4b/Cxcl12a paralogue axis) 
has also been shown to play a crucial function during inflammatory responses, for example, 
promoting the metastatic behaviour of CXCR4-positive cancer human-xenotransplants40. 
Notably in both mammalian models and in zebrafish, this axis is regulated by the activity 
of the atypical chemokine receptor CXCR7/ACKR3, which acts as a Cxcl12 ligand 
scavenger to maintain an efficient formation of ligand gradient and facilitate cell 
migration76. 
 
At least 2 cxcl8 genes were identified and characterised in zebrafish, which are both 
induced by inflammation, wounding and infection. Similar to the human CXCL8 (IL8), the 
zebrafish paralogues are potent neutrophil chemoattracts via the Cxcr2 receptor, although 
in contrast to humans, expression of Cxcr1 alone does not seem to permit any significant 
Cxcl8-dependent recruitment84,85,86,87. In mammals, CXCR2 is highly promiscuous and can 
respond to a range of CXC-chemokines (Table 1). Therefore, it is likely that multiple 
ligands also exist for this receptor in zebrafish. As indicated in this thesis (Chapter 7), the 
zebrafish-specific chemokine Cxcl18b also partly requires signalling via Cxcr2, and not 
Cxcr1, to evoke optimal recruitment of neutrophils. 
 
Chemokine function in mycobacterial diseases 
Since chemokines and chemokine receptors direct cells to specific sites within the tissues, 
these molecules may be highly relevant for the progression of TB and granuloma 
formation, for example by directly controlling the cellular trafficking at the granuloma. 
There have been a variety of studies aimed at characterising expression of chemokines in 
response to Mtb in vitro and in vivo. Mtb is a strong inducer of chemokine expression. 
Following Mtb infection of human or mice macrophages in vitro, these cells exhibit rapid 
expression of many chemokines, detectable as early as 2 hours post-infection88,89. 
Mammalian macrophages can produce the chemokines CCL2-3-4-5-7-12, CXCL2-9-10-
11, and CX3CL1 with a response that, in many cases, depends on the pathogen 
virulence90,91,92,93,94,95,96,97. The cell wall components of mycobacteria are considered crucial 
for chemokine induction, as the production of several chemokines is significantly reduced 
following exposure to wall-deficient mycobacteria97. Macrophages are not the only cells 
inducing expression of chemokines upon Mtb infection. Chemokine expression is also 
induced in cells intrinsic to tissue surrounding the infection and other attracted 
leukocytes88,98. Expression of CCL2 and CXCL5-8-9-10-11 was detected in human or 
murine epithelial cells in response to virulent strains of M. tuberculosis98,99,100,101. 
Circulating granulocytes from TB patients produced high levels of CCL2-3 and CXCL1-
8102,103, bronchoalveolar lavage of patients displayed elevated levels of CCL2-5-7-12, 
CXCL8-1090,104,105 and plasma/serum level of CCL4-11-24-26 and CXCL10 were also 
found increased106,107,108. Two other studies that profiled gene expression of Mtb-infected 
murine and non-human-primate lungs described overall upregulation of CXCL1-2-3-5-9-
10-11-13 and CCL2-3-4-5-7-8-12-19-2098,109,110. Recent studies also revealed that, in TB of 
the central nervous system (TB meningitis), microglia (specialised macrophages residing in 
the brain) can also produce several chemokines, including CCL2-5 and CXCL10111. These 
studies indicate that a variety of cells participate in generating chemotactic/chemokinetic 
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cues in response to mycobacteria (Figure 2). Regarding the specificity of recruited cells, 
the chemokines reported are known to induce mobilisation of diverse types of cells 
(monocyte/macrophages, neutrophils, eosinophils, T cells, natural killer cells, dendritic 
cells, and others) according to the expression pattern of their receptor counterparts on 
target cells (Table 1, Figure 2)41,42,65. 
 
Regulation of the expression of signals inducing chemokine ligands still requires complete 
characterisation, as much in TB as in other physiological and pathological contexts. 
Chemokines are regulated by many cytokines and infection-related products. There is 
evidence for example that IFNγ, TNFα and Mtb-components can induce expression of 
chemokines (Figure 2). Expression of chemokines by macrophages appears to be highly 
influenced by TNFα production, which controls CCL2-5 and CXCL9-10-11112. TNFα is 
produced by macrophages themselves in response to Mtb infection and blockade of TNFα 
signalling can attenuate chemokine production. Notably, CXCL9-10-11, which are 
generally regarded as IFNγ inducible chemokines, were also found to be induced by TNFα 
during mycobacterial infection112,113. However, IFNγ itself is also found increased in TB 
patients and TNFα/IFNγ may synergise to induce these and other chemokines. 
 
While expression of chemokines is increased by Mtb infection, the expression of 
chemokine receptors remains much more stable. However, transcriptional profiling of the 
murine lung revealed a general upregulation of CXCR3-6 and of CCR1-5-998,110. Clinically 
relevant might be also the fact that monocytes increase expression of CCR5 and CXCR4 
(HIV co-receptors) in response to intracellular Mtb, which may result in increased 
infectivity of HIV in cases of Mtb/HIV co-infections114,115. In another study, dendritic cells 
having taken up Mtb were found to upregulate CCR7, which induces their reverse 
migration from the infection focus to the draining lymph nodes (expressing its ligands 
CCL19-21) and permits a faster priming of the T cell-mediated adaptive immunity116,117. 
Similarly, upon recruitment to the lung, T cells upregulate CXCR3 and CCR5 receptors. 
However, this upregulation maintains them at the infected locus, since high levels of 
CXCR3 and CCR5 ligands are produced at the lesion118.  
 
Leprosy represents another relevant mycobacterial disease, caused by the species 
Mycobacterium leprae. The disease, which essentially affects the skin and the peripheral 
nervous system, is still endemic in several developing countries, where it represents a 
relevant cause of permanent disability119. Leprosy manifests itself in two main polarised 
forms, namely lepromatous leprosy and tuberculoid leprosy. Lepromatous leprosy is 
characterised by exuberant bacillary replication and failure of T-helper 1 activation (which 
is essential to counteract the pathogen). Conversely, tuberculoid leprosy, is characterised 
by reduced count of bacilli, expression of T-helper 1 cytokines and is generally restricted to 
delimited skin lesions. Compared to TB, leprosy still remains poorly understood, for 
several limitations, which include the scarce cultivability in axenic conditions120,121,122 and 
the limited availability of animal models123,124. However, several studies have demonstrated 
that expression levels of different chemokines, including CXCL8-9-10 and CCL2-3-7, are 
sensitive to leprosy infection125,126,127,128,129. Notably, recent studies have also demonstrated 
that the expression of several chemokine ligands and receptors can be specifically 
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In particular, it was identified that expression of CCL17 or CCL18 are either correlated to 
the lepromatous (CCL18) or to the tuberculoid (CCL17) form130, and that the expression 
levels of both CXCR3 and its ligand CXCL10 can be used as indicator of leprosy type 1 
reaction, a severe complication of leprosy, characterised by acute activation of the cell-
mediated immune response with consequent inflammation and nerve damage131. 
 
In vivo analysis of chemokine axes in murine TB models 
While large amounts of data are available from in vitro studies, the expression and 
relevance of chemokines have only been characterised to a limited degree in vivo and the 
real meaning of these molecules for the pathology of TB remains elusive and speculative in 
several cases (Table 1). Using knockout murine models it was shown that CCR2 and its 
ligand CCL2 are essential for migration of macrophages and dendritic cells to the lungs 
and to control infection92,94. However, the susceptibility of these mice was found to be 
dose-dependent, since these animals were highly susceptible to a moderate or high dose of 
Mtb administered intravenously, but did not have increased bacterial loads compared to 
wildtypes (wt) when exposed to low dose aerosol or intravenous infection132,133. Another 
controversial finding came from the study of a CCR4 knockout (KO). In a model of acute 
M. bovis-BCG pulmonary infection, these animals exhibited higher susceptibility and 
increased bacterial burden. However, a follow-up study showed that CCR4-/- mice were not 
more susceptible to low dose of Mtb infection110,134. CCR6 mutants also displayed 
increased susceptibility to M. bovis135, but studies with Mtb are still necessary. The 
function of CCR5 signalling is also controversial; an initial study in CCR5−/− mice reported 
no difference in the bacterial burden evoked by Mtb136 and suggested that another receptor, 
such as CCR1 (which can bind the same ligands of CCR5, including CCL3-5), could 
compensate for CCR5 loss. Another study performed with CCL5 mutant mice with low 
dose aerosol infection, revealed instead an increased bacterial burden early after infection. 
In this study, recruitment of immune cells via CCL5 was predominantly evoked by CCR5, 
suggesting that compensation may occur at later time points but that CCR5 and CCR1 are 
not entirely redundant early after infection137. Furthermore, in the CCR2−/− mice studies 
described above, it was reported that while the number of macrophages migrating to the 
infection is initially lower, new cohorts of monocyte/macrophages can still be recruited at 
later time points. It was hypothesised that the initial increased burden in these animals 
evokes a higher upregulation of other chemokines in a second phase, which still sustains 
infiltration of immune cells and formation of granulomas92,94. These examples illustrate 
well the difficulties that can be experienced when addressing chemokine function in vivo. 
 
A murine model was also employed to study the function of CXCR3 and its ligands 
CXCL9-10-11 during Mtb infection. A beneficial effect of CXCR3 mutation was observed, 
with associated decrease in number, size and density of granulomas110,138. Unexpectedly, 
the recruitment of T cells was increased, rather than diminished in CXCR3 mutants, and the 
improved resistance of CXCR3-deficient mice was attributed to the function of CXCR3 in 
T-cell priming, rather than T-cell recruitment138,139. Mice deficient for either CXCR2 or its 
ligand CXCL5 had reduced lung pathology in comparison to their wt counterparts, and this 
phenotype was linked to a reduced accumulation of neutrophils in the mutants and to 
decreased detrimental neutrophil-dependent inflammation101. CXCL8, one of the most 
potent chemoattractants for neutrophils in humans, which is abundantly expressed upon 
Mtb infection, is however absent in mice140, which makes it difficult to exactly address the 
role of CXCR2-signalling using this model. Finally, a study of Mtb infection in a   
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CX3CR1-/- mouse model, showed that this mutation, while affecting infiltration of different 
leukocyte subsets, did not lead to protection or increased susceptibility to the pathogen, 
indicating that this receptor is dispensable141. 
 
In few cases, specific chemokine axes have been shown to play unique, non-redundant, 
functions in vivo. For example, both receptor and ligand mutants of the CXCR5/CXCL13 
pair were shown to display decreased control of Mtb, linked to aberrant recruitment of a 
specific set of CXCR5+ lymphocytes114,115,142. Similarly, the function of CCR7 in dendritic 
cell reverse migration to the draining lymph nodes to prime the adaptive immune response 
was also found to be unique116,117. 
 
Regarding the relevance of atypical chemokine receptors for the response to mycobacterial 
infection, a recent study on D6/ACKR2 KO mice showed that these animals are highly 
susceptible to low dose aerosol exposure to Mtb, owing to the increased number of 
monocyte/macrophages, dendritic cells and T cells infiltrated in the lesioned tissues. 
Blockade of a wide spectrum of chemokines with a cocktail of antibodies could rescue the 
phenotype of D6 deficiency, which suggests that the activity of D6/ACKR2 as a chemokine 
scavenger receptor is fundamental to maintain a balanced activation of leukocyte 
recruitment via chemokine signalling143. 
 
Despite the seemingly large redundancy in function exerted by chemokines in TB 
suggested by in vitro and in vivo models, human studies have still shown associations 
between mutations of multiple chemokine ligands (CCL2-5, CXCL8-10) and TB, 
indicating that besides the apparent redundancy, several chemokines may have defined 
roles to play in the pathogenesis of TB which we still do not entirely 
comprehend144,145,146,147,148,149,150,151. 
 
Taken together, it has been difficult to dissect the function of chemokine signalling in TB 
using the mice as an in vivo model. This situation may reflect, at least partly, the fact that 
mice do not represent an ideal model for TB, since Mtb is not a natural murine pathogen 
and infection in mice does not recapitulate the primate pathology. Additionally, the use of 
the murine-Mtb infection model leads to restrictions in terms of research opportunities. In 
vivo imaging and longitudinal studies in rodents require invasive and technically 
challenging procedures. Furthermore, work with the mouse model imposes severe ethical 
restrictions, since adult animals must be sacrificed for the experiments or for intra-uterine 
collection of embryos/foetuses. Moreover, research prospects are severely limited by the 
use of the Mtb pathogen, which represents a serious health risk for the researchers. To 
circumvent all these difficulties, in this thesis we have exploited the zebrafish-Mm natural 
infection model to evaluate the role of chemokines in mycobacterial infection. Using this 
surrogate system, we took advantage of its attractive optical and genetic tools to obtain a 
more dynamic representation of how the chemokine axes calibrate the immune response to 
mycobacteria. 
Contribution of this thesis: a brief outline 
In this thesis, we applied the zebrafish (Danio rerio)-Mycobacterium marinum natural 
infection model to obtain novel insights into the dynamic processes underlying host-
pathogen interactions and, in particular, to dissect how chemokines, a class of small 
chemotactic proteins, orchestrate the response of immune cell types to mycobacterial 
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infection. Several chemokine axes are conserved from fish to mammals and the similarities 
between human-M. tuberculosis and zebrafish-M. marinum pathology are remarkable. 
These two aspects, together with the excellent possibilities for intravital imaging provided 
by zebrafish transparency, have enabled us to study more dynamically chemokine-
dependent processes in an in vivo context and allowed us to dissect how these axes are 
implicated in defined spatio-temporal windows of mycobacterial disease. 
 
The work presented in this thesis has helped to elucidate the function of several chemokine 
axes in mycobacterial disease, and contributed to interpret the translational impact of the 
zebrafish model for biomedical research. This chapter (Chapter 1) introduces the 
chemokine signalling system and the current knowledge of its role in tuberculosis from in 
vitro and murine studies. Chapter 2 elaborates on the translational value of the zebrafish 
model and reviews how the application of this model has advanced our understanding of 
host-pathogen interactions for different infectious diseases. Chapter 3 and Chapter 4 
dissect the function of the chemokine receptor Cxcr3.2 and of its ligands Cxcl11aa and 
Cxcl11af during the response to mycobacterial infection, expanding on the effects of this 
signalling system for both direct chemotaxis of macrophages and control of their intrinsic 
microbicidal competence against mycobacteria. Chapter 5 describes the generation and 
initial characterisation of a cxcr3.3 mutant zebrafish line and explores the possibility of 
atypical receptor crosstalk at play between Cxcr3.3 and Cxcr3.2. Chapter 6 presents the 
importance of the homoeostatic chemokine receptor Cxcr4b in order to sustain a pro-
granuloma angiogenetic programme. In Chapter 7 we characterised the function of the 
chemokine ligand Cxc18b, a fish-specific inflammatory chemokine that, similarly to Cxcl8, 
exerts a neutrophil-specific chemotactic activity, at least partly via Cxcr2. Finally, Chapter 
8 summarises and contextualises the findings of this thesis in relation to the current 
scientific literature. 
 
Due to the high redundancy of chemokines and to the practical limitations when attempting 
to study tuberculosis in a murine system, the use of a zebrafish platform to address 
chemokine signalling during mycobacterial pathogenesis promises to greatly contribute to 
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Studying macrophage biology in the context of a whole living organism provides unique 
possibilities to understand the contribution of this extremely dynamic cell subset in the 
reaction to infections, and has revealed the relevance of cellular and molecular processes 
that are fundamental to the cell-mediated innate immune response. In particular, various 
recently established zebrafish infectious disease models are contributing substantially to 
our understanding of the mechanisms by which different pathogens interact with 
macrophages and evade host innate immunity. Transgenic zebrafish lines with 
fluorescently labelled macrophages and other leukocyte populations enable non-invasive 
imaging at the optically transparent early life stages. Furthermore, there is a continuously 
expanding availability of vital reporters for subcellular compartments and for probing 
activation of immune defence mechanisms. These are powerful tools to visualise the 
activity of phagocytic cells in real time and shed light on the intriguing paradoxical roles of 
these cells in both limiting infection and supporting the dissemination of intracellular 
pathogens. This Review will discuss how several bacterial and fungal infection models in 
zebrafish embryos have led to new insights into the dynamic molecular and cellular 
mechanisms at play when pathogens encounter host macrophages. We also describe how 
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The immune system has evolved through the constant interplay between microbes and their 
multicellular hosts. Selective forces acting on both sides have driven the evolution of a 
wide variety of virulence mechanisms in pathogens and alternative control mechanisms in 
their hosts. In vivo modelling of infectious disease is essential for understanding this 
complexity and translating it into novel therapeutic interventions. The immune system, 
innate and adaptive, is well conserved among vertebrates. The zebrafish (Danio rerio) 
offers an optically and genetically accessible vertebrate model to study host-pathogen 
interactions1,2,3. At the embryonic and early larval stages, zebrafish provide the opportunity 
of studying the relevance of innate immunity in a context where no adaptive response has 
yet been developed, given that early lymphocytes make their first appearance in 4-day-old 
larvae and a full adaptive immunity requires several weeks to be mounted4,5. 
 
Macrophages and neutrophils are the main phagocytic cell types of the innate immune 
system. Zebrafish models provide unique tools for studying the function of phagocytic 
cells, and these studies can effectively complement studies in other infectious disease 
models. Other recent reviews highlighted the use of zebrafish for understanding neutrophil 
biology6,7. Here, we will discuss six zebrafish models for important human pathogens 
(Mycobacterium, Salmonella, Burkholderia, Staphylococcus, Shigella and Candida), 
emphasising the novel insights that these models have recently provided into macrophage 
biology and highlighting how this could lead to the finding of new host-derived therapeutic 
strategies. 
 
ZEBRAFISH MACROPHAGE BIOLOGY AND TOOLS FOR INVESTIGATING 
MACROPHAGE FUNCTION 
Ontogeny and properties of early macrophages in zebrafish 
The first macrophage precursors appear in the zebrafish embryo as early as 20 hours post 
fertilisation (hpf) from the anterior lateral plate mesoderm8. Following migration to the 
yolk sac, they differentiate and either invade the head mesenchyme, where they will later 
differentiate into microglial cells (the resident macrophages of the brain) or enter the blood 
circulation8,9. These cells, named primitive macrophages, retain proliferative capability and 
have been reported to exist in mammals too8,10. They can remove apoptotic cells, are able 
to sense and respond to invading microbes and can eradicate non-pathogenic infections. 
Primitive macrophages readily phagocytose microbes from the blood circulation or when 
present in tissues. In contrast, neutrophils (which develop slightly later) are less efficient in 
phagocytosing microbes in the blood but are potent scavengers of surface-associated 
bacteria11. 
 
Primitive macrophages are gradually replaced by different lineages of macrophages 
deriving from definitive haematopoiesis, the process that will produce specialised 
pluripotent cells with the ability to differentiate into all types of mature blood cells. The 
first wave of definitive haematopoiesis starts at 24 hpf in the posterior blood island or 
caudal haematopoietic tissue (CHT) with the differentiation of erythromyeloid 
progenitors12. By 48 hpf, these pluripotent progenitors are replaced with another subset of 
haematopoietic stem and progenitor cells (HSPCs), now able to also differentiate into the 
lymphoid lineage. These cells originate from the AGM (aorta, gonads and mesonephros), 
derived from the lateral posterior mesoderm. After leaving the AGM, they migrate to and 
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nest in the CHT and will provide the second wave of definitive haematopoiesis12,13. 
Development of HSPCs and their emergence from aortic endothelium is remarkably 
conserved between zebrafish and mammals14,15,16. 
 
Following the second wave of haematopoiesis, macrophage precursors are released into the 
circulation and will extravasate to seed tissues throughout the whole body, where they 
differentiate into tissue macrophages. Starting from 4 days post fertilisation (dpf), the 
kidney marrow, which is the main haematopoietic tissue of the adult fish, develops and will 
progressively replace the embryonic haematopoietic system. Another component of the 
mononuclear phagocyte system is represented by the dendritic cell (DC) population, which 
is also present in zebrafish larvae and can be detected from 8–12 dpf 17,18. 
 
The infection studies discussed below, using zebrafish embryo and larval models, do not 
distinguish macrophages from circulating monocytes. Furthermore, possible functional 
differences between macrophages from primitive or definitive haematopoietic origins are 
generally not addressed. For more detailed and comparative descriptions of the processes 
of haematopoiesis in zebrafish and mammals we refer to other reviews19,20. 
 
Macrophage defence mechanisms and subversion by intracellular pathogens 
Macrophages sense the presence of infection through microbial-specific molecules and 
host-derived inflammatory mediators. Their chemoattraction to the site of infection 
depends largely on the function of G-protein-coupled receptors21,22. Scavenger and 
complement receptors play a major role in phagocytosis23 and Toll-like receptors (TLRs), 
in cooperation with other pattern-recognition receptors (PRRs), initiate the innate immune 
response24. TLRs, found on the cell surface and membranes of vesicular compartments, 
recognise pathogen- and damage-associated molecular patterns (PAMPs and DAMPs, 
respectively). Another main class of PRRs, the NOD-like receptors (NLRs), performs the 
same function in the cytosol25,26. Some NLRs participate in the assembly of the 
inflammasome, a multiprotein complex able to activate the caspase-1 cascade, which 
triggers processing of pro-inflammatory cytokines, such as IL1β (interleukin 1 beta) and 
full activation of the innate immune response27. 
 
When engulfed by macrophages, microorganisms are exposed to a number of defence 
mechanisms within the resulting phagosome and through its subsequent fusion with 
lysosomes. These include the production of reactive oxygen and nitrogen species (ROS and 
RNS, respectively)28,29, exposure to antimicrobials, the activity of proteases and 
acidification30,31,32. Escape from the phagosome triggers septin caging and antibacterial 
autophagy as additional defence mechanisms33,34. 
 
Intracellular pathogens have evolved many strategies to counteract these defences. These 
counter-strategies are mediated by virulence factors, which are often secreted directly into 
the host cell via specialised secretion systems such as the T3SS (type III secretion system) 
of Gram-negative pathogens and the T7SS (type VII secretion system) of pathogenic 
mycobacteria35,36. Pathogens can also induce significant reprogramming of their host cells 
through manipulation of signalling pathways and chromatin remodelling; however, these 
mechanisms are still poorly understood37,38. Intracellular pathogens often block phagosome 
maturation and fusion with lysosomes or manipulate the vesicular system such that the 
phagosome is modified to resemble the endoplasmic reticulum or a Golgi-like 
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compartment39. Furthermore, several pathogens inject virulence factors that promote actin 
polymerisation to actively stimulate their uptake by both non-phagocytic and phagocytic 
cells40. Pathogens that are able to escape from the phagosome have mechanisms to evade 
autophagy and can spread from the initially infected cell to other cells by acquiring actin-
based motility40,41. Other virulence mechanisms can induce inflammation and different cell-
death programs to facilitate the dissemination of infection42. These different virulence 
strategies are schematically depicted in Figure 1. 
 
Macrophage markers and transgenic lines 
The development of transgenic zebrafish lines with fluorescently labelled leukocytes 
(Supplementary Table 1) has been key to the successful application of zebrafish for 
immunological studies. However, until recently, the lack of a specific reporter for the 
macrophage lineage limited the study of this myeloid subset. This has now been remedied 
with the development of the csf1ra and mpeg1 reporter lines43,44. These genes are robust 
markers for macrophages at embryonic and larval stages, because they are co-expressed 
with the pan-leukocytic marker lcp1 but not with the neutrophil markers mpx and lyz45,46. 
Despite the fact that csf1ra is macrophage-specific within the immune cell types, it is also 
expressed in neural crest cells and derivatives, such as the xanthophores. Nevertheless, the 
highly motile macrophages can be distinguished easily from the immobile xanthophores in 
time-course experiments43. Reporter lines using the mpeg1 promoter label macrophages but 
not xanthophores (Figure 2A, Supplementary Movie 1) and, combined with a neutrophil 
marker, can show the different kinetics of macrophage and neutrophil responses to 
infection and wounding, as well as the dynamic interactions between the two cell types44. 
The mpeg1 reporter also labels microglia and it has been suggested to label other antigen-
presenting cells, such as the Langerhans dendritic cells, but these could not be detected 
before 8–9 dpf18. 
 
Expression of the Gal4 transcription factor under the control of macrophage or neutrophil 
promoters in combination with a UAS:nitroreductase-mCherry line allows for the specific 
ablation of one of the two phagocyte populations. This approach can be used to investigate 
their individual contributions to the immune response and infectious disease 
pathogenesis43,47. Alternatively, spi1/pu.1 antisense morpholino knockdown can be used to 
block the development of either macrophages exclusively or of both macrophages and 
neutrophils, depending on the concentration used48. Similarly, irf8 tools have also been 
used to deplete specific myeloid cell populations and to skew the development of their 
progenitors towards macrophages or neutrophils. Morpholino knockdown of irf8 can 
completely deplete macrophage differentiation while stimulating an increased output of 
neutrophils and irf8 overexpression can direct myeloid development towards macrophage 
differentiation49. 
 
Many other transgenic lines that label either the entire myeloid population, the early 
myeloid subset, microglia or all antigen-presenting cells are also very useful for the study 












plethora	 of	 microbicidal	 components	 cooperate	 in	 a	 multidirectional	 assault	 to	 the	 microbes	 (2).	 By	
transferring	virulence	factors,	often	via	secretion	systems	(injectosomes),	some	pathogens	can	avoid	the	
classical	 maturation	 steps	 of	 these	 compartments,	 creating	 a	 favourable	 niche	 for	 their	 intracellular	
growth	 (3,	 4,	 5).	 Fusion	 of	 the	 phagosome	with	 endosomes	 and/or	 lysosomes	 can	 be	 blocked	 (6)	 and	
fusion	 with	 Golgi-	 and	 reticulum-like	 vesicles	 can	 be	 promoted	 (3),	 resulting	 in	 the	 formation	 of	
specialised	 replicative	 vacuoles	 (4,	 5),	 in	 some	 cases	 also	 directed	 to	 non-lytic	 expulsion	 (7).	 Several	
intracellular	 pathogens	 are	 able	 to	 escape	 directly	 into	 the	 cytosol	 (8).	 Here,	 septin	 cages	 (9),	 galectin	
decoration	 (10),	ubiquitylation	 (11)	and	 specific	 routes	of	antimicrobial	autophagy	 (12)	are	activated	 to	
capture	 the	escapers	and	 redirect	 them	 to	 lytic	 compartments.	Additionally,	ubiquitylation	of	microbial	
proteins	(11)	labels	these	for	proteasomal	degradation	(13).	Several	intracellular	pathogens	can	efficiently	
counteract	this	second	line	of	intracellular	defence	and	replicate	freely	within	the	cytosol	(14),	frequently	
also	manipulating	 the	 cell	 cytoskeleton	 (15)	 to	 sustain	 their	 extrusion	 and	 dissemination	 to	 other	 host	
cells	(16).	Intracellular	infections	have	profound	influences	also	on	a	wide	spectrum	of	host	functions.	Cell	
signalling	 pathways	 can	 be	manipulated	 to	modulate	 the	 host	 inflammatory	 response	 (17)	 and	 control	
gene	 expression	 (18).	 Some	 pathogens	 are	 also	 known	 to	 induce	 epigenetic	modification	 of	 their	 host	
cells,	 leading	 to	 reprogramming	 (19).	 Some	 virulence	 factors	 directly	 impact	 the	 homoeostatic	
mechanisms	 by	 interfering	 with	 normal	 mitochondrial	 functionality	 (20),	 membrane	 polarity	 and	
communication	with	 the	 extracellular	milieu	 (21).	 The	ultimate	possibility	 for	 the	host	 to	 eradicate	 the	




In vivo visualisation of macrophage function 
Visualisation of live macrophage behaviour in zebrafish embryos can be achieved with 
great structural detail using digitally enhanced differential interference contrast (DIC) 
microscopy8,50,51,52. More recently, there has been tremendous progress in the use of 
transgenic marker lines (Supplementary Table 1) and labelled pathogens that facilitate 
live imaging in spatial and temporal dimensions (Figure 2, Supplementary Movies 2-3). 
 
Photoconvertable fluorescent proteins such as Kaede and Dendra2 have been exploited to 
show that cells from the CHT can be recruited distally to infection foci and wounds53 and 
that Mycobacterium-infected macrophages egress from primary granulomas to initiate 
secondary infection foci52. For imaging of phagocyte migration, pathogens or specific 
chemoattractants can be injected subcutaneously or into body cavities such as the otic 
vesicle and hindbrain ventricle, which can be reached without generating extensive tissue 
damage, thereby preventing wound-induced leukocyte mobilisation11,54,55,56,57,58. To 
visualise phagocytosis and the intracellular fate of bacteria, the pHrodo dye can be 
conjugated to bioparticles or to live or heat-killed bacteria (Figure 2D), providing 
constitutive fluorescence in one channel and additional fluorescence in another channel 
following exposure to an acidic environment59. Furthermore, the nature of the 
compartments where the pathogens reside can be investigated with combinations of 
different vital stains, most of which are permeable into zebrafish embryos when added to 
the water. Several pH-sensitive dyes (LysoSensor and LysoTracker) do not distinguish 
between lysosome-dependent or -independent phagosome acidification mechanisms, but 
they can be used simultaneously with methods for detection of the activity of lysosomal 









(green).	Random	patrolling	of	macrophages	 is	 shown	 in	 Supplementary	Movie	1.	B.	 Phagocytosis	of	M.	
marinum	 (Mm;	 green)	 injected	 into	 the	 subcutaneous	 area	 overlying	 a	 somite	 in	 a	 2-dpf	
Tg(mpeg1:mCherry-F)	 embryo.	 The	 arrow	 points	 at	 a	macrophage	 (red)	 in	 the	 process	 of	 phagocytosis	
between	 47	 and	 60	minutes	 post	 infection.	 The	 images	 are	 particulars	 and	 stills	 from	 Supplementary	
Movie	 2	 (10	 to	 60	 minutes	 post	 infection).	 C.	 Macrophage-mediated	 dissemination	 of	 M.	 marinum	




sensitive	 green	 pHrodo	 are	 contained	 within	 subcellular	 compartments	 of	 macrophages,	 which	 are	
intensely	labelled	by	the	membrane-bound	mCherry	of	the	Tg(mpeg1:mCherry-F)	line.	White	arrows	point	
at	bacteria	in	acidified	compartments,	where	the	pHrodo	dye	is	activated.	Yellow	arrows	point	at	bacteria	
in	 non-acidified	 compartments.	 Note	 that	 most	 of	 the	 intracellular	 mycobacteria	 are	 not	 acidified,	








Different methods allow in situ detection of ROS and RNS responses during infection in 
zebrafish embryos62,63,64,65. Also, tools for visualising ATP, calcium effluxes and apoptosis 
have been efficiently used in zebrafish60,66,67. Furthermore, an increasing number of 
transgenic marker lines for vesicular compartments are becoming available that will help in 
elucidating the subcellular locations where pathogens reside in vivo (Supplementary 
Table 2). 
 
NEW INSIGHTS INTO MACROPHAGE-PATHOGEN INTERACTIONS 
Mycobacterium marinum 
M. marinum is a natural pathogen of zebrafish that causes granulomatous necrotic lesion 
formation in host tissues. These lesions are histologically very similar to those generated 
by Mycobacterium tuberculosis, the aetiological agent of human tuberculosis68,69. In adult 
zebrafish, M. marinum can cause a latent infection and the bacteria can be reactivated from 
dormancy by immunosuppressive treatment, as is the case for M. tuberculosis, which is 
estimated to have infected one-third of the world population70,71. Tuberculosis therapy is 
limited by a number of problems, including the poor response of dormant mycobacteria to 
antibiotics, the increasing prevalence of multidrug-resistant strains and the lack of an 
effective vaccine against latent or reactivated tuberculosis72. The lack of a mouse model for 
tuberculosis that fully recapitulates the disease and the risk of working with the human 
pathogen owing to its airborne transmission emphasise the need for alternative models. The 
unique accessibility of the early stages of granuloma formation in zebrafish larvae has 
made the zebrafish-M. marinum host-pathogen pair one of the most productive models 
used to unravel the core pathogenic processes of mycobacterial infections3,50,73 (Figure 
3A). Notably, the use of this model has already provided several direct translational 










Figure	 3.	 Models	 of	 intracellular	 infections	 in	 zebrafish	 (Legend	 on	 the	 previous	 page).	 Schematic	
comparison	of	the	infection	phenotypes	caused	by	different	pathogens	following	intravenous	injection	in	
zebrafish	 embryos.	A.	M.	marinum	 can	 replicate	within	 phagosomes	 and	 also	 escape	 into	 the	 cytosol.	
Eventually,	 the	 host	 macrophages	 succumb	 to	 the	 infection	 and	 the	 pathogen	 spreads	 to	 new	
macrophages	 that	 have	 been	 recruited	 through	 bacterial	 virulence	 mechanisms.	 This	 leads	 to	 the	
formation	 of	 granulomatous	 lesions.	 Occasionally,	 infected	 macrophages	 can	 egress	 from	 the	 primary	
granuloma	 and	 seed	 secondary	 granulomas.	 B.	 S.	 typhimurium	 avoids	 the	 phagosomal	 defences	 by	
inducing	 the	 formation	 of	 non-lytic	 compartments	 [Salmonella-containing	 vacuoles	 (SCVs)].	 Upon	
replication,	 the	pathogen	 induces	pyroptotic	 cell	 death.	 Extracellular	Salmonella	 continues	 to	 replicate.	
Damage-	 and	 pathogen-associated	 signals	 contribute	 to	 uncontrolled	 inflammation	 (‘cytokine	 storm’),	
which	is	rapidly	fatal	for	the	host.	C.	B.	cenocepacia	can	also	replicate	within	intracellular	compartments.	
Additionally,	 it	 can	 be	 non-lytically	 expelled	 from	 the	 host	 macrophages.	 Within	 the	 extracellular	
environment,	 the	 pathogen	 stimulates	 leukocyte	 aggregation	 and	 continues	 replication.	 The	 resulting	
uncontrolled	bacteraemia	is	the	major	cause	of	the	fatal	complications.	D.	S.	aureus	is	largely	resistant	to	
intracellular	 killing	when	phagocytosed	by	macrophages	 and	 leads	 to	 their	 necrotic	 death.	 By	 contrast,	
when	 phagocytosed	 by	 neutrophils,	 most	 of	 the	 pathogen	 can	 be	 efficiently	 neutralised.	 However,	
resistant	 clones	 occasionally	 emerge	 and	 expand	within	 these	 cells.	 This	 “intraphagocyte	 niche”	 is	 the	
reason	of	the	monoclonality	of	focal	staphylococcal	abscesses.	E.	S.	flexneri	can	invade	non-immune	cells.	
Within	these	cells,	the	pathogen	escapes	immediately	into	the	cytosol	and	gains	actin-based	motility,	by	
which	 it	 disseminates	 from	 cell	 to	 cell.	 Within	 macrophages,	 the	 pathogen	 can	 also	 escape	 from	 the	
phagosome,	but	here	a	more	efficient	cytosolic	control	partially	combats	the	invader,	delaying	(although	
not	avoiding)	macrophage	cell	death.	Neutrophils	represent	efficient	scavengers	for	extracellular	Shigella	
released	 from	 dying	 epithelial	 cells	 and	 macrophages	 but	 the	 infection	 is	 still	 rapidly	 lethal.	 F.	
Phagocytosis	of	C.	albicans	by	macrophages	leads	to	a	standoff	phase,	where	the	host	does	not	degrade	




Infection of zebrafish embryos with M. marinum has demonstrated that macrophages are 
sufficient to initiate granuloma formation in the absence of adaptive immunity50. 
Subsequently, this model changed the widespread view of granulomas, historically 
regarded solely as host-protective structures, by showing that early granulomas promote 
mycobacterial dissemination (Figure 3A) and that their formation is driven by virulence 
determinants of the RD1 locus, encoding ESX-1, a secretion system conserved in all 
pathogenic mycobacteria3,35,52,74. Furthermore, the ESX-1-secreted protein ESAT-6 (Early 
secreted antigenic target 6) was found to induce matrix metalloproteinase Mmp9 
production by epithelial cells surrounding the infection focus, which in turn facilitates 
macrophage infiltration. As a result, the application of Mmp9 antagonists has been 
suggested as a host-directed anti-tuberculosis therapy75 (Table 1). The notion that 
granulomas are dynamic structures, even during latent infection, is supported by a study of 
M. tuberculosis infection in the macaque model76. 
 
Mycobacteria are well known for developing drug tolerance. The zebrafish embryo model 
has demonstrated that their intramacrophage localisation correlates with development of 
resistance and that granulomas promote dissemination of this resistant population. 
Upregulation of bacterial efflux pumps, which are required for intracellular growth, can 
mediate drug tolerance both in M. marinum-infected zebrafish and in M. tuberculosis-
infected human macrophages. Efflux-pump inhibitors, already available on the market, can 
reduce this tolerance and their addition to standard anti-tuberculosis therapy might, 





























































































































Table	 1.	 Therapeutic	 strategies	 inspired	 by	 the	 zebrafish	model	 to	 counteract	 intracellular	 infections	
(Table	on	the	previous	page).	The	zebrafish	host	model	has	contributed	extensively	to	the	investigation	of	
novel	 therapeutic	 strategies,	 oriented	 on	 modulating	 host-derived	 responses.	 Metalloproteinase	
inhibitors	 can	 reduce	 the	 tissue	 inflammatory	 response	 guiding	 phagocytes	 towards	 mycobacterial	
infections,	thus	attenuating	the	expansion	of	primary	granulomas	and	the	seeding	of	secondary	infectious	
foci.	 Efflux	 pumps,	 although	 not	 representing	 a	 host	 target,	 impact	 directly	 on	 the	 capability	 of	 the	
pathogens	 to	 adapt	 to	 the	 intracellular	 growth	 and	 their	 blockade	 can	 reduce	 drug	 tolerance.	 Several	
classes	 of	 established	 anti-inflammatory	 drugs	 are	 beneficial	 for	 subsets	 of	 tuberculosis	 and	 leprosy	
patients,	 dependent	 on	 their	 genotypically-determined	 inflammatory	 status	 (suppression	 of	 excessive	
inflammatory	response).	Levels	of	ROS	and	RNS	work	as	a	double-edged	sword	and	their	tight	control	can	
stimulate	 a	 positive	 outcome	 of	 the	 infectious	 process.	 Drugs	 scavenging,	 suppressing,	 or	 boosting	
ROS/RNS	 production	 are	 thereby	 valuable	 therapeutic	 tweezers	 to	 fine	 tune	 their	 balance.	 Finally,	 the	




Another important insight into tuberculosis pathogenesis concerns the relevance of the 
inflammatory status. A zebrafish mutagenesis screen revealed Lta4h (Leukotriene A4 
hydrolase) as a host factor that strongly correlates with M. marinum susceptibility79. This 
enzyme is required for producing LTB4 (Leukotriene B4), a powerful proinflammatory 
chemoattractant. Lta4h deficiency correlates with a less inflamed status, due to redirection 
of its substrates to anti-inflammatory lipoxins, resulting in reduced levels of 
proinflammatory cytokines such as tumour necrosis factor (TNF). The crucial role of TNF 
in controlling mycobacterial infection is exemplified by the increased risk of tuberculosis 
in patients with chronic inflammatory disorders treated with TNF antagonists80. However, 
excessive production of TNF is also associated with higher susceptibility to tuberculosis. 
This has been shown in zebrafish and other animal models as well as in tuberculosis 
meningitis patients, where a polymorphism at the LTA4H locus that causes increased TNF 
production has been linked with more progressive disease symptoms79,81. Hyper-inflamed 
and hypo-inflamed statuses have both been associated with necrotic death of infected 
macrophages and consequent extracellular release of the pathogen82,83. In conditions of low 
inflammation, macrophages passively undergo necrotic death because they are unable to 
control intracellular bacterial growth, whereas, in conditions of high inflammation, 
macrophages actively initiate two ROS-mediated necroptotic pathways, dependent on the 
activation of the mitochondrial permeability transition pore complex (mPTPC) and of the 
lysosomal acid sphingomyelinase (aSMase). Drugs targeting these pathways prevent 
activation of the necroptotic program in the zebrafish model82. The crucial role of the 
inflammatory status emphasises the importance of designing personalised patient therapies: 
patients with the proinflammatory LTA4H genotype might benefit from classical anti-
inflammatory drugs [such as corticosteroids or non-steroidal anti-inflammatory drugs 
(NSAIDs)]; however, these drugs should be avoided in patients with the opposite 
genotype79,84. Drugs that directly block the ROS-linked necroptotic pathways will benefit 
the proinflammatory genotypes without generating detrimental effects on the other 
genotypes, because the necroptotic pathways are exclusively triggered in hyper-inflamed 
conditions83 (Table 1). 
 
The inflammatory response is initiated by TLR recognition of PAMPs. Myd88, a central 
adaptor in TLR signalling, was recently shown to be required for control of systemic M. 
marinum infection in zebrafish embryos85. In contrast, the initial recruitment of 
macrophages to a localised M. marinum infection in the hindbrain was found to be largely 
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Myd88 independent58. This effect was linked to the presence of PDIM (phthiocerol 
dimycocerosate) lipid on the surface of pathogenic mycobacteria, which masks the 
underlying PAMPs. Non-pathogenic mycobacteria, which lack PDIM, induce a robust 
immune response and are efficiently contained. Mutation of the PDIM transporter 
(ΔmmpL7) and of a factor involved in PDIM synthesis (Δmas) can restore Myd88-
dependent macrophage recruitment and allow an efficient intracellular RNS response 
against invading bacteria. Interestingly, in the absence of a TLR response, macrophages 
can still be recruited. This Myd88-independent recruitment was found to be mediated by 
cell-surface phenolic glycolipids (PGLs), which induce macrophage recruitment through a 
pathway that is analogous to the mammalian CCL2-CCR2 (CC-motif chemokine ligand–
receptor 2) axis. The macrophages recruited in this situation are suggested to be more 
permissive to intracellular bacterial growth, because they do not drive the strong 
intracellular RNS response. These observations might also explain why M. tuberculosis 
establishes infection in the lower rather than in the higher respiratory tracts, because the 
latter is exposed to resident and environmental microbes that can make macrophages more 
competent for intracellular killing via a continuous transduction of TLR-dependent 
immune signalling58. 
 
Although macrophages are the main cell type infected by M. marinum following 
intravenous injection, neutrophils are also important for early infection control in zebrafish. 
In the early granuloma, the protective role of neutrophils was found to depend on ROS 
production56. Prior to granuloma formation, neutrophils, both infected and non-infected, 
also produce RNS65. This RNS production is dependent on inducible nitric oxide synthase 
(iNOS) and can be modulated by genetic or pharmacological modulation of Hif-α 
(Hypoxia-inducible factor alpha) transcription factors. Increasing Hif-1α signalling or 
decreasing Hif-2α signalling primes neutrophils with higher levels of RNS prior to 
infection, thereby limiting susceptibility to mycobacterial infection. Increasing host RNS 
output by therapeutic targeting of the Hif-α pathway might shift the balance in favour of 
the host and can thereby be explored as a strategy to complement antibiotic interventions 
(Table 1). 
 
In addition to the classical microbicidal mechanisms of macrophages, antibacterial 
autophagy has emerged as an important supplementary control mechanism in 
mycobacterial infections34. Using the zebrafish model, colocalisation of mycobacteria with 
the autophagic marker Lc3 has been demonstrated in vivo2. Moreover, actin tail formation 
and recruitment of septin cages have been visualised, the latter also being associated with 
Lc3 and autophagy86. The induction of dram1 (DNA damage-regulated autophagy 
modulator 1) during infection suggests an immunological function of this autophagy 
modulator and the zebrafish model could be further exploited to investigate therapeutic 
targeting of selective autophagy pathways86,87. 
 
Very recently, a zebrafish larval model has also been established to study a rapidly growing 
Mycobacterium, M. abscessus, an emerging pathogen that causes severe pulmonary 
infections in individuals with cystic fibrosis61. The study showed that the virulent rough 
morphotype of M. abscessus is transported to the central nervous system by macrophages, 
where bacteria released from dying cells form massive amounts of serpentine cords that 
grow too large to be phagocytosed, leading to acute and lethal infection. Furthermore, M. 
tuberculosis can also be disseminated by zebrafish larval macrophages and is sensitive to 
antibiotic treatment in this model88. It will be of interest to investigate novel therapeutic 
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strategies emerging from the study of M. marinum (Table 1) also in the zebrafish models 
for these human pathogens. 
 
Salmonella enterica serovar Typhimurium (S. typhimurium) 
Like many other Gram-negative enterobacteria, Salmonella can infect a diverse range of 
hosts and cause zoonotic diseases89. The S. enterica serovar Typhimurium, often referred to 
as S. typhimurium, represents a common agent of enteric fever, gastroenteritis and 
bacteraemia, often linked to food poisoning. Although the bacterium is not a natural fish 
pathogen, zebrafish embryos are strongly susceptible to S. typhimurium in experimental 
settings. Pathogenesis in fish involves some of the acute symptoms seen in humans, 
including bacteraemia and a strong proinflammatory host response (‘cytokine storm’), 
which are associated with early lethality of the zebrafish embryos90,91. The life cycle of S. 
typhimurium has been well characterised in infected cell cultures and in mammalian 
systems: the pathogen is able to alternate phases of intracellular replication within 
phagocytes and extracellular growth within the damaged tissue92,93. Similar observations 
have been made in the zebrafish embryo model. S. typhimurium, like M. marinum, can 
survive intracellularly in macrophages of zebrafish embryos (Figure 3B), but infected cells 
do not disseminate into tissues. Instead, following intravenous injection, the infection 
remains restricted to the vasculature, with bacteria multiplying both in macrophages and 
extracellularly at the epithelium of blood vessels90. Although infection with wildtype 
bacteria causes early lethality, bacteria with mutations in lipopolysaccharide (LPS) are 
attenuated in macrophages and are more sensitive to extracellular lysis, likely due to 
complement factors90. 
 
In sharp contrast with M. marinum infection, S. typhimurium infection leads to a cytokine 
storm within hours after intravenous injection2,91,94. At the transcriptional level, this 
response is similar to that observed in infection with the natural fish pathogen Edwardsiella 
tarda85. This proinflammatory transcriptional response provides a useful readout for 
characterising the consequences of mutation or knockdown of host genes involved in the 
immune response. Deficiencies in the TLR signalling components Myd88 and Traf6 
strongly reduce expression of transcriptional regulators, signalling components and 
effectors of the immune response85,95. Conversely, these gene groups are hyper-induced 
following knockdown of the protein tyrosine phosphatase Shp1 (also known as Ptpn6)96. 
These observations are consistent with the function of these genes in mammalian animal 
models and human patients, where MYD88 and TRAF6 mutations are associated with 
immunodeficiencies and SHP1 mutations cause inflammatory phenotypes and autoimmune 
defects. Control of S. typhimurium and other infections in zebrafish is impaired both under 
conditions of a reduced or hyper-induced immune response, indicating the importance of 
highly balanced regulatory mechanisms85,96. Micro-RNAs (miRNAs), including members 
of the miR-146 family, have been implicated in fine-tuning of the mammalian innate 
immune response and, in zebrafish embryos, miR-146 is induced by S. typhimurium in a 
Myd88-Traf6-dependent manner. Although no major effects on known targets of the 
Myd88-Traf6 pathway were observed, apolipoprotein-mediated lipid transport emerged as 
a newly identified infection-inducible pathway under control of this miRNA family97. 
 
The signals involved in recruitment of phagocytes to local infection remain to be 
elucidated. Chemokines, such as Cxcl8 (Il8) and the orphan ligand Cxcl-c1c/Cxcl18b, are 
highly induced rapidly upon S. typhimurium infection91. Using other bacterial infection 
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models, the function of the CXCL8-CXCR2 signalling axis in neutrophil recruitment has 
been shown to be conserved in zebrafish55,57. Local S. typhimurium infection has also been 
shown to induce the recruitment of macrophages via the chemokine receptor Cxcr3.2, one 
of the zebrafish orthologues of human CXCR346. The ligand association of Cxcr3.2 
remains to be established. 
 
In addition to phagocyte recruitment, localised infection also triggers emergency-driven 
haematopoiesis62. Early neutropaenia is a frequent outcome of S. typhimurium hindbrain 
infection in zebrafish embryos and this is compensated for by increased granulopoiesis. 
The activity of iNOS (and thus the production of the pleiotropic mediator nitric oxide), was 
found to be necessary to stimulate the expansion and proliferation of HSPCs in response to 
infection-dependent neutropaenia. The induction of iNOS is dependent on expression of 
the transcription factor C/ebpβ (CCAAT enhancer-binding protein β) in HSPCs. This is 
suggested to be an effect of elevated circulating levels of Gcsf (Granulocyte colony 
stimulating factor), produced by activated macrophages at the infection site62. 
 
The S. typhimurium infection model has recently led to new insight into the connection 
between infection control and host cell metabolic modulation63. Profound adaptations in 
glucose and lipid metabolism occur within infected immune cells. For example, in response 
to stimulation by Salmonella pathogenic factors, macrophages increase their uptake of 
lipids to fuel ROS production63. In line with this, S. typhimurium infection induces the 
expression of the mitochondria-associated enzyme Irg1 (Immunoresponsive gene 1) within 
infected zebrafish macrophages. This protein directs the catabolism of fatty acids to sustain 
mitochondrial oxidative phosphorylation and in turn leads to the production of 
mitochondrial ROS, contributing to intracellular degradation of phagocytosed bacteria. Irg1 
holds promise as a new therapeutic target at the interface of inflammation and 
metabolism62 (Table 1). 
 
Burkholderia cenocepacia 
The B. cepacia complex (Bcc) is represented by several closely related Gram-negative 
species that are able to survive freely in the environment or replicate within different hosts, 
including amoebae, invertebrates, vertebrates and plants98. In humans, opportunistic 
infection by Bcc frequently occurs in cystic fibrosis or immunocompromised individuals 
and represents a recurrent cause of fatal complications99. The capability to survive and 
infect a wide range of hosts suggests that Bcc species are highly adaptable to different 
niches and produce multiple virulence factors; however, the complex mechanisms of host-
pathogen interactions underlying infections with B. cenocepacia and other Bcc strains 
remain largely unknown. In particular, it has been difficult to establish conclusively 
whether B. cenocepacia can survive intracellularly. Visualising infection in zebrafish 
embryos helped to answer this key question, by demonstrating the ability of this pathogen 
to survive within macrophages (Figure 3C). Following the creation of an intramacrophage 
replication niche, the bacterial infection disseminates by non-lytic expulsion from infected 
cells, induces immune cell aggregations and ultimately causes fatal systemic 
bacteraemia100. 
 
The zebrafish model system has also provided a valuable contribution to the investigation 
of the in vivo relevance of several B. cenocepacia virulence factors. A quorum-sensing-
deficient cepR strain was shown to be strongly attenuated, indicated by a reduced ability to 
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replicate intracellularly and to disseminate efficiently from infected macrophages. 
Furthermore, differences in virulence were observed between strains from a panel of 
clinical isolates100. Loss of the third replicon, pC3 (a non-essential megaplasmid associated 
with several virulence determinants), results in highly attenuated infection in multiple 
hosts, including zebrafish embryos101,102. Mutants in pC3 are not able to grow significantly 
in vivo but are not eradicated, suggesting that the pC3-linked virulence factors are 
dispensable for intramacrophage survival101. A function in adaptation to a wide range of 
environments, rather than a direct role in modulating intracellular growth, might explain 
the prevalence of the pC3 replicon among Bcc isolates102. 
 
Together, these studies demonstrate the usefulness of the zebrafish model for analysis of B. 
cenocepacia mechanisms of intracellular survival and virulence. 
 
Staphylococcus aureus 
S. aureus is the causative agent of a wide range of infectious pathologies such as sty, 
pneumonia, endocarditis, osteomyelitis and septicaemia103, which remain important causes 
of morbidity and of complications in hospitalised patients. Although not a natural pathogen 
of zebrafish, both embryos104 and adults105 exhibit clear acute symptoms when infected 
with this Gram-positive pathogen, providing a useful model for bacteraemia (Figure 3D). 
 
S. aureus has long been considered an extracellular pathogen, but there is accumulating 
evidence that it can also survive and replicate in phagocytes106. The zebrafish embryo 
model has contributed significantly to our understanding of the nature and relevance of the 
intracellular phase in the life cycle of this pathogen47,104. Live imaging showed that, upon 
intravenous infection, S. aureus is completely phagocytosed by macrophages and 
neutrophils104,107. Although some embryos clear the infection in a phagocyte-dependent 
manner, other embryos develop overwhelming infection, indicating that the bacteria can 
subvert the phagocyte-killing mechanisms47. 
 
When larvae are co-infected with two isogenic, but differently labelled, S. aureus clones, 
the infection evolves by forming focal lesions that are predominantly monoclonal and, 
during the course of overwhelming infection, the ratio between the original strains is often 
skewed towards one predominating strain47. This phenomenon is fully dependent on 
phagocyte activity. These data suggest that most of the phagocytes are able to clear the 
infection but a population of phagocytes provides an intracellular protective niche in which 
some bacteria gain the ability to replicate and resist, to ultimately be released and 
disseminate. Consistent with this, co-infection in a murine sepsis model resulted in kidney 
abscesses that contained predominantly one strain of S. aureus and thus were likely 
founded by single bacteria108. The relevance of this work for clinical treatments is 
underscored by a recent study showing that the use of sub-curative antibiotic doses can 
support the preferential expansion of antibiotic-resistant bacteria during a mixed 
infection109. Selective ablation of macrophages or neutrophils in the zebrafish model has 
revealed that neutrophils are most likely to form the privileged niche responsible for 
disseminated infection of S. aureus104. Interesting remaining questions include elucidation 
of the mechanisms by which some bacteria from the initial inoculum are able to avoid 
being killed by neutrophils and determination of whether S. aureus can also resist 





S. flexneri, a human-adapted Escherichia coli species, is a causative agent of diarrhoea and 
dysentery in humans, generally deriving from orofaecal contaminations. Like other 
enterobacteria, it mostly affects the digestive tract; however, in advanced infectious stages, 
it can lead to bacteraemia and systemic sepsis. In the early phase of infection, the pathogen 
can interact with membranes of host cells, inject virulence determinants and induce ruffling 
and internalisation40. In this actively induced ingestion mechanism resides its capability to 
establish intracellular infection in non-phagocytic cells, such as epithelial cells associated 
with the digestive tract. Once it is internalised, it can escape from phagosomes and survive 
freely in the cytosol. Subsequently, the pathogen can spread through intestinal epithelial 
cells by actin-based motility (Figure 3E). Microfold cells allow Shigella to transverse the 
intestinal epithelium, where they encounter macrophages. Death of infected macrophages 
and subsequent destabilisation of the epithelium due to inflammation allows more Shigella 
to infiltrate the tissue and invade epithelial cells through the basal membrane. Survival and 
replication in macrophages, eventually followed by macrophage pyroptosis, is fundamental 
to allowing dissemination and extensive colonisation of the intestinal epithelium111. 
 
Recently, a zebrafish model for S. flexneri was established and this has been used to show 
that intravenously administrated bacteria can survive and replicate both in macrophages 
and in non-immune cells86. The pathogenicity of Shigella is highly dependent on the 
presence of T3SS virulence factors and avirulent strains can be successfully combated by 
the zebrafish innate immune system and are not able to induce phagocytosis in non-
phagocytic cells. Live imaging shows that replication of S. flexneri in macrophages 
ultimately induces cell death, whereas bacteria are more efficiently contained and degraded 
within neutrophils. Neutrophils also act as scavengers, eliminating infected dead cells. 
Macrophages are not able to retain the infection within vacuoles and bacteria spread into 
the cytosol, where they can colocalise with actin and septin cages (Figure 3E). 
 
In mammalian cultured cells, cytosolic S. flexneri can be targeted for autophagy via both 
ubiquitin-dependent and -independent pathways, and, as a counteractive mechanism, the 
bacteria can secrete virulence factors to escape autophagy41,112. Colocalisation with the 
autophagy marker Lc3 followed by electron microscopic analysis in the zebrafish model 
confirmed that autophagy targeting is associated with entrapment of S. flexneri in septin 
cage-like structures33,86. Reduction of autophagy, via knockdown of the autophagy-related 
receptor p62, increases the infection burden of zebrafish larvae and this effect is specific 
only for the T3SS-positive strain that is able to escape into the cytosol86. These data 
support the hypothesis that antibacterial protection provided by efficient autophagic 
machinery is essential to properly counteract S. flexneri infection. The ability to monitor S. 
flexneri infection in a transparent zebrafish host provides new possibilities to assess the 
relevance of autophagy in vivo in immune and non-immune cells, and to develop new 
strategies for anti-bacterial therapies targeting this process (Table 1). 
 
Candida albicans 
C. albicans is an opportunistic dimorphic fungus that grows in yeast and hyphal forms113. 
Most of the human population carries C. albicans as a harmless constituent of the 
epidermal, mucosal and intestinal flora. However, uncontrolled systemic candidiasis and 
fungal growth on the mucosal surfaces can cause severe and life-threatening infectious 
complications, particularly in immunocompromised individuals. In zebrafish embryos, as 
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in humans, C. albicans can be phagocytosed by both neutrophils and macrophages114,115. 
Live observations reveal that, in a non-compromised zebrafish host, this intracellular 
localisation leads to a transitory standoff phase in which the yeast form survives and 
replicates, but does not germinate or lyse the host cell (Figure 3F). Subsequently, the fungi 
switch to the more virulent hyphal form and proliferate exuberantly in individuals that fail 
to contain the infection, whereas they revert to the yeast form in most surviving 
embryos115. Intracellular yeast forms are unable to undergo the yeast-to-hyphal transition, 
even under conditions of impaired oxidative-stress response, in contrast with previous in 
vitro data in which filamentous growth was observed within cultured macrophages116. 
Therefore, macrophages apparently have an enhanced ability to control infection in the in 
vivo environment. 
 
Although germination was shown to be independent of the phagocyte-specific NADPH 
oxidase (PHOX), this enzyme was found to be essential to produce an efficient oxidative-
stress response against C. albicans and to control filamentous growth115,116. Previously, the 
limitation of fungal growth was ascribed mainly to direct fungal destruction by ROS; 
however, imaging in zebrafish revealed a non-canonical role for PHOX and for the 
epithelial dual NADPH oxidase (DUOX) in recruitment of phagocytes to C. albicans 
infection sites. Therefore, impaired phagocyte recruitment to invading Candida under 
conditions of NADPH oxidase deficiency seems to be the cause of the overall reduction in 
containment of the infection and, consequently, of massive extracellular hyphal growth. 
Although localised infection with wildtype C. albicans is unable to induce chemoattraction 
under conditions of NADPH oxidase deficiency, infection with a yeast-locked mutant 
strain (edt1Δ/Δ) can be efficiently counteracted by phagocyte recruitment and 
internalisation, even in pan-NADPH-oxidase-depleted conditions. This suggests that the 
hyphal transition (or another edt1-associated program) is also able to attenuate ROS-
independent phagocyte recruitment, thus explaining the relevance of host ROS-driven 
chemoattraction mechanisms to counteract C. albicans infection116. 
 
CONCLUDING REMARKS 
The study of intracellular pathogens in zebrafish macrophages has led to new mechanistic 
insights that are inspiring novel host-directed therapeutic strategies (Table 1). The real-
time imaging possibilities in zebrafish will also be very useful for elucidating the 
mechanisms underlying macrophage migration processes, as has already been 
demonstrated by the study of neutrophils in the larval system6,7,55. A question that is very 
relevant both for infectious diseases and for cancer biology concerns the presence of 
different pro- and anti-inflammatory macrophage subtypes in zebrafish. Classically 
activated (M1) and alternatively activated (M2) macrophages, resembling the phenotypes 
of mammalian macrophages, have been identified in different fish species117. That different 
macrophage subtypes might already be present in early zebrafish larvae has been 
suggested, but this remains to be further investigated118. The early larval stages, which are 
optimally suited for imaging and for genetic and pharmacological interventions, can give 
much information on the intracellular survival mechanisms of pathogens, as demonstrated 
by the studies discussed herein. The early larval stages are also very useful for studying the 
response of microglia to brain injuries or infection, contributing to a deeper understanding 
of the role of these specialised macrophages in neurodegenerative diseases67,119. Studying 
the antigen-presentation function of macrophages and DCs at later developmental stages is 
becoming increasingly feasible owing to advances in technologies for generating stable 
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mutant lines120,121,122. Dynamic interactions between macrophages and neutrophils that are 
emerging from recent studies in zebrafish are of considerable interest for further 
study44,56,65. The use of the zebrafish model has already provided insights into the in vivo 
relevance of intracellular defence mechanisms such as ROS and RNS production and 
autophagy. We expect that further use of this powerful model will continue to make 
important contributions towards the understanding of innate immunity and of the virulence 
strategies that pathogens use to subvert innate host defences. 
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Tg(lyz:eGFP)	 Neutrophils(b)	 -11	kb	of	lyz	upstream	the	translation	start	 125	
Tg(lyz:DsRed2)	 Neutrophils(b)	 -6.35	kb	of	lyz	upstream	the	translation	start	 125	























Tg(mpeg1:mCherry-F)	 Macrophages	 -1.86	kb	of	mpeg1	upstream	the	translation	start	 61	
Tg(mpeg1:Dendra2)	 Macrophages(e)	 As	in	ref.44	 129	





































































Tg(-4spi1b:lyn-eGFP)	 Early	myeloid	cells(g)	 As	in	ref.60	 46	
	
Supplementary	 Table	 1.	 Zebrafish	 fluorescent	 reporter	 lines	 for	 immune	 cells	 (continued	 from	 the	
previous	 page).	 Notes:	 (a) Expression in macrophages, neutrophils and thymocytes was shown for 
embryonic and young larval stages. Expression in myelomonocyte progenitors in head-kidneys of 
adults was also documented; (b) Discrepancies about expression of the construct in primitive 
macrophages reported; (c) Observations limited to embryonic and early larval stage. Labelling of 
primitive macrophages was determined based on the presence of fluorescent cells over the yolk at 26 
hpf. Expression in macrophages from the second wave of primitive haematopoiesis and definitive 
haematopoiesis not demonstrated.	 (d)	 APCs	 are	 here	 indicated	 as	 macrophages,	 dendritic	 cells,	 B	
lymphocytes	 and	 eosinophils.	 Fluorescence	 visible	 from	 5dpf	 and	 abundantly	 labelling	 APCs	 only	 from	
12dpf;	expression	in	keratinocytes	reported	in	adults	and	juveniles;	(e)	Loss	of	expression	after	6	dpf	and	in	
the	 adults	 reported;	 labelling	 of	 Langerhans	 dendritic	 cells	 in	 larvae	 suggested;	 (f)	Existence	 of	 a	 set	 of	
GFPlow	 macrophage-like	 cells	 distinguishable	 by	 confocal	 microscopy	 reported	 by	 some	 laboratories;	 (g)	
























































































































HYPERLINK TO SUPPLEMENTARY MOVIES 
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The recruitment of leukocytes to infectious foci depends strongly on the local release of 
chemoattractant mediators. The human CXC chemokine receptor 3 (CXCR3) is an 
important node in the chemokine signalling network and is expressed by multiple 
leukocyte lineages, including T cells and macrophages. The ligands of this receptor 
originate from an ancestral CXCL11 gene in early vertebrates. Here, we used the optically 
accessible zebrafish embryo model to explore the function of the CXCR3-CXCL11 axis in 
macrophage recruitment and show that disruption of this axis increases the resistance to 
mycobacterial infection. In a mutant of the zebrafish orthologue of CXCR3 (cxcr3.2), 
macrophage chemotaxis to bacterial infections was attenuated, although migration to 
infection-independent stimuli was unaffected. Additionally, attenuation of macrophage 
recruitment to infection could be mimicked by treatment with NBI74330, a high-affinity 
antagonist of CXCR3. We identified two infection-inducible CXCL11-like chemokines as 
the functional ligands of Cxcr3.2, showing that the recombinant proteins exerted a Cxcr3.2-
dependent chemoattraction when locally administrated in vivo. During infection of 
zebrafish embryos with Mycobacterium marinum, a well-established model for 
tuberculosis, we found that Cxcr3.2 deficiency limited the macrophage-mediated 
dissemination of mycobacteria. Furthermore, the loss of Cxcr3.2 function attenuated the 
formation of granulomatous lesions, the typical histopathological features of tuberculosis, 
and led to a reduction in the total bacterial burden. Prevention of mycobacterial 
dissemination by targeting the CXCR3 pathway, therefore, might represent a host-directed 
therapeutic strategy for treatment of tuberculosis. The demonstration of a conserved 
CXCR3-CXCL11 signalling axis in zebrafish extends the translational applicability of this 













In	 zebrafish,	 the	 chemokine	 receptor	 Cxcr3.2	 is	 important	 to	 guide	 macrophage	 recruitment	 to	
mycobacterial	 infection	 foci,	 via	 infection-dependent	 induction	 of	 its	 ligands	 Cxcl11aa	 and	 Cxcl11af.	
Cxcr3.2	mutants	display	reduced	trafficking	of	macrophages	to	the	nascent	granuloma	lesions,	which	both	









the	 production	 of	 chemokines	 by	 the	 infected	 host.	 However,	 the	 role	 of	 chemokine	 signalling	 in	
mycobacterial	disease	remains	poorly	explored.	CXC	chemokine	receptor	3	(CXCR3)	is	an	important	node	
in	 the	 chemokine	 signalling	 network	 and	 has	 been	 extensively	 studied	 in	 T	 cells.	 Emerging	 evidence	




in	 macrophages	 during	 the	 early	 stages	 of	 mycobacterial	 infection.	 They	 found	 that	 mutation	 of	 a	
zebrafish	CXCR3	homologue	attenuates	the	 infection-dependent	recruitment	of	macrophages	and	 limits	








macrophage	 responses	 that	 drive	 the	 initiation	 and	 expansion	 of	 mycobacterial	 granulomas,	 the	
pathological	hallmark	of	tuberculosis	disease.	The	beneficial	effect	of	CXCR3	mutation	on	the	control	of	
mycobacterial	infection	in	the	zebrafish	host	should	drive	further	research	into	the	CXCR3-CXCL11	axis	as	
a	 potential	 target	 for	 host-directed	 therapy	 against	 tuberculosis.	 Research	 into	 such	 novel	 therapeutic	
approaches	is	important	in	view	of	the	increasing	prevalence	of	antibiotic-resistant	mycobacterial	strains.	






Macrophages are extremely dynamic phagocytic cells, able to integrate and respond to a 
wide spectrum of signals from infected tissues. A variety of receptors on their cell 
membrane can sense pathogen-associated molecular patterns (PAMPs), which induce the 
innate immune response1. Some of these PAMPs, such as N-formylated bacterial peptides, 
have direct chemoattractant activity on phagocytes2. Moreover, a crucial contribution to 
efficient phagocyte recruitment is provided by lipidic and peptidic chemoattractant factors, 
produced or activated directly by the host locally at the infection site3,4,5. In this group of 
compounds, the inflammatory chemokines play a major role. This subclass of small 
chemotactic proteins is induced upon infection and is able to exert target-specific activities 
towards subsets of leukocytes, both myeloid and lymphoid6. In humans, CXCL9 [also 
known as MIG (monokine-induced by IFN-γ)], CXCL10 [IP-10 (IFN-γ-inducible protein 
10)] and CXCL11 [I-TAC (IFN-inducible T cell α chemoattractant)] are IFN-inducible 
chemokines and mediate recruitment of T cells, natural killer (NK) cells and 
monocytes/macrophages at the infection site, predominantly through their cognate G-
protein coupled receptor, CXCR37,8. This signalling axis has been implicated in several 
physiological activities, including maturation of T cells and vasculogenesis9,10. 
Additionally, CXCR3 and its ligands have been linked to inflammatory and immune-
related diseases, of autoimmune9,11,12,13, infectious14,15,16,17 or malignant18,19,20,21 nature. 
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Most of the literature on mammalian systems focuses on the role of this receptor in 
maturation, priming, activation and migration of T cells9,11,22. However, recent studies have 
demonstrated that CXCR3 also plays an important role in directing macrophage activities, 
both under physiological and under pathological conditions10,20,23,24. 
 
The zebrafish embryo model provides a useful platform to study chemokine-dependent cell 
migration, combining excellent possibilities for intravital imaging with the availability of a 
vast array of genetic tools25. Homologous relationships between mammalian and zebrafish 
CXCR4-CXCL12 and CXCR2-CXCL8 receptor-ligand pairs have been well established 
and studies in zebrafish have contributed significantly to the understanding of the role of 
these signalling axes in developmental processes, neutrophil motility, long-range 
neutrophil mobilisation and infection-induced chemotaxis26,27,28,29,30. Based on phylogeny 
reconstructions, the CXCR3-CXCL11 axis emerged for the first time in a common ancestor 
of zebrafish and mammals31. In placental mammals, amphibians and reptiles, a single copy 
per haplotype of CXCR3 is generally present, whereas CXCR3 was lost in the divergence of 
avian and marsupial mammalian clades. Several teleost fish show an expansion of the 
CXCR3 family31,32,33, including zebrafish, where three copies, namely cxcr3.1 
(ENSDARG00000007358), cxcr3.2 (ENSDARG00000041041) and cxcr3.3 
(ENSDARG00000070669), are located in tandem on chromosome 1634. The CXCL9-
CXCL10-CXCL11 triplet of CXCR3 ligands in mammals is likely to have originated from a 
relatively recent common ancestor35. The situation in fish is variegated and, in some cases, 
specific expansions have taken place. In zebrafish, a cluster of seven putative cxcl11 genes, 
which are grouped together in a single locus on chromosome 5, share both homology and 
synteny with human CXCL1134. However, an association between the different isoforms of 
Cxcl11 ligands and Cxcr3 receptors has not been described, and the in vivo relevance of 
this signalling axis in the zebrafish model has not been addressed. 
 
In previous work we have shown that one of the three CXCR3 paralogues, cxcr3.2, is 
expressed in macrophages of 1-day-old zebrafish embryos36. In the present study, we used 
a cxcr3.2 mutant to investigate the role of Cxcr3 signalling in macrophage mobilisation and 
function. In agreement with previous morpholino knockdown results, the receptor loss-of-
function resulted in the attenuation of macrophage recruitment to local infection with 
Salmonella typhimurium. Moreover, we identified two infection-inducible CXCL11-like 
chemokines, which act as functional ligands of Cxcr3.2 with chemoattractant activity on 
macrophages. Finally, we demonstrate here that cxcr3.2 is required for efficient 
recruitment of macrophages to Mycobacterium marinum infection and for the 
dissemination of this pathogen into host tissues, which is driven by macrophages. The 
zebrafish-M. marinum host-pathogen pair is widely used to model human tuberculosis and 
has provided important insights into the interaction of mycobacteria with host 
macrophages37,38,39,40,41,42. M. marinum is closely related to the human pathogen 
Mycobacterium tuberculosis, and the zebrafish model replicates the formation of 
granulomas, the typical histopathological hallmark of human tuberculosis43,44. The results 
presented here demonstrate a novel function for the CXCR3-CXCL11 signalling axis in 
macrophage responses that drive the initiation and expansion of these granulomatous 





cxcr3.2 is expressed in phagocyte populations during zebrafish embryonic and larval 
development 
We previously reported that cxcr3.2 expression could be detected by fluorescent in situ 
hybridisation at 1 day post fertilisation (dpf) in phagocytes expressing the macrophage 
marker csf1r (colony stimulating factor 1 receptor) and not in cells positive for the 
neutrophil marker mpx (myeloperoxidase)36. However, we were unable to detect its 
expression with the same method at later stages. To determine whether cxcr3.2 continues to 
be expressed in macrophages during the embryonic and larval development, we analysed 
RNA expression levels from FACS-sorted mpeg1:mCherry-F+ and mpx:eGFP+ cells from 
the double-transgenic line Tg(mpeg1:mCherry-F/mpx:eGFP). These data show that 
macrophages (mpeg1:mCherry-F+ population) maintain cxcr3.2 expression at 2 and at 6 
dpf (Figure 1A–C and Supplementary Figure 1). Expression of cxcr3.2 could also be 
detected in neutrophils (mpx:eGFP+ population). In addition, cxcr3.3 could be detected in 
both phagocyte types, whereas cxcr3.1 was not specifically enriched in the sorted cell 
populations (Figure 1C and Supplementary Figure 1). 
 
The cxcr3.2hu6044 line carries a nonsense mutation in cxcr3.2 
Sequencing of an ENU (N-ethyl-N-nitrosourea)-mutagenised zebrafish library resulted in 
the identification of a cxcr3.2 mutant allele, cxcr3.2hu6044, which carries a T-to-G 
(deoxythymidine to deoxyguanosine) substitution, creating a premature stop codon. This 
mutation leads to the interruption of the protein translation after 15 amino acids, before the 
region that encodes all the transmembrane domains that are essential for the function of the 
receptor (Figure 1D and Supplementary Figure 2). The nonsense cxcr3.2hu6044 mutation is 
not likely to lead to a functional truncated protein by using a downstream AUG codon as a 
signal for translation initiation. The second AUG in frame is located 354 nucleotides (118 
amino acid residues) downstream from the canonical start codon and use of this codon as a 
translation start would lead to a truncated product lacking both the most N-terminal 
extracellular domain and the first two transmembrane domains. Furthermore, because the 
mutation occurs downstream of all the splicing sites, the possibility of alternative splicing 
and/or altered pre-RNA maturations seems unlikely and this was excluded by sequencing 
of the cDNA of cxcr3.2 in mutants and wildtypes (wt). The cxcr3.2 locus is closely linked 
to the loci of cxcr3.1 and cxcr3.3 owing to their chromosome proximity. To evaluate the 
presence of additional alterations in these genes as a consequence of the ENU mutagenesis, 
we sequenced their genetic loci in the AB/TL wt strain in our facility (used to outcross the 
mutant) and in two families of cxcr3.2+/+ and cxcr3.2−/− fish. We did not identify additional 
nonsense mutations, although we could detect several non-synonymous single-nucleotide 
polymorphisms (nsSNPs), which are described in Supplementary Table 1. However, all 
the nsSNPs that were found in the cxcr3.2−/− line were also present in the AB/TL fish line, 
indicating that these changes are likely to be natural wt polymorphisms and not an effect of 
the ENU mutagenesis. To address the possible relevance of these nsSNPs with respect to 
the protein function, we used the PROVEAN software tool (Protein Variation Effect 
Analyser; http://provean.jcvi.org)45,46. None of the nsSNPs was predicted to impact on the 
protein functionality (Supplementary Table 1). Therefore, it is unlikely that single amino 
acid replacements in the protein sequences of Cxcr3.1 or Cxcr3.3 would affect the 












Figure	 1.	 Characterisation	 of	 cxcr3.2−/−	 embryos	 in	 unchallenged	 conditions	 (Figure	 on	 the	 previous	
page).	 A–C.	 Expression	 of	 cxcr3.2	 and	 its	 paralogues	 cxcr3.1	 and	 cxcr3.3	 in	 FACS-sorted	 phagocytes.	
Graphs	represent	the	relative	induction	fold	of	the	macrophage	marker	mpeg1	(A),	the	neutrophil	marker	
mpx	(B),	and	of	the	cxcr3	paralogues	(C)	in	FACS-sorted	macrophages	and	neutrophils	from	the	combined	
transgenic	 line	 Tg(mpeg1:mCherry-F/mpx:eGFP)	 at	 2	 dpf.	 Expression	 of	 cxcr3.2	 and	 cxcr3.3	 could	 be	
detected	 in	 both	 macrophages	 and	 neutrophils,	 whereas	 cxcr3.1	 was	 not	 significantly	 enriched	 in	 the	
FACS-sorted	 populations	 when	 compared	 with	 the	 non-labelled	 cell	 fraction.	 Sample	 size	 (n):	 five	
replicates.	Errors	bars:	mean±s.e.m.	Reference	gene:	eif4a1b.	D.	Effect	of	the	cxcr3.2	point	mutation.	Top:	
gene	 structure	 of	 cxcr3.2.	 Boxes	 represent	 exons,	 of	 which	 the	 grey	 parts	 correspond	 to	 the	 coding	
sequence.	Bottom	right:	cxcr3.2	wildtype	(wt)	and	mutant	allele.	A	single	T-to-G	mutation	at	nucleotide	48	
generates	 an	 early	 stop	 codon.	 Bottom	 left:	 consequence	 of	 cxcr3.2	mutation	 at	 the	 protein	 level.	 In	
cxcr3.2	 mutant	 zebrafish,	 only	 a	 peptide	 of	 15	 amino	 acids	 can	 be	 translated,	 which	 lacks	 all	 the	
conserved	transmembrane	domains	(TM1-7).	Nucleotide	and	amino	acid	positions	are	enumerated	from	
the	 translation	 start	 codon.	E.	 Normal	 viability	 of	 cxcr3.2−/−	mutants.	 Percentage	 of	 genotypes	 deriving	





and	cxcr3.2−/−	embryos	at	3	dpf	and	the	numbers	of	stained	cells	 residing	 in	 the	caudal	haematopoietic	
tissue	were	counted.	Exclusively	Lp-stained	cells	were	considered	as	macrophages	(F)	and	Lp/Mpx	double-
positive	cells	as	neutrophils	(G).	No	significant	differences	were	detected.	Total	number	of	larvae	(n)	per	
group	 in	 both	 F	 and	 G:	 15.	 Error	 bars:	 median	 and	 interquartile	 range.	 H-I.	 Spatial	 distribution	 of	
macrophages.	 A	 macrophage-specific	 transgenic	 reporter	 driven	 by	 the	 mpeg1	 promoter	








average	 speed	 of	 individual	 macrophages	 was	 calculated	 by	 tracking	 15–21	 macrophages	 from	 three	




cxcr3.2 mutation does not affect macrophage development but alters their basal 
motility 
Crossing of heterozygous cxcr3.2hu6044 carriers generated homozygous embryos in 
Mendelian proportions with their heterozygous and wt siblings. Screening of the adult 
offspring from a heterozygous incross showed that, in laboratory conditions, cxcr3.2−/− fish 
do not exhibit differences in survival and development compared with their wt siblings 
(Figure 1E) and could only be distinguished by genotyping. 
 
Based on combined immunostaining for the pan-leukocyte marker Leukocyte-plastin (Lp) 
and Mpx activity staining47, cxcr3.2−/− embryos showed similar numbers of macrophages 
and neutrophils as their wt siblings (Figure 1F-G). With the aim of investigating the 
relevance of cxcr3.2 expression in macrophage behaviour, we crossed the cxcr3.2 mutation 
into the Tg(mpeg1:Gal4/UAS:Kaede) background. Labelled macrophages showed similar 
numbers and spatial distribution in mutant and wt (Figure 1H-I). However, a basal 
macrophage migratory deficiency was observed in the mutants (Figure 1J–L and 
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Supplementary Movies 1-2). The aberrant motility might be explained by the presence of 
constitutive quantities of Cxcr3.2 ligands in the macrophage microenvironment, which 
could contribute to a higher basal activity of cxcr3.2+/+ macrophages. 
 
Mutation of cxcr3.2 does not affect chemoattraction of macrophages byCxcr3.2-
independent factors 
To test whether the basal motility defect of cxcr3.2−/− macrophages affected the stimulus-
directed chemoattraction to cxcr3.2-independent factors, we locally injected the 
chemoattractant factors leukotriene B4 (LTB4) and N-formyl-methionyl-leucyl-
phenylalanine peptide (fMLP) into the hindbrain ventricle of embryos at 30 hpf (hours post 
fertilisation). At this developmental stage, the neutrophil population is not fully 
differentiated48,49 and the population of phagocytes infiltrating the hindbrain upon 
chemotactic stimulation consists predominantly of macrophages (Supplementary Figure 
3); therefore, we could use Lp immunostaining to identify recruited macrophages. No 
significant difference was observed in the numbers of cxcr3.2+/+ and cxcr3.2−/− 
macrophages accumulated to either stimuli in 3 hours (Figure 2A–H). In addition, we also 
employed a previously described chemically induced inflammation (ChIn) assay50, using 
copper sulphate treatment of embryos at 3 dpf to induce acute inflammation of lateral line 
neuromast hair cells. At this stage, macrophages were counted as Lp-positive and Mpx-
negative cells using the combined Lp/Mpx staining. Also in this assay, no significant 
difference in the numbers of macrophages recruited to the inflamed neuromasts was 
observed between cxcr3.2+/+ and cxcr3.2−/− larvae (Figure 2I). Therefore, we concluded 
that cxcr3.2 mutation does not affect the capability of macrophages to respond to 
stimulatory sources independent of Cxcr3.2 signalling and that the basal motility defect 
does not influence the experimentally induced macrophage recruitment. 
 
Early migration of macrophages to localised infection is affected by mutation of 
cxcr3.2 or treatment with a CXCR3 antagonist 
To determine whether Cxcr3.2 signalling contributes significantly to the recruitment of 
macrophages to different types of bacterial infections, we injected either M. marinum or S. 
typhimurium into the hindbrain ventricle of embryos at 30 hpf. In both infection models, a 
significant reduction of the number of macrophages accumulating at the infected site was 
detected in cxcr3.2−/− embryos at 3 hpi (hours post injection) (Figure 3A). A similar 
reduction of macrophage recruitment was also observed when M. marinum was locally 
injected into the otic vesicle at 3 dpf (Figure 3B). To visualise the dynamics of the 
macrophage migration in vivo, we used the combined mutant-transgenic line 
Tg(mpeg1:Gal4/UAS:Kaede)/cxcr3.2−/− and followed the early response of mpeg1-positive 
cells to M. marinum infection in the otic vesicle of 4 dpf larvae by confocal time-lapse 
imaging. In agreement with the previous results, a difference in the trend of macrophage 
recruitment was observed between the mutant and the wt over a time course of 5 hours 
(Figure 3C-H, Supplementary Movies 3-4). Furthermore, at locations distal from the 
infection site, macrophages in wt larvae showed more frequently an activated morphology 
with formation of branched protrusions (Figure 3E) when compared with the mutant line 
(Figure 3H). To quantify this phenomenon, we classified the distal macrophages of locally 
infected larvae according to their circularity index (CI), which estimates by an index 









Figure	 2.	 Macrophage	 chemoattraction	 by	 Cxcr3.2-independent	 factors.	 A–H.	 Chemoattraction	 of	
macrophages	 by	 LTB4	 and	 fMLP.	 cxcr3.2+/+	 (A–C)	 and	 cxcr3.2−/−	 (D–F)	 embryos	 at	 30	 hpf	 were	 locally	
injected	into	the	hindbrain	cavity	with	10.1	ng/ml	(30	nM)	LTB4	(representative	images	B	and	E)	or	with	
0.2	mg/ml	(0.5	mM)	of	fMLP	(representative	 images	C	and	F).	Mock	control	 injections	with	the	solvents	
were	 0.02%	 EtOH	 in	 PBS	 for	 the	 LTB4	 treatment	 and	 5%	 DMSO	 in	 PBS	 for	 the	 fMLP	 treatment	
(representative	 images	 A	 and	 D).	 Lp-stained	 cells	 accumulated	 in	 3	 hours	 within	 the	 hindbrain	 limits	






chemically-induced	 inflammation.	 Copper	 sulphate	 treatment	 was	 performed	 on	 3	 dpf	 embryos	 and	
macrophages	accumulated	in	3	hours	at	the	damaged	neuromasts	of	the	lateral	line	were	counted	as	Lp-










Figure	 3.	 Cxcr3.2-dependent	 macrophage	 recruitment	 to	 localised	 bacterial	 infections	 (Figure	 on	 the	








following	 M.	 marinum	 infection	 in	 the	 otic	 vesicle.	 Tg(mpeg1:Gal4/UAS:Kaede)	 cxcr3.2+/+	 and	
Tg(mpeg1:Gal4/UAS:Kaede)	 cxcr3.2−/−	 larvae	 were	 injected	 with	 200	 CFU	 of	M.	marinum	 into	 the	 otic	
vesicle	 (dotted	 line)	 at	 3	 (B)	 or	 4	 (C–H)	 dpf.	 At	 4	 hpi	 of	 3	 dpf	 larvae,	 the	 accumulation	 of	
mpeg1:Gal4/UAS:Kaede-positive	 cells	within	 the	 perimeter	 of	 the	 otic	 vesicle	was	 reduced	 in	 cxcr3.2−/−	
larvae	 (B).	 Following	 injection	 at	 4	 dpf,	 macrophages	 are	 less	 able	 to	 penetrate	 the	 otic	 vesicle,	 but	
accumulate	 in	 the	surrounding	area	 (white	arrows	 in	D	and	G),	as	 shown	 in	 representative	 time	course	
movies	(Supplementary	Movies	3-4)	and	stills	from	these	movies	at	1	hpi	(C,F)	and	5	hpi	(D,G).	A	reduced	
accumulation	was	observed	 in	 the	 cxcr3.2	mutant.	At	 a	 distal	 location	 in	 the	 trunk	 (E,H),	macrophages	
seemed	 to	 show	 more	 frequently	 a	 branched	 morphology	 in	 cxcr3.2+/+	 and	 a	 round	 morphology	 in	
cxcr3.2−/−	 (black	 arrows	 in	 E	 and	 H).	 Sample	 size	 (n)	 in	 B:	 28,	 21.	 Error	 bars:	median	 and	 interquartile	





in	 the	 different	 intervals	 of	 CI,	whereas	 the	 graph	 in	 J	 represents	 the	 divergence	 in	 distribution	 of	 the	
cxcr3.2+/+	 and	cxcr3.2−/−	macrophages	 in	 the	different	 classes	of	CI,	 calculated	as	 the	 ratio	between	 the	
percentage	 of	 cxcr3.2+/+	 or	 cxcr3.2−/−	 macrophages	 in	 a	 certain	 CI	 interval	 and	 the	 overall	 mean	
percentage	[(mutant	+	wt)/2]	of	macrophages	in	that	interval	(see	Materials	and	Methods).	Macrophages	
of	cxcr3.2+/+and	cxcr3.2−/−	 larvae	were	distributed	 in	a	different	 fashion	along	the	different	classes,	with	
the	classes	of	high	circularity	more	populated	in	the	mutants	and	the	classes	of	reduced	circularity	more	
populated	 in	 the	wildtype	 (wt).	K	and	L	show	representative	macrophages	analysed	 in	 I	and	 J	and	their	





injected	 in	 the	 hindbrain	 ventricle	 at	 30	 hpf	 with	 mock	 or	 200	 CFU	 of	Mm.	 Embryos	 were	 kept	 in	
NBI74330	 or	 vehicle	 medium	 for	 an	 additional	 3	 hours	 and	 then	 collected	 for	 Lp	 immunostaining.	
Treatment	 with	 NBI74330	 reduced	 the	 macrophage	 chemotaxis	 to	 infection	 in	 cxcr3.2+/+	 embryos	 to	
similar	 levels	 as	 the	 vehicle-treated	 cxcr3.2−/−	 embryos,	 and	 no	 significant	 additive	 effect	 of	 cxcr3.2	




The different intervals of circularity were differently populated in wt and mutant larvae, 
with the classes of reduced circularity (0 to 0.4) being more populated in cxcr3.2+/+ larvae 
and the classes of higher circularity (0.6–0.8) being more populated in cxcr3.2−/− larvae 
(Figure 3I–L). These results provide evidence that the Cxcr3.2-dependent signalling 
pathway mediates a significant component of the macrophage recruitment to pathogens in 
the early phase of the infection. To determine whether the infection-dependent macrophage 
recruitment can also be modulated pharmacologically, we tested a chemical inhibitor of 
human CXCR3, NBI7433051, which binds with high affinity to a pocket formed by the 
transmembrane domains of CXCR3. Key amino acid residues in this pocket are conserved 
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between the human and the zebrafish receptors (Supplementary Figure 4). Treatment 
with this CXCR3 antagonist attenuated the macrophage recruitment to local M. marinum 
infection in cxcr3.2+/+ embryos to a similar level as that of the vehicle-treated cxcr3.2−/− 
embryos and did not show a cooperative effect with the cxcr3.2 mutation (Figure 3M). 
These results support the conservation of CXCR3 signalling between fish and mammals. 
 
A group of CXCL11-like chemokines are inducible upon local and systemic infection 
in zebrafish 
Although our analysis of the cxcr3.2 mutant supports the role of Cxcr3.2 in macrophage 
chemotaxis to infections, the chemokine ligands that signal via this receptor are unknown. 
The assignment of ligand-receptor pairs is complicated by the relatively poor conservation 
of chemokine sequences among vertebrates and the species-specific expansions of the 
chemokine gene clusters34. However, systematic study of the orthologous relationships 
between vertebrate chemokines indicated that seven CXCL11-like chemokine genes, 
located in tandem on chromosome 5 (cxcl11aa, cxcl11ac, cxcl11ad, cxcl11ae, cxcl11af, 
cxcl11ag, cxcl11ah), have evolved in zebrafish as a counterpart to the mammalian CXCL9, 
CXCL10 and CXCL11 genes34. The amino acid similarity between the CXCL11-like 
chemokines in zebrafish and human CXCL11 exceeds the similarity that human CXCL9, 
CXCL10 and CXCL11 show among each other (Supplementary Figure 5; 
Supplementary Table 2). We, therefore, considered the zebrafish CXCL11-like 
chemokines as putative ligands for the Cxcr3.2 receptor. Because Cxcr3.2 was clearly 
involved in the early phase of the infection response, we reasoned that the ligands that 
induce Cxcr3.2-mediated chemotaxis should be promptly upregulated upon local infection. 
For this reason, we collected RNA samples from whole embryos infected in the hindbrain 
with 200 colony-forming units (CFU) of either S. typhimurium or M. marinum at 1 and 3 
hpi and designed gene-specific primers for the members of the cxcl11 gene cluster. 
Because of the high level of sequence conservation between cxcl11af and cxcl11ag (only 2 
bp difference on the cDNA leading to a single semiconservative residue change of an 
aspartic acid with a glutamic acid), a promiscuous primer pair was used that can amplify 
both gene transcripts (cxcl11af/ag). Analysis by qRT-PCR revealed that, at 1 hpi, 
cxcl11af/ag showed twofold upregulation with M. marinum infection and fourfold 
upregulation with S. typhimurium infection, although no statistical significance was 
observed compared with the mock-injected controls (Figure 4A). At 3 hpi the expression 
of cxcl11aa, cxcl11ae and cxcl11af/ag was significantly upregulated to levels of two- to 
4.5-fold (Figure 4B). In particular, cxcl11aa displayed the highest levels of induced 
transcription (~4.5-fold induction) with both the pathogens tested, suggesting this 
chemokine as an effective signalling ligand of Cxcr3.2 involved in the response to 
infection. We verified that the genes induced by local infection were also responsive to 
systemic infection with M. marinum. Upregulation of cxcl11aa and cxcl11ae was detected 
both at 4 hpi and at 4 dpi (days post injection) during M. marinum systemic infection, 
whereas cxcl11af/ag was significantly induced to levels of ~fourfold only at the later stage 
of infection (Figure 4C-D). Additionally, at this time point, cxcl11ac and cxcl11ad were 








30	 hpf	 or	 mock-injected	 with	 PBS	 were	 collected	 at	 1	 hpi	 (A)	 and	 3	 hpi	 (B).	 A	 subset	 of	 CXCL11-like	
chemokine	genes	shows	upregulation	by	qPCR	in	the	infected	groups,	which	becomes	significant	at	3	hpi.	





Recombinant Cxcl11aa and Cxcl11af exert macrophage chemoattraction in vivo in a 
Cxcr3.2-dependent manner 
To assess the chemoattractant properties of the infection-inducible chemokines Cxcl11aa, 
Cxcl11af and Cxcl11ae, we used Pichia pastoris strain X-33 to express recombinant 
proteins. As a control, we also expressed zebrafish Cxcl8a (Il8), known to be a potent and 
neutrophil-specific chemoattractant27,29. All three purified CXCL11-like chemokines 
showed chemoattractant capabilities towards macrophages when locally injected in vivo 
into the hindbrain at 30 hpf (Figure 5), whereas no significant macrophage recruitment 
was exerted by Cxcl8a (Supplementary Figure 6). Similar levels of these chemokines 
were injected in the otic vesicle at 54 hpf to evaluate their chemoattractant capabilities 
towards neutrophils (Supplementary Figure 6B-C). Cxcl11aa and Cxcl11af did not show 
chemoattraction of neutrophils under these conditions, whereas Cxcl11ae and Cxcl8a 
exerted significant neutrophil chemoattraction. To determine whether the macrophage 
chemoattraction is dependent on cxcr3.2, hindbrain injections of the recombinant proteins 
were performed in both wt and cxcr3.2 mutants. Both Cxcl11aa and Cxcl11af did not 
stimulate recruitment upon local injection in cxcr3.2 mutants when compared with their 
mock controls (Figure 5A,C). In contrast, the chemoattraction of phagocytes mediated by 
Cxcl11ae was independent of cxcr3.2 mutation (Figure 5B, Supplementary Figure 6C). 
Taken together, these results support a direct ligand-receptor interaction between Cxcr3.2 
and the chemokines Cxcl11aa and Cxcl11af that mediates the chemoattraction of 
Cxcr3.2	signalling	in	macrophage	recruitment	and	infection	dissemination	
71	
macrophages. Differently, Cxcl11ae, which exerted a Cxcr3.2-independent phagocyte 
chemoattraction, is likely to signal via a yet-unidentified receptor. 
 
 
Figure	 5.	Macrophage	 chemoattraction	 by	 locally	
injected	 recombinant	 chemokines	 in	 cxcr3.2	
mutant	 and	 wildtype	 siblings.	 Recombinant	
proteins	 or	 buffer	 (mock)	 were	 injected	 into	 the	
hindbrain	 ventricle	 at	 30	 hpf	 and	 macrophages	
accumulating	in	3	hours	within	the	hindbrain	limits	





68,	 39,	 58.	 Error	 bars:	 median	 and	 interquartile	
range.	 Note	 that	 macrophage	 chemoattraction	
mediated	by	Cxcl11aa	and	Cxcl11af	 is	abolished	by	





Mutation of cxcr3.2 affects mycobacterial infection dissemination and granuloma 
formation 
Pathogenic mycobacteria have the ability to resist intracellular macrophage digestion and 
they can use the macrophages as a vector for distal dissemination of the infection38. We 
hypothesised that cxcr3.2 depletion, preventing a high level of macrophage accumulation 
to the local infection site, might also prevent extensive dissemination and help to locally 
restrict the infection. To test this hypothesis we followed M. marinum hindbrain infection 
for 24 hours and evaluated the frequency of infection dissemination in cxcr3.2+/+ and 
cxcr3.2−/− zebrafish embryos. At 24 hpi, almost 50% of the wt embryos displayed 
dissemination of the infection from the head to the trunk and tail, whereas, in more than 










Figure	 6.	 Effect	 of	 cxcr3.2	 mutation	 on	 dissemination	 of	 local	 mycobacterial	 infection	 within	 24	 hpi	
(Figure	on	the	previous	page).	A-B.	Representative	images	of	cxcr3.2+/+	and	cxcr3.2−/−	embryos	with	local	
and	disseminated	mycobacterial	 infection.	Embryos	were	 infected	at	30	hpf	by	 injecting	200	CFU	of	M.	
marinum	 into	 the	 hindbrain	 and	 images	 were	 taken	 at	 24	 hpi	 (54	 hpf).	 In	 cxcr3.2+/+	 embryos,	 single	
infected	cells	are	visible	distally	from	the	infection	(white	boxes).	Scale	bar:	200	μm.	C–E.	Details	of	distal	
infection	 emerging	 from	hindbrain	 infection.	 The	 black	 arrows	 (C)	 point	 at	 single	M.	marinum-infected	
cells,	present	in	the	tail	of	a	cxcr3.2+/+fish	at	24	hpi	but	notably	absent	in	the	example	of	a	cxcr3.2−/−	fish	
(D).	Particulars	of	the	infected	hindbrains	of	the	same	embryos	are	shown	in	the	boxed	inserts	on	the	left,	







M.	 marinum	 infection	 dissemination	 in	 the	 head	 in	 cxcr3.2+/+	 and	 cxcr3.2−/−	 embryos.	 Representative	
figures	of	cxcr3.2	wildtype	(wt;	G)	and	mutant	(H)	embryos	and	quantification	(I)	of	dissemination	in	the	
head	 at	 6	 hours	 post	 M.	 marinum	 infection	 in	 the	 hindbrain.	 Embryos	 were	 scored	 positive	 for	
dissemination	 if	one	or	more	 infected	macrophages	were	observed	outside	the	hindbrain	 limits	 (dotted	




egressing	 from	 the	 hindbrain.	 The	 image	 sequence	 (taken	 from	 a	 cxcr3.2+/+	 embryo)	 represents	 over	 a	
time	course	of	~1.5	hours	that	macrophages	(green)	can	facilitate	the	dissemination	of	M.	marinum	(red)	







Dissemination to other areas of the head could be seen already as early as 6 hpi and also 
this phenotype was attenuated in cxcr3.2−/− embryos (Figure 6G–I). Disseminated bacteria 
outside the hindbrain and/or midbrain were residing in phagocytes and, in time course 
experiments, we could visualise that egression of mycobacteria from the ventricles is 
facilitated by macrophages (Figure 6J), in agreement with previously published results38. 
When dissemination to the tail and trunk occurred, one to five dissemination foci could be 
detected in the cxcr3.2+/+ embryos, whereas cxcr3.2−/− embryos never showed more than 
one or two bacterial clusters distally from the original injection point. At 5 dpi, the 
bacterial burden in the hindbrain was similar between wt and mutant larvae, but mutants 
still showed lower levels of dissemination of the infection towards distal areas (Figure 7A-
B). The infection foci generated distally developed into typical granuloma-like aggregates, 
as previously described for the zebrafish-M. marinum model26. The size of these 
granulomatous lesions was significantly reduced in the cxcr3.2−/− mutant larvae (Figure 
7C-F). Therefore, we concluded that cxcr3.2-mediated signalling strongly influences the 
dynamics of the infection progression and of granuloma formation. To further investigate 
the relevance of cxcr3.2 signalling in the formation of granulomas, we injected 200 CFU of 
M. marinum systemically in 1 dpf embryos via the caudal vein, which, in the wt leads to 
many granulomatous lesions38. Images of single granulomas at 5 dpi, stained for both 
macrophages and neutrophils, revealed that granuloma-like aggregates could still be 
formed in cxcr3.2 mutants. Similar structures and phagocyte compositions were observed 
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when lesions of similar sizes in wt and mutant were compared (Figure 8A-B). However, it 
must be noted that a large variation in granuloma structure and composition already exists 
when comparing different granulomas within the same larva or between different 
wildtypes, and this makes it very difficult to assess the effect of a mutation on the general 




Figure	 7.	 Effect	 of	 cxcr3.2	 mutation	 on	 dissemination	 of	 local	 mycobacterial	 infection	 at	 5	 dpi.	A-B.	
Quantification	of	total	 levels	of	 infection	burden	in	the	head	and	in	the	trunk	and	tail	of	6	dpf	zebrafish	
larvae.	 Embryos	 were	 injected	 at	 30	 hpf	 in	 the	 hindbrain	 ventricle	 with	 200	 CFU	 of	 M.	 marinum.	
Comparable	 levels	of	 infection	are	reached	locally	 in	the	head	(A),	but	disseminated	infection	burden	in	
the	 trunk	 and	 tail	 was	 significantly	 reduced	 in	 cxcr3.2−/−	 larvae	 (B).	 Data	 were	 accumulated	 from	 two	
independent	experiments.	Sample	size	 (n):	42,	39.	Error	bars:	median	and	 interquartile	 range.	C-D.	 Size	
and	 morphology	 of	 distal	 granulomas	 in	 cxcr3.2+/+	 and	 cxcr3.2−/−	 larvae.	 Distal	 bacterial	 clusters	 that	
originated	occasionally	 in	cxcr3.2−/−	embryos	appeared	generally	smaller	 than	the	ones	more	 frequently	
formed	 in	 the	 cxcr3.2+/+	 siblings.	 Size	 was	 determined	 by	 fluorescent	 bacterial	 quantification	 of	 single	
distant	granulomas	in	cxcr3.2+/+	and	cxcr3.2−/−	 (C)	and	five	representative	images	of	each	are	shown	(D).	
Data	were	accumulated	from	two	independent	experiments.	Sample	size	(n):	35	and	17	distal	granulomas	
from	42	and	39	observed	cxcr3.2+/+	 and	cxcr3.2−/−	 embryos,	 respectively.	 Scale	bar:	200	μm.	Error	bars:	
median	 (A,B)	 or	 mean	 (C)	 and	 interquartile	 range.	 E-F.	 Late	 effects	 of	 distal	 infection	 emerging	 from	
hindbrain	 infection.	 Representative	 images	 of	 cxcr3.2+/+	 (E)	 and	 cxcr3.2−/−	 (F)	 embryos	 at	 5	 dpi.	 Black	






Despite this, we observed that Cxcr3.2 deficiency provided partial protection against 
mycobacterial infection. Not only did mutants exhibit reduced levels of infection burden 
(Figure 8C-E), but also a reduced number of bacterial clusters (Figure 8F) and smaller 
average bacterial cluster size (Figure 8G). Taken together with the results of hindbrain 
infection, these data demonstrate the important role of Cxcr3.2-dependent signalling in 
guiding macrophage-mycobacteria interactions, and show how this signalling leads to 









(Figure	 on	 the	 previous	 page).	 A–D.	 Representative	 images	 of	 granulomas	 in	 systemically	 infected	





Scale	 bar	 in	 C-D:	 200	 μm.	 E–G.	 Quantification	 of	 the	 impact	 of	 cxcr3.2	 mutation	 on	 mycobacterial	
granuloma	 formation.	 Total	 infection	 burden	 (total	 infection	 fluorescent	 pixels;	 E),	 total	 number	 of	





The chemokine receptor CXCR3 and its ligands play important roles in the pathogenesis of 
infectious diseases, autoimmune disorders and cancer11,14,15,16,17,19,20,21,22,23,24. In this study, 
we report on the function of CXCR3 signalling in macrophage recruitment to infection foci 
and in the early establishment of mycobacterial granulomas. We found that the Cxcr3.2 
receptor, one of the three zebrafish homologues of human CXCR3, interacts with infection-
inducible zebrafish homologues of the CXCL11 ligand family and is required for the 
mobilisation of macrophages to different pathogens, such as locally delivered M. marinum 
or S. typhimurium. Furthermore, mutation of cxcr3.2 reduced the macrophage-mediated 
dissemination of M. marinum, leading to attenuation of the formation and expansion of 
granulomatous lesions in both local and systemic models of mycobacterial infection. 
 
CXCR3 is best known as a canonical marker for Th1 cells, but several recent studies have 
raised interest in the expression of this receptor by macrophages. These studies have 
implicated CXCR3 signalling in processes as diverse as the recruitment of macrophages to 
allografts24, the macrophage-mediated remodelling of blood vessels10 and the polarisation 
of macrophages towards an M2 phenotype that promotes tumour progression20. 
Furthermore, CXCR3 signalling has been shown to play a crucial role in the murine 
neonatal response to sepsis23. Like murine neonates, zebrafish embryos and early larvae 
rely heavily on their innate immune system for defence against infection. During zebrafish 
embryogenesis, macrophages are the first leukocyte cell type to develop and they express 
cxcr3.2 from day 136. In mutants of cxcr3.2, or in wt embryos treated with a human 
CXCR3 antagonist (NBI74330), we observed a significant reduction in the recruitment of 
macrophages to local bacterial infection in the hindbrain. In contrast, Cxcr3.2-deficient 
macrophages were able to normally migrate in response to chemically induced wounding 
or towards Cxcr3.2-independent chemoattractants, such as LTB4 and fMLP. These data 
suggest that Cxcr3.2 signalling is specifically activated by pathogen-induced chemokine 
signals. We considered a cluster of CXCL11-like chemokines as the putative ligands of 
Cxcr3.2 and confirmed that two of these, Cxcl11aa and Cxcl11af, exerted chemoattractant 
activity on macrophages following hindbrain injection of the recombinant proteins. Most 
likely, Cxcl11ag, which is near-identical to Cxcl11af, also signals through Cxcr3.2. It is 
currently unknown whether the cxcl11 genes in zebrafish are IFN-γ-inducible like their 
mammalian counterparts, but IFN-γ responsive elements are present in the promoters of 
these genes52. In addition, because we were unable to detect expression of the zebrafish 
cxcl11 genes in situ, the cell types producing these chemokines remain to be established. 
However, qRT-PCR showed rapid upregulation of cxcl11aa and cxcl11af/ag gene 
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expression following infection, supporting their function as the ligands mediating the 
infection-dependent recruitment of Cxcr3.2-positive macrophages. 
 
Expression analysis on FACS-sorted phagocyte populations showed that also cxcr3.3 is 
expressed in macrophages, but macrophage motility and recruitment defects in the cxcr3.2 
mutant line indicates that expression of cxcr3.3 cannot compensate for the loss of function 
of cxcr3.2. In addition, the expression analysis revealed that also neutrophils express 
cxcr3.2 at 2 and 6 dpf. Injection of Cxcl11aa or Cxcl11af into the otic vesicle at 2 dpf did 
not chemoattract a higher number of neutrophils within 3 hours than mock injections, 
whereas comparable concentrations of these chemokines were able to recruit macrophages 
into the hindbrain, and comparable concentrations of Cxcl8a and Cxcl11ae mobilised 
neutrophils when delivered in the otic vesicle. Different explanations can be given for this 
effect. Firstly, it is possible that different concentrations of chemokines are required to 
efficiently chemoattract different cell types. Secondly, the requirement of co- stimulatory 
signals or cell-specific co-receptors might be different between the phagocyte populations. 
Thirdly, although macrophages and neutrophils at 2 dpf seem to express comparable levels 
of cxcr3.2 mRNA, it remains unknown whether similar protein levels of Cxcr3.2 are 
exposed on their membranes. It should be noted that macrophages and their progenitors are 
marked by cxcr3.2 expression already at 1 dpf, whereas its expression could not be 
detected at this time point on neutrophil progenitors36. In line with this consideration, it is 
possible that this different timing in messenger expression impacts the protein levels at 2 
dpf. 
 
Macrophages are essential for the dissemination of pathogenic mycobacteria and mediate 
the formation of both primary and secondary granulomas in the zebrafish host following 
infection with M. marinum38,39. When M. marinum was locally injected into the hindbrain 
ventricle of 1-day-old embryos, almost half of the embryos exhibited dissemination within 
24 hours, where single infected macrophages migrated out of the ventricle and localised 
distally. In cxcr3.2 mutants, this dissemination of the infection was significantly reduced, 
which might be a consequence of the diminished macrophage attraction to the primary 
infection source or a direct effect on the retromigration ability of cxcr3.2 mutant 
macrophages. When the bacteria were injected intravenously, cxcr3.2 mutation reduced the 
formation and the expansion of granulomas, thereby attenuating the dissemination of 
bacteria and the overall burden of systemic infection. This phenotype might be explained 
by the reduced motility of macrophages in cxcr3.2 mutants because it has been shown that 
early granulomas in zebrafish larvae expand by spreading of the infection to newly 
recruited macrophages53. In agreement, the phenotype of cxcr3.2 mutant larvae resembles 
those caused by deficiency in other host (mmp9) or bacterial (ESAT-6) factors that also 
impair macrophage recruitment53,54. 
 
The zebrafish larval tuberculosis model is limited to the study of the initial stages of 
granuloma formation by macrophages in a context where the adaptive immune system is 
not yet functional. A beneficial effect of CXCR3 mutation has also been observed during 
chronic infection of BALB/c mice with Mycobacterium tuberculosis14. In this model, the 
resistance of CXCR3-deficient mice was attributed to the function of CXCR3 in T-cell 
priming. Another study using C57BL/6 mice showed that CXCR3 mutation affected early 
granuloma formation after aerosol M. tuberculosis infection and correlated this with the 
invasion of polymorphonuclear neutrophils that produce chemokine signalling via 
CXCR317. Together, the studies in mice and zebrafish models support further investigation 
Chapter	3	
78	
of the CXCR3 signalling axis as a host therapeutic target for tuberculosis. Our study is the 
first to implicate this signalling axis in macrophage responses that drive the initiation and 
expansion of mycobacterial granulomas. In future work it will, therefore, be of great 
interest to investigate how macrophage and T-cell responses determined by CXCR3 
signalling cooperate in the control of mycobacterial infections, using adult zebrafish or 
mammalian models of tuberculosis. 
 
Recently, another chemokine receptor, Ccr2, has also been shown to mediate macrophage 
recruitment following hindbrain infection of M. marinum in zebrafish embryos37. This 
Ccr2-mediated pathway is dependent on the presence of phenolic glycolipids on the 
mycobacterial cell surface and it recruits a population of macrophages that are permissive 
for mycobacterial growth, because activation of the host immune response is largely 
avoided owing to the presence of other cell surface lipids in virulent mycobacteria 
(phthiocerol dimycocerosate lipids), which physically mask the underlying PAMPs. M. 
marinum bacteria lacking phenolic glycolipids were still able to recruit macrophages, and 
morpholino knockdown of either Ccr2 or its ligand Ccl2 attenuated recruitment but did not 
fully abolish it. These observations indicate that redundant and/or synergistic mechanisms 
are cooperating in macrophage mobilisation. Combined experiments will be necessary to 
reveal whether the Ccr2-Ccl2 axis is (partially) redundant or synergistic with the Cxcr3-
Cxcl11-mediated macrophage recruitment shown here. 
 
Interestingly, we found that Cxcr3.2 is also involved in the basal motility of macrophages 
under physiological conditions. We hypothesise that the lower basal motility of 
macrophages in cxcr3.2 mutants could be due to the inability to sense small amounts of 
Cxcr3.2 ligands secreted in the macrophage microenvironment. Possibly, the macrophages 
themselves could be involved in an autocrine or paracrine secretion of these ligands. 
Similar mechanisms acting via CXCR3 signalling have already been described in the 
literature. Keratinocytes have been shown to express CXCL10 and CXCR3 to guide their 
own migration for re-epithelialisation in a wound-healing response55. Similarly, synovial 
fibroblasts use this ligand-receptor pair to regulate their invasion of joints in rheumatoid 
arthritis56. Furthermore, myeloid cells and haematopoietic progenitors secrete many 
different chemokines, including CXCR3 ligands, to regulate haematopoiesis in an 
autocrine or paracrine manner57. The autocrine or paracrine production of Cxcr3.2 ligands 
could potentially work as a local macrophage stimulator, which might significantly 
contribute to the surveillance activities that macrophages exert in tissues. During 
mycobacterial disease, similar mechanisms might be stimulated within the core of the 
granulomatous lesions, and could be involved in the in-and-out trafficking properties of 
macrophages, characteristic of these dynamic structures58,59. In various animal models of 
tuberculosis, including the most clinically relevant macaque model, abundant expression of 
CXCR3 ligands is detected in the core and in the direct neighbourhood of the 
granulomatous lesions59,60,61. Our study suggests that this is relevant not only for the 
recruitment of T cells, but also for regulating macrophage activities in the 
immunopathology of the granulomatous lesion. A number of studies with selective agonists 
or antagonists of CXCR3 have already shown beneficial effects on inflammation-
associated diseases62,63 and the zebrafish model might be a suitable model to test their 
effectiveness on mycobacterial infections. 
 
Concluding, here we propose a dual biological role of Cxcr3.2-Cxcl11aa/af ligand-receptor 
signalling. First, our results implicate Cxcr3.2 and its ligands in surveillance against 
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pathogens by promoting the random patrolling of inactive macrophages. Second, we show 
that this pathway is involved in the mobilisation of macrophages during infection. 
Depending on the specific interactions of different pathogens with their hosts, a Cxcr3.2-
dependent response could be beneficial for the resolution of infection or have an 
unfavourable effect because, on the one hand, it can sustain the recruitment of 
macrophages to the infection site, but, on the other hand, it can promote the dissemination 
of bacteria, as in the case of mycobacterial infection. 
 
MATERIALS AND METHODS 
Zebrafish lines and maintenance – Zebrafish lines were handled in compliance with the 
local animal welfare regulations and maintained according to standard protocols (zfin.org). 
The breeding of adult fish was approved by the local animal welfare committee (DEC) of 
the University of Leiden (license number: 10612) and adhered to the international 
guidelines specified by the EU Animal Protection Directive 2010/63/EU. Adult zebrafish 
were not sacrificed for this study. All experiments in this study were performed on 
embryos/larvae before the free-feeding stage and did not fall under animal experimentation 
law according to the EU Animal Protection Directive 2010/63/EU. 
 
Fish lines used in this work were the following: wildtype (wt) strain AB/TL, double-
transgenic line Tg(mpeg1:mCherry-F/mpx:eGFP)64,65 homozygous mutant (cxcr3.2−/−) and 
wt siblings (cxcr3.2+/+) of cxcr3.2hu6044, Tg(mpeg1:Gal4-VP16/UAS-E1b:Kaede), in short 
referred to as Tg(mpeg1:Gal4/UAS:Kaede)66, and the combination of 
Tg(mpeg1:Gal4/UAS:Kaede) with the cxcr3.2 mutant strain. The cxcr3.2hu6044 allele was 
identified by sequencing of an ENU (N-ethyl-N-nitrosourea)-mutagenised zebrafish library 
and was obtained from the Hubrecht Laboratory and the Sanger Institute Zebrafish 
Mutation Resource. Heterozygous F2 carriers were outcrossed twice against wt and were 
subsequently incrossed. Resulting cxcr3.2−/− and cxcr3.2+/+ siblings were raised and used 
to obtain embryos for all the experiments. The combined mutant-transgenic line 
Tg(mpeg1:Gal4/UAS:Kaede/cxcr3.2−/− or cxcr3.2+/+) were obtained by crossing 
heterozygous carriers with the original transgenic line and subsequently incrossing the 
heterozygous offspring. For genotyping, genomic DNA was amplified using forward 
primer 5′-GGCATCTTTTTTGTTACAGCCTACAGCTTA-3′ and reverse primer 5′-
TGGCGATATCGGCGGATAACA-3′, amplifying a 201 base pair (bp) product containing 
the mutation. The forward primer introduces an additional base change, which only in 
combination with the mutant allele generates the consensus for DdeI restriction enzyme. 
Therefore, the mutant allele was distinguished from the wt by specific digestion into a 174 
fragment that can be separated from the undigested wt amplicon on a 2.5% agarose gel. 
Alternatively, genotyping was performed by KASP assay using the primers 5′-
CATCATAGGAAGTACTGTTGTAGTCA-3′, 5′-
CATCATAGGAAGTACTGTTGTAGTCC-3′ and 5′-
GGCATCTTTTTTGTTACAGCCTACAGATT-3′. Robustness of both methods was 
verified several times by sequencing of the amplicons. 
 
Embryos were grown at 28.5°C in egg water (60 µg/ml sea salt, Sera Marin, Heinsberg, 
Germany). For live-imaging or injection assays, larvae were anaesthetised in egg water 
medium containing 0.02% buffered Tricaine (3-aminobenzoic acid ethyl ester; Sigma-
Aldrich, St Louis, MO, USA). To prevent melanisation, larvae were generally maintained 
in egg water supplemented with 0.003% PTU (1-phenyl-2-thiourea; Sigma-Aldrich).  
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Sequencing – Sequencing of the full coding sequence of cxcr3.1, cxcr3.2 and cxcr3.3 was 
obtained by amplification with primers described in Supplementary Table 3. For cxcr3.2 
and cxcr3.3, both genomic and cDNA templates extracted from pools of 15–20 embryos 
were used. Amplification was performed with Phusion high-fidelity DNA polymerase 
(Thermo-Scientific, Pittsburgh, PA, USA). DNA amplicons were then gel-extracted on 
1.5% agarose and column-purified with PureLink quick gel extraction and PCR 
purification kit (Invitrogen, Life Technologies, Carlsbad, CA, USA). Sequencing with 
M13Fw, M13Rv universal primers (incorporated in the amplification primers) or with 
custom-made primers was outsourced to Baseclear (Leiden, The Netherlands). For cxcr3.1, 
sequencing results derive exclusively from genomic DNA amplifications. Amplification of 
cDNA templates for cxcr3.2 resulted in a band of identical size in mutant, wt and AB/TL, 
thereby excluding altered exon/intron arrangements attributable to the ENU-mutagenesis 
per se or to the cxcr3.2hu6044 allele. 
 
Bacterial cultures and infection delivery – Approximately 200 CFU (1 nl) of M. 
marinum strain Mma20 expressing mCherry67, or Salmonella enterica serovar 
Typhimurium (S. typhimurium) strain SL1027 expressing DsRed68, were grown and 
harvested as described previously47,69. Embryos were staged at 30 hpf and bacteria or mock 
control [phosphate buffer saline (PBS) supplemented with 0.1% phenol red (Sigma-
Aldrich) and 2% polyvinylpyrrolidone-40 (Sigma-Aldrich)] were locally injected in the 
hindbrain cavity as described previously47,69. Injections of bacteria in the otic vesicle, as 
shown in Figure 3, were performed either at 3 dpf (Figure 3B,I-L) or at 4 dpf (Figure 3C-
H). When infection was delivered systemically, the same dose was instead injected in the 
caudal vein as in reference69. As a control, the same dose was spotted onto plates, 
incubated and counted. Embryos were kept into fresh PTU egg water, incubated at 28.5°C, 
and collected for qRT-PCR or used for imaging at 1–6 dpf. In Figure 8A,B, embryos were 
fixed at 6 dpf in 4% paraformaldehyde in PBSTx (1× PBS supplemented with 0.8% Triton 
X-100; Sigma-Aldrich) and prepared for Myeloperoxidase (Mpx) activity stain with TSA 
staining kit (PerkinElmer Inc., Waltham, MA, USA), followed by immunostaining against 
the pan-leukocyte marker Leukocyte-plastin (Lp) as described previously47,69. 
 
FACS-sorting, RNA isolation and qRT-PCR – Mpeg1:mCherry-F-positive, mpx:eGFP-
positive and unlabelled cells were sorted from Tg(mpeg1:mCherry-F/mpx:eGFP) at 2 and 
6 dpf. FACS-protocol and RNA isolation were performed according to reference70. To 
evaluate the induction of the cxcl11 genes upon infections, pools of 18–20 embryos were 
collected for RNA isolation, snap-frozen in liquid nitrogen and subsequently stored at 
−80°C. RNA was extracted using Qiazol reagent (Qiagen, Valencia, CA, USA) according 
to the manufacturer’s guidelines. Residual genomic DNA was removed by DNA-free kit 
(Ambion, Life Technologies). The cDNA was prepared using the iScript cDNA-synthesis 
kit (Invitrogen, Life Technologies) and was used as a template for qRT-PCR reaction with 
iQ SYBR Green Supermix according to the manufacturer’s instructions (Bio-Rad 
Laboratories, Munich, Germany). Specificity of the amplification reaction was analysed 
using dissociation curves. Each qRT-PCR was performed in technical duplicate and on 
biological replicates as indicated in the figure legends. Reference genes were eif4a1b or 
eif5 (eukaryotic translation initiation factor 4a isoform 1b or 5) for FACS-sorted cells and 
ppiab (peptidylprolyl isomerase ab/cyclophilin a) for infection experiments. Fold changes 
were determined using the ΔΔ comparative threshold method. Primers are reported in 
Supplementary Table 3.  
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Production of recombinant chemokines and local injections – Synthetic coding 
sequences for Cxcl11aa, Cxcl11af, Cxcl11ae and Cxcl8a (included as negative control) 
were generated (Baseclear) according to database accessions (Supplementary Table 2). 
To enable secretion in yeast, the sequences were codon optimised and the predicted 
zebrafish signal peptide was replaced with yeast alpha-factor secretion signal, as a result 
from cloning into pPICZα expression vector (Invitrogen, Life Technologies). Additionally, 
a HA (human influenza haemagglutinin)-tag was added at the C-terminus to facilitate the 
purification process and identification. The recombinant chemokines were produced by 
Pichia pastoris strain X-33 transformed with the chemokine vectors as described 
previously71. Proteins were purified via Fast Protein Liquid Chromatography in NaCl salt 
gradient and finally desalted and concentrated by membrane filtrations on Amicon Ultra 
Centrifugal filter devices with a nominal molecular weight limit of 3 kilodaltons (Amicon, 
Merck KGaA, Ireland), using 50 mM sodium phosphate buffer pH 6.5 as a washing and 
suspension vehicle. Purity and identity of the proteins were confirmed by trypsinisation and 
electrospray mass-spectrometry. The recombinant chemokines (0.5–1.2 mg/ml), LTB4 
(leukotriene B4; Santa Cruz Biotechnology, Santa Cruz, CA, USA; 10.1 ng/ml), fMLP (N-
formyl-methionyl-leucyl-phenylalanine; Sigma-Aldrich; 0.2 mg/ml) or mocks [sodium 
phosphate buffer pH 6.5 for the chemokines, 5% DMSO (Sigma-Aldrich) in PBS for fMLP 
and 0.02% ethanol (Sigma-Aldrich) in PBS for LTB4] were supplemented with 0.1% 
phenol red and injected at 30 hpf in the hindbrain ventricle (1 nl) or at 52 hpf in the otic 
vesicle (0.5 nl) as described previously47,69. In both cases, embryos were fixed at 3 hpi in 
4% paraformaldehyde in PBSTx and prepared for Lp immunostaining as in reference47. At 
30 hpf, the population of fully differentiated leukocytes is represented almost exclusively 
by macrophages48,49; thereby, we could assume that nearly all the Lp-stained cells able to 
migrate and infiltrate in the ventricle represented macrophages at this developmental stage. 
As is shown in Supplementary Figure 3, only one to two mpx-positive cells [mpx-whole 
mount in situ hybridisation as in reference47] could be counted within the perimeter of the 
hindbrain in this experimental setting at 3 hours post local bacterial infection, which is less 
than 10% of the cells positive for the macrophage marker mfap4. At later developmental 
stages, in order to discern between neutrophils and macrophages, samples were processed 
also with a neutrophil-specific Mpx activity staining as described previously47), by using 
the leukocyte peroxidase (Myeloperoxidase) staining kit (Sigma-Aldrich) for the 
histochemical detection of the enzymatic activity of Mpx. Leukocytes accumulated at the 
injected cavity (macrophages: Lp-positive and Mpx-negative; neutrophils: Mpx-positive) 
were counted using a Leica MZ16FA fluorescence stereomicroscope (Leica Microsystems, 
Rijswijk, The Netherlands). 
 
Chemically induced (ChIn) inflammation assay – 3-dpf larvae were exposed to 10 µM 
copper sulphate (CuSO4; Sigma-Aldrich) for 2 hours as described previously
50. Treated 
larvae were then fixed and used for combined Mpx activity staining and Lp 
immunostaining as described above. 
 
Pharmacological treatment with NBI74330 – Bath-treatment with the CXCR3 high-
affinity antagonist NBI74330 or vehicle treatment (0.5% DMSO) was started at 27 hpf by 
exposing dechorionated embryos to 50 µM of the drug in medium. Embryos were 
incubated for 3 hours at 28.5°C and then injected in the hindbrain with mock or M. 
marinum as described above. Injected embryos were maintained for an additional 3 hours 
in 50 µM NBI74330 or vehicle alone and then fixed in 4% paraformaldehyde/PBSTx and 




Imaging and image quantification – Fixed or live embryos and larvae were imaged using 
a Leica MZ16FA fluorescence stereomicroscope. For time-lapse experiments, samples 
were mounted in 2% low-melting-point agarose (SphaeroQ, Burgos, Spain) and images 
were acquired with a laser-scanning confocal microscope (Leica TCS SPE, Leica 
Microsystems or Zeiss Observer 6.5.32, Carl Zeiss, Sliedrecht, The Netherlands). To assess 
the average speed of macrophages (Figure 1J-K), a time-lapse experiment was performed 
and quantification was obtained on overlaid z-stacks by Fiji/ImageJ software (NIH, 
Bethesda, MD, USA) using the ManualTrack plug-in as described elsewhere72. The 
average speed was calculated as the average of all the speeds assumed by every single 
macrophage at each time point. Analysis was performed by cumulating three experiments 
in which 15–21 macrophages per embryo were followed. To quantify the morphological 
differences between macrophages in cxcr3.2 mutants and wt, bacteria were injected into 
the otic vesicle of Tg(mpeg1:Gal4/UAS:Kaede/cxcr3.2+/+ or cxcr3.2−/−) larvae at 3 dpf and 
fixed at 4 hpi. Images of macrophages were acquired in the trunk. Perimeter and area of the 
cells were obtained by Fiji/ImageJ using the Analyse Particles plug-in. The circularity 
index (CI) corresponding to each cell was obtained by the formula: CI=4π 
(area/perimeter2), resulting in an index that ranges from 0 (infinitely branched structure) to 
1 (perfect circle). Macrophages were classified in five different intervals of circularity 
based on their CI (0.0 to 0.19, 0.2 to 0.39, 0.4 to 0.59, 0.6 to 0.79, 0.8 to 1.0) and the 
average percentages of macrophages in each interval were estimated for cxcr3.2+/+ 
orcxcr3.2−/− (Figure 3I). To estimate the divergence of distribution of cxcr3.2+/+and 
cxcr3.2−/− macrophages from the overall mean, the percentages in each interval were 
divided by the average percentage of mutants and wt assumed in that interval, using the 
formulas: Deviation(cxcr3.2+/+)= %cxcr3.2+/+/[(%cxcr3.2+/+ + %cxcr3.2−/−)/2] and 
Deviation(cxcr3.2−/−)= %cxcr3.2−/−/[(%cxcr3.2+/+ + %cxcr3.2−/−)/2] (Figure 3J). To quantify 
the dissemination of bacterial infection (Figure 6F,I), the presence or absence of infection 
distally from the infected site was evaluated, giving a score of 1 in case of dissemination 
and a score of 0 in case of absent dissemination. Quantification of total bacterial pixels 
(Figure 7A-B and Figure 8E) was obtained using dedicated bacterial pixel count program 
as in reference73. Total bacterial cluster count (Figure 8F) was performed manually from 
images. Quantification of the area of single distal clusters (Figure 7C) and average area of 
disseminated granulomas (Figure 8G) were performed using ImageJ quantification tools as 
in reference74). 
 
Statistical analysis – In the survival test (Figure 1E), non-significant deviation from 
Mendelian rate was evaluated by χ2 test on four independent replicates. For qRT-PCR, 
statistical significance was estimated on five (Figure 1A-C), four (Figure 4A-B) or three 
(Figure 4C-D) biological replicates by two-tailed t-tests on ln(n)-transformed relative 
induction folds. All the other experiments were statistically analysed using GraphPad 
Prism 4 or 5 (GraphPad Software, La Jolla, CA, USA). Where correction for non-
parametric distribution was required (Figure 1F,G, Figure 2, Figure 3A,B, Figure 3M, 
Figure 5, Figure 6, Figure 7A,B, Figure 8E,F), comparisons between two groups were 
performed with two-tailed Mann-Whitney test and comparisons among more than two 
groups were performed with Kruskal-Wallis test, followed by Dunn’s multiple comparison 
test. When a parametric distribution was assumed (Figure 1A-C, Figure 1L, Figure 3I-J, 
Figure 4, Figure 8G), comparisons between two groups were performed with a two-tailed 
t-test. In Figure 7C, significance was estimated with an unpaired t-test with Welch’s 
Cxcr3.2	signalling	in	macrophage	recruitment	and	infection	dissemination	
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correction, suitable to compare parametric data having different variances. Significance (P-
value) is indicated with: ns, non-significant; *P<0.05; **P<0.01; ***P<0.001. 
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Supplementary	 Figure	 1.	 Expression	 of	 cxcr3.2	 and	 its	 paralogues	 cxcr3.1	 and	 cxcr3.3	 in	 FACS-sorted	
phagocytes	at	6	dpf.	Graphs	represent	the	relative	induction	fold	of	the	macrophage	marker	mpeg1	(A),	
the	 neutrophil	 marker	 mpx	 (B),	 and	 of	 the	 cxcr3	 paralogues	 (C)	 in	 FACS-sorted	 macrophages	 and	
neutrophils	 from	 the	 combined	 transgenic	 line	Tg(mpeg1:mCherry-F/mpx:eGFP)	 at	 6	 dpf.	 Expression	 of	
cxcr3.2	 and	 cxcr3.3	 could	 be	 detected	 in	 both	 macrophages	 and	 neutrophils,	 while	 cxcr3.1	 was	 not	










Supplementary	 Figure	 2.	 Protein	 sequence	 multiple	 alignment	 of	 human	 and	 zebrafish	 CXCR3	
chemokine	 receptors	 (Figure	 on	 the	 previous	 page).	 Residue	 colour	 from	 blue	 to	 yellow	 indicates	
increasing	degree	of	amino	acid	conservation.	The	alignment	and	the	tree	were	obtained	using	CLC	main	
workbench	 6.8.4	 by	Neighbour-Joining	 Algorithm.	Gap	 costs	were	 given	with	 a	 penalty	 score	 of	 10	 for	
each	 gap	 open,	 and	 an	 additional	 score	 of	 1	 per	 each	 extension;	 no	 cost	was	 associated	 to	 end	 gaps.	
Extracellular	 (light	 green	bars),	 Transmembrane	 (black	bars),	 and	 Intracellular	 (light	 blue	bars)	 domains	
were	predicted	with	CLC	main	workbench	6.8.4.	Ligand	binding	domains	(dark	green	bars)	and	conserved	
residues	 or	 similar	 residues	 within	 the	 binding	 domains	 (black	 asterisks)	 were	 predicted	 according	 to	
reference75.	The	numbers	at	the	tree	nodes	denote	the	bootstrap	for	10000	replicates.	Single	alignment	
of	 the	 predicted	 zebrafish	 chemokine	 receptor	 proteins	 to	 the	 canonical	 isoform	 of	 CXCR3	 (hsaCXCR3	
isoform	 1)	 were	 performed	 with	 clustalO	 algorithm	 (http://www.	 uniprot.org/align)	 and	 provided	 the	





Supplementary	 Figure	 3.	 Macrophages	 are	 the	 predominant	
phagocyte	cell	type	recruited	to	local	hindbrain	infection	in	31-33	
hpf	 embryos.	 Embryos	 were	 locally	 injected	 into	 the	 hindbrain	
cavity	at	30	hpf	with	100	CFU	of	M.	marinum	and	fixed	at	1	and	3	
hpi.	Double	 fluorescent	 in	 situ	 hybridisation	was	 performed	with	
mfap4	as	a	macrophage	marker	and	mpx	as	a	neutrophil	marker36.	
The	 average	 number	 of	 mfap4-positive	 macrophages	 in	 the	
hindbrain	 at	 1	 or	 3	 hpi	 exceeds	 the	 average	 number	 of	 mpx-
positive	 neutrophils	 approximately	 10-fold	 and	 a	 significant	
difference	 between	 the	 time	 points	 was	 observed	 only	 for	




Supplementary	 Figure	 4.	 Predicted	 molecular	 docking	 of	 NBI74330	 into	 the	 transmembrane	 minor	














Supplementary	 Figure	 5.	 Phylogenetic	 tree	 of	
human	 and	 zebrafish	 chemokine	 protein	
sequences.	 The	 alignment	 and	 the	 tree	 were	
obtained	 using	 CLC	 main	 workbench	 6.8.4	 by	
Neighbour-Joining	Algorithm.	Gap	costs	were	given	
with	a	penalty	score	of	10	for	each	gap	open,	and	
an	 additional	 score	 of	 1	 per	 each	 extension;	 no	
cost	was	associated	 to	end	gaps.	Additionally,	 the	
CXC	 motif	 of	 the	 chemokine	 was	 set	 as	 fixed	
alignment	 point.	 The	 numbers	 at	 the	 tree	 nodes	
denote	 the	 bootstrap	 for	 10000	 replicates.	 Light	
blue:	Cxcl11-like	cluster,	containing	human	CXCL11	
and	 seven	 zebrafish	 Cxcl11-like	 chemokines.	 Dark	
blue:	human	CXCL9	and	CXCL10.	Green:	Cxcl8-like	
cluster,	 containing	 human	 CXCL8	 (IL8)	 and	








A.	 Chemoattraction	of	macrophages	 to	 the	hindbrain	 ventricle.	 Recombinant	 proteins	 or	 buffer	 (mock)	
were	 injected	 into	 the	 hindbrain	 ventricle	 of	 wildtype	 (AB/TL)	 embryos	 at	 30	 hpf	 and	 Lp-stained	 cells	
accumulating	 in	 3	 hours	 within	 the	 hindbrain	 limits	 were	 counted	 as	 macrophages.	 Cxcl11af	 but	 not	
Cxcl8a	 significantly	 attracted	macrophages.	 Sample	 size	 (n):	 106,	 100,	 94,	 112.	 Error	 bars:	median	 and	
interquartile	 range.	 B-C.	 Chemoattraction	 of	 neutrophils	 to	 the	 otic	 vesicle.	 Recombinant	 proteins	 or	
mock	were	injected	into	the	otic	vesicle	of	wildtype	(AB/TL)	embryos	(B)	or	cxcr3.2+/+	and	cxcr3.2-/-	siblings	
(C)	 at	 54	 hpf	 and	 neutrophils	 accumulating	 in	 3	 hours	within	 the	 otic	 vesicle	were	 counted	 after	Mpx	
activity	 staining.	 Neutrophil	 attraction	 by	 recombinant	 Cxcl8a	 (Il8)	 (B)	was	 in	 agreement	with	 previous	
reports27.	Note	 that	Cxcl11ae	significantly	 recruited	neutrophils	 in	all	 zebrafish	 lines,	while	Cxcl11af	 (B),	
Cxcl11aa	(C),	and	fMLP	(C)	did	not	exert	significant	neutrophil	attraction	above	mock	 injections.	Sample	




Protein	 Amino	acid	position	 Strain	 Variant	 PROVEAN	score	 Predicted	effect	
Cxcr3.1	 203	
Reference*	 E	 0.000	 Neutral	
AB/TL	 E/K	 -0,945	 Neutral	
cxcr3.2+/+	 E/K	 -0,945	 Neutral	
cxcr3.2-/-	 E	 0.000	 Neutral	
Cxcr3.1	 292	
Reference	 E	 0.000	 Neutral	
AB/TL	 E/K	 -1.803	 Neutral	
cxcr3.2+/+	 E	 0.000	 Neutral	
cxcr3.2-/-	 K	 -1.803	 Neutral	
Cxcr3.1	 351	
Reference	 K	 0.000	 Neutral	
AB/TL	 R	 0.645	 Neutral	
cxcr3.2+/+	 R	 0.645	 Neutral	
cxcr3.2-/-	 R	 0.645	 Neutral	
Cxcr3.2	 16	
Reference	 Y	 0.000	 Neutral	
AB/TL	 Y	 0.000	 Neutral	
cxcr3.2+/+	 Y	 0.000	 Neutral	
cxcr3.2-/-	 STOP	 cxcr3.2hu6044	 Non-sense	
Cxcr3.2	 93	
Reference	 V	 0.000	 Neutral	
AB/TL	 I	 0.048	 Neutral	
cxcr3.2+/+	 I	 0.048	 Neutral	
cxcr3.2-/-	 I	 0.048	 Neutral	
Cxcr3.3	 48	
Reference	 M	 0.000	 Neutral	
AB/TL	 L	 0.332	 Neutral	
cxcr3.2+/+	 L	 0.332	 Neutral	
cxcr3.2-/-	 L	 0.332	 Neutral	
Cxcr3.3	 75	
Reference	 C	 0.000	 Neutral	
AB/TL	 C/P	 -0.547	 Neutral	
cxcr3.2+/+	 C/P	 -0.547	 Neutral	
cxcr3.2-/-	 C	 0.000	 Neutral	
Cxcr3.3	 95	
Reference	 S	 0.000	 Neutral	
AB/TL	 T	 2.931	 Neutral	
cxcr3.2+/+	 T	 2.931	 Neutral	
cxcr3.2-/-	 T	 2.931	 Neutral	
Cxcr3.3	 236	
Reference	 E	 0.000	 Neutral	
AB/TL	 E/D	 -0.328	 Neutral	
cxcr3.2+/+	 E/D	 -0.328	 Neutral	
cxcr3.2-/-	 E	 0.000	 Neutral	
Cxcr3.3	 238	
Reference	 M	 0.000	 Neutral	
AB/TL	 M/L	 -0.611	 Neutral	
cxcr3.2+/+	 M/L	 -0.611	 Neutral	
cxcr3.2-/-	 M	 0.000	 Neutral	
Cxcr3.3	 244	
Reference	 M	 0.000	 Neutral	
AB/TL	 M/I	 -0.473	 Neutral	
cxcr3.2+/+	 M/I	 -0.473	 Neutral	
cxcr3.2-/-	 I	 -0.473	 Neutral	
Cxcr3.3	 297	
Reference	 T	 0.000	 Neutral	
AB/TL	 S	 -0.463	 Neutral	
cxcr3.2+/+	 S	 -0.463	 Neutral	
cxcr3.2-/-	 S	 -0.463	 Neutral	
Cxcr3.3	 327	
Reference	 L	 0.000	 Neutral	
AB/TL	 L/Q	 -2.562	 Neutral	
cxcr3.2+/+	 L/Q	 -2.562	 Neutral	
cxcr3.2-/-	 Q	 -2.562	 Neutral	
Cxcr3.3	 346	
Reference	 D	 0.000	 Neutral	
AB/TL	 D/E	 0.098	 Neutral	
cxcr3.2+/+	 D/E	 0.098	 Neutral	
cxcr3.2-/-	 D	 0.000	 Neutral	
Cxcr3.3	 350	
Reference	 V	 0.000	 Neutral	
AB/TL	 V/E/D	 0.895/1.275	 Neutral	
cxcr3.2+/+	 V/E/D	 0.895/1.275	 Neutral	
cxcr3.2-/-	 D	 0.895	 Neutral	
Cxcr3.3	 378	
Reference	 Q	 0.000	 Neutral	
AB/TL	 Q/E	 -0.077	 Neutral	
cxcr3.2+/+	 Q/E	 -0.077	
	




Supplementary	 Table	 1.	 Non-synonymous	 single	 nucleotide	 polymorphisms	 in	 cxcr3.1,	 cxcr3.2,	 and	
cxcr3.3	 coding	 sequences	 (Legend	 on	 the	 next	 page).	 Several	 non-synonymous	 single	 nucleotide	
polymorphisms	 (nsSNPs)	 are	 present	 in	 cxcr3.1,	 cxcr3.2,	 and	 cxcr3.3	 genes	 that	 are	 inherited	 in	
association	with	 the	 ENU-mutagenised	 cxcr3.2hu6044	 allele.	 Except	 for	 the	 Cxcr3.1	 E292K	 variant,	 all	 the	
nsSNPs	 linked	 to	 the	 cxcr3.2-/-	 fish	 did	 not	 differ	 from	 the	 ones	 represented	 also	 in	 the	 cxcr3.2+/+	 fish.	
Furthermore,	all	nsSNPs,	including	the	Cxcr3.1	E292K	variant,	were	detected	also	in	the	AB/TL	wt	strain.	
Analysis	using	the	PROVEAN	software	tool	(Protein	Variation	Effect	Analyser,	http://provean.jcvi.org)45,46,	
predicts	 that	 the	 nsSNPs	 are	 unlikely	 to	 have	 an	 impact	 on	 the	 protein	 functionality.	 The	 threshold	 to	
score	the	possibility	of	protein	non	functionality	was	set	to	-4.146.	Note:	Amino	acid	notations	for	Cxcr3.3	
are	 represented	 accordingly	 to	 their	 position	 in	 Cxcr3.3	 splicing	 isoform	 2.	 No	 additional	 amino	 acid	
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Chemokine receptors and their cognate ligands are essential host factors that control 
leukocyte migration and inflammation. We previously described that disruption of the 
CXCR3-CXCL11 receptor-ligand signalling axis in zebrafish carrying a cxcr3.2 null 
mutation attenuates macrophage motility and recruitment to infectious foci. Importantly, 
these defects in macrophage function are associated with increased resistance to 
Mycobacterium marinum, a zebrafish pathogen widely used to study tuberculosis 
pathogenesis and macrophage parasitism. Here we revealed by RNA deep sequencing that 
lysosomal genes are significantly upregulated in sorted macrophages from the cxcr3.2 
mutant. In vivo assays subsequently showed increased lysosomal content, augmented 
acidification of phagosomes containing bacteria, and increased microbicidal capacity in 
cxcr3.2 mutants. Tracking of macrophage lysosomes in vivo revealed that these organelles 
mostly localise at the leading edge of motile cells. We show that maintenance of polarised 
lysosomes during cell migration requires a functional cxcr3.2 gene, suggesting that 
Cxcr3.2-dependent signalling affects lysosomal content by sustaining lysosomal 
exocytosis. Strikingly, macrophages respond to M. marinum infection by upregulation of 
Cxcl11aa, the cognate ligand of Cxcr3.2, in a Myd88/Nfκb dependent manner. This 
suggests that mycobacteria take advantage of the Myd88-immune signalling to sustain 
cxcl11aa expression, manipulate the Cxcr3.2 pathway and ultimately control the lysosomal 
content of the parasitised cell. Taken together, these data reveal a molecular pathway that 
links macrophage chemotaxis to lysosomal function. In the absence of this pathway, 
macrophages are primed for antimicrobial defence by enhanced lysosomal gene expression 
and microbicidal capacity. In turn, exploitation of this circuit by intracellular parasites 
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Chemokines are a class of endogenous peptides with chemoattractive properties, produced 
at sites of infection and inflammation to induce the recruitment of leukocytes1. These 
motogenic mediators can control both random and directional motility, also known as 
chemokinesis and chemotaxis, respectively2. Activation of chemokine receptors transduces 
a complex cascade of signals that results in cell polarisation3, characterised by an 
asymmetrical shape of the cell body and by an unequal distribution of the cytosolic 
contents, including organelles such as mitochondria and lysosomes4,5. To efficiently 
migrate into inflamed tissues, macrophages must acquire and maintain these spatial and 
functional asymmetries, and therefore expression of chemokine receptors on their plasma 
membrane is critical for their function. 
 
In both mammalian and teleost species, macrophages express the CXC-motif chemokine 
receptor CXCR36,7, which, via its cognate ligands CXCL9-10-11, has been shown to exert 
remarkably pleiotropic functions on these cells. These activities not only include a direct 
control of macrophage trafficking to localised infectious/inflamed foci8,9,10,11 but also their 
capability to activate differential functional programs in response to microenvironmental 
signals. This is well exemplified, for instance, by the impairment of macrophage-mediated 
vascular remodelling12, the skewing of M1/M2 differentiation13 and the increased clearance 
of pathological protein aggregates14 or steatotic lipid inclusions15 in CXCR3-deficient 
conditions. 
 
Despite that much effort has been made to elucidate the sequence of events activated by the 
transduction of chemokine signals, we are only beginning to understand the transcriptional 
and subcellular effects of the chemokine-mediated cell polarisation and the implications of 
these effects on the immune function of leukocytes. Additionally, our current 
understanding of chemokine responses derives mostly from studies performed in vitro. 
Here we used the zebrafish model and RNA-sequencing analysis of sorted macrophages to 
elucidate the downstream targets affected by chemokine signalling in vivo. Using the 
mutant line of the chemokine receptor cxcr3.2 (a functional homologue of the mammalian 
CXCR3), we show that the disruption of CXCR3-CXCL11 signalling results in 
transcriptional upregulation of lysosomal genes and primes the microbicidal function of 
macrophages. This transcriptional signature is linked with reduced macrophage motility in 
cxcr3.2 mutants and attenuated susceptibility to the fish and macrophage pathogen 
Mycobacterium marinum (Mm)10. 
 
Our findings provide a novel addition to the current understanding of the leukocyte 
chemotactic process, since it was recently shown that lysosome delivery to the leading 
edge of motile cells and their local exocytosis is critical to permit chemotactic migration 
and to fuel lipid endomembranes to the lamellipodium. Strikingly, we found that 
mycobacterial immune recognition by Myd88-dependent signalling can induce large 
autocrine induction of Cxcl11aa, the cognate ligand of Cxcr3.2. Therefore, this immune 
recognition/chemokine/lysosome circuit might represent an unexpected macrophage-
autonomous mechanism of pathogen virulence. Mycobacterial parasitism may exploit the 
chemokine signalling to dissipate lysosomal function and maintain a macrophage 




Macrophage chemotactic signalling controls lysosomal function 
To identify genes and pathways affected by chemoattractant-induced chemotaxis, we used 
a zebrafish cxcr3.2 null model which displays attenuated macrophage motility and aberrant 
macrophage recruitment to infection foci (Figure 1)10. By deep-sequencing analysis of 
FACS-sorted cxcr3.2 mutant and wildtype (wt) mpeg1:mCherry-F-positive macrophages, 
we found 699 significantly regulated genes. Using gene enrichment analysis tools we 
classified the regulated genes according to the affected pathways, cellular components, 
molecular functions and biological processes (Table 1-2). These functional analyses 
suggested alterations in lysosome biogenesis/maturation, Golgi-to-lysosome vesicular 
trafficking and lysosomal maintenance. Classification of gene products according to their 
cellular localisation also revealed that lysosome- and Golgi-related genes are mostly 
upregulated in the cxcr3.2 mutants (Figure 2). Taken together, these data suggest that a 
coordinated induction of lysosomal genes takes place in cxcr3.2 mutant macrophages and 
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Term	 Count	 P-Value	 Fisher	Exact	
Fold	
Enrichment	
Endocytosis	 17	 4,5E-03	 1,9E-03	 2,2	
Lysosome	 13	 3,6E-03	 1,3E-03	 2,6	
Neurotrophin	signalling	pathway	 13	 5,8E-03	 2,1E-03	 2,5	
Tight	junction	 12	 2,6E-02	 1,1E-02	 2,1	
PPAR	signalling	pathway	 12	 1,3E-04	 2,6E-05	 4,1	
Leukocyte	transendothelial	migration	 12	 1,1E-02	 4,0E-03	 2,4	
Antigen	processing	and	presentation	 10	 7,9E-03	 2,5E-03	 2,8	
Adipocytokine	signalling	pathway	 10	 1,8E-03	 4,6E-04	 3,5	
	 GO:Cellular	components	
Term	 Count	 P-Value	 Fisher	Exact	
Fold	
Enrichment	
Cell	 	 	 	 	
					Perinuclear	region	of	cytoplasm	 24	 4,00E-04	 1,60E-04	 2,3	
					Vacuole	 20	 2,40E-03	 1,00E-03	 2,2	
													Lysosome	 17	 4,90E-03	 2,00E-03	 2,2	
					Pigment	granule	 13	 9,40E-05	 2,10E-05	 4	
					Coated	vesicle	 12	 3,20E-02	 1,40E-02	 2,1	
Membrane	 	 	 	 	
					Basolateral	plasma	membrane	 17	 3,30E-03	 1,40E-03	 2,3	
					Membrane	raft	 12	 1,60E-02	 6,50E-03	 2,3	
					Organelle	outer	membrane	 13	 4,20E-04	 1,10E-04	 3,4	
					Cytoplasmic	vesicle	membrane	 12	 1,30E-02	 5,20E-03	 2,3	
	 GO:Molecular	functions	
Term	 Count	 P-Value	 Fisher	Exact	
Fold	
Enrichment	
Transporter	activity	 		 		 		 		
			Inorganic	cation	TMT	activity	 15	 1,6E-03	 5,6E-04	 2,6	
								Monovalent	inorganic	TMT	activity	 12	 1,8E-03	 5,2E-04	 3,1	
												Hydrogen	ion	TMT	activity	 10	 6,5E-03	 2,0E-03	 3	
				Anion	TMT	activity	 13	 9,3E-03	 3,6E-03	 2,4	
				Primary	active	TMT	activity	 10	 4,0E-02	 1,7E-02	 2,2	
								P-P-bond-hydrolysis-driven	TMT	activity	 10	 4,0E-02	 1,7E-02	 2,2	
Protein	binding	 		 		 		 		
			Protein	complex	binding	 16	 7,0E-03	 3,0E-03	 2,2	
				Unfolded	protein	binding	 15	 1,0E-04	 2,6E-05	 3,5	
				Heat	shock	protein	binding	 10	 1,7E-03	 4,3E-04	 3,6	
Transcription	corepressor	activity	 12	 2,1E-02	 8,5E-03	 2,2	
		 		 		 		 		
Cysteine-type	peptidase	activity	 11	 4,0E-02	 1,7E-02	 2,1	
	
Table	 1.	 KEGG-pathways,	 cellular	 components	 and	 molecular	 functions	 affected	 in	 cxcr3.2	 mutants.	









Biological	regulation	 		 		 		 		
				Regulation	of	cell	death	 66	 5,0E-09	 2,2E-09	 2,2	
				Response	to	organic	substance	 61	 4,3E-09	 1,8E-09	 2,3	
				Negative	regulation	of	molecular	function	 28	 1,5E-04	 6,2E-05	 2,2	
				Small	GTPase	mediated	signal	transduction	 25	 5,1E-04	 2,2E-04	 2,2	
				Negative	regulation	of	catalytic	activity	 23	 7,6E-04	 3,2E-04	 2,2	
				Regulation	of	binding	 18	 6,0E-05	 1,7E-05	 3,1	
				Response	to	bacterium	 18	 9,6E-04	 3,5E-04	 2,5	
				Regulation	of	cell	motion	 16	 6,1E-03	 2,5E-03	 2,2	
				Regulation	of	transcription	factor	activity	 14	 1,2E-04	 3,0E-05	 3,6	
				Regulation	of	I-kappaB	kinase/NF-kappaB	cascade	 13	 6,6E-04	 1,8E-04	 3,2	
				Response	to	oxidative	stress	 13	 2,1E-02	 8,9E-03	 2,1	
				Negative	regulation	of	protein	modification	process	 12	 5,1E-03	 1,7E-03	 2,7	
				Regulation	of	immune	effector	process	 11	 4,5E-03	 1,4E-03	 2,9	
				Negative	regulation	of	response	to	stimulus	 11	 4,2E-03	 1,3E-03	 2,9	
				Innate	immune	response	 11	 3,5E-02	 1,5E-02	 2,1	
				Detection	of	stimulus	 10	 3,3E-02	 1,3E-02	 2,3	
Cellular	process	 		 		 		 		
			Cell	death	 56	 3,4E-07	 1,5E-07	 2,1	
				Membrane	organisation	 32	 4,3E-05	 1,8E-05	 2,2	
				Mitochondrion	organisation	 14	 2,0E-03	 6,8E-04	 2,7	
				Histone	modification	 10	 4,0E-02	 1,7E-02	 2,2	
				Protein	folding	 19	 1,2E-04	 3,7E-05	 2,9	
				Regulation	of	translation	 11	 3,3E-02	 1,4E-02	 2,1	
Localisation	 		 		 		 		
				Intracellular	transport	 51	 1,4E-06	 6,4E-07	 2,1	
								Protein	targeting	 17	 7,1E-03	 3,1E-03	 2,1	
								Golgi	vesicle	transport	 14	 1,3E-03	 4,0E-04	 2,8	
								Nucleocytoplasmic	transport	 14	 5,8E-03	 2,2E-03	 2,4	
				Organic	acid	transport	 12	 2,3E-02	 9,9E-03	 2,2	
				Protein	localisation	in	organelle	 13	 8,8E-03	 3,4E-03	 2,4	
				Protein	import	 12	 1,0E-02	 3,8E-03	 2,4	
Metabolic	process	 		 		 		 		
				Monosaccharide	metabolic	process	 18	 4,2E-03	 1,8E-03	 2,2	
				Carbohydrate	catabolic	process	 14	 2,2E-04	 5,6E-05	 3,4	
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Deficiency in cxcr3.2 signalling affects intra-macrophage replication of mycobacteria 
To quantify the lysosomal content of cxcr3.2-/- and cxcr3.2+/+ macrophages, we stained 
lysosomes using LysoTracker, which is permeable in zebrafish larvae by bath exposure16. 
Notably, macrophages in cxcr3.2 mutant embryos displayed an increased staining when 
compared to wt (Figure 3A). To determine whether the lysosomal function is dysregulated 
in cxcr3.2 mutant macrophages, we injected pH-rodo labelled E. coli bioparticles and 
quantified phagosome acidification in vivo. In cxcr3.2-deficient embryos, the level of 
acidification at 30-45 minutes post injection (mpi) was significantly increased (~2 fold), 
indicating that lysosomes are still functional and that phagolysosome maturation is 
increased by cxcr3.2 deficiency (Figure 3B-D). Therefore, both RNA-sequencing analysis 
and functional in vivo assays suggested an increased lysosomal function. 
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To evaluate whether the enhanced lysosomal functionality results in better infection 
control, we investigated the capability of cxcr3.2 mutant macrophages to counteract initial 
infection with the intra-macrophage bacterial parasite M. marinum strain M (MmM), a wt 
isolate of the natural fish pathogen, which represents an established paradigm to study 
human mycobacterial diseases, such as tuberculosis and leprosy17,18,19,20. As expected, the 
acidification of MmM (24-28 hours post infection, hpi) was increased in cxcr3.2 mutants 
(Figure 4A). To assess the basal intracellular killing ability of macrophages in wt and 
cxcr3.2 mutant embryos, we injected MmΔerp bacteria21,22,23  and scored the capability of 
macrophage to contain the infection at 44 hpi. Consistent with previous acidification 
results, we found the intracellular killing of MmΔerp to be significantly increased in 
cxcr3.2 mutants (Figure 4B-C).  
 
We have previously shown that cxcr3.2 mutants display deficient macrophage-dependent 
mycobacterial dissemination and a reduced expansion rate of granuloma-like structures, 
which was attributed to the reduced macrophage trafficking within the granulomatous 
lesions10. However, the assays used here are performed at an initial infection stage that 
precedes the granulomatous phase. Furthermore, MmΔerp stain fails to induce macrophage 
aggregation21. Additionally, since bacteria are systemically delivered, the direct implication 
of macrophage recruitment at this stage is unlikely, as all bacteria are readily available to 
circulating macrophages and are rapidly phagocytosed. Of note, the level of intracellular 
bacteria at 30 mpi (MmM) and the number of established intra-macrophage infectious 
niches at 44 hpi (MmΔerp) were found similar in cxcr3.2 mutants and wt (Figure 4D-E), 
suggesting no difference in the level of initial phagocytosis and mycobacteria multiplicity 
per macrophage but only in their intramacrophage replication/killing rate. Taken together, 
these data show that cxcr3.2 mutation, by increasing the lysosomal functionality, exerts a 
bacteriostatic function and antagonises intra-macrophage bacterial replication. 
 
Cxcr3.2 controls macrophage polarity and lysosome localisation to the leading edge 
Previous in vitro studies linked CXCR3 signalling to lysosomal function. Stimulation of 
chemokine-dependent motility affected localisation of lysosomes into the cell and mediated 
their calcium-dependent fusion to the plasma membrane, a mechanism also known as 
lysosome exocytosis5. Despite that LysoTracker staining could not be trusted to quantify 
the occurrence of exocytosis in terms of signal decrease during cell migration (due to high 
frequency of image acquisition and high laser intensity, provoking bleaching) we could use 
this vital staining to determine whether macrophages displayed asymmetrical lysosome 
distribution during cell migration in vivo. Strikingly, we could establish that in wt 
macrophages, lysosomes are significantly localised to the leading edge of the moving cell, 
while their position remained central or non-correlated in non-moving macrophages 
(Figure 5, Supplementary Movie 1-2). In contrast, in cxcr3.2-deficient embryos, the 
lysosomal content of macrophages did not correlate with the movement of the cell. These 
observations strongly suggest that a cxcr3.2-dependent signalling is required to maintain 
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Infected macrophages express Cxcl11aa via Myd88-dependent immune recognition 
We previously demonstrated that cxcl11aa is highly upregulated during mycobacterial 
infection10. To determine the source of Cxcl11aa, we FACS-sorted mpeg1:mCherry-F 
positive macrophages from Mm infected and mock-injected larvae and quantified the level 
of cxcl11aa expression in the fluorescent (macrophages) and unlabelled (negative) cell 
fraction. In uninfected conditions, the expression of cxcl11aa was significantly enriched in 
the macrophage cell fraction (Figure 6A). This finding is in agreement with the function of 
Cxcr3.2 in the maintenance of the basal macrophage patrolling, which is most likely 
exerted via a chemokinetic autocrine/paracrine mechanism10. Additionally, during 
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Notably, this did not require the bacterial locus RD1 (Region of Difference 1), a 
pathogenicity locus encompassing the secretion system of ESAT-6 (Early Secreted 
Antigenic Target 6 kDa), which is associated with mycobacterial virulence and formation 
of tubercular granulomas24 (Supplementary Figure 1). 
 
Next, we asked whether cxcl11aa induction requires the central immune mediator Myd88, 
which links pathogen recognition by Toll-like receptors to activation of the transcription 
factor Nfκb25. Therefore, we quantified the expression levels of Cxcl11aa in myd88 
deficient larvae. Since myd88 mutants display an increased infection level when infected 
with the same initial infection load as wt siblings25, we compensated this with a reduced 
inoculum, to obtain a similar infection level at 4 days post infection (Figure 6B-D). Both 
with the reduced and the regular inoculums, myd88 mutants displayed a marked 
incapability to upregulate cxcl11aa, indicating that transduction of an active Myd88/Nfκb 
signalling is key to upregulate macrophage production of Cxcl11aa (Figure 6B). In 
agreement with this, we observed that Nfκb activation is also required to maintain the 
random patrolling of macrophages under uninfected conditions, suggesting that 
Myd88/Nfkb signalling is required for both induction and constitutive expression of 
cxcl11aa (Supplementary Figure 2). 
 
Based on our results, we propose a novel mechanism by which mycobacteria recognition 
can trigger acquisition of a permissive (lysosome-low) macrophage phenotype. 
Intracellular infection leads to immune recognition via Myd88. This, in turn, leads to 
induction of cxcl1aa and autocrine activation of its cognate chemokine receptor Cxcr3.2. 
Since in the absence of the Cxcr3.2-mediated pathway transcription of lysosomal genes is 
enhanced, wt activation of Cxcr3.2 signalling might contribute to attenuate the lysosome 
function and facilitate their exocytosis by controlling their recruitment to the leading edge. 
These effects would dissipate the innate capability of macrophages to counteract infection 
via lysosomal acidification and, therefore, increase the chances of successful establishment 
of an intracellular replication niche. 
 
DISCUSSION 
Lysosomes have long been known as cellular organelles that are principally involved in 
degradation and recycling of senescent/damaged cellular parts and undesired cytosolic 
contents, such as unfolded proteins and invading microbes. However, much broader 
functions for lysosomes are recently emerging. Not only have lysosomes been shown to 
function as signalling centres that control cellular adaptation to environmental cues, but 
lysosomes have also been shown to play a critical role in cell migration. Here we report a 
novel link between chemotactic signalling and transcriptional regulation of lysosomal 
function. Our study of a zebrafish mutant in the orthologue of chemokine receptor CXCR3 
demonstrates that upregulation of lysosomal gene expression due to suppressed CXCR3-
dependent motility can prime macrophages to better control intracellular infection. 
Furthermore, we show that mycobacterial parasitism activates this chemokine signalling 
cell-autonomously in the host macrophages, which suggests that intracellular 
mycobacterial colonisation, by exploiting CXCL11-CXCR3 signalling, might attenuate the 
lysosomal function and facilitate the establishment of parasitosis. 
 
CXCR3 is best known for its expression by T cells, but evidence that this receptor is 
crucial to control the function of monocyte/macrophage lineages (including tissue 
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macrophages8,9, perivascular macrophages12, tumour associated macrophages13, 
microglial14, Kupffer15 and dendritic cells26,27) continue to emerge, with a range of 
implications spanning from chemotaxis to cell homoeostatic maintenance and regulation of 
gene expression. Notably, expression of CXCR3 orthologues by the myelomonocytic 
lineages (and its chemotactic properties towards CXCL9-10-11 cues) is conserved among 
vertebrates, from fish to mammals6,7,8,9,10,12,28,29,30. We previously described that 
macrophage motility and recruitment to infectious foci is attenuated in zebrafish carrying a 
null mutation in cxcr3.2, the orthologue of mammalian CXCR3. Furthermore, we found 
this mutation to be associated with increased resistance to tuberculosis caused by Mm 
infection. Here, by analysing the transcriptional signature dependent on Cxcr3.2, we found 
that the presence of this receptor on macrophages affects the transcriptional control of 
lysosomal genes. Failure to execute the Cxcr3.2-dependent pathway in null mutants led to a 
transcriptional reprogramming of macrophages, characterised by a predominant 
upregulation of genes involved in Golgi and lysosomal vesicle trafficking as well as 
various lysosomal genes, including proton-transporting ATPases and endopeptidases, for 
example cathepsin L. By functional in vivo assays we subsequently demonstrated that 
mutation of cxcr3.2 also prevents lysosome polarisation during macrophage migration, and, 
as a consequence of the upregulation of lysosomal genes, cxcr3.2-deficient macrophages 
display an increased lysosomal content, an increased acidification rate of bacteria-
containing compartments and enhanced Mm killing. 
 
The link between lysosomal function and chemotaxis has only recently emerged. 
Chemotactic signals, by stimulating an increase in cytosolic calcium, enable migration of 
lysosomes to the leading edge of moving cells5. At the leading edge, high levels of 
cytosolic calcium mediate formation of SNARE complexes by modulating the activity of 
proteins of the synaptotagmin family, including SYT7 and SYTL5. Synaptotagmins, 
together with specific RABs, permit docking and fusion of lysosomes to the plasma 
membrane (lysosomal exocytosis). This process is thought to facilitate cell migration by 
providing a source of phospholipid bilayer and by promoting the release of the uropod 
(trailing edge). Lysosome exocytosis has also been reported to occur for plasma membrane 
repair and for various secretion processes, for example by cytotoxic T-cells and mast 
cells31,32. Notably, apart from chemotactic triggers, lysosomal exocytosis has been 
described during several intracellular infections, including of mycobacterial nature33. 
 
In agreement with the in vitro evidence for the role of lysosomes in sustaining chemotaxis, 
our in vivo results demonstrate that Cxcr3.2-dependent signalling controls localisation of 
lysosomes in the moving cell at the leading edge, the site where they eventually exocytose. 
Our study additionally revealed that reduced transduction of chemokine signals can affect 
lysosomal maintenance also at transcriptional level, since depletion of cxcr3.2 led to 
upregulation of lysosomal gene expression. The existence of a concerted transcriptional 
basis that controls lysosomal homoeostasis is consistent with recent reports34. The master 
transcription factor EB (TFEB) was reported to control the Coordinated Lysosomal 
Expression and Regulation (CLEAR) gene network35. Under aberrant lysosomal storage 
conditions, or when lysosomes are under stress (for example during the response to 
infections), TFEB dissociates from the lysosome surface and translocates to the nucleus 
where it promotes direct transcription of lysosomal genes. We suspect that reduced 
trafficking of lysosomes, as a consequence of abolished basal motility in cxcr3.2 mutants, 
may be sensed as a stressor and lead to activation of the CLEAR response, which in turn 
will increase intracellular lysosome content and thereby prime Cxcr3.2-deficient 
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macrophages to better withstand infection. In line with this hypothesis, it has been reported 
that TFEB and the CLEAR-network are activated to increase the pool of lysosomes in the 
proximity of the plasma membrane and to promote their exocytosis36. Interestingly, this 
mechanism is mediated by raising intracellular Ca2+ levels through the activation of 
lysosomal Ca2+ channels, differently from chemokine-based Ca2+ fluxes, which mostly 
derive from IP3-dependendent modulation of endoplasmic reticulum storage. This may 
suggest that the CLEAR response in the chemotactic-deficient conditions of cxcr3.2 
mutants attempts to restore normal lysosome trafficking by stimulating the alternative 
mobilisation of Ca2+ from lysosomal storage. Notably, the CLEAR network appears to be 
involved in the regulation of additional lysosome-associated processes, including 
autophagy, exo/endocytosis, melanogenesis, phagocytosis, and immune response, as well 
as in several non-lysosomal responses, such as expression of digestive enzymes, genes 
related to sugar metabolism, MAPK signalling, adipocytokine signalling pathway, 
chemokine signalling etc37. This might in part explain why several of these CLEAR-related 
pathways appear regulated also in our study (Table 1-2). 
 
Multiple genetic diseases, including lysosomal storage disorders such as Gaucher’s, 
Niemann-Pick’s disease and Tay-Sachs syndrome, are associated with impaired lysosomal 
function and increased susceptibility to infections38,39,40. Knockdown of the zebrafish 
orthologues of three genes linked to lysosomal storage disorders in man 
(glucocerebrosidase 1, hexosaminidase A, and arylsulfatase A) was recently found to result 
in hypersusceptibility to tuberculosis41. Similarly, knockdown of the gene for cathepsin L 
and mutation of a transcriptional coregulator, Snapc1b, which regulates cathepsin L, 
caused tuberculosis hypersusceptibility in the zebrafish model41. All these genetic 
deficiencies are associated with an inability of macrophages to contain the mycobacterial 
infection due to a severe migration defect that results from the progressive accumulation of 
cellular debris in lysosomes41. A comparable defect is found in zebrafish mutants in 
components of Rag-regulator complex, which is part of the CLEAR network42. In these 
mutants, microglial cells (the resident macrophages of the brain) are unable to digest 
apoptotic neurons despite an expanded lysosomal compartment. Adding to these studies, 
our work reveals that lysosome function can be genetically enhanced by a transcriptional 
response that is directly linked with chemotactic signalling. Macrophages in cxcr3.2 
mutants are still able to migrate normally in response to Cxcr3.2-independent cues, but 
their basal motility and ability to disseminate mycobacterial infection are reduced10. We 
propose that these altered chemotactic responses together with the enhanced lysosomal 
function act synergistically to increase the resistance of cxcr3.2 mutants to tuberculosis. In 
addition, we have shown that, by exploiting a Myd88-dependent signalling axis, 
mycobacteria can increase the expression of Cxcl11aa, the cognate ligand of Cxcr3.2. This 
implicates that immune recognition of the pathogen can lead to activation of the 
chemokine/lysosome circuit that will ultimately suppress the antimicrobial capability of the 
host cells. 
The regulative function exerted by CXCR3 on lysosomal maintenance seems to be 
conserved between zebrafish and mammals. A previous study in CXCR3-knockout mice 
revealed that microglial cells can eliminate more efficiently amyloid deposits and prevent 
the onset of Alzheimer disease more efficiently in CXCR3-deficient conditions. This 
phenotype was, at least partly, due to an increased size of the lysosomal compartment and 
to a more efficient maturation of phagolysosomes occurring in these cells14. Furthermore, 
CXCR3 expression was linked to diet-induced steatohepatitis (liver inflammation with fat 
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accumulation) through induction of lipogenic genes and impairment of autophagolysosome 
maturation. In this model, pharmacological blockade of CXCR3 using receptor antagonists 
could reverse the disease and facilitated clearance of lipid inclusions15. 
Taken together, our work indicates that CXCR3-CXCL11 signalling exerts multiple 
functions on macrophages during the inflammatory processes, by controlling their initial 
recruitment to infection foci, their reverse migration facilitating tissue dissemination of 
mycobacteria, their motility during granuloma formation and, as shown in here, their 
intrinsic microbicidal/degradative capabilities. Mycobacteria seem to have evolved 
multiple mechanisms for manipulating this signalling axis to regulate macrophage 
trafficking to the infection focus, drive macrophage-dependent dissemination and 
ultimately suppress the basal bactericidal property of the host cell. Application of anti 
CXCR3-therapies may, therefore, represent a valuable strategy to combat mycobacterial 
diseases on multiple fronts, and possibly to counteract also other non-infectious diseases 
that arise from lysosomal dysfunctions. 
 
MATERIALS AND METHODS 
Zebrafish lines and maintenance – Zebrafish lines were handled in compliance with the 
local animal welfare regulations and maintained according to standard protocols (zfin.org). 
The breeding of fish lines was approved by the local animal welfare committee (DEC) of 
Leiden University (license number: 10612) and adhered to the international guidelines 
specified by the EU Animal Protection Directive 2010/63/EU. All experiments were 
performed on embryos/larvae that had not reached the stage of independent feeding. Fish 
lines used in this work were the following: the macrophage reporter line 
Tg(mpeg1:mCherry-Fump2)43, (cxcr3.2hu6044)10 homozygote mutant (cxcr3.2-/-) and wildtype 
(cxcr3.2+/+) siblings, the combination of (cxcr3.2hu6044) allele with Tg(mpeg1:mCherry-
Fump2), and the (myd88hu3568)25 homozygote mutant (myd88-/-) and wildtype (myd88+/+) 
siblings. Embryos were generally maintained at 28.5°C in egg water (60 µg/ml sea salt, 
Sera Marin, Heinsberg, Germany). For pH sensitive experiments (pH-rodo acidification 
assay, LysoTracker staining), embryos were placed in E2 medium (15 mM NaCl; 0.5 mM 
KCl, 1.0 mM MgSO4, 150 µM KH2PO4, 50 µM Na2HPO4, 1mM CaCl2; 0.7 mM NaHCO3) 
at least 6 h before the experiment and maintained in E2 medium during the experimental 
work. Larvae destined to image acquisition were maintained in medium water 
supplemented with 0.003% PTU (1-phenyl-2-thiourea; Sigma-Aldrich, St Louis, MO, 
USA) from ~8 hpf to prevent pigmentation. Anaesthesia of embryos/larvae was achieved 
with 0.02% buffered Tricaine (3-aminobenzoic acid ethyl ester; Sigma-Aldrich) in egg 
water or E2 medium. 
 
FACS-sorting, RNA isolation, cDNA preparation and RNA-sequencing analysis – 
mpeg1:mCherry-F-positive and unlabelled cells were sorted from                    
Tg(mpeg1:mCherry-F/cxcr3.2-/-) and wt siblings at 6 dpf. Dissociation of larvae and FACS 
was performed according to reference44. RNA was obtained using the miRNeasy mini kit 
(Qiagen), and residual genomic DNA was eliminated by DNase treatment (RNase-Free 
DNase Set, Qiagen). cDNA preparation was performed using the SMARTer® Universal 
Low Input RNA Kit for Sequencing (Clontech) according to the manufacturer’s guidelines. 
Illumina RNA sequencing and the mapping and counting of reads was outsourced to ZF-
screens (Leiden, the Netherlands) and performed as in reference44. Statistical analysis of 
the read count data was performed using the DESeq2 bioinformatic package 
Chapter	4	
114	
(https://bioconductor.org/packages/release/bioc/html/DESeq2.html)45 and default settings 
for paired analysis test, using triplicate data sets of mpeg1:mCherry-F positive cells, 
derived from three pools of > 150 larvae/each, obtained from three independent group 
crosses of cxcr3.2-/- and cxcr3.2+/+. Before processing, lowly expressed genes (sum of 
reads from three mutant and three wt replicates < 50 total reads), were removed. For gene 
ontology analysis, we selected significantly expressed genes using a p.adj < 0.05 and 
│log2(fold change)│> 0.5 cut off. Significantly affected KEGG-pathways, GO:cellular 
components, GO:molecular functions or GO:biological processes (Table 1-2) were 
predicted by submission of the list of human orthologues of the significantly regulated 
zebrafish genes to DAVID bioinformatic tools (https://david.ncifcrf.gov)46. Zebrafish-
human orthologous correspondences were derived from g:profiler 
(http://biit.cs.ut.ee/gprofiler)47 and curated with manual annotations (zebrafish gene 
products that did not have an annotated human orthologue were assigned to the closest 
human orthologue based on the same gene name or high protein sequence identity when 
blasted to the Ensembl human protein database; genes that did not have any clear human 
orthologue were discontinued). The cut-off for gene enrichment analysis was set to p.value 
< 0.05, Fisher Exact test < 0.05, number of affected genes ≥ 10, fold enrichment > 2. To 
generate Figure 2A-C, genes were annotated to compartments according to their 
GO:cellular component annotations (using Gene ontology annotation database available at 
geneontology.org). Genes could be associated with multiple compartments. Statistical 
divergence of Lysosome and Golgi-related genes from the general trend of the other 
regulated genes (Figure 2 B) was tested by chi-squared test analysis (with Bonferroni post-
hoc correction for False Discovery Rate). 
 
Microinjections, bacterial cultures and infection delivery – Where not differently 
specified, approximately 200 CFU of Mycobacterium marinum strain M (or where 
specified its isogenic mutant strains Mm Δerp or Δrd1) constitutively fluorescently labelled 
with eGFP, mCherry, mCrimson or Wasabi22,48 were injected in a volume of 1-2 nl into the 
blood island/caudal vein of zebrafish embryos at 28-30 hpf. For the assessment of the 
microbicidal activity of macrophages against initial mycobacterial infection, a single-cell 
suspension of MmΔerp-Wasabi was injected from -80°C frozen single-use aliquots, using a 
protocol adapted from reference22. Briefly, bacteria from a 1-week-old plate were 
inoculated to an OD600 of 0.2 in 10 ml 7H9 medium supplemented with ADC enrichment. 
The culture was grown for 24 h to reach an OD of 1.0. Bacteria were washed 3 times in 
Phosphate Buffer Saline (PBS) and suspended in PBS supplemented with 10% glycerol to 
an OD600 of 5.0. 50 µl aliquots were frozen in liquid nitrogen and stored at -80°C. Upon 
thawing, the vital bacteria were quantified by plating as being approximately 100 CFU/nl. 
In all the other cases, bacteria were prepared from a fresh culture as described in 
reference10. For the acidification assay (Figure 3A-D) 1 ng E. coli pH-rodo bioparticles 
conjugate for phagocytosis (Invitrogen) were injected into the blood island/caudal vein at 
32-37 hpf and imaged over the yolk at 30-45 mpi. Similarly, for the phagocytosis assay 
(Figure 4E) MmM-mCrimson bacteria were injected in mpeg1:mCherry-F individuals at 
33-34 hpf, fixed at 30-32 mpi and imaged over the yolk as fixed samples (see below). 
 
LysoTracker staining – For visualisation of acidic compartments, 2 dpf embryos were 
stained for 1-2 hours with 10 µM LysoTracker green DND-26 (Invitrogen) in E2 medium 
via bath exposure. Before imaging, embryos were quickly rinsed 3 times with E2 medium 




Imaging and image quantification – For still image and time-lapse acquisition, fixed or 
live embryos/larvae were mounted in 1.5-2% low-melting-point agarose (SphaeroQ, 
Burgos, Spain) and imaged with a Zeiss Observer 6.5.32 laser-scanning confocal 
microscope (Carl Zeiss, Sliedrecht, The Netherlands). To quantify LysoTracker 
acidification of macrophages (Figure 3A), the mean intensity of LysoTracker staining 
overlapping with the mpeg1:mCherry-F transgene at 2dpf was measured using Fiji/Image J 
quantification tools. Similarly, to quantify Mm acidification in vivo (Figure 4A) the mean 
intensity of LysoTracker staining overlapping with MmM-mCrimson signal (1 dpi/2 dpf) 
was measured. To evaluate acidification of E. coli bioparticles (Figure 3B), the intensity of 
bioparticles clusters was analysed from pictures. % of phagocytosis of MmM at 30 mpi was 
quantified as % of MmM-Wasabi signal overlapping with mpeg1:mCherry-F signal (over 
the yolk) from fixed (O/N in 4% paraformaldehyde in Phosphate Buffer Saline 
supplemented with 0.08% of Triton X100) embryos. All images used for quantification in 
Figure 3-4 were acquired with Plan-Neofluar 40x/0.9 Imm corr objective (Carl Zeiss). 
Data are expressed as % relative to wt (set to 100%). To score the microbicidal activity of 
macrophages against mycobacteria (Figure 4B-C), Tg(mpeg1:mCherry-F) embryos 
injected with Wasabi-labelled MmΔerp were fixed at 44 hpi, according to reference23 and 
intra-macrophage mycobacterial sites of growth were counted (blind) using a C-
Apochromat 63x/1.20 W Korr UV-VIR-IR objective (Carl Zeiss). In Figure 4C, the level 
of infection per macrophage was classified into three classes based on the severity of 
bacterial content (1-5 bacteria, 6-10 bacteria or >10 bacteria). In Figure 4B, each larva was 
assigned to one of these three classes according to its predominant macrophage phenotype 
(most frequently observed class of macrophage phenotype per individual larva). In case 
multiple classes showed the same percentage of macrophage phenotype, larvae were 
assigned to the most severe class among those. 
 
Time-lapse analysis – The average speed and tracks of macrophages (Figure 1, 
Supplementary Figure 2) were calculated as previously described in reference10, from 
movies acquired with an EC Plan-Neofluar 10x/0.30 M27 objective (Carl Zeiss) for 1 hour 
and an acquisition frequency of 2 minutes. Localisation of lysosomes to the leading edge 
(Figure 5, Supplementary Movie 1-2) was quantified by time-lapse imaging of 
LysoTracker-positive moving macrophages using Plan-Neofluar 40x/0.9 Imm corr 
objective and at an acquisition rate of <1 photogram/30 sec. The position of LysoTracker 
was quantified at the maximum extension of the cell during the time-lapse acquisition, by 
determining the ratio between the level of cell LysoTracker staining in the anterior and in 
the posterior half of the cell in the direction of movement. 
 
qRT-PCR – To address dependency of cxcl11aa on myd88 signalling, and the effect of 
bacterial infection on cxcl11aa induction, RNA was isolated from myd88-/- and myd88+/+ 
whole larvae (infected with MmM, Figure 6B) and from cxcr3.2-/- and cxcr3.2+/+ larvae 
(infected with MmM or its isogenic attenuated strain MmΔrd1, Supplementary Figure 1) 
at 4 dpi according to reference10. To address the macrophage specificity of cxcl11aa 
induction during infection (Figure 6A), we sorted the macrophage population of 
Tg(mpeg1:mCherry-F) line (and the unlabelled population) from infected or uninfected 
(mock injected) larvae at 5 dpi and extracted RNA as described above. cDNA synthesis, 
qRT-PCR protocol and analysis were performed as previously described in reference10. 
Expression of cxcl11aa was compared to ppiab for whole-mount analyses and to eif5 for 




CTTCAGCGTGGCTATGACTTCCAT; ppiabFw: ACACTGAAACACGGAGGCAAAG; 
ppiabRv: CATCCACAACCTTCCCGAACAC; eif5Fw: CAAGTTTGTGCTGTGTCCCG; 
eif5Rv: AGCCTTGCAGGAGTTTCCAA. 
 
Statistical analysis – Statistical significance was analysed using GraphPad Prism 6 
(GraphPad Software, La Jolla, CA, USA). RNA sequencing statistical analysis was 
performed as described above in the dedicated section. Data in Figure 1, Figure 3, Figure 
4A and Figure 5 were statistically analysed by two-tailed t-tests. Individual two-tailed t-
tests were used also to analyse the difference in % of macrophage phenotypic class upon 
infection (Figure 4C). Chi-squared contingency was used to test different distribution of 
larva phenotypes upon infection (Figure 4B). No difference in number of infected 
macrophages in the counting area (Figure 4D) was assessed by Mann-Whitney test. 
Differences in infection burden in Figure 6D and in cell speed in Supplementary Figure 
2 were statistically tested by Kruskal-Wallis test followed by $idák comparison test of 
selected pairs. For qRT-PCR, statistical significance was estimated by two-tailed t-tests on 
ln(n)-transformed relative induction folds. Significance (P-value) is indicated with: ns, 
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Supplementary Figure 1. cxcl11aa induction does not require the RD1 pathogenicity locus and cxcr3.2 
mutants are still able to upregulate cxcl11aa at comparable levels to wt.  
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Zebrafish immune cells express three homologues of the human chemokine receptor 
CXCR3. We have recently shown that one of these homologues, Cxcr3.2, plays an 
important role in macrophage migration and dissemination of mycobacterial infection, 
suggesting that inhibition of CXCR3 signalling could be used as a host-directed therapeutic 
strategy for treatment of tuberculosis. However, the functions of the other CXCR3 
isoforms in zebrafish remain to be elucidated. Here, we successfully applied CRISPR/Cas9 
genome editing tools to obtain non-sense mutants of the cxcr3.3 gene. Additionally, we 
introduced several optimisations to the CRISPR/Cas9 editing system that facilitated an 
efficient application of the method in terms of time, costs and yield. As a result, cxcr3.3 
was efficiently mutated in 70% of injected embryos, leading to a similar yield of adult 
germ-line mosaic carriers. Initial characterisation of cxcr3.3 mutants revealed that 
homozygote mutation is viable, does not provoke evident discomfort to the carriers and is 
maintained according to Mendelian proportions. When tested in the zebrafish tuberculosis 
model, cxcr3.3 mutants displayed an increased burden of mycobacterial infection. 
Unexpectedly, this phenotype is opposite to that of cxcr3.2 mutants that more efficiently 
counteract initial mycobacterial replication and mycobacterial dissemination in the 
granulomatous stage. Sequence analysis of CXCR3 from fish and other vertebrates 
revealed that Cxcr3.3 in zebrafish may function as an atypical chemokine receptor 
(ACKR), since it displays replacement of key amino acid residues essential to mediate the 
activation of heterotrimeric G-proteins. Notably, the presence of atypical Cxcr3 receptors 
appears conserved among fish species, although it was possibly lost at the radiation of 
tetrapods, since only classical CXCR3 receptors are present in amphibians, reptiles and 
mammals. This suggests that Cxcr3.3 may exert a regulatory function on Cxcr3.2 
signalling by scavenging/competition for ligands. Further mechanistic studies should be 
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Chemokines constitute a family of potent chemotactic molecules which play complex 
pleiotropic functions in the control of the immune response and of host-pathogen 
interactions1. The zebrafish (Danio rerio) is an attractive vertebrate model to study this 
complexity in vivo, as it provides both a genetically tractable system, to generate new 
genetically-encoded tools, and an optically-accessible platform to follow the dynamics of 
immune cells and processes intravitally2. The genetic tractability of zebrafish enabled 
generation of a multitude of transgenic and mutant lines of interest for the immune system 
and in particular to study chemokine receptors, a class of 7-loop transmembrane (7TM) and 
G-protein coupled receptors (GPCR) that signal via their cognate chemokine ligands. For 
example, wildtype (wt) and mutated versions of Cxcr4b have been fused with fluorescent 
proteins to study receptor expression/internalisation dynamics and its function in 
controlling cell migration and phagocyte mobilisation3,4. Random mutagenesis screening 
programmes5 have provided widely used null chemokine ligand and receptor mutants, such 
as cxcl12a6, cxcr4b7, cxcr7b8 (also known as atypical chemokine receptor 3b, ackr3b), 
and cxcr3.29. These mutants, used in combination with transgenic reporters that allow 
differential labelling of immune cell types, have been critical for in vivo analysis of 
immune responses and cell motility. 
 
Recent advances in genome editing strategies provided the possibility to specifically target 
genes of interest, including chemokine ligands and receptors10,11. As a consequence, these 
technologies are contributing to greatly expand the array of genetic tools available to the 
zebrafish field. State-of-the-art genome editing techniques include zinc finger nucleases 
(ZFN), transcription activator-like effector nucleases (TALEN), and clustered regularly 
interspaced short palindromic repeats-associated protein 9 (CRISPR/Cas9) 
technology12,13,14. All these techniques have been efficiently applied to zebrafish genome 
editing, for both insertion of transgenic constructs and generation of transmissible 
mutations15,16,17,18. However, CRISPR/Cas9 technology has several advantages when 
compared to ZFN and TALEN techniques and is, therefore, becoming the predominantly 
used method for genome manipulation13. In both ZFNs and TALENs, recognition of the 
DNA target site and the endonuclease activity are driven by specific protein domains. 
However, in CRISPR/Cas9 technology, recognition of the target depends on a short guide 
RNA (shgRNA) which pairs to the target site by nucleotide matches, while the actual 
endonuclease activity is catalysed by a universal Cas9 protein, driven to the target site by 
matching to a constant region of the shgRNA (Figure 1). 
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Because of this difference, the construction of ZFN and TALEN nucleases requires 
complex and laborious multistep cloning strategies or acquisition of costly synthetic 
constructs to build up the DNA templates encoding the target-specific ZFN/TALEN 
recognition protein domains. A major advantage of CRISPR/Cas9 technology is that it 
requires only simple molecular biology tools (primers/short oligo templates or simple 
cloning procedures) to engineer the shgRNA template responsible for the base-pairing-
dependent target recognition.  
 
In the CRISPR/Cas9 protocol used in this study, the shgRNA consists of 101 bases with a 
20-nucleotide-long sequence complementary to the DNA target site (at its 5’ extremity) 
(Figure 1)12,13. This sequence is fundamental for the target recognition via base-pairing. 
The remaining shgRNA sequence contains the RNA hairpins required to form a complex 
with the Cas9 endonuclease. Cas9 does not participate in the recognition of the 20-base 
target site; however, it requires that the target site is followed by a Protospacer Adjacent 
Motif (PAM) sequence (most commonly 5’-NGG-3’)12,13. The PAM sequence provides an 
anchoring site, which is fundamental for efficient cleavage. Following recognition of the 
target site, a double strand break will be generated within the genomic target site, most 
likely three nucleotides upstream of the PAM sequence. The 8-12 bases immediately 
upstream of the PAM motif represent the “seeding sequence” and any mismatches in this 
region will abolish shgRNA/Cas9 activity. Mismatches beyond this nucleotide sequence 
are generally tolerable12,13. This has a direct impact on the specificity and on off-target 
effects that the CRISPR/Cas9 technique might have, compared with other gene editing 
techniques which generally require recognition of longer consensus sequences. However, a 
new variant of high fidelity Cas9, carrying sequence optimisations designed to reduce non-
specific DNA contacts, is already available and appears to not provoke any detectable off-
target effects19. Due to its simple approach, high efficiency and low costs, the 
CRISPR/Cas9 technique is becoming the elective technique for genome editing. 
 
Like other teleosts, zebrafish have experienced three rounds of whole genome duplication 
(WGD) resulting in an increase of the copy number of several genes20. Moreover, some 
further zebrafish-specific chemokine gene cluster expansions have been observed. 
Comparative analysis of the zebrafish and human genomes revealed that whilst there are at 
least 36 putative chemokine receptors and 75 putative chemokine ligands in zebrafish, only 
25 chemokine receptors and 45 chemokine ligands have been mapped to the human 
genome20. The CXC-motif subfamily of chemokine receptors and ligands 
(CXCRs/CXCLs) is involved in multiple processes, spanning from the trafficking of 
leukocytes to the regulation of angiogenesis. These CXCR/CXCL subfamilies are less 
divergent between lower vertebrates and mammals, compared with other chemokine ligand 
and receptor families. For example, at least 11 canonical CXCRs and 20 CXCLs have been 
identified in zebrafish, versus 7 canonical CXCRs and 17 CXCLs described in humans20. 
 
Several cases of functional and ligand/receptor partnership conservation have been 
described for the zebrafish and mammalian CXCR/CXCL counterparts. CXCR2/CXCL8 
signalling leads to the chemoattraction of human neutrophils and their recruitment to 
inflamed sites21,22. Notably, an orthologous Cxcr2/Cxcl8a signalling axis exists in 
zebrafish23, while this powerful neutrophil chemoattractant signal is not represented in 
rodents24,25. CXCR4/CXCL12 interaction is involved in haematopoietic stem cell (HSC) 
and leukocyte mobilisation/homoeostasis26,27, in cancer and HIV pathogenesis28,29. 
Similarly, the Cxcr4b/Cxcl12a zebrafish axis recapitulates several conserved roles in innate 
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immunity, such as the retention of neutrophils and macrophages in haematopoietic tissues4, 
recruitment of HSCs to the definitive sites of haematopoiesis30 and in metastasis of cancer 
xenografts31. The CXCR4/CXCL12 axis is duplicated in zebrafish and a Cxcr4a/Cxcl12b 
axis also exists32. However, the two seemingly redundant systems experience sub-
functionalisation and each control specific functions played by their mammalian 
CXCR4/CXCL12 counterpart. Notably, while disruption of this axis is embryonic lethal in 
mammals33,34,35 the partial redundancy of the CXCR4/CXCL12 system permits the 
existence of viable knockouts, displaying attenuated and more specific phenotypes, which 
proved extremely useful to study particular aspects regulated by this axis in vivo. 
 
CXCR3 is expressed by different types of leukocytes, including T lymphocytes, natural 
killer cells, macrophages and dendritic cells and plays an important part in trafficking and 
function of these cell types in inflammatory and autoimmune diseases36,37,38,39. The ligand 
of this receptor in mammals is represented by a triplet of inflammatory chemokines, 
namely CXCL9-10-11. In zebrafish, three copies of this gene are present, cxcr3.1, cxcr3.2, 
cxcr3.3 (Figure 2A)9. Of these three isoforms, only cxcr3.2 has been recently 
characterised, as being involved in controlling the microbicidal capability of 
macrophages40, the migration of macrophages to infection foci, and macrophage-mediated 
dissemination of mycobacterial infection9. It is still unknown whether the other two 
isoforms have complementary/redundant functions. Likewise, the cluster of CXCL9-10-11 
chemokines (which represent the class of interacting partners of CXCR3-like receptors) is 
also expanded in zebrafish and includes 7 ligands, namely Cxcl11aa-ac-ad-ae-af-ag-ah9,20. 
While the sole human CXCR3 responds to CXCL9-10-11, it seems that not all the 
zebrafish Cxcl11 ligands are able to elicit a Cxcr3.2-dependent response9. Cxcl11aa and 
Cxcl11af were shown to mobilise macrophages via Cxcr3.2, while Cxcl11ae was able to 
comparably recruit macrophages also in the cxcr3.2 null mutants. This suggests that 
Cxcr3.1, Cxcr3.2 and Cxcr3.3 and their ligand partners are not completely redundant and 
interchangeable, similar to the Cxcr4a/b/Cxcl12a/b system32. RNA-sequencing and qRT-
PCR data of Fluorescence-Activated Cell Sorting (FACS) of macrophages, neutrophils and 
immature T cells revealed that cxcr3.1 was only detectable in immature T cells, while 
cxcr3.2 and cxcr3.3 were significantly expressed by both macrophages and neutrophils9,41, 
suggesting cell-type functional specialisation. 
 
Our previous analysis of a zebrafish cxcr3.2 mutant in the zebrafish embryo model for 
tuberculosis suggested that inhibition of CXCR3 signalling could be used as a host-directed 
therapeutic strategy for treatment of the mycobacterial infection causing this disease9. As 
mentioned above, cxcr3.2 and cxcr3.3 display a similar macrophage and neutrophil-
specific expression profile in the embryo model. Since a cxcr3.3 mutant was not available 
and the function of this gene in recruitment, development and mobilisation of immune cells 
is unknown, we aimed here to apply CRISPR/Cas9 technology to disrupt cxcr3.3. We 
additionally present our own adaptations to the CRISPR/Cas9 method which allowed 
synthesis of shgRNAs from a PCR-based template and in vivo selection of target sites with 
high mutagenesis efficiency. Finally, we present a preliminary characterisation of the 
cxcr3.3 mutants we obtained in the zebrafish tuberculosis model. Notably, cxcr3.3 
mutation revealed the opposite effect to that seen in the context of cxcr3.2 mutation. 
Interestingly, cxcr3.3 does not contain the DRY (Asp-Arg-Tyr) motif, which is 
fundamental to transduce GPCR signalling, which suggests that this receptor may act as an 
atypical chemokine receptor. These findings emphasise the need for an in-depth 
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CRISPR target design 
There are several bioinformatic tools available to design CRISPR targets. Finding a 
putative target site is simple since virtually any genomic 5’-(N)21GG-3’ sequence is a 
possible site for CRISPR targeting (Figure 1). However, since the synthesis or shgRNA 
implies transcription from a T7 promoter and since T7 RNA-polymerase most preferably 
initiates transcription from a G, this forces the design of efficiently transcribed targets to 
respect the 5’-G(N)20GG-3’ sequence constraint. Notably, other transcription promoters 
may be used to drive expression of the shgRNA (e.g. U6, SP6), which would not require 
the presence of a G at the +1 position. Likewise, recently novel versions of Cas9 (derived 
from other bacteria and requiring alternative PAM sequences) are also available. Therefore, 
if necessary, alternative designs are possible. Apart from the transcription-related and 
Cas9-related constraints, many other filtering criteria apply when selecting a target site. 
These include the intronic-exonic architecture, the probability of epigenetic 
modification/accessibility of the target at the genomic site, the GC content, the specificity 
of the target site/probability of off-target effects, the existence of self-complementarities 
and secondary structures in the shgRNA. Therefore, different online tools provide a 
classification of the targets according to scoring criteria that take into account several 
variables. 
 
To target cxcr3.3, we selected 4 candidate target sequences, respecting the 3’-G(N)20GG-5’ 
signature and falling into a relatively proximal region of the coding sequence of cxcr3.3 
(within 396 dNTPs/132 aa from the translation start) (Figure 2B-E and Table 1). The first 
2 targets (Target A and B) were obtained using a CRISPR/Cas9-dedicated engine from 
ZiFiT Targeter Version 4.2 (http://zifit.partners.org/ZiFiT/CSquare9Nuclease.aspx). The 
other two targets (Targets C and D) were obtained as 2 top scoring hits by the CHOPCHOP 
web-tool (https://chopchop.rc.fas.harvard.edu/index.php)42. ZiFit does not provide any 
support in the selection of the targets, based on their properties. Therefore, the list of 
putative targets was screened manually, based on proximity of the target to the 5’ end of 
cxcr3.3 and on the presence of putative off-targets. Differently, the CHOPCHOP web-tool 
uses a specific algorithm that scores and ranks potential target sites42. A Bowtie-based 
alignment system (an ultrafast and efficient algorithm to align short sequences to full 
genomes43) allows the identification of the most specific target sites. Target sites are 
therefore ranked based on number of off-targets, number of mismatches (when searching 
for putative off-targets), proximity of the target site to the ATG of translation start (the 
more proximal, the better), GC content (best if 50-60%), and the presence of a G at 
position 20 (which appears to improve the cutting rate44). For comparison, we also used a 
published target for eGFP15 (Table 1), aiming to assay by fluorescence the efficiency of the 
CRISPR knockout by mutation of an eGFP transgene from a zebrafish transgenic line 
(Tg(fli1a:eGFP)45, see results sections for explanation and further details). 
 
Preparation of shgRNA 
Most of recent reports used a cloning-based strategy to obtain a DNA template for in vitro 
transcription of shgRNA16,46,47.48,49,50,51. However, few reports have indicated that short 
transcripts can be also transcribed with cloning-free systems based on synthetic DNA 
oligonucleotide templates15,17,52,53. This second option appears more desirable, since it 
would facilitate and accelerate the synthesis process, and is suited to set up a standardised 
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method that can be immediately adapted for targeting new genes of interest or to carry 
multiple targets at once. The downside of the oligonucleotide-based synthetic strategies 
versus the plasmid-based ones may be the limited yield of templates, the large costs of 
synthesis and the poor transcription efficiency to obtain the final RNA product. In order to 
identify the most efficient system to obtain shgRNA, we compared three different sources 
of DNA template (Figure 3): full-length (122-bases) synthetic single-stranded DNA 
(ssDNA) template (Method 1); dsDNA derived from a PCR-based complementation and 
amplification of full-length (122-bases) synthetic ssDNA oligonucleotide (Method 2); 
dsDNA template derived from PCR-based complementation and amplification of two 81-
base-long semi-complementary oligonucleotides (Method 3). Although the T7 RNA 
polymerase does not require a dsDNA template, it requires the T7 promoter site to be 
double-stranded,54. Therefore, for Method 1, RNA was transcribed upon annealing of an 
equimolar concentration of T7 primer, in order to complement the T7 promoter site (See 
Materials and Methods for more details). Comparing the yields of shgRNA product 
obtained with the 3 methods, we found that the Method 1 was extremely inefficient, 
yielding < 0.2 µg of total RNA. Method 2 and 3 had comparable efficiencies, yielding over 
40 µg of total RNA product (Table 2). Between Method 2 and 3, we found Method 3 
technically more convenient. Since the target site-specific sequence is localised at the 5’ 
extremity of the DNA template, it could be confined entirely into the forward 81-mer 
oligonucleotide. This means that the reverse 81-mer oligonucleotide matches exclusively to 
the constant shgRNA region (common to any shgRNAs). Synthesis of >100 bp synthetic 
oligos (Method 1 and 2) is costly, takes longer delivery time, requires polyacrylamide gel 
electrophoresis (PAGE)-based purification, and is more prone to introduction of sequence 
errors. This is particularly true for a shgRNA template, that includes long stretches of 
repetitive nucleotides. By using Method 3, we could avoid ordering of a new 122-mer for 




	 Target	site,	5’	to	3’	 Orientation	 Position	
cxcr3.3	Target	A	 GATCCCCAAAGAGTAAAGCATGG	 Reverse	strand	 122-144	
cxcr3.3	Target	B	 GGGGATCTTATTGGGGCTGCTGG	 Forward	strand	 138-160	
cxcr3.3	Target	C	 GACTGGTTCTGGCAGTATTGTGG	 Forward	strand	 167-189	
cxcr3.3	Target	D	 GATGTTGGCCTTCATCAGTGTGG	 Forward	strand	 372-394	
eGFP	Target	 GGGCACGGGCAGCTTGCCGGTGG	 Reverse	strand	 149-171	
	














Method	1		 <10	 <10	 <10	 -		 -	
Method	2		 1968.3	 3023.0	 1850.5	 -	 -	
Method	3		 -	 -	 -	 1627.4	 2514.5	
	
Table	 2.	 Yields	 (ng/μl)	 of	 the	 different	 methods	 used	 in	 this	 study.	 Concentration	 refers	 to	 20	 μl	










uses	 a	 synthetic	 122-bases	 ssDNA	 oligonucleotide	 (purified	 by	 PAGE,	 black),	 annealed	 to	 a	 T7	 primer	
(orange)	as	a	direct	template	for	RNA	transcription.	Method	2	uses	a	dsDNA	template	derived	from	a	PCR-
based	complementation	and	amplification	(violet)	of	the	122-bases	synthetic	ssDNA	oligonucleotide	(as	in	
Method	 1).	 Method	 3	 uses	 a	 dsDNA	 template	 derived	 from	 PCR-based	 complementation	 and	
amplification	 (violet)	 of	 2	 half-length	 partially	 complementary	 oligonucleotides	 (81-bases	 each,	
purification	by	standard	desalting	method,	green).	
 
Of note, the 81-mer oligo can be synthesised and purified by standard methods used to 
synthesise custom-made primers. The use of a PCR-based shgRNA template described 
here eliminates completely laborious cloning steps and permits to obtain a working 
shgRNA within 7-9 hours from the receipt of the 81-mer primer, while a cloning-based 

























































Note:	 PCR-based	 templates	 are	 transcribed	
with	 high	 efficiency	 (no	 risk	 of	 endotoxins,	







Note:	 plasmid	 templates	are	 transcribed	with	
a	 reduced	 efficiency	 (chance	 of	 residual	
endotoxins,	 large	 amount	 of	 non-template	




Additional	 materials:	 Restriction	 enzyme,	
restriction	 buffer,	 ligase,	 ligation	 buffer	 +	 ATP,	
liquid	and	solid	culturing	media	+	antibiotics.	
Critical	steps:	RNA	in	vitro	transcription.	 Critical	 steps:	 primer	 annealing,	 ligation,	







Method validation and RNA concentration titration for efficient targeting in vivo 
To validate our method of shgRNA synthesis and to confirm the activity of the Cas9 
mRNA, we co-injected the Cas9 mRNA with a shgRNA targeting eGFP in fertilised eggs 
of homozygote Tg(fli1a-eGFP)45, a well-characterised zebrafish transgenic line where GFP 
is expressed by the endothelium of lymphatic and blood vessels45. We adapted to our 
synthetic strategy (Method 2) a published eGFP CRISPR target site which was already 
successfully used to suppress eGFP signal in a zebrafish transgenic line15. To assess the 
dependency of the targeting efficiency from the mRNA concentration and to assess general 
toxicity effects, a gradient of Cas9 mRNA and eGFP-shgRNA were injected ranging 
between 150 and 300 pg for the Cas9 mRNA and between 25 and 250 pg for the eGFP-
shgRNA. Embryos were visualised under the fluorescent microscope at 30 and 48 hpf to 
screen for eGFP signal. Depending on the signal, the embryos were categorised into 3 
groups: normal eGFP signal, mosaic eGFP expression or severe/complete abrogation of 
eGFP expression (Figure 4A-D). The combination of the highest doses (300 pg for Cas9 
mRNA and 250 pg for eGFP-shgRNA) yielded the most effective targeting and resulted in 
the complete or almost complete loss of eGFP in about 20% of the Tg(fli1a-eGFP) and in a 
mosaic phenotype in 30% of embryos. The rest of the injected embryos maintained an 
apparent homogeneous eGFP expression, although the vast majority of them showed to 
some extent a reduced signal intensity when compared to the uninjected Tg(fli1a-eGFP) 
controls. It must be emphasised here that injections were performed in eggs which were 
homozygote for the fli1a-eGFP transgene, meaning that complete and mosaic loss of eGFP 
is derived from biallelic targeting in the whole organism or in a proportion of the cells. 
This experiment, therefore, demonstrates high efficiency of our PCR-based method for 
CRISPR-targeting. 
 
Detection of CRISPR/Cas9 mutagenesis and efficiency 
Next, we aimed to choose a screening methodology to validate active CRISPR targeting of 
genes such as cxcr3.3 for which we did not expect a direct phenotypic targeting evidence. 
Several reports identify a T7 Endonuclease I (T7EI) assay as a screening methodology15,16. 
T7EI assay detects the presence of heteroduplex DNA (dsDNA carrying one or more 
mismatches), which is a result of the denaturation and renaturation of PCR amplicons 
derived from chimeric and/or heterozygote individuals. T7EI specifically digests 
heteroduplex DNA (e.g. derived from genome editing), by introducing double-strand 
breaks, whilst it does not digest homoduplex DNA (e.g. derived from uninjected controls). 
As a result, upon incubation with T7EI, the PCR product from individuals carrying 
mutations will be digested and will form multiple bands on agarose gels, whilst amplicons 
derived from wt embryos will appear unaffected and display a single band on gel. 
Detection of eGFP disruption could be achieved with this method (not shown); however, 
we have experienced poor robustness and reproducibility, since, in several cases, embryos 
with a complete loss of eGFP signal (and validated as disrupted eGFP individuals by 
Sanger sequencing) were indistinguishable from the uninjected embryos. At the end of a 
PCR reaction, all the DNA is in a homoduplex form. To permit formation of heteroduplex 
DNA, a specific protocol of denaturation-renaturation has to be performed 
(https://www.neb.com/protocols/2014/08/11/determining-genome-targeting-efficiency-
using-t7-endonuclease-i). As a consequence, this method requires specific thermocycling 
conditions respecting precise timings and temperature gradients, which to some extent are 
also dependent on each specific PCR template (e.g. GC content, amplicon length etc.) and 
!"#$%&"'(#')*+,")#'&"(*&+*-.)/012*$"3*-.)/010!
"$$!
should be fine-tuned empirically per each amplicon for optimal results. Therefore, we 
preferred screening of targeting by Sanger sequencing as a genotyping strategy. 
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Comparing a wt and a mutated sequence by Sanger sequencing, one should observe a read 
composed of single peaks for the wt (indicating existence of only one base at each position 
in the amplicon), whilst a mutant sequence will be composed of single peaks upstream of 
the mutation point and by distorted multi-peaked reads from that point beyond, due to 
insertions and deletions of bases and to the simultaneous presence of wt and mutated reads 
(Figure 4E). 
 
Of note, from our experience CRISPR mosaics display more than two alternative reads, 
indicating the concurrent occurrence of several mutations (Figure 4-5). Most likely this is 
due either to a) biallelic editing, leading to alternative mutations of the two genetic alleles, 
b) alternative repair mechanisms occurring in the forward and reverse strand of the 
genomic DNA, c) alternative mechanisms of repair taking place in daughter cells, or d) 
delayed CRISPR editing, occurring independently in individual daughter cells at more than 
1-cell stage. Despite the fact that Sanger sequencing is required to confirm efficient 
targeting, we also found, in agreement with other laboratories, that long runs (>1h) on high 
percentage agarose gels (4%) permits detection of effective targeting in most of the 
samples where genome editing occurs. When compared to wt, amplifications derived from 
successful editing, do not appear as a sharp narrow band, but as a smeared band around the 
expected molecular weight (most commonly slightly higher). Of note, if electrophoresis is 
run for shorter times and/or on lower % agarose gels, mutant bands most commonly appear 
indistinguishable from wt. 
 
Generation of a CRISPR/Cas9 mutant for cxcr3.3 
ShgRNAs against the 4 target sites for cxcr3.3 were injected at concentrations ranging 
between 30 and 150 pg along with 150 pg of Cas9mRNA. However, among the 4 selected 
targets, only one (Target C) displayed clear and efficient genome editing. When injected at 
the highest concentration, this shgRNA yielded an average efficiency per injection session 
of 70±17% as assessed via Sanger sequencing (Figure 4E). The other three targets 
consistently failed in generating mutations at the target site and were therefore 
discontinued. Over 200 eggs were injected with cxcr3.3 Target C and raised to adulthood 
(F0). The offspring of 14 F0 adult fish (outcrossed to AB/TL) were genotyped. The results 
revealed that the final success rate of adult carriers was 71.4% (10/14). The tested carriers 
were able to transmit the mutated alleles with an efficiency of heterozygote F1 ranging 
between 17% and 100%, depending on the founder. The exact entity of the mutation 
carried by each heterozygote was determined by Sanger sequencing. By this method, 
heterozygotes display a double-peaked read from the mutated point onwards. By 
subtracting the wt sequence from the double-peaked read we could, therefore, obtain the 
read relative to the mutant allele (Figure 5A). This method proved very efficient for the 
selection of desirable mutations and of isogenic heterozygote carriers to generate full 
homozygote mutants by incross (Figure 5B-E). Our heterozygote sequence analysis also 
demonstrated that single F0 founders, when crossed to wt, could generate heterozygote 
offspring carrying different kinds of mutant alleles (Figure 5E). In particular, 4/10 
founders generated offspring with more than 1 mutated allele and 3/10 transmitted more 
than 2 and up to 4 mutant alleles, indicating that the mechanisms of alternative repair 
and/or delayed targeting also contributed to the generation of alternative mutations, 
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Figure	 5.	 Identification	 and	 selection	 of	 cxcr3.3	 mutations	 (Figure	 on	 the	 previous	 page).	A.	Double-






nucleotides.	 Mutant	 Δ46	 displays	 a	 wt-subtracted	 read	 that	 matches	 the	 wt	 sequence	 46	 nucleotides	
downstream	the	start	of	the	mutation	(blue	label),	indicating	that	the	mutant	carrying	this	alteration	has	a	
deletion	of	46	nucleotides.	Black	arrows	at	the	end	of	the	mutant	sequences	indicate	where	the	shorter	
mutant	 allele	 sequence	 has	 terminated,	 due	 to	 the	 end	 of	 the	 amplicon.	 Upon	 this	 position	 only	 the	
longer	wt	sequence	is	read,	therefore,	the	sequence	appears	again	single-peaked.	B.	Sequence	alignment	
of	 confirmed	 homozygote	 mutants,	 generated	 from	 incross	 of	 heterozygote	 carriers	 of	 the	 same	
mutation.	 Blue	 asterisks	 indicate	 nucleotides	 that	 are	 naturally	 polymorphic	 in	 the	wt	 population.	C-D.	
Alignment	of	all	identified	mutations	and	their	consequence	at	protein	level.	In	D,	red	boxes	indicate	the	
predicted	transmembrane	helices,	regions	in	grey	indicate	sequences	that	diverge	from	the	wt	sequence	
(translation	 of	 inserted	 nucleotides	 and	 of	 frame-shifted	 coding	 sequences).	 Notably	 Δ1+4	 and	 Δ18	
mutations	would	lead	to	in-frame	mutant	variants,	with	3	additional	amino	acids	or	6	deleted	amino	acids	
at	 the	 end	 of	 the	 TM1	 domain,	 respectively.	 All	 the	 other	 mutations	 would	 generate	 frameshifts	 and	
premature	protein	truncation.	E.	Analysis	of	the	offspring	of	10	cxcr3.3	F0	founders	(#1-#10).	Several	F0	
can	transfer	multiple	kinds	of	mutations	to	their	offspring	(crosses),	indicating	that	biallelic	targeting	and	
alternative	mechanisms	of	damage	 repair/delayed	 targeting	 contribute	 to	 the	generation	of	 alternative	
mutant	alleles.	Data	also	show	that	 some	 individual	 founders	carry	 identical	mutations,	 suggesting	 that	
preferred	types	of	mutations	are	mediated	by	CRISPR/Cas9	targeting.	
 
The profile of the F1 generation from different founders also suggested that preferred 
mutations may occur. For example, specific mutations (Δ5, Δ8 and Δ11) occurred in more 
independent founders (3/10, 4/10 and 5/10 respectively). Additionally, 6/10 independent 
founders carried at least one large (>10 dNTPs) mutation, which are particularly useful to 
permit a simple procedure for genotyping by PCR and gel electrophoresis. 
 
Mutation of cxcr3.3 does not alter development and survival of homozygote mutants, 
but affects M. marinum infection burden 
Among the identified mutations we selected the non-sense cxcr3.3Δ46 and the cxcr3.3Δ11 
alleles to further investigate the function of cxcr3.3. These mutations were chosen since 
they were transmitted with high frequency from the F0 founder to its heterozygote 
offspring, which enabled to timely obtain sufficiently-sized and properly mating isogenic 
families. Additionally, since these mutations consist of > 10 bp deletions, genotypes could 
be distinguished using PCR and gel electrophoresis. Heterozygote carriers of cxcr3.3Δ46 
and of cxcr3.3Δ11 mutations were incrossed with isogenic mutation carriers to obtain 
homozygote mutant, heterozygote and homozygote wt offspring, which was raised to 
adulthood as mixed families. We found that in both families cxcr3.3 mutants maintained 
Mendelian proportions with the other genotypes, therefore we concluded that cxcr3.3 
mutation is viable and does not confer a major disadvantage to the carriers (Figure 6A-B). 
Phenotypic inspection of embryos and larvae also did not reveal any significant 
developmental differences between mutant and wt siblings. Adult homozygote mutants 
were fertile and could produce viable offspring. To address whether cxcr3.3 may have a 
function in controlling the immune response, we injected mutant and wt (either derived 
from heterozygote incross or from homozygote mutant and wt siblings incrosses) at 1 dpf 
with the fish pathogen Mycobacterium marinum (Mm). At 4 dpi both cxcr3.3Δ46 and 
cxcr3.3Δ11 mutant larvae displayed a significantly higher infection burden than their wt 
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counterparts, indicating that cxcr3.3 mutation is detrimental to combat mycobacterial 
infection (Figure 6C-F). This phenotype is opposite to that previously described for a 
cxcr3.2 mutant, which shows an attenuated formation of granulomatous lesions and 
increased resistance to Mm infection9. In view of the opposing infection phenotypes of 
these two receptor mutants, we analysed the infection burden evoked by Mm in larvae 
exposed to NBI74330, an antagonist of CXCR3 that, based on binding pocket similarity 
should inhibit both Cxcr3.2 and Cxcr3.3 in zebrafish (Figure 6F-G). Treatment with this 
compound revealed a cxcr3.2 mutant-like phenotype and a reduction of mycobacterial 
infection burden (Figure 6H). 
 
Cxcr3.3 in zebrafish and other teleosts displays sequence features common to atypical 
chemokine receptors 
While further in-depth characterisation of cxcr3.3 mutants is still necessary to fully 
understand the function of the Cxcr3.3 receptor and its crosstalk with Cxcr3.2, we used 
computational sequence analysis to examine whether the opposing functions of these 
receptors in controlling mycobacterial infection could have a structural basis. We found 
that, when compared to human CXCR3 and zebrafish Cxcr3.1 and Cxcr3.2, Cxcr3.3 
displays specific amino acid substitutions. In particular, the DRY sequence (Asp-Arg-Tyr), 
an extremely conserved motif that permits coupling of the chemokine receptors to the 
heterotrimeric G-proteins, contains an R (Arg) to C (Cys) replacement (Figure 7, 
Supplementary Figure 1)56. 
 
The R of the DRY motif is the most conserved residue of functional G-coupling GPCRs 
and presents 100% conservation among typical human CXC receptors (CXCR1-2-3-4-5-6-
8). Replacement of this residue is known to abolish transduction of heterotrimeric G-
protein signalling in chemokine receptors57, as this amino acid is believed to interact 
directly with the G subunits to catalyse GDP release and therefore serves as an effector for 
G-protein activation58,59. Alteration of the DRY consensus is recurrent in atypical 
chemokine receptors (ACKRs; > 71% of the cases in humans) and in related GPCRs, such 
as viral GPCR-like seven transmembrane proteins or atypical anaphylotoxin receptors. 
Examples in humans are DARC/ACKR1 (DRY to GHR), D6/ACKR2 (DRY to DKY), 
CCRL2/ACKR5 (DRY to QRY), PITPNM3/ACKR6 (DRY to SSR) and C5L2 (DRY to 
DLC, a decoy interceptor for the anaphylotoxin C5a). Exceptions are represented by 
CXCR7/ACKR3 and CCRL1/ACKR4, whose DRY sequences are not divergent, and in 
which failure of G-protein activation is most likely due to the replacement of other residues 
of the so-called micro-switch elements that permit transition of the GPCR from the inactive 
to the active form60,61. Notably, several replacements in the micro-switch elements are 
present also specifically in Cxcr3.3, when compared to its human and zebrafish 
orthologues (Figure 7). 
 
To further dissect whether the existence of an atypical Cxcr3 is an exclusive prerogative of 
zebrafish, we analysed the sequence of the CXCR3 proteins derived from 19 vertebrate 
genomes (11 fish, 1 amphibian, 2 reptiles, and 5 mammals). We found that, while in 
tetrapods the R residue of CXCR3 is 100% conserved, in 82% of the fish species analysed 
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Notably, as in the case of zebrafish Cxcr3.3, polymorphisms in the DRY sequence of 
Cxcr3 isoforms in other fish are also linked to the substitution of micro-switch elements 
(Figure 8). In one of the two fish species (Cod) where no DRY-altered isoforms are 
observed, several micro-switches are still present in one of the isoforms, which would, 
therefore, suggest that in this organism one of the Cxcr3 isoforms is also atypical (Figure 
8). It must be noted that two tetrapod sequences also displayed alteration of the DRY 
sequence, although not of the R residue. (DRY to ERY and DRY to NRY). Synonymous 
D/E change (present in the anole lizard Cxcr3.2) is frequently observed in other GPCRs 
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The non-conservative D/N replacement (present in xenopus Cxcr3.2) has been reported to 
abrogate chemokine signalling in some studies on other receptors62. However, no other 
micro-switch substitutions were associated with this Cxcr3 isoform, which therefore is 
most likely phylogenetically homologous to the typical Cxcr3 receptors. Overall, our study 
suggests that early in teleost evolution an alternative atypical cxcr3 gene evolved, a feature 
that is currently maintained in a variety of modern fish species, but lost during the radiation 
of higher vertebrates. 
 
Based on the fact that Cxcr3.3 receptors has an evolutionarily conserved alteration of the 
DRY motif and of regulative micro-switch elements, we propose that this receptor may 
antagonise the canonical Cxcr3 isoforms by competing for ligands. Changes in the DRY 
and in micro-switches do not generally alter the ligand binding domains and their 
capability to efficiently bind ligands. However, the expression of this atypical isoform may, 
in turn, reduce the possibility for Cxcl11 ligands to bind and signal via their classical 
receptors, therefore modulating the levels of signals evoked in the stimulated cells. In the 
context of mycobacterial infection, where depletion of canonical signalling via Cxcr3.2 is 
beneficial to the host, depletion of cxcr3.3 could translate instead into an exuberant 
exploitation of Cxcr3.2 signalling with, in turn, detrimental effects on the host. 
 
DISCUSSION 
By using cxcr3.3 targeting as a case study, we have set up a simple and fast protocol for 
efficient CRISPR/Cas9 mutagenesis in zebrafish (Graphical protocol). This method uses 
the synthesis of a dsDNA template by annealing, PCR filling and amplification of two 
semi-complementary 81-mer oligonucleotides. This DNA amplicon serves as a template 
for the shgRNA in vitro transcription. Upon transcription of the shgRNA and of a 
zebrafish-optimised NLS-Cas9-NLS mRNA, the two components can be coinjected into 
zebrafish embryos at the 1-cell stage. Target efficiency can be detected by Sanger 
sequencing of injected individuals, according to the emergence of secondary reads in the 
electropherogram within the target site. ShgRNAs that do not yield high targeting 
efficiency can be discontinued, while highly efficient targets can be injected in a larger egg 
batch for culturing. The selected target that we used to obtain cxcr3.3 mutants, yielded over 
70% efficiency in adult germ-line transmitted gene editing and required screening of as few 
as 10 F0 positive individuals to identify several large (> 10 dNTPs) mutations, which 
allowed easy detection of genotypes by PCR and gel electrophoresis. From the analysis of 
the F1 generations we found that our targeting method led to biallelic editing and that other 
mechanisms of independent attempts of repair/delayed targeting also contributed to the 
generation of alternative genome modifications. This translated into a high percentage 
(40%) of F0 founders carrying more than one mutation in their germ-line.  
 
The high yield and the biallelic targeting of this strategy also imply that this approach 
might be explored as an alternative to morpholino-based transient knockdown, with the 
advantages that CRISPR/Cas9 constructs are more affordable in terms of costs, do not 
evoke morpholino-dependent toxicity phenotypes, and their targeting leads to stable gene 
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produce	a	quantitative	amount	of	 template,	 this	product	 requires	 further	PCR	amplification	using	short	
constant	primers	that	anneal	to	the	termini	of	the	product	(T7	sequence	and	extremity	of	the	invariable	
shgRNA	sequence).	Once	the	amplicon	has	been	cleaned	up	and	confirmed	by	sequencing,	it	can	be	used	
as	 a	 DNA	 template	 to	 produce	 the	 shgRNA.	 Simultaneously,	 also	 the	 Cas9	 mRNA	 can	 be	 in	 vitro	
transcribed	 from	 a	 NotI-linearised	 plasmid	 template.	 The	 two	 mRNAs	 require	 column	 clean	 up,	 gel-
electrophoresis	and	nanodrop	quality	control	and	quantification.	Single-use	aliquots	of	both	RNAs	can	be	
stored	 for	 undefined	 time	 at	 -80°C.	 A	 mix	 of	 shgRNA	 and	 Cas9	 mRNA	 can	 be	 injected	 into	 zebrafish	
fertilised	eggs.	Different	shgRNA	(shgRNA1,	2	and	3)	may	be	injected	side	by	side,	to	maximise	the	chance	




animals.	 The	 mutations	 will	 be	 transferred	 to	 part	 of	 the	 offspring	 in	 heterozygosis.	 Because	 the	 wt	
sequence	 is	 known,	 the	exact	mutations	 carried	by	each	 founder	 can	be	extrapolated	 from	 the	double	
peak	 sequencing	 reads	 of	 their	 heterozygote	 offspring.	 The	 preferred	 mutations	 (e.g.	 large	 deletions	
generating	a	frameshift)	can	be	selected	for	further	characterisation.	Since	a	single	F0	founder	has	been	
shown	 to	 frequently	 transfer	multiple	mutated	 alleles	 to	 its	 offspring,	 it	 is	 likely	 that	 an	 F1	 family	will	
consist	 of	 a	 mixed	 population	 of	 animals	 carrying	 various	mutations	 of	 the	 target	 gene.	 The	 different	
alleles	can	be	distinguished	by	DNA	extraction	and	genotyping	from	the	fin	clip.	Isogenic	founders	can	be	
pooled	 together	 to	 generate	 isogenic	 F1	 families,	 carrying	 only	 one	 kind	 of	mutation.	 Finally,	 at	 three	
months	post	fertilisation	(mpf)	these	families	(that	consist	exclusively	of	heterozygotes)	can	be	incrossed	
to	obtain	homozygote	mutants,	wt	and	heterozygotes	(F2).	The	ratio	between	the	genotypes	in	F2	can	be	




Using the CRISPR/Cas9 editing system we obtained several stable mutant lines of cxcr3.3 
and performed an initial characterisation of them. Under physiological conditions, we did 
not observe any advantage/disadvantage in carrying a cxcr3.3 mutant allele, in either 
heterozygotes or homozygotes. However, we found that infected mutant individuals 
display an increased susceptibility to the pathogen Mm, which indicates an underlying 
function of Cxcr3.3 in the control of mycobacterial infection. We currently do not know 
the exact mechanisms by which Cxcr3.3 is required to respond to mycobacteria and further 
analysis is needed. Strikingly, the phenotype of this mutant in control of mycobacterial 
infection differs from that of the cxcr3.2 mutants, which display a reduced susceptibility to 
the same pathogen9. A possible hypothesis, confirmed by structural predictions is that 
Cxcr3.2 and Cxcr3.3 antagonise each other by ligand competition and/or induction of 
alternative transduction signals. Several chemokine receptors have been shown to 
antagonise or synergise each other64. ACKRs, for example, are seven transmembrane 
receptors homologous to chemokine GPCRs that have a modified or missing canonical 
DRY motif within the second intracellular loop, which makes them unable to couple to G-
proteins and induce the full spectrum of “classical” GPCR signalling and cellular 
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responses, including cell migration65,66. Several mechanisms by which ACKRs influence 
the responses to chemokines have been shown. D6/ACKR2, for example, is an ACKR for a 
wide array of CC chemokines. Upon binding to these ligands, the ligand-receptor complex 
is internalised and transferred to late endosomes. Here the ligands dissociate and are 
degraded by endolysosome maturation, while the receptor is recycled and re-expressed at 
the plasma membrane. This mechanism allows D6/ACKR2 to scavenge CC chemokines 
and reduce binding to their canonical G-protein coupled receptors67. 
 
CXCR7/ACKR3 is another member of the atypical chemokine receptor group, which 
cannot couple to G-proteins, despite still being able to bind β-arrestin and transmit MAPK-
mediated signalling to some extent60,64. The zebrafish model has helped to elucidate the 
role of CXCR7 in the scavenging of CXCL12 ligand, thereby controlling the formation of a 
CXCL12 gradient which permits optimal migration. While binding of CXCL12 to CXCR4 
transmits active chemokine signalling, binding of the same ligand to CXCR7 does not elicit 
G-coupled signal transduction. This translates into a reduced ligand binding to CXCR4 and 
therefore to an attenuated activation of the CXCR4-dependent cascade. This mechanism 
has been shown in zebrafish and mammals to finely control the direction of cell migration, 
as CXCR4 and CXCR7 are expressed with different expression dynamics and patterns (e.g. 
they mature and reside at the membrane with different timings)6,68. Additionally, similar to 
D6/ACKR2, CXCR7/ACKR3 sequesters CXCL12 and mediates its intracellular 
degradation69. 
 
Even “classical” chemokine receptors when simultaneously expressed may interfere with 
each other. Heterodimerisation of GPCRs is a well-known process. Several studies suggest 
that particular combinations may affect the receptor conformations and lead to dampened 
capability to bind ligands or to transduce signalling. Expression of chemokine receptors in 
absence of their ligands can also interfere with the signalling of other receptors whose 
ligands are present, when both are expressed by the same cell. Consuming/sequestering 
intracellular signalling molecules (e.g. β-arrestin or heterotrimeric G complexes, which are 
associated with resting receptors in unstimulated conditions) can in fact uncouple the 
antagonised receptor from its downstream signalling machinery70. 
 
Sequence alignment of zebrafish and human CXCR3 receptors indicates that the key DRY 
motif required to couple with heterotrimeric G-protein complexes is altered in Cxcr3.3, 
while Cxcr3.1 and Cxcr3.2 maintain an intact consensus sequence. Replacement of R with 
C in Cxcr3.3 suggests that this receptor belongs to the group of atypical chemokine 
receptors. In line with this theory it is possible that depletion of cxcr3.3 would increase the 
availability of Cxcl11 ligands for Cxcr3.2, therefore inducing an enhanced (and detrimental 
for the host) Cxcr3.2-dependent signalling. Consistent with this hypothesis, the CXCR3 
antagonist NBI74330, predicted to inhibit both Cxcr3.2 and Cxcr3.3, evokes an infection 
phenotype similar to that of cxcr3.2 mutation, which means that Cxcr3.3 blockade cannot 
be detrimental if Cxcr3.2 signalling is also simultaneously depleted. That similar dynamics 
take place in vivo during mycobacterial infection is already indicated by a recent study on 
D6/ACKR2 knockout mice, which showed that these animals are more susceptible to 
mycobacterial infection, due to the increased number of monocyte/macrophages, DCs and 
T cells infiltrated in the lesioned tissues. Blockade of several chemokines with a 
combination of antibodies could rescue the phenotype of D6 deficiency, which suggests 
that the activity of D6/ACKR2 as a chemokine scavenger receptor is fundamental to 




Notably, interference with Cxcr3.2/Cxcr3.3 signalling might not act exclusively at the level 
of ligand-competition, since we also have previously found that cxcr3.3 expression is 
controlled (at least in macrophages) by expression of cxcr3.2, as macrophages from 
cxcr3.2-deficienct larvae displayed a 1.5-fold decrease of cxcr3.3 expression too40. This is 
particularly intriguing considering that not only did cxcr3.2 control cxcr3.3, but also 
several genes for Cxcl11 ligands (Cxcl11aa-af-ag), whose expression in macrophages was 
2-to-3-fold reduced in cxcr3.2 mutants40. Functional signal transduction assays for Cxcr3.3 
and analysis of cxcr3.2-cxcr3.3 double mutant phenotypes will help to understand the exact 
interactions at play between these two paralogues. 
 
It is noteworthy that, besides modifications in structural motifs required for G-protein 
activation, the preferential cellular expression and/or intracellular localisation may 
represent another aspect of Cxcr3.2/Cxcr3.3 biology contributing to their ability to activate 
G-protein-dependent signalling. Regarding cell specificity, both genes are expressed in 
macrophages and neutrophils. However, cxcr3.2 is expressed more predominantly by 
macrophages, while cxcr3.3 is more highly expressed by neutrophils9. This may result in a 
differential (cell-specific) ratio of receptor copies available for ligand binding in the two 
cell subsets. This may also explain why cxcr3.2 mutation, despite the gene being expressed 
by both macrophages and neutrophils, displayed predominantly a macrophage phenotype 
rather than an effect on neutrophils. Injection of Cxcl11aa-af ligands, for example, could 
elicit significant macrophage recruitment, while neutrophil chemoattraction was 
comparable to mock-injected individuals9. This observation might indicate that the 
scavenging activity exerted by Cxcr3.3 in neutrophils reflects weak activation of G-protein 
signalling by Cxcl11 ligands in these cells, insufficient to support cell migration. In 
contrast, predominant expression of cxcr3.2 over cxcr3.3 in macrophages might permit 
sufficient active signal to sustain chemotaxis. Taken together, the generation and 
characterisation of the zebrafish cxcr3.3 mutant line has provided more information on the 
translational utility of this model for biomedical research. Furthermore, it may also shed 
light on the evolution of typical and atypical chemokine receptors and on the selective 
forces acting on the immune system genes that, by duplication and functional 
specialisation, permitted the evolution of complex regulative mechanisms to tightly control 
biological processes. 
 
MATERIAL AND METHODS 
Synthesis of shgRNA – Primers and oligos up to 81 nucleotides were obtained from 
Sigma-Aldrich, using standard synthetic procedures (25 nmol synthesis scale, purification 
via desalting method). The 122-base template oligonucleotides were ordered from 
Integrated DNA Technologies (1 nmol synthesis scale, purification via PAGE Ultramer 
method), since the nucleotide length exceeds the maximum sequence length supported by 
Sigma-Aldrich and standard synthetic procedures. Sequences are reported in 
Supplementary Table 1. DNA template synthesis for the three methods described above 
was performed as follows. 
 
In Method 1, the 122-mer oligos and the T7 promoter primer were suspended in TES 
buffer (10 mM Tris-HCl, pH=8, 1 mM EDTA, 0.1 M NaCl) to a 100 µM concentration. 
Before in vitro transcription, an equimolar amount (1:1 volumes, 50 µM each) of the 122-
base oligo and of the T7 promoter primer were mixed. Annealing was obtained by 
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transferring the solution to a 95⁰C water bath. After 1 min, the bath was switched off and 
let cool down to room temperature (about 30 minutes). The annealed mixture was then 
transferred to ice, diluted 10x with RNAse-free water and used as a template for in vitro 
transcription. 
 
In Method 2, the 122-mer oligos were suspended as in Method 1 (100 µM in TES buffer) 
and 1 ng was used as a template in a PCR reaction (50 µl reaction, 200 µM dNTPs, 1 unit 
DreamTaq polymerase (Thermo Fisher Scientific), initial denaturation 95⁰C/3 min 35 
amplification cycles 95⁰C/30 s, 55⁰C/60 s, 72⁰C/30 s, final extension step 72⁰C/15 min), 
using template amplification primers as reported in Supplementary Table 1 (0.5 µM 
each). The PCR product was column-purified using a PCR clean-up combo kit 
(Invitrogen), eluting the product in 20 µl of RNase-free water, and the expected size was 
checked by gel electrophoresis. 
 
In Method 3, semi-complementary 81-mer oligo pairs (0.04 µM each) were annealed 
together and the product was completed by a short PCR program (50 µl reaction, 200 µM 
dNTPs, 1 unit DreamTaq polymerase, initial denaturation 95⁰C/3 min, 5 amplification 
cycles 95⁰C/30 s, 55⁰C/60 s, 72⁰C/60 s, final extension step 72⁰C/15 min). The mix was 
removed from the thermocycler, maintained at room temperature, supplemented with 
template amplification primers as in Method 2 (0.5 µM each), and then returned to the 
thermocycler for further amplification (initial denaturation 95 ⁰C/3 min, amplification 35 
cycles 95⁰C/30 s, 55⁰C/60 s, 72⁰C/30 s, final extension step 72⁰C/15 min). The product 
was then purified by column clean-up as in Method 2. When running the PCR reaction 
using only one 81-mer oligo as a negative control we have frequently observed 
amplification at comparable size of the expected product of a complete reaction. This was 
most likely due to the existence of self-complementary stretches in the oligos. However, 
secondary reactions did not occur when both oligos were provided, as demonstrated by 
Sanger sequencing of the amplicons. 
 
In vitro transcription of shgRNA – For in vitro transcription of shgRNA, we used the 
MEGAshortscript T7 kit (Invitrogen) and 2530 fmols of template DNA (corresponding to 
100 ng of ssDNA annealed to T7 primer for Method 1 and to 200 ng of PCR-derived 
dsDNA for Method 2 and 3). Purification of the shgRNA was achieved using the 
miRNeasy isolation kit (Qiagen) according to manufacturer’s guidelines and eluting 2x10 
µl in RNase-free water. Efficiencies for each method are reported in Table 2. 
Concentration was measured by nanodrop and integrity was checked by non-denaturing 2% 
gel electrophoresis and RNA-chip (RNA 6000 Pico kit, Agilent technologies) on 2100 
Expert bioanalyzer (Agilent Technologies). The shgRNA may appear on the non-
denaturing gel as a single or double band, depending on temperature and on how delayed 
the running of the gel is from the column elution. When maintained at room temperature 
the shgRNA formed two bands, with a more intense one at lower molecular weight. If the 
RNA was warmed to > 55⁰C and immediately loaded, it appeared as a single band 
coinciding with the lowest molecular weight size. Most likely the secondary band, seen 
when shgRNA is maintained at RT, represents a dimeric form or an alternative 
conformational structure. For the purpose of storage, shgRNA was aliquoted and stored at  
-80⁰C. 
 
Preparation of Cas9 mRNA – Several versions of engineered Cas9 are currently 
available. For this study, we opted for a zebrafish-codon optimised Cas9 version derived 
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from S. pyogenes. The Cas9 we used was also engineered to contain (at both its amino and 
carboxyl termini) a Nuclear Localisation Signal (NLS) derived from the SV40 large T-
antigen sequence, which would facilitate translocation of the protein to the cell nucleus. 
The plasmid used was previously described in reference15. In this plasmid, the Cas9 coding 
sequence is cloned downstream of the SP6 promoter and upstream of an SV40 
polyadenylation site and a NotI unique restriction site, which is used for plasmid 
linearisation prior to in vitro transcription. The plasmid was purified using an EndoFree 
Plasmid Purification (Maxi prep) kit (Qiagen) from 100 ml of O/N culture, and according 
to manufacturer’s guidelines. Total plasmid DNA was suspended in 700 μl and quantified 
as approximately 1 μg/μl concentration. 25 μg of DNA were linearised with 0.2 units/μl of 
NotI (New England BioLabs) in 1x NEB Buffer 3.1 for 2 h at 37⁰C in a 200 μl reaction. 
Complete digestion was assessed by 1% agarose gel electrophoresis. The linearised 
plasmid was purified by precipitation by Sodium Acetate/EtOH method. The pellet was 
washed with 70% EtOH, air-dried and resuspended in 50 µl RNase-free water. The Cas9 
mRNA was then synthesised using the mMESSAGE mMACHINE SP6 kit (Invitrogen), 
according to the manufacturer’s guidelines and using 1 μg of purified linearised plasmid as 
a template for a 20 μl reaction. The mRNA was then column-purified using the RNeasy 
MiniElute Cleanup kit (Qiagen), eluted in 20 μl (2x10 μl) of RNase-free water and 
quantified by Nanodrop as approximately 1 μg/μl. The integrity of RNA was assessed by 
2% non-denaturing agarose gel electrophoresis, on which Cas9 mRNA appeared with two 
discrete bands. Single use 2 μl aliquots of 1 μg/μl Cas9 mRNA were stored at -80 ⁰C. 
 
Zebrafish lines and maintenance – Zebrafish lines were handled in compliance with the 
local animal welfare regulations and maintained according to standard protocols (zfin.org). 
The breeding of adult fish was approved by the local animal welfare committee (DEC) of 
the University of Leiden (license number: 10612) and adhered to the international 
guidelines specified by the EU Animal Protection Directive 2010/63/EU. Adult zebrafish 
were not sacrificed for experiments. Fish lines used in this work were the following: wt 
strain AB/TL and Tg(fli1a:eGFPy1)45. Anaesthesia of embryos/larvae used for live imaging 
was achieved with 0.02% buffered Tricaine (3-aminobenzoic acid ethyl ester, Sigma-
Aldrich) in egg water. 
 
shgRNA/Cas9 microinjections – To assess efficiency and toxicity, eGFP-shgRNA and 
Cas9 mRNA were mixed and injected at different concentrations, as described in the 
results section and in Figure 4. For generation of the cxcr3.3 mutant lines, 1 nl of 150 pg 
of Cas9 mRNA and 150 pg of cxcr3.3-shgRNA Target C was considered optimal as this 
did not lead to toxic/phenotypic effects or major lethality. Injections were performed in the 
cell of fertilised eggs at 5-10 minutes post fertilisation. Left over mix from the injection 
needle was run on 2% non-denaturing agarose gel to control integrity during the injection 
phase. The mix would segregate into 4 bands, 2 corresponding to the Cas9 mRNA and 2 
corresponding to the shgRNA. 
 
Genotyping – Genotypes were assessed by PCR using the primers reported in 
Supplementary Table 1, extracting genomic DNA from 1-2 dpf embryos or fin clips of > 
6 week-old juveniles/adults. Successful injections were confirmed by Sanger sequencing 
(Baseclear or Macrogen, The Netherlands). Mutations were identified from heterozygote 
F1 fish by agarose gel electrophoresis (2-4%) and confirmed by Sanger sequencing from 




Survival analysis – Heterozygotes carrying the same mutation were incrossed to generate 
homozygote mutants, wt and heterozygotes. The mixed family was cultured to sexual 
maturity and then genotyped by PCR/gel electrophoresis. No significant divergence from 
Mendelian proportions was observed in the genotype rates (assessed by chi-squared test). 
 
Infection burden – Homozygote mutants and wt, derived either from heterozygote parents 
or from homozygote siblings incross, were injected via the blood island at 28-30 hpf with 
100-250 CFU of mCherry-labelled Mycobacterium marinum M strain. Infection burden 
was quantified at 4 dpi by fluorescent pixel enumeration as previously described9. 
Significance was assessed by Mann-Whitney test (Figure 6 C) and with unpaired t-test 
with Welch’s correction for data with different variances (Figure 6F,H). *P<0.05; 
**P<0.01; ***P<0.001. Error bars: mean±s.e.m. 
 
ACKNOWLEDGEMENTS 
We thank Anna-Pavlina Haramis and Rui Zhang for the discussions and the collaboration 
in setting up the CRISPR/Cas9 technology. 
 
This work was supported by the Smart Mix Program of the Netherlands Ministry of 
Economic Affairs and the Ministry of Education, Culture and Science, the European 
Commission 7th framework project ZF-HEALTH (contract number HEALTH-F4-2010-
242048), and the European Marie-Curie Initial Training Network FishForPharma (contract 
number PITN-GA-2011-289209).  
Antagonistic	functions	of	Cxcr3.2	and	Cxcr3.3	
149	










































































eGFP	gFw	 eGFP	 AAACGGCCACAAGTTCAGCG	 Genot.	
Primers	 used	 for	 PCR	
genotyping	 of	 targeted	
genomic	loci	
eGFP	gRv	 eGFP	 TCACCTTGATGCCGTTCTTCTG	 Genot.	
cxcr3.3A-B	gFw	 cxcr3.3	 ACATGGAGGTAGAGCTTCACGG	 Genot.	
cxcr3.3A-B	gRv	 cxcr3.3	 CTCACCTTAAACAGAACTCCAGCC	 Genot.	
cxcr3.3C	gFw	 cxcr3.3	 GAGGTAGAGCTTCACGGATTGT	 Genot.	
cxcr3.3C	gRv	 cxcr3.3	 GAGAGCAGCAGAAGACTGTCAA	 Genot.	
cxcr3.3D	gFw	 cxcr3.3	 TAAATTGATTTTAATCGACTTGACG	 Genot.	














1 Zlotnik A, Yoshie O. Chemokines: a new classification system and their role in immunity. Immunity. 2000 
Feb;12(2):121-7. 
2 Torraca V, Masud S, Spaink HP, Meijer AH. Macrophage-pathogen interactions in infectious diseases: new 
therapeutic insights from the zebrafish host model. Dis Model Mech. 2014 Jul;7(7):785-97. 
3 Donà E, Barry JD, Valentin G, Quirin C, Khmelinskii A, Kunze A, Durdu S, Newton LR, Fernandez-Minan A, 
Huber W, Knop M, Gilmour D. Directional tissue migration through a self-generated chemokine gradient. Nature. 
2013 Nov 14;503(7475):285-9. 
4 Walters KB, Green JM, Surfus JC, Yoo SK, Huttenlocher A. Live imaging of neutrophil motility in a zebrafish 
model of WHIM syndrome. Blood. 2010 Oct 14;116(15):2803-11. 
5 Busch-Nentwich E, Kettleborough R, Dooley CM, Scahill C, Sealy I, White R, Herd C, Mehroke S, Wali N, 
Carruthers S, Hall A, Collins J, Gibbons R, Pusztai Z, Clark R, Stemple DL. Sanger Institute Zebrafish Mutation 
Project mutant data submission. ZFIN Direct Data Submission. 2013. 
6 Valentin G, Haas P, Gilmour D. The chemokine SDF1a coordinates tissue migration through the spatially 
restricted activation of Cxcr7 and Cxcr4b. Curr Biol. 2007 Jun 19;17(12):1026-31. 
7 Knaut H, Werz C, Geisler R, Nüsslein-Volhard C; Tübingen 2000 Screen Consortium. A zebrafish homologue 
of the chemokine receptor Cxcr4 is a germ-cell guidance receptor. Nature. 2003 Jan 16;421(6920):279-82. 
8 Lewellis SW, Nagelberg D, Subedi A, Staton A, LeBlanc M, Giraldez A, Knaut H. Precise SDF1-mediated cell 





																																								 																																							 																																							 																																	
9 Torraca V, Cui C, Boland R, Bebelman JP, van der Sar AM, Smit MJ, Siderius M, Spaink HP, Meijer AH. The 
CXCR3-CXCL11 signaling axis mediates macrophage recruitment and dissemination of mycobacterial infection. 
Dis Model Mech. 2015 Mar;8(3):253-69. 
10 Siekmann AF, Standley C, Fogarty KE, Wolfe SA, Lawson ND. Chemokine signaling guides regional 
patterning of the first embryonic artery. Genes Dev. 2009 Oct1;23(19):2272-7. 
11 Bussmann J, Wolfe SA, Siekmann AF. Arterial-venous network formation during brain vascularization 
involves hemodynamic regulation of chemokine signaling. Development. 2011 May;138(9):1717-26. 
12 Jinek M, Chylinski K, Fonfara I, Hauer M, Doudna JA, Charpentier E. A programmable dual-RNA-guided 
DNA endonuclease in adaptive bacterial immunity. Science. 2012 Aug 17;337(6096):816-21. 
13 Mali P, Esvelt KM, Church GM. Cas9 as a versatile tool for engineering biology. Nat Methods. 2013 
Oct;10(10):957-63. 
14 Ran FA, Hsu PD, Wright J, Agarwala V, Scott DA, Zhang F. Genome engineering using the CRISPR-Cas9 
system. Nat Protoc. 2013 Nov;8(11):2281-308. 
15 Jao LE, Wente SR, Chen W. Efficient multiplex biallelic zebrafish genome editing using a CRISPR nuclease 
system. Proc Natl Acad Sci U S A. 2013 Aug 20;110(34):13904-9. 
16 Hwang WY, Fu Y, Reyon D, Maeder ML, Tsai SQ, Sander JD, Peterson RT, Yeh JR,Joung JK. Efficient 
genome editing in zebrafish using a CRISPR-Cas system. Nat Biotechnol. 2013 Mar;31(3):227-9. 
17 Hruscha A, Krawitz P, Rechenberg A, Heinrich V, Hecht J, Haass C, Schmid B. Efficient CRISPR/Cas9 
genome editing with low off-target effects in zebrafish. Development. 2013 Dec;140(24):4982-7. 
18 Auer TO, Del Bene F. CRISPR/Cas9 and TALEN-mediated knock-in approaches in zebrafish. Methods. 2014 
Sep;69(2):142-50. 
19 Kleinstiver BP, Pattanayak V, Prew MS, Tsai SQ, Nguyen NT, Zheng Z, Joung JK. High-fidelity CRISPR-
Cas9 nucleases with no detectable genome-wide off-target effects. Nature. 2016 Jan 28;529(7587):490-5. 
20 Nomiyama H, Osada N, Yoshie O. Systematic classification of vertebrate chemokines based on conserved 
synteny and evolutionary history. Genes Cells. 2013 Jan;18(1):1-16. 
21 Lindley I, Aschauer H, Seifert JM, Lam C, Brunowsky W, Kownatzki E, Thelen M, Peveri P, Dewald B, von 
Tscharner V, et al. Synthesis and expression in Escherichia coli of the gene encoding monocyte-derived 
neutrophil-activating factor: biological equivalence between natural and recombinant neutrophil-activating factor. 
Proc Natl Acad Sci U S A. 1988 Dec;85(23):9199-203. 
22 Hoffmann E, Dittrich-Breiholz O, Holtmann H, Kracht M. Multiple control of interleukin-8 gene expression. J 
Leukoc Biol. 2002 Nov;72(5):847-55. 
23 de Oliveira S, Reyes-Aldasoro CC, Candel S, Renshaw SA, Mulero V, Calado A. Cxcl8 (IL-8) mediates 
neutrophil recruitment and behavior in the zebrafish inflammatory response. J Immunol. 2013 Apr 
15;190(8):4349-59. 
24 Tanino Y, Coombe DR, Gill SE, Kett WC, Kajikawa O, Proudfoot AE, Wells TN, Parks WC, Wight TN, 
Martin TR, Frevert CW. Kinetics of chemokine-glycosaminoglycan interactions control neutrophil migration into 
the airspaces of the lungs. J Immunol. 2010 Mar 1;184(5):2677-85. 
25 Mukaida N. Pathophysiological roles of interleukin-8/CXCL8 in pulmonary diseases. Am J Physiol Lung Cell 
Mol Physiol. 2003 Apr;284(4):L566-77. 
26 Nagasawa T, Hirota S, Tachibana K, Takakura N, Nishikawa S, Kitamura Y, Yoshida N, Kikutani H, 
Kishimoto T. Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC 
chemokine PBSF/SDF-1. Nature. 1996 Aug 15;382(6592):635-8. 
27 Sallusto F, Baggiolini M. Chemokines and leukocyte traffic. Nat Immunol. 2008 Sep;9(9):949-52. 
28 Balkwill F. The significance of cancer cell expression of the chemokine receptor CXCR4. Semin Cancer Biol. 
2004 Jun;14(3):171-9. 
29 Feng Y, Broder CC, Kennedy PE, Berger EA. HIV-1 entry cofactor: functionalcDNA cloning of a seven-
transmembrane, G protein-coupled receptor. Science. 1996 May 10;272(5263):872-7. 
30 Tamplin OJ, Durand EM, Carr LA, Childs SJ, Hagedorn EJ, Li P, Yzaguirre AD, Speck NA, Zon LI. 
Hematopoietic stem cell arrival triggers dynamic remodeling of  the perivascular niche. Cell. 2015 Jan 15;160(1-
2):241-52. 
31 Tulotta C, Stefanescu C, Beletkaia E, Bussmann J, Tarbashevich K, Schmidt T,Snaar-Jagalska BE. Inhibition 
of signaling between human CXCR4 and zebrafishligands by the small molecule IT1t impairs the formation of 
triple-negativebreast cancer early metastases in a zebrafish xenograft model. Dis Model Mech.2016 Feb 
1;9(2):141-53. 
32 Chong SW, Emelyanov A, Gong Z, Korzh V. Expression pattern of two zebrafish genes, cxcr4a and cxcr4b. 
Mech Dev. 2001 Dec;109(2):347-54. 
33 Nagasawa T, Nakajima T, Tachibana K, Iizasa H, Bleul CC, Yoshie O, Matsushima K, Yoshida N, Springer 




																																								 																																							 																																							 																																	
factor/stromal cell-derived factor 1 receptor, a murine homolog of the human immunodeficiency virus 1 entry 
coreceptor fusin. Proc Natl Acad Sci U S A. 1996 Dec 10;93(25):14726-9. 
34 Tachibana K, Hirota S, Iizasa H, Yoshida H, Kawabata K, Kataoka Y, Kitamura Y,Matsushima K, Yoshida N, 
Nishikawa S, Kishimoto T, Nagasawa T. The chemokine receptor CXCR4 is essential for vascularization of the 
gastrointestinal tract. Nature. 1998 Jun 11;393(6685):591-4. 
35 Zou YR, Kottmann AH, Kuroda M, Taniuchi I, Littman DR. Function of the chemokine receptor CXCR4 in 
haematopoiesis and in cerebellar development. Nature. 1998 Jun 11;393(6685):595-9. 
36 Zhou J, Tang PC, Qin L, Gayed PM, Li W, Skokos EA, Kyriakides TR, Pober JS,Tellides G. CXCR3-
dependent accumulation and activation of perivascular macrophages is necessary for homeostatic arterial 
remodeling to hemodynamic stresses. J Exp Med. 2010 Aug 30;207(9):1951-66. 
37 Krauthausen M, Kummer MP, Zimmermann J, Reyes-Irisarri E, Terwel D, Bulic B, Heneka MT, Müller M. 
CXCR3 promotes plaque formation and behavioral deficits in an Alzheimer's disease model. J Clin Invest. 2015 
Jan;125(1):365-78. 
38 Oghumu S, Varikuti S, Terrazas C, Kotov D, Nasser MW, Powell CA, Ganju RK,Satoskar AR. CXCR3 
deficiency enhances tumor progression by promoting macrophage M2 polarization in a murine breast cancer 
model. Immunology. 2014 Sep;143(1):109-19. 
39 Cohen SB, Maurer KJ, Egan CE, Oghumu S, Satoskar AR, Denkers EY. CXCR3-dependent CD4⁺ T cells are 
required to activate inflammatory monocytes for defense against intestinal infection. PLoS Pathog. 
2013;9(10):e1003706. 
40 Torraca V, in’t Veld E, Meijer AH. Disruption of chemotactic signalling primes the lysosomal function of 
macrophages to counteract mycobacterial parasitism. Chapter 4 of this thesis.	
41 Cui C. Chemokine signaling in innate immunity of zebrafish embryos. Doctoral Thesis, Leiden University. 
2012 Dec 20. 
42 Montague TG, Cruz JM, Gagnon JA, Church GM, Valen E. CHOPCHOP: a CRISPR/Cas9 and TALEN web 
tool for genome editing. Nucleic Acids Res. 2014 Jul;42(Web Server issue):W401-7. 
43 Langmead B, Trapnell C, Pop M, Salzberg SL. Ultrafast and memory-efficient alignment of short DNA 
sequences to the human genome. Genome Biol. 2009;10(3):R25. 
44 Wang T, Wei JJ, Sabatini DM, Lander ES. Genetic screens in human cells using the CRISPR-Cas9 system. 
Science. 2014 Jan 3;343(6166):80-4. 
45 Lawson ND, Weinstein BM. In vivo imaging of embryonic vascular developmentusing transgenic zebrafish. 
Dev Biol. 2002 Aug 15;248(2):307-18. 
46 Grone BP, Marchese M, Hamling KR, Kumar MG, Krasniak CS, Sicca F, Santorelli FM, Patel M, Baraban SC. 
Epilepsy, Behavioral Abnormalities, and Physiological Comorbidities in Syntaxin-Binding Protein 1 (STXBP1) 
Mutant Zebrafish. PLoS One. 2016 Mar 10;11(3):e0151148. 
47 D'Agostino Y, Locascio A, Ristoratore F, Sordino P, Spagnuolo A, Borra M, D'Aniello S. A Rapid and Cheap 
Methodology for CRISPR/Cas9 Zebrafish Mutant Screening. Mol Biotechnol. 2016 Jan;58(1):73-8. 
48 Taylor SM, Alvarez-Delfin K, Saade CJ, Thomas JL, Thummel R, Fadool JM, Hitchcock PF. The bHLH 
Transcription Factor NeuroD Governs Photoreceptor Genesis and Regeneration Through Delta-Notch Signaling. 
Invest Ophthalmol Vis Sci. 2015 Nov;56(12):7496-515. 
49 Chang N, Sun C, Gao L, Zhu D, Xu X, Zhu X, Xiong JW, Xi JJ. Genome editing with RNA-guided Cas9 
nuclease in zebrafish embryos. Cell Res. 2013 Apr;23(4):465-72. 
50 Yu C, Zhang Y, Yao S, Wei Y. A PCR based protocol for detecting indel mutations induced by TALENs and 
CRISPR/Cas9 in zebrafish. PLoS One. 2014 Jun 5;9(6):e98282. 
51 Irion U, Krauss J, Nüsslein-Volhard C. Precise and efficient genome editing in zebrafish using the 
CRISPR/Cas9 system. Development. 2014 Dec;141(24):4827-30. 
52 Varshney GK, Pei W, LaFave MC, Idol J, Xu L, Gallardo V, Carrington B, Bishop K, Jones M, Li M, Harper 
U, Huang SC, Prakash A, Chen W, Sood R, Ledin J, Burgess SM. High-throughput gene targeting and 
phenotyping in zebrafish using CRISPR/Cas9. Genome Res. 2015 Jul;25(7):1030-42. 
53 Brocal I, White RJ, Dooley CM, Carruthers SN, Clark R, Hall A, Busch-Nentwich EM, Stemple DL, 
Kettleborough RN. Efficient identification of CRISPR/Cas9-induced insertions/deletions by direct germline 
screening in zebrafish. BMC Genomics. 2016 Mar 24;17(1):259. 
54 Arnaud-Barbe N, Cheynet-Sauvion V, Oriol G, Mandrand B, Mallet F. Transcription of RNA templates by T7 
RNA polymerase. Nucleic Acids Res. 1998 Aug 1;26(15):3550-4. 
55 Ran FA, Hsu PD, Wright J, Agarwala V, Scott DA, Zhang F. Genome engineering using the CRISPR-Cas9 
system. Nat Protoc. 2013 Nov;8(11):2281-308. 
56 Nomiyama H, Yoshie O. Functional roles of evolutionary conserved motifs and residues in vertebrate 




																																								 																																							 																																							 																																	
57 Lagane B, Ballet S, Planchenault T, Balabanian K, Le Poul E, Blanpain C, Percherancier Y, Staropoli I, 
Vassart G, Oppermann M, Parmentier M, Bachelerie F. Mutation of the DRY motif reveals different structural 
requirements for the CC chemokine receptor 5-mediated signaling and receptor endocytosis. Mol Pharmacol. 
2005 Jun;67(6):1966-76. 
58 Rovati GE, Capra V, Neubig RR. The highly conserved DRY motif of class A G protein-coupled receptors: 
beyond the ground state. Mol Pharmacol. 2007 Apr;71(4):959-64. 
59 Acharya S, Karnik SS. Modulation of GDP release from transducin by the conserved Glu134-Arg135 sequence 
in rhodopsin. J Biol Chem. 1996 Oct 11;271(41):25406-11. 
60 Cancellieri C, Vacchini A, Locati M, Bonecchi R, Borroni EM. Atypical chemokine receptors: from silence to 
sound. Biochem Soc Trans. 2013 Feb 1;41(1):231-6. 
61 Nygaard R, Frimurer TM, Holst B, Rosenkilde MM, Schwartz TW. Ligand binding and micro-switches in 
7TM receptor structures. Trends Pharmacol Sci. 2009 May;30(5):249-59. 
62 Auger GA, Pease JE, Shen X, Xanthou G, Barker MD. Alanine scanning mutagenesis of CCR3 reveals that the 
three intracellular loops are essential for functional receptor expression. Eur J Immunol. 2002 Apr;32(4):1052-8. 
63 Zou J, Redmond AK, Qi Z, Dooley H, Secombes CJ. The CXC chemokine receptors of fish: Insights into 
CXCR evolution in the vertebrates. Gen Comp Endocrinol. 2015 May 1;215:117-31. 
64 Ulvmar MH, Hub E, Rot A. Atypical chemokine receptors. Exp Cell Res. 2011 Mar 10;317(5):556-68. 
65 Nibbs R, Graham G, Rot A. Chemokines on the move: control by the chemokine "interceptors" Duffy blood 
group antigen and D6. Semin Immunol. 2003 Oct;15(5):287-94. 
66 Mantovani A, Bonecchi R, Locati M. Tuning inflammation and immunity by chemokine sequestration: decoys 
and more. Nat Rev Immunol. 2006 Dec;6(12):907-18. 
67 Fra AM, Locati M, Otero K, Sironi M, Signorelli P, Massardi ML, Gobbi M, Vecchi A, Sozzani S, Mantovani 
A. Cutting edge: scavenging of inflammatory CC chemokines by the promiscuous putatively silent chemokine 
receptor D6. J Immunol. 2003 Mar 1;170(5):2279-82. 
68 Dambly-Chaudière C, Cubedo N, Ghysen A. Control of cell migration in the development of the posterior 
lateral line: antagonistic interactions between the chemokine receptors CXCR4 and CXCR7/RDC1. BMC Dev 
Biol. 2007 Mar 29;7:23. 
69 Naumann U, Cameroni E, Pruenster M, Mahabaleshwar H, Raz E, Zerwes HG, Rot A, Thelen M. CXCR7 
functions as a scavenger for CXCL12 and CXCL11. PLoS One. 2010 Feb 11;5(2):e9175. 
70 Bamberg CE, Mackay CR, Lee H, Zahra D, Jackson J, Lim YS, Whitfeld PL, Craig S, Corsini E, Lu B, Gerard 
C, Gerard NP. The C5a receptor (C5aR) C5L2 is a modulator of C5aR-mediated signal transduction. J Biol Chem. 
2010 Mar 5;285(10):7633-44. 
71 Di Liberto D, Locati M, Caccamo N, Vecchi A, Meraviglia S, Salerno A, Sireci G, Nebuloni M, Caceres N, 
Cardona PJ, Dieli F, Mantovani A. Role of the chemokine decoy receptor D6 in balancing inflammation, immune 

















The chemokine receptor CXCR4 promotes 
granuloma formation by sustaining a mycobacteria-
induced angiogenesis programme 
 
 
Vincenzo Torraca, Claudia Tulotta, B. Ewa Snaar-Jagalska and Annemarie H. 
Meijer 
 








The chemokine receptor CXCR4 promotes granuloma formation by 
sustaining a mycobacteria-induced angiogenesis programme 
 
 
Vincenzo Torraca, Claudia Tulotta, B. Ewa Snaar-Jagalska and Annemarie H. 
Meijer 
 
Institute of Biology, Leiden University, The Netherlands 
 
CXC chemokine receptor 4 (CXCR4) plays a critical role in chemotaxis and leukocyte 
differentiation. Furthermore, there is increasing evidence that links this receptor to 
angiogenesis. Using the well-established zebrafish-Mycobacterium marinum model for 
tuberculosis, angiogenesis was recently found to be essential to promote the development 
of cellular aggregates called granulomas that contain the mycobacterial infection and are 
the hallmark of tuberculosis disease. Here, we found that initiation of the infection-
dependent pro-angiogenic programme in mycobacterial disease is dependent on CXCR4 
signalling. The nascent granulomas in cxcr4b-deficient zebrafish embryos were poorly 
vascularised, which in turn also delayed bacterial growth in these mutants. Suppressed 
infection expansion in cxcr4b mutants could not be attributed to an overall deficient 
recruitment of leukocytes or to different intramacrophage bacterial growth rate, as cxcr4b 
mutants displayed similar microbicidal capabilities against initial mycobacterial infection 
and the cellular composition of granulomatous lesions was similar to wildtype siblings. 
Expression of vegfaa was upregulated to a similar extent in cxcr4b mutants and wildtypes, 
suggesting that the granuloma vascularisation phenotype of cxcr4b mutants is independent 
of vascular endothelial growth factor. However, transcriptional analysis of pro-
inflammatory markers (il1b, cxcl18b) showed that poor vascularisation of the infected 
tissues in cxcr4b mutants is associated with an attenuated inflammatory response. In 
summary, our study demonstrates that CXCR4-mediated signalling is necessary to induce 
granuloma-associated angiogenesis and suggests that targeting CXCR4 could provide a 
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CXCR4 is a critical chemokine receptor that controls migration and differentiation of a 
variety of cell types. In the bone marrow, interaction of CXCR4 with its ligand CXCL12 
(SDF1) is required for retention of haematopoietic stem/progenitor cells and their complete 
differentiation before release into circulation1,2. During inflammatory responses, CXCR4 
also sustains the trafficking of mature myeloid and lymphoid cells to sites of inflammation. 
Additionally, CXCR4 signalling on other cells is involved in key migratory mechanisms 
during development/embryogenesis and CXCR4 has been linked to the metastatic 
behaviour of cancer cells3,4,5,6,7,8. CXCR4 is also well known to play a critical function in 
HIV pathogenesis, since this factor represents an important HIV co-receptor, mediating 
viral entry into the host cells9. 
 
The zebrafish model system has been widely used to study the implication of CXCR4 
signalling in different processes. The zebrafish Cxcr4b/Cxcl12a signalling system is 
implicated in the migration of the primordial germ cells, the lateral line primordium, the 
migration of haematopoietic stem cells, the recruitment of leukocytes to infectious foci and 
sites of injury and the invasive movement of cancer cells in tumour metastasis2,7,10,11,12,13,14. 
In other model systems, CXCR4 signalling has also been connected to tumour-sustained 
angiogenesis15,16,17. In particular, CXCR4 stimulation was found to induce expression of 
vascular endothelial growth factor (VEGF) in human breast carcinoma cells and conversely 
blockade of CXCR4/CXCL12 signalling was able to suppress tumour angiogenesis and 
tumour growth in vivo in a murine model15. 
 
Tuberculosis (TB) is caused by Mycobacterium tuberculosis (Mtb) infection and this 
disease typically manifests by the formation of aggregates of infected and non-infected 
immune cells that are known as granulomas. Several studies reported that human 
tuberculous granulomas are extensively vascularised18,19,20. However, very little is 
understood about the actual relevance of angiogenesis for granuloma formation in TB 
patients. Additionally, the mechanism by which the vascularisation programme is initiated 
by the pathogen remains elusive21,22. In zebrafish larvae, Mycobacterium marinum (Mm), a 
close relative of Mtb, causes a disease that recapitulates significant aspects of human TB, 
which include the formation of necrotising granulomas and the initiation of specific 
transcriptional and morphological changes in Mycobacterium-infected macrophages23,24. 
Using the zebrafish model, it was recently found that Mm can also induce granuloma-
associated angiogenesis and that initiation of this programme coincides with local 
induction of hypoxia and of the pro-angiogenic factor vegfaa22. Notably, the presence of 
macrophages was strictly necessary for mycobacterial-induced vegfaa expression and 
initiation of granuloma vascularisation. In tumours, activation of CXCR4/CXCL12 
signalling is tightly linked to both the development of hypoxia and to the activation of 
angiogenesis15,16,17. Therefore, we hypothesised that this signalling might also affect 
granuloma vascularisation. 
 
Here we show that Cxcr4b-deficient zebrafish larvae display an attenuated induction of the 
angiogenic programme at the nascent granulomas. This phenotype was not due to different 
cellular composition of granulomas, to different chemotaxis of immune cells to the infected 
areas or to a direct transcriptional control on vegfaa, which was still produced in the cxcr4b 
deficient fish, despite the lack of granuloma vascularisation. Our data suggest that cxcr4b 
might be alternatively implicated in pathogenic angiogenesis by controlling the release of 
!"#$%&'()*#+,-*',*'.$/*)0-1/'/*.,-.2*23,3'
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inflammatory pro-angiogenic mediators which maintain a permissive microenvironment 
that sustains vascularisation. Taken together, our study indicates that Cxcr4b-mediated 
signalling is required to mediate the full angiogenesis response to mycobacterial infections, 
and that suppression of pathological angiogenesis with CXCR4 blockers could be explored 
as an adjuvant treatment of TB patients. 
 
RESULTS 
Cxcr4b signalling controls granuloma-induced angiogenesis 
To study granuloma-associated angiogenesis, a trunk infection model was recently 
established in zebrafish embryos (Figure 1A-B). In this model a transgenic Tg(kdrl:eGFP) 
background (labelling arterial and venous endothelium) was used to monitor host 
vascularisation in the environment of the nascent granulomatous lesions (Figure 1C-E) 
22,25. To study whether cxcr4b has a function in granuloma vascularisation, we injected 
mCherry-fluorescent Mm in cxcr4b mutant and wildtype (wt) siblings at 2 days post 
fertilisation (dpf) and measured bacterial expansion and vascularisation of the infected area 
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In cxcr4b-/- larvae, the expansion of the infection progressed at a significantly lower rate as 
compared to the lesions in wt (Figure 1F-K). Simultaneously, the association of 
vascularisation with the granulomas was impaired in these mutants and, differently from 
wt, cxcr4b mutants did not have a significant positive correlation between granuloma size 
and length of associated abnormal vasculature (Figure 2A-C). Corroborating these results, 
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The interdependence between granuloma expansion and angiogenesis had been previously 
described22 and mechanistically resembles closely the angiogenic switch in tumorigenesis, 
in which tumour size is directly related to the local induction of pathogenic 
vascularisation26. Altogether, our findings suggest that cxcr4b mutation affects granuloma 
expansion by primarily affecting the initiation of the angiogenesis programme, and the 
difference in infection burden appears to be the consequence, rather than the cause, of 
impaired angiogenetic support of granuloma formation. 
 
cxcr4b mutation does not alter the migratory and microbicidal capabilities of 
macrophages or the cellular composition of the granulomatous lesions 
Since others had previously found that intramacrophage residence of mycobacteria is 
indispensable for initiation of angiogenesis22, we investigated whether the difference in 
promotion of angiogenesis in cxcr4b mutants could be explained by aberrant macrophage 
recruitment (and therefore different intracellular/extracellular ratios), differential 
microbicidal capability of macrophages, or alteration in the macrophage composition of 
granulomatous lesions. When mycobacteria were injected locally into the hindbrain 
ventricle, a comparable number of leukocytes were promptly recruited (3 hpi) to the 
infected site in mutants and wt (Figure 3A-B). To assess the possibility of an altered 
microbicidal capability, we injected the Mm mutant strain Δerp, which is highly susceptible 
to macrophage clearance and replicates intracellularly at a low rate, thereby permitting 
quantification of mycobacterial growth in individual macrophages by live microscopy. At 
44 hpi the percentage of macrophages displaying low (1-5 bacteria), moderate (6-10 
bacteria) or high (>10 bacteria) infection load was quantified and cxcr4b mutants showed 
similar distribution of the infection phenotypes as wt siblings, indicating that depletion of 
cxcr4b does not alter the macrophages capability to counteract intracellular infection 
(Figure 3C-D). That cxcr4b mutation might affect the content of macrophages in the 
mature granulomas was also excluded, as the percentage of mycobacteria co-localising 
with macrophages was similar in mutant and wt siblings (Figure 3E-G). In zebrafish 
larvae, cxcr4b is expressed both by the macrophage lineage (marked by mpeg1) and by the 
neutrophil lineage (marked by mpx) (Figure 3H). However, it is unlikely that the 
angiogenesis deficiency in cxcr4b mutants depended on cxcr4b expression by neutrophils, 
as suggested by irf8 morpholino knockdown, which skews myelopoiesis towards 
neutropoiesis at the expense of primitive macrophage development (Figure 3I-J)27. In this 
situation the initial deficiency in macrophages was already sufficient to abrogate the 
angiogenetic response, indicating that neutrophils alone cannot support angiogenesis and 
therefore that the cxcr4b mutation phenotype implicates a macrophage-related function. 
However, since recruitment of macrophages, cellular composition of lesions and 
intramacrophage killing of bacteria were comparable between mutants and wt (Figure 3), 
we hypothesised that cxcr4b mainly affects the interaction of the macrophages with the 
surrounding tissue. 
	
The granuloma vascularisation defect in cxcr4b mutants associated with reduced 
inflammatory gene expression 
Since CXCR4 was previously linked to tumour angiogenesis via a transcriptional control 
on VEGF signalling15, we addressed whether cxcr4b mutation controlled granuloma 
































































































































































































































macrophages	 (A)	and	neutrophils	 (B)	3	hours	post	 local	hindbrain	 (HB)	 infection	at	2	dpf	with	Mm	was	
unaffected	 by	 cxcr4b	 mutation.	 Each	 value	 represents	 the	 recruitment	 measured	 in	 1	 embryo	 (2	
replicates,	 cumulated).	 C-D.	 cxcr4b	 is	 dispensable	 for	 the	 capability	 of	 macrophages	 to	 counteract	
intracellular	replication	of	Mm	Δerp.	Infected	macrophages	(mpeg1:mCherry-F+)	were	classified	into	three	
phenotypic	 classes,	 according	 to	 the	 severity	 of	 intracellular	 infection	 (1-5,	 6-10,	 or	 >10	 bacteria).	 C	
represents	the	%	of	macrophages	per	larva	that	populates	each	class.	D	represents	the	overall	distribution	
of	 macrophage	 phenotypes	 (macrophages	 from	 all	 larvae	 cumulated).	 Graphs	 are	 cumulated	 from	 2	
independent	 replicates.	 E-G.	%	of	mpeg1:mCherry-F	 signal	 overlapping	with	Mm-GFP	 signal	 in	 cxcr4b-/-	
and	 cxcr4b+/+.	No	 significant	 deviation	 in	macrophage	 composition	 of	 the	 trunk	 granuloma	 lesions	was	
detected.	Each	data	point	represents	1	lesion	(1	replicate).	Representative	example	images	are	shown	in	F	
and	G.	H.	Expression	of	cxcr4b	in	macrophages	(mpeg1+)	and	neutrophils	(mpx+).	Both	cell	subsets	express	
cxcr4b	 at	 significantly	 higher	 levels	 than	 the	 negative	 (non-fluorescent)	 cell	 population.	Data	 represent	
fold	 changes	 relative	 to	 the	 negative	 cell	 fraction.	 Cells	 were	 sorted	 at	 2	 dpf	 (3	 replicates).	 I-J.	
Macrophages	 are	 indispensable	 to	 mediate	 granuloma	 vascularisation	 (I)	 and	 an	 increased	 number	 of	
neutrophils	 (by	 irf8	morpholino	 knockdown)	 cannot	 compensate	 for	macrophage	 deficiency,	 neither	 in	
cxcr4b-/-	nor	in	cxcr4b+/+.	Deficient	bacterial	expansion	in	irf8	knockdown	condition	(irf8-MO)	compared	to	




Treatment with Sunitinib (a Vegf receptors inhibitor)28 or cxcr4b mutation reduced trunk 
granuloma size to the same level (Figure 4A), although Vegf receptor inhibition could still 
synergise with cxcr4b mutation and could more severely suppress granuloma 
vascularisation (Figure 4B). However, it should be noted that treatment with Sunitinib (but 
not cxcr4b mutation) also affected to some extent physiological angiogenesis, as the 
frequency of physiological sprouting from intersegmental vessels and their lateral fusion 
was also reduced by this treatment (not shown). Since the angiogenesis response to 
mycobacterial infection was found to coincide with local induction of vegfaa22 and since 
mammalian CXCR4 has been linked to a transcriptional regulation of VEGFA15, we 
addressed whether cxcr4b affected angiogenesis by exerting a similar transcriptional 
control on vegfaa expression in our model. Whole mount qRT-PCR analysis revealed that 
both mutants and wt upregulated vegfaa to a comparable level (Figure 4C). We also found 
that the levels of vegfaa induction, although significant, were limited (1.5-fold) when 
compared to the induction of other infection-inducible genes, which could be seen highly 
upregulated in the same conditions (Figure 4C). Likewise, expression of cxcl12a 
(encoding the ligand of Cxcr4b) showed limited but comparable induction in mutants and 
wt (Figure 4C). Expression of Cxcr4b mRNA was not relevantly altered by the infection 
and remained comparable between wt and mutants (the cxcr4b mutant mRNA differs from 
the wt only because of a point mutation and can, therefore, be normally tested by qRT-
PCR). Signalling via CXCR4 has been linked to the induction of inflammatory genes 
during the response to infections29,30 and the local chronic induction of inflammation 
mediators is known to play a critical role to sustain vascularisation of damaged/inflamed 
tissues31,32. Several inflammatory molecules (mainly interleukins IL1β-6-8 and TNFα) have 
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In agreement, the use of the transgenic reporter Tg(il1b:eGFP-F)34 revealed high 
expression of il1b by Mm-infected cells composing the granulomatous lesions in zebrafish 
larvae (Figure 4D-E). Therefore, we analysed the expression profile of il1b and several 
other Mm-inducible inflammatory genes (tnfa, cxcl11aa, cxcl18b and mmp9). All these 
genes could be still induced in cxcr4b mutants. However, two of the analysed genes, 
namely cxcl18b and il1b were significantly less induced in the mutants, when compared to 
wt (Figure 4C). Taken together, this suggests that a differential inflammatory response can 
be elicited in cxcr4b mutants and wt during the infection progression. 
	
DISCUSSION 
Using intravital imaging in the zebrafish–Mm infection model, we have investigated the 
function of the homoeostatic chemokine receptor Cxcr4 in the development of 
mycobacterial infection and granuloma formation. We found that zebrafish embryos/larvae 
carrying a homozygote mutation of cxcr4b developed an attenuated disease which could be 
associated with the inability of these mutants to induce local angiogenesis. Supporting that 
Cxcr4b promotes granuloma formation by sustaining a mycobacteria-induced angiogenesis 
programme, the positive correlation between granuloma growth and vascularisation that is 
normally observed in wt larvae, was lost in cxcr4b mutants. Furthermore, pharmacological 
blockade of the angiogenesis programme by Vegfr inhibitor could fully abolish the 
differences between mutants and wt in the exacerbation of mycobacterial infection. The use 
of angiogenesis inhibitors has previously been proposed as a host-targeted therapy to 
suppress the formation of granulomas in TB patients22. Based on our results, the CXCR4 
receptor could be explored as a novel target for anti-angiogenic tuberculosis therapy. 
 
It is unlikely that the granuloma vascularisation phenotype requires expression of cxcr4b 
by the endothelial cells per se, since several studies have identified that venous/arterial 
endothelium (kdrl+) does not express high levels of cxcr4b and that this gene can be found 
expressed only in sporadic sprouting lymphatic vessels (kdrl-)12,35. Although our own 
transcriptional analysis of FACS-sorted kdrl+ cells at 5 dpi revealed that transcript of 
cxcr4b can be detected in these cells, this gene is more abundantly expressed by the 
macrophage (mpeg1+) fraction (Supplementary Figure 1). Our study suggests that cxcr4b 
function in evoking angiogenesis requires the presence of macrophages, since skewing 
haematopoiesis towards neutrophils at the expenses of macrophages severely affected the 
induction of the angiogenesis. This conclusion is in line with previous data showing that 
macrophage depletion by transcription factor spi1/pu.1 knockdown reduced the recruitment 
of new vessels to the Mm infection foci22. Together, these results support that cxcr4b exerts 
its function on macrophages in a cell-autonomous fashion, and affects their capability to 
promote angiogenesis. 
 
Macrophages of cxcr4b mutants were normally capable of migrating to initial 
mycobacterial infection foci and were equally suited to contain initial intramacrophage 
bacterial replication, therefore excluding significant effects of cxcr4b on the establishment 
of mycobacteria/macrophage parasitism. Apart from the deficiency in the expansion rate 
and the absence of associated vascularisation, infectious lesions of cxcr4b-/- were 
structurally undistinguishable from those of wt when granulomas of similar sizes were 
compared. Since previous studies reported that vegfaa expression pattern coincided with 
the local promotion of granuloma angiogenesis22, we hypothesised that Cxcr4b might 
support angiogenesis via promotion of vegfaa expression. The induction levels of vegfaa in 
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Mm infected larvae were low and we could not detect a significant difference between 
infected cxcr4b mutants and wt. Several studies have shown that VEGF induction in 
inflammatory processes can be transient and largely variable36,37,38. Therefore, a direct 
function of cxcr4b in the regulation of Vegf/Vegfr signalling cannot be completely 
excluded by our study. Interestingly, we observed a more pronounced effect of cxcr4b 
mutation on the induction of inflammatory mediators, especially ilb and cxcl18b. Several 
reports showed that CXCR4 signalling can support inflammation. In particular, elegant 
studies revealed that CXCR4 can cross-talk with the plasma membrane Toll-like receptor 
TLR4 and act as a potent co-stimulatory mediator29,30. This leads us to hypothesise that 
cxcr4b may contribute to the maintenance of a favourable pro-angiogenesis 
microenvironment, by sustaining the production of inflammatory factors. 
 
There is growing evidence of a tight link between the angiogenesis process and 
inflammation31,32. Many factors that are produced to promote the inflammatory response 
can also promote angiogenesis. Inflammatory cells, especially macrophages, are 
exceptional producers of these pro-angiogenic mediators, which include prostaglandins, 
TNFα, interleukins (especially IL1β-6-8)31,32,33. IL8/CXCL8 is both chemotactic and 
mitogenic for endothelial cells39,40. Similarly, IL1β has been reported to be a potent inducer 
of endothelial cell migration and proliferation, which induces profound morphological 
transformations of these cells and changes in the expression profile, including induction of 
genes that are intimately involved in the regulation of blood vessel formation33,41,42. A 
transcriptional analysis of endothelial cells upon stimulation with either VEGF or IL1 
reported about 80% overlap of their transcriptional signature, which coincided with a 
cluster of core pro-angiogenetic genes involved in cell proliferation, chemotaxis and blood 
vessel differentiation43. In a matrigel model for angiogenesis, both IL1β and VEGF 
signalling were indispensable and neutralisation of either one of these factors was 
sufficient to fully abolish the angiogenic response33,42. 
 
In our study Il1β, which was significantly suppressed at transcriptional levels in infected 
cxcr4b mutants compared to infected wt larvae, may represent a key impaired pro-
angiogenetic mediator. Additionally, Cxcl18b, a fish specific chemokine, appeared also 
significantly downregulated in these mutants. Despite that the role of this chemokine has 
not been fully elucidated, our own studies indicate that this chemokine shares high 
functional similarities with IL8/CXCL844, indicating that, similarly to IL8/CXCL8, 
Cxcl18b might also be important for chemotaxis and cell division of the endothelial cells. 
The importance of inflammation for granuloma vascularisation in the zebrafish trunk-
granuloma model is also suggested by previous studies, where attenuated (ESX1-deficient) 
Mm could not induce angiogenesis even when larvae were injected with larger inoculums 
to compensate for the infection burden difference22. Similarly, also non-chronic infections 
(E. coli) did not evoke the angiogenetic programme22. Whether cxcr4b sustains activation 
of the angiogenic programme by supporting the release of inflammatory mediators that are 
chemotactic/mitogenic for the endothelial cells will require additional characterisation and 
the zebrafish model may represent an elective surrogate system to further address the 
angiogenesis/inflammation co-dependency in vivo. 
 
Concluding, the angiogenesis programme mounted at the granuloma is important to sustain 
the further expansion of the lesion and is a complex multifaceted process that involves 
pathogen virulence factors, macrophage response to intracellular infection and granuloma 
aggregation, induction of local hypoxia and vegfaa signalling22. Our addition to this 
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scenario is that the homoeostatic chemokine receptor CXCR4 is critical to permit the 
induction of the angiogenetic programme, a mechanism that could be exerted by 
modulation of the inflammatory pro-angiogenetic mediators released in the granuloma 
microenvironment, such as IL1β. Manipulation of the inflammation/angiogenesis interface 
triggers significant consequences to the pathology of the mycobacterial infection and 
interfering with this programme via host-directed therapies can be useful to limit 
mycobacterial disease. This and previous studies have shown that similar suppression of 
mycobacterial growth can be obtained by directly blocking VEGF/VEGFR signalling or by 
limiting the inflammatory response22,23,45,46,47. However, blockade of CXCR4 may provide 
a preferential treatment, for example in HIV-positive TB patients, where CXCR4 plays 
also a relevant function in viral entry, therefore, its suppression would simultaneously 
counteract both mycobacterial and viral infection. 
 
MATERIALS AND METHODS 
Zebrafish lines and maintenance – Zebrafish lines were handled in compliance with the 
local animal welfare regulations and maintained according to standard protocols (zfin.org). 
The study was approved by the local animal welfare committee (DEC) of the University of 
Leiden (licence number: 10612). Fish lines used in this work were the following: wildtype 
strain AB/TL, Tg(il1b:eGFP-Fzf550)34 the double transgenic line Tg(mpeg1:mCherry-F 
ump2/mpx:eGFPi114)48,49, cxcr4b homozygote mutant (cxcr4b-/-) and wildtype (cxcr4b+/+) 
siblings of (cxcr4bt26035)8,14 crossed into the transgenic backgrounds of Tg(kdrl:eGFPs843)25 
or Tg(mpeg1:mCherry-Fump2). Embryos were grown at 28.5°C in egg water (60 µg/ml sea 
salt, Sera Marin, Heinsberg, Germany). Larvae destined to image acquisition were 
maintained in egg water supplemented with 0.003% PTU (1-phenyl-2-thiourea, Sigma-
Aldrich, St Louis, MO, USA) from 8-12 hpf to prevent melanisation. Anaesthesia of 
embryos/larvae used for live imaging was achieved with 0.02% buffered Tricaine (3-
aminobenzoic acid ethyl ester, Sigma-Aldrich) in egg water. 
 
Bacterial cultures and infection delivery – Approximately 60-100 CFU suspended in a 
volume of 10 nl of M. marinum strain M (or where specified its isogenic mutant strain 
Δerp) constitutively expressing mCherry, eGFP or Wasabi50,51 were injected into the trunk 
at 2 dpf22, while approximately 50 CFU in a volume of 1 nl were injected into the hindbrain 
(HB, 2 dpf). For recruitment assays and qRT-PCR experiments, the same volume of mock 
[2% polyvinylpyrrolidone-40 (Sigma-Aldrich) in phosphate buffer saline (PBS)] was 
injected in control embryos, as a reference control. Bacteria were grown and harvested 
from an O/N culture as described previously52,53. For morpholino experiments (irf8 
knockdown) and collection of samples for qRT-PCR, trunk infections were performed at 
33 hpf (instead of 2 dpf). For the assessment of the microbicidal activity of macrophages 
against initial mycobacterial infection, single cell suspensions of Mm Δerp-mWasabi were 
injected into the caudal vein at 33 hpf from -80ºC frozen single-use aliquots, using a 
protocol adapted from reference51. Briefly, bacteria from a 1-week-old plate were 
inoculated to an OD600 of 0.2 in 10 ml 7H9 medium supplemented with ADC enrichment. 
The culture was grown for 24 h to reach an OD of approximately 1.0. Bacteria were 
washed 3 times with PBS and suspended in PBS supplemented with 10% glycerol to an 
OD600 of 5.0. To generate a single cell suspension, bacteria were passed 10 times through 
a syringe. 50 µl aliquots were frozen in liquid nitrogen and stored at -80ºC. Upon thawing, 
the vital bacteria were quantified by plating as being approximately 100 CFU/nl. For 
quantification of macrophage and neutrophils recruitment to mycobacteria, 2 dpf embryos 
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were infected in the hindbrain, fixed at 3 hpi in 4% paraformaldehyde in PBS 
supplemented with 0.08% Triton X-100 and prepared for combined L-plastin (Lp) 
immunostaining and myeloperoxidase (Mpx) enzymatic activity staining as in reference54. 
Leukocytes accumulated at the injected cavity (macrophages: Lp-positive and Mpx-
negative; neutrophils: Mpx-positive) were counted using a Leica MZ16FA fluorescence 
stereomicroscope (Leica Microsystems, Rijswijk, The Netherlands). 
 
RNA isolation, FACS and qRT-PCR – To evaluate the induction of genes upon 
infections (Figure 4C), whole-embryo RNA extraction, cDNA synthesis and qRT-PCR 
were performed at 5 dpi from a pool of embryos injected at 33 hpi (4 replicates), according 
to the procedure described in reference52. To demonstrate expression by phagocytes 
(Figure 3H), RNA was isolated from mpx+ and mpeg1+ cells sorted at 2 dpf from the 
double transgenic line Tg(mpeg1:mCherry-Fump2/mpx:eGFPi114), according to previous 
reports55,52. Similarly, to evaluate expression of cxcr4b by endothelial cells 
(Supplementary Figure 1), RNA was isolated from kdrl+ or mpeg1+ cells of cxcr4b+/+ and 
cxcr4b-/- larvae (5 dpi/6 dpf) derived from paired crosses of Tg(mpeg1:mCherry-
F/cxcr4b+/+) x Tg(kdrl:eGFP/cxcr4b+/+) and Tg(mpeg1:mCherry-F/cxcr4b-/-) x 
Tg(kdrl:eGFP/cxcr4b-/-). 
 
Reference housekeeping genes were ppia1b for whole-mount samples and eif4a1b for 
FACS-sorted samples. qRT-PCR primers are reported in Supplementary Table S1. 
 
Pharmacological inhibition of VEGF signalling – For pharmacological inhibition of 
VEGF signalling, the VEGFR tyrosine kinase inhibitor Sunitinib (1 µM, Sigma-Aldrich) or 
vehicle treatment (0.1% DMSO, Sigma-Aldrich), were applied directly to the egg water 
and refreshed every 2 days according to reference28. 
 
Irf8 knockdown – 1 nl of 1 mM irf8 splicing morpholino (5′-
AATGTTTCGCTTACTTTGAAAATGG-3′, Gene tools)27 or the same concentration of a 
standard control morpholino (5′-CCTCTTACCTCAGTTACAATTTATA-3′, Gene tools) 
were injected in one-cell stage zebrafish fertilised eggs according to reference27. 
 
Imaging and image quantification – Fixed or live embryos and larvae were imaged using 
a Leica MZ16FA fluorescence stereomicroscope. The size of individual granulomas was 
quantified at 5 dpi (at 4 dpi in case of irf8 morpholino knockdown) by pixel count, using 
Fiji/ImageJ software (NIH, Bethesda, MD, USA) according to reference52. The length of 
abnormal vasculature at the granulomas was quantified at the same stage from images 
according to reference22. To score the microbicidal activity of macrophages against 
mycobacteria, MmΔerp-Wasabi bacteria prepared as described above were injected into the 
caudal vein of Tg(mpeg1:mCherry-F)/cxcr4b-/- and Tg(mpeg1:mCherry-F)/cxcr4b+/+ 
embryos. Intramacrophage mycobacterial sites of growth were counted (blind) from fixed 
embryos at 44 hpi according to reference47 , using Zeiss Observer 6.5.32 confocal 
microscope and a C-Apochromat 63x/1.20 W Korr UV-VIR-IR M27 objective (Carl Zeiss, 
Sliedrecht, The Netherlands). The level of infection per macrophage was classified into 
three groups based on bacterial content (1-5 bacteria, 6-10 bacteria or >10 bacteria). To 
estimate similar macrophage content of granulomas, the percentage of colocalisation of 
Tg(mpeg1:mCherry-F) and Mm M-eGFP was quantified ad 5 dpi using Fiji/ImageJ 
dedicated colocalisation plugin. Confocal images in Figure 4 were taken from trunk 
granulomas at 5 dpi/6 dpf, using Zeiss Observer 6.5.32 confocal microscope and an EC 
!"#$%&'()*#+,-*',*'.$/*)0-1/'/*.,-.2*23,3'
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Plan-Neofluar 20x/0.50 M27 (Figure 4D) or C-Apochromat 63x/1.20 W Korr UV-VIR-IR 
M27 objective (Figure 4E). 
 
Statistical analysis – Statistical significance was analysed using GraphPad Prism 6 
(GraphPad Software, La Jolla, CA, USA). Differences in granuloma sizes, angiogenesis, 
recruitment and bacteria/macrophage co-localisation were statistically tested by Mann-
Whitney test (comparison between 2 groups) or Kruskal-Wallis test followed by %idák 
comparison test (multiple group comparisons) (Figure 2A-B, Figure 3A-B-E, Figure 4A-
B). Bacterial cluster size/angiogenesis correlation (Figure 2C) was analysed by Pearson 
correlation test and the difference between mutant and wt regressions was computed by 
GraphPad Prism 6 dedicated linear regression analysis tool. No differences in bacterial 
replication and in the distribution of macrophages in the three phenotypic classes (as 
defined above) were analysed by two-tailed t-tests per each phenotypic class (Figure 3C) 
and by chi-square contingency test (Figure 3D) respectively. For qRT-PCR (Figure 4C), 
statistical significance was estimated by two-tailed t-tests on ln(n)-transformed relative 
induction folds. Significance (P-value) is indicated with: ns, non-significant; *P<0.05; 
**P<0.01; ***P<0.001, ****P<0.0001. Error bars: mean±s.e.m. 
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The zebrafish (Danio rerio) model has proven successful in many infection/inflammation-
related studies. To ensure the translational impact of the zebrafish model in this field, it is 
important to clarify the homologies between the zebrafish and the human immune systems. 
Cxcl18b is a chemokine found in zebrafish and conserved in several piscine and amphibian 
species, although this lineage has not been maintained in the divergence of amniotes. The 
function of Cxcl18b is yet to be elucidated. However, this ligand represents a valid 
inflammatory marker in fish, found recurrently upregulated during infection/inflammation. 
In this study, we produced recombinant zebrafish Cxcl18b and, by local injections in vivo, 
we found that this ligand exhibits specific chemotactic properties towards neutrophils, 
comparable to those exerted by Cxcl8a, also known as Il8, the best characterised neutrophil 
chemotactic factor in both humans and teleosts. By pharmacological manipulations, we 
found that, like Cxcl8a, Cxcl18b requires the chemokine receptor Cxcr2 for optimal 
chemotaxis, although Cxcl18b, differently from Cxcl8a, could still mediate residual 
recruitment of neutrophils under conditions of Cxcr2 inhibition. However, the remaining 
recruitment of Cxcl18b did not rely on expression of cxcr1 or cxcr4b, two other known 
neutrophil receptors. To visualise the cxcl18b expression pattern we generated a 
Tg(cxcl18b:eGFP) reporter line and found that this transgene is induced upon bacterial 
infection with Mycobacterium marinum, in agreement with previous mRNA expression 
data. The cxcl18b reporter expression coincides with the areas of bacterial growth but 
seems not directly induced in infected cells. Instead, it is predominantly expressed by non-
infected cells participating in the initial formation of inflammatory granulomatous lesions 
that are critical to the pathogenesis of mycobacterial infection. Together, these results 
suggest that Cxcl18b could be an important contributor to neutrophil chemotaxis in the 
granuloma microenvironment in the zebrafish model and emphasise the need for a better 
understanding of how this inflammatory chemokine relates to the better-characterised class 




















The	 chemokine	 Cxcl18b	 is	 able	 to	 specifically	 promote	 neutrophil	 chemotaxis.	 This	 is	 at	 least	 partly	
evoked	 by	 signalling	 via	 the	 neutrophil	 chemokine	 receptor	 CXCR2.	During	 infection	with	M.	marinum,	
several	cells	that	participate	in	the	formation	of	the	granulomas	produce	the	chemokine	ligand	Cxcl18b.	
Generally,	these	cells	are	not	intracellularly	infected	and	do	not	express	the	neutrophil	and	macorphage	





The constant interplay between microbes and their hosts is the driving force for the 
evolution of pathogens and of the host immune system. Complex systems of pathogen 
virulence and corresponding control mechanisms in their hosts have originated from their 
co-evolution. Studying infectious diseases in the context of a whole living organism 
provides the possibility to better understand these mechanisms and to translate them into 
novel therapeutic strategies. Both the innate and the adaptive immune systems are well 
conserved among vertebrates and the zebrafish (Danio rerio) is an excellent model 
organism to study the biology of infectious and inflammatory diseases, especially because 
of the optical accessibility of its early embryonic and larval stages1,2. The transparency of 
the zebrafish allows direct visualisation of cellular migration processes in response to 
chemotactic cues and infections. To facilitate in vivo analysis, many fluorescent reporter 
lines have been developed that label different immune cell types, including macrophages 
and neutrophils3,4. Additionally, the use of the zebrafish has been extended by combining 
the optical properties of this model with pharmacological and genetic tools that well apply 
to this species, due to high permeability to compounds by submersion and to the ease of 
application of gene editing techniques5,6. 
 
Chemokines are a family of small cell-signalling proteins that direct the migration of cells 
expressing the corresponding receptors towards a ligand concentration gradient. The CXC 
subgroup of chemokines (containing the Cysteine-X-Cysteine motif) is well conserved 
between mammalian and teleost species. In mammals, this family can be further divided 
into ELR+ and ELR− chemokines, based on the presence or absence of the Glutamic acid-
Leucine-Arginine motif preceding the CXC sequence. ELR+ chemokines include CXCL1-
2-3 (GROα-β-γ), CXCL5 (ENA78), CXCL6 (GCP2), CXCL7 (NAP2) and CXCL8 (IL8). 
These are potent chemoattractants of neutrophils7,8,9,10,11,12, while ELR− chemokines, such 
as CXCL9 (MIG), CXCL10 (IP-10) and CXCL11 (I-TAC), are best known for the 
attraction of lymphocytes and monocyte/macrophages and possess poor chemotactic ability 
towards neutrophils. In fish, the ELR sequence is not conserved in chemokines that exert 
neutrophil chemotactic properties13. However, it has been demonstrated that the zebrafish 
Cxcl8/Il8 (Interleukin 8) paralogues, despite being ELR-deficient, are still potent attractors 
of neutrophils5,14,15. 
 
CXCL8 is the best-studied neutrophil chemoattractant in humans11,12 and is conserved in 
zebrafish5,14,15, while absent in rodents16,17. In both zebrafish and mammals, Cxcl8/CXCL8 
signals via the receptor Cxcr2/CXCR25,12,14. In mice this receptor still exerts a chemotactic 
activity towards neutrophils, but this is evoked by binding to other ELR+ chemokines 
CXCL1-2-3-5-712, to the non-chemokine tripeptide PGP (Pro-Gly-Pro, a molecule that 
derives from extracellular matrix breakdown)18 and to MIF (macrophage migration 
inhibitory factor, a non-chemokine component which inhibits macrophage migration but 
sustains neutrophil recruitment)19. The CXCR2 receptor is promiscuous in humans too and 
can respond to CXCL1-2-3-5-6-7-87,8,12, PGP18,20 and MIF19. Finally, in humans, the 
activity of CXCL8 is non-specific for CXCR2, since this ligand, together with CXCL6-7, 
can also induce neutrophil chemotaxis via CXCR1, another chemokine receptor, closely 
related to CXCR221. We currently know that two zebrafish Cxcl8 chemokines, Cxcl8a and 
Cxcl8bb, require the chemokine receptor Cxcr2 to promote neutrophil chemotaxis5,14,15. It 
is also known that Cxcl8a, differently from its human counterpart, does not require the 
zebrafish Cxcr1 receptor and chemoattracts neutrophils essentially via Cxcr214. Whether 
Cxcl18b-dependent	neutrophil	recruitment	
177	
other lineages of chemokine and non-chemokine ligands are chemotactic towards Cxcr1-2 
in zebrafish is not currently known. 
 
A cluster of genes that conserves high sequence homology and synteny with the human 
CXCL9-10-11 gene cluster also exists in zebrafish22,23. Two of these (Cxcl11aa and 
Cxcl11af) are infection-inducible and require the chemokine receptor Cxcr3.2, an 
orthologue of mammalian CXCR3. Similarly to the mammalian axis, the Cxcr3.2 receptor 
induces macrophage recruitment23. In addition, macrophages and neutrophils in zebrafish 
express and are mobilised via Cxcr4b24 and this receptor has been shown to cross 
communicate with the human CXCL12, the ligand of human CXCR425. 
 
Together with the conservation of the CXCR2, CXCR3, and CXCR4 signalling axes, 
zebrafish also has a series of other CXC motif chemokines that cannot be unambiguously 
classified with respect to the mammalian counterparts, due to the short sequence and the 
fast evolution and divergence of chemokine genes22. The absence of the ELR motif in 
neutrophil-competent teleost chemokines additionally complicates phylogenetic 
reconstructions and functional classification. Cxcl18b (formerly named Cxcl-c1c) is highly 
induced in zebrafish upon infection with different pathogens and shares sequence 
similarities and expression patterns with the zebrafish orthologues of both Cxcl8 and 
Cxcl11 chemokines (48-53% amino acid similarities to Cxcl8a, Cxcl8bb, Cxcl11aa and 
Cxcl11af)22,26,27,28. Blasting Cxcl18b to the murine and human protein databases reveals 
instead that murine CXCL3 and human CXCL11 are its two most closely related 
mammalian chemokines (48% and 47% amino acid similarity, respectively). 
 
Like other inflammatory chemokines, cxcl18b transcription was found to rely on the 
activation of the Myd88-dependent innate immunity signalling pathway during the 
response to Edwardsiella tarda, Mycobacterium marinum (Mm) and Salmonella enterica 
serovar Typhimurium26,27. Recently, it was also demonstrated that Cxcl18b is upregulated 
in response to treatment with toxic and pro-apoptotic compounds, which indicates this gene 
as a marker of inflammation in general28,29. However, the function of Cxcl18b has yet to be 
elucidated and clarification of its role has an important translational significance, since the 
zebrafish model is being increasingly used to study chemokine axes, leukocyte biology, 
and inflammatory processes30. This study demonstrates that Cxcl18b is an additional 
neutrophil chemotactic factor. We show that the function of Cxcl18b relies, at least partly 
on chemokine receptor Cxcr2, and not on Cxcr1 and Cxcr4b. Finally, using a novel 
reporter line, we show the expression of this chemokine during the pathological 
inflammation occurring upon mycobacterial infection. 
 
RESULTS 
Production and quality confirmation of recombinant Cxcl18b 
In order to study the chemotactic properties of Cxcl18b, we set out to produce recombinant 
protein using a yeast (Pichia pastoris) expression system. The coding sequence for 
Cxcl18b was synthetically generated according to the Ensembl database accession 
(ENSDARG00000075045/ENSDART00000111598). The sequence was codon optimised 
for expression in yeast and supplemented with an HA (human influenza haemagglutinin)-
tag at the C-terminus, to permit identification with an anti-HA-antibody. Additionally, to 
facilitate secretion by Pichia pastoris, the predicted zebrafish signal peptide of Cxcl18b 
was replaced with the yeast alpha-factor secretion signal, as a result of cloning of the 
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Cxcl18b sequence into the pPICZ" expression vector. Expression of the construct in 
successful (Zeocine-resistant) transformants was induced by culturing several isolates in 
buffered minimal medium supplemented with 0.5% methanol that is used as an inducer of 
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Eight colonies were tested for optimal expression and secretion, by western blot analysis 
against the HA-sequence on the supernatant of induced cultures (Figure 1A). In western 
blot analysis Cxcl18b displayed two bands (~20 kDa and ~40 kDa), of which the one with 
the higher molecular weight most likely represents a dimer, as chemokine ligands are 
known to form very stable dimers31,32,33,34. Deviation of molecular weight of the monomer 
from expectation (11.5 kDa), is most likely due to extensive glycosylation, as multiple 
glycosylation sites were predicted and chemokines are known to be highly glycosylated15. 
The Cxcl18b-positive clone that appeared to produce the highest levels of chemokine was 
used for macroscale preparation of Cxcl18b. The supernatant of an induced culture, 
containing Cxcl18b was concentrated and purified in PBS (phosphate buffer saline) by 
column filtration. Identity and purity of Cxcl18b in the sample was determined by 
trypsinisation and electrospray mass spectrometry analysis, which revealed high purity of 
the protein and undetectable protein contaminations of the recombinant Cxcl18b with 
Pichia pastoris proteins (Figure 1B-C). 
 
Cxcl18b induces chemotaxis of neutrophils, but not macrophages 
To study the function of Cxcl18b, the isolated chemokine was injected into the hindbrain 
ventricle of embryos at 2 dpf (days post fertilisation), in neutrophil-specific (mpx:eGFP-
positive cells4) or macrophage-specific (mpeg1:Gal4/UAS:Kaede-positive cells3) 
transgenic reporter backgrounds. Embryos were fixed 3 hours post injection (hpi). As a 
negative control for injections (mock), the supernatant of a non-transformed Pichia 
pastoris culture was processed with the same purification procedure. Injection of either 0.2 
or 2 ng of purified recombinant Cxcl18b elicited significantly higher mobilisation of 
neutrophils when compared to mock, while it did not impact on macrophage recruitment 
(Figure 2), indicating that Cxcl18b has chemotactic specificity toward neutrophils. 
Injection of either 0.2 or 2 ng of Cxcl18b did not affect the overall level of recruitment in a 
dose-dependent manner, suggesting that receptor saturation may have occurred. 
 
Cxcl18b requires Cxcr2 receptor, but not Cxcr1 and Cxcr4b, for efficient recruitment 
of neutrophils 
The chemokine receptor Cxcr2/CXCR2 is a key controller of neutrophil chemotaxis in both 
teleosts and mammalian species5,12,14. In mammals, activation of neutrophil migration via 
CXCR2 can be obtained by stimulation with a wide spectrum of inflammatory CXC 
chemokines, including CXCL1-2-3-5-6-7-87,8,9. Hence, CXCR2 represents a ligand-
promiscuous, but neutrophil-specific, receptor. In zebrafish, 2 functional Cxcl8 ligands 
(Cxcl8a and Cxcl8bb) of Cxcr2 have been identified5,14,22. However, considering the 
capability of the mammalian CXCR2 to accommodate a multiplicity of chemokines of 
different lineages, it is very likely that also in zebrafish other CXC chemokines are 
redundant with Cxcl8 ligands. Therefore, we hypothesised that the neutrophil chemotactic 
properties of Cxcl18b might also be exerted by activation of Cxcr2. To test this hypothesis 
we pharmacologically inhibited Cxcr2 with SB225002, a non-peptide inhibitor that can 
suppress both mammalian and zebrafish CXCR2 activity against its ligands, such as 
CXCL1 and CXCL85,35. As a positive control, zebrafish Cxcl8a 
(ENSDARG00000104795/ENSDART00000161996), isolated with a comparable method23, 
was used, since it was previously demonstrated that blockade of Cxcr2 with SB225002 can 
affect Cxcl8-dependent chemotaxis in zebrafish5. Cxcl8a and Cxcl18b elicited increased 
recruitment of neutrophils in control (DMSO vehicle-treated) groups and a significantly 
diminished chemotactic potency in SB225002-treated groups, which indicated that both 
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Cxcl8a and Cxcl18b require Cxcr2 to mediate optimal neutrophil chemotaxis (Figure 3A). 
However, the chemotactic capability of Cxcl8a was more severely suppressed by the drug 
treatment, as compared to the effect exerted by the same treatment on Cxcl18b chemotaxis, 
since this could still recruit more neutrophils than mock in Cxcr2-depleted condition. We 
also tested the activity of Cxcl18b under condition of cxcr1 morpholino knockdown and in 
a cxcr4b mutant line, since these other two receptors are also expressed by zebrafish 
neutrophils14,24. However, Cxcl18b did not display significantly diminished 
chemoattractant power in cxcr1 or cxcr4b depleted conditions, indicating that these 
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To address whether redundant function between Cxcr1 and Cxcr2 might explain that cxcr1 
morpholino injection did not impair neutrophil recruitment, we blocked Cxcr1/2 signalling 
by cxcr1 knockdown and simultaneous Cxcr2 pharmacological inhibition. Similar as in the 
case of Cxcr2 inhibition (Figure 3A), simultaneous blockade of Cxcr1 and Cxcr2 
significantly reduced neutrophil recruitment, but some residual chemotactic activity was 
observed (Figure 3B). 
 
A Tg(cxcl18b:eGFP) reporter lines labels mycobacterial-induced inflammation 
Since previous expression studies indicated that Cxcl18b is induced in response to several 
bacterial infections26,27, we constructed a Tg(cxcl18b:eGFP) reporter line to visualise and 
longitudinally follow the expression pattern of cxcl18b in vivo. To validate inflammation-
dependent induction of the reporter line, we injected embryos with Mycobacterium 
marinum (Mm), a fish pathogen which leads to the formation of granulomatous lesions in 
the zebrafish species and is widely used as a surrogate model for tuberculosis36. These 
inflammatory lesions consist of immune cell aggregates that have migrated and collected 
bacteria at the infection focus. 
 
The initial stages of granuloma formation mostly consist of macrophages, while 
neutrophils are mostly recruited at a more advanced stage. Granulomas in the zebrafish 
embryonic/larval model form without requiring the presence of adaptive immune cells, as 
these lesions can be generated at developmental stages that anticipate ontogenesis of 
lymphocytes36. When Tg(cxcl18b:eGFP) embryos were challenged with Mm, the cxcl18b-
driven eGFP accumulated in the areas where initial aggregates were forming (Figure 4), 
consistent with previous evidence reported by transcriptomic and in situ gene expression 
studies26,27. At 36 hpi, cells residing in the caudal haematopoietic tissue and endothelial 
cells appeared to upregulate the transgene. (Figure 4E-F). As the infection progressed, the 
expression of the reporter continued to accumulate at the nascent granulomas in the cells 
surrounding the lesion. However, confocal imaging of the infected larvae indicates that the 
infected cells are not the main producers of cxcl18b, rather this is produced by non-infected 
cells in the immediate surrounding tissue (Figure 5A-F). However, these cxcl18b-
expressing cells localised in tight proximity to the cells where most of the infection was 
residing, participating in the formation of the nascent granulomatous aggregates. At 3-4 dpi 
(days post infection), highly cxcl18b-expressing cells could be found within the granuloma 
lesion. Considering the capability of some of the Cxcl18b+ cells to emit long dendrites 
(Figure 5C-F), we investigated whether these cells could represent uninfected phagocytes 
(macrophages and neutrophils). Therefore, we crossed the Tg(cxcl18b:eGFP) transgenic 
line with Tg(lyz:DsRed) or Tg(mpeg1:mCherry-F) lines and infected the offspring with 
Mm-mCrimson to induce Cxcl18b expression. As expected, the infection resided 
essentially in cxcl18b-negative cells, although the nascent granuloma aggregates contained 
several cxcl18b-positive cells. Strikingly, the cxcl18b transgene expression did not overlap 
with lyz and mpeg1 transgenes, indicating that Cxcl18b is expressed by non-phagocytic 
cells that participate in the granuloma aggregate. Since we identified Cxcl18b as a potent 
neutrophil chemoattractant and neutrophils are known to be attracted to the granulomatous 
aggregates37,38, we propose that Cxcl18b-producing non-phagocytic cells that compose the 
































on	 the	 previous	 page).	 A-F.	During	 the	 formation	 of	 granulomas,	 the	 cells	 that	 express	 high	 levels	 of	
cxcl18b:eGFP	consist	predominantly	of	uninfected	cells	that	participate	in	the	cell	aggregates	initiating	the	
granuloma.	Phenotypic	inspection	shows	that	some	of	these	cells	can	emit	long	protrusions	(arrow	in	C).	
G-L.	 Cxcl18b-expressing	 cells	do	not	 represent	phagocytic	 cells	 since	 this	marker	does	not	overlap	with	






Our study reports that the inflammatory chemokine Cxcl18b, a reliable marker of 
inflammation in zebrafish, displays expression patterns and chemotactic properties towards 
neutrophils, similar to those of the zebrafish Cxcl8 paralogues. Both Cxcl8 chemokines and 
Cxcl18b require the chemokine receptor/neutrophil marker Cxcr2 to mediate an optimal 
neutrophil emigration5. 
 
Our study therefore indicates that, like in mammalian species, the zebrafish Cxcr2 is a 
promiscuous receptor, able to respond to a variety of CXC ligands12. However, while 
Cxcl8a heavily relies on Cxcr2 activity to induce chemotaxis, Cxcl18b can still elicit 
significant (although diminished) neutrophil recruitment in Cxcr2-depleted conditions, 
indicating that another neutrophil receptor can mediate residual Cxcl18b chemotaxis in 
Cxcr2-blocked conditions. We excluded the possibility that this receptor may be Cxcr4b or 
Cxcr1, other two chemokine receptors expressed by the neutrophil lineage which can affect 
neutrophil chemotaxis in zebrafish and/or mammals21,24, since Cxcl18b could still elicit 
normal recruitment of neutrophil in a cxcr4b mutant line or in cxcr1 knockdown 
conditions. These data are in line with previous studies in zebrafish that demonstrated that 
Cxcr1 is also not required to sense the zebrafish Cxcl8a and Cxcl8bb chemokines that 
essentially recruit via Cxcr25,14, and with the fact that Cxcr4b mostly elicits cell recruitment 
via the Cxcl12a ligand39. The residual recruitment of neutrophils upon Cxcl18b injection 
can be explained either with the existence of another neutrophil receptor that contributes to 
Cxcl18b-mediated recruitment, or with the possibility that the Cxcr2 inhibitor may not 
have completely suppressed Cxcr2 function, which could lead to some residual neutrophil 
recruitment when saturating doses of chemokine ligands are provided. 
 
In this study, we have also constructed a cxcl18b reporter line that can be used to further 
investigate what cell types are involved in the production of the Cxcl18b neutrophil-
chemotactic cue. Our analysis of the Cxcl18b transgene expression indicates that non-
phagocytic cells at the infection site are responsible for cxcl18b expression in response to 
Mm bacterial challenge. This observation suggests an important contribution of stromal 
cells in the granuloma microenvironment to the development of inflammation. A better 
understanding of responses in the granuloma microenvironment is particularly relevant in 
view of the emerging role of inflammation in the pathogenesis of tuberculosis, with several 
recent studies emphasising the need for a well-balanced inflammatory response in order to 
provide protective functions yet prevent pathological consequences40,41. Additional 
combination of Tg(cxcl18b:eGFP) with other reporter lines for inflammatory phagocytes 
or inflamed tissues (e.g. tnfa42 and il1b43 reporters) and transcriptional profiling of cxcl18b-
expressing cells may further help to elucidate the nature and the importance of the cxcl18b 
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positive cells in the promotion of inflammation and in driving neutrophilic infiltration in 
mycobacterial granulomas. 
 
In a recent study, Cxcl18b was the most upregulated chemoattractant detected at 4 hours 
post tail fin amputations44, indicating that Cxcl18b is also induced upon sterile acute 
inflammation. Notably, in this study the expression of Cxcl18b was fully suppressed by 
treatment with the glucocorticoid beclomethasone. Treatment with this anti-inflammatory 
drug coincided with the abolishment of neutrophil recruitment to the wound, while it did 
not affect macrophage recruitment44. Given our evidence that Cxcl18b is a powerful and 
neutrophil-specific chemotactic cue, it is very likely that neutrophil chemotaxis was 
impaired by beclomethasone treatment owing at least partly to suppression of cxcl18b 
induction. Previous studies performed in a similar model showed that, at 1 hour post 
wounding (hpw), the two zebrafish Cxcl8a and Cxcl8bb genes were also significantly 
induced. While induction of Cxcl18b was not addressed at 1 hpw, induction of Cxcl8a and 
Cxcl8bb was found to be very transient and significantly dropped down at 4 hpw5. Taken 
together, these studies suggest that Cxcl8a-bb and Cxcl18b might represent differently 
timed chemotactic cues which may be responsible for the recruitment of different waves of 
neutrophils during acute and chronic inflammatory responses. The recombinant Cxcl8a and 
Cxcl18b proteins and the cxcl18b reporter line presented here will possibly aid in studying 
the dynamics of cxcl18b expression and permit to clarify shared and distinct functions of 
Cxcl8 isoforms and Cxcl18b in orchestrating neutrophil function. Understanding to what 
extent Cxcl18b is redundant with Cxcl8 isoforms and whether the two clades of 
chemokines also display specific functions in the regulation of the inflammatory response 
could also shed light on the divergences and/or convergences existing between fish and 
mammalian chemokine axes and on the evolutionary diversification of chemokine ligands. 
 
MATERIALS AND METHODS 
Zebrafish lines and embryo/larvae handling – Zebrafish were handled in compliance 
with the local (Leiden University) animal welfare policies and were maintained according 
to standard protocols (zfin.org). All experiments in this study were performed on 2 dpf 
embryos, therefore prior the free feeding stage and did not fall under animal 
experimentation law according to the EU Animal Protection Directive 2010/63/EU. 
Embryos were kept in egg water (60 µg/ml sea salt; Sera Marin) at 28.5°C. To prevent 
pigmentation, embryos were maintained in water supplemented with 0.003% PTU (1-
phenyl-2-thiourea, Sigma-Aldrich). For the recruitment assays, neutrophils and 
macrophages were labelled with the transgenes Tg(mpx:eGFPi114)4 or Tg(mpeg1:Gal4-
VP16gl24/UAS-E1b:Kaedes1999t)3 [in short referred to as Tg(mpeg1:Gal4/UAS:Kaede)], 
respectively. For confocal microscopy (Figure 5), neutrophil and macrophage lines 
Tg(lyz:DsRednz50)45 and Tg(mpeg1:mCherry-Fump2)46 were single crossed to the 
cxcl18b:eGFP line (see below). To address chemotactic properties of Cxcl18b via Cxcr4b, 
mutants (cxcr4b-/-) and wildtype siblings (cxcr4b+/+) of (cxcr4bt26035)47, crossed into the 
Tg(mpx:eGFPi114) background were used. 
 
Production and verification of recombinant Cxcl18b – The coding sequence for 
Cxcl18b (ENSDARG00000075045/ENSDART00000111598) was optimised for 
expression in yeast, supplemented with an HA (human influenza haemagglutinin)-tag at the 
C-terminus and cloned into pPICZα expression vector (Invitrogen, Life Technologies). The 
expression plasmid was linearised with SacI and transformed into Pichia pastoris strain X-
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33 as described previously23,48. Successful transformants were selected on YPD-agar (1% 
yeast extract 2% peptone 2% dextrose 2% agar, Sigma-Aldrich) by resistance to 100 µg/ml 
Zeocine and reselected on 1000 µg/ml Zeocine plates. Highly resistant clones were selected 
for expression efficiency by liquid culturing the isolates in 10 ml YPD medium (30ºC, 180 
rpm, O/N), transfer to 2.5 ml buffered minimal methanol medium (100 mM potassium 
phosphate buffer pH 6, 1.34% yeast nitrogen base, 4·10-5% biotin, 0.5% methanol, Sigma-
Aldrich), and cultured (30ºC, 180 rpm) for five days (with additional 0.5% methanol 
supplemented daily). The supernatant of the cultures was probed for anti-HA reactivity on 
western blot, using a custom-made horseradish peroxidase-directly conjugated antibody. 
One clone was selected for large-scale culture (250 ml). Cxcl18b-HA accumulated in the 
supernatant was concentrated and purified in PBS by filtration between columns with a cut-
off of 50 kDa and 3 kDa (Amicon Ultra Centrifugal filters, Merck KGaA). Identity and 
purity of Cxcl18b in the sample was determined by trypsinisation and electrospray mass 
spectrometry analysis, which revealed high quality of the protein and undetectable protein 
contaminations of the recombinant Cxcl18b with Pichia pastoris proteins (Figure 1B-C). 
To obtain a mock control for injections, isolation was performed from the supernatant of 
non-transformed isogenic P. pastoris, cultured in identical condition (with the exception of 
Zeocine 100 µg/ml present in the starter plate and pre-culture for the transformed isolate). 
We confirmed chemokine purity and identity by in-solution trypsinisation and electrospray 
mass spectrometry. Quantification was obtained by BCA-assay (Micro BCATM Protein 
Assay Kit, Thermo Fisher Scientific, Life Technologies), the protein concentration 
assessed by the assay in the mock is subtracted from the total Cxcl18b protein 
concentration. 
 
Recruitment assays – Cxcl18b, Cxcl8a or mock (produced as described above), were 
diluted in PBS to the desired concentration (0.2 ng/nl and 2 ng/nl) and injected (1 nl) into 
the hindbrain ventricle of 2 dpf embryos. Prior and during injections, embryos were 
anaesthetised in egg water medium containing 0.02% buffered Tricaine (3-aminobenzoic 
acid ethyl ester; Sigma-Aldrich). The embryos were fixed (O/N) at 3 hours post injection 
(hpi) in PBSTx (1× PBS supplemented with 0.8% Triton X-100, Sigma-Aldrich) 
containing 4% paraformaldehyde. Subsequently, the embryos were washed in PBS and the 
fluorescently labelled cells within the hindbrain perimeter were counted (blinded) using a 
Leica MZ16FA fluorescence stereomicroscope. 
 
Pharmacological inhibition of Cxcr2 – For the Cxcr2 inhibition assays, we followed and 
adapted the protocol used in reference5. Briefly, 2 dpf larvae were preincubated for 1 hour 
at 28.5°C in presence or absence of the selective nonpeptide inhibitor SB225002 (Sigma-
Aldrich) at a concentration of 5 µM in egg water. Since the compound is initially 
suspended in DMSO, the control group was exposed to the same concentration of DMSO 
(Sigma-Aldrich) alone (0.05%) as in the SB225002 group. Upon injection, embryos were 
returned and maintained in SB225002 or vehicle treatment until they were fixed (3 hpi) in 
4% paraformaldehyde in PBSTx O/N. 
 
Knockdown of Cxcr1 – 3 nl of 75 µM cxcr1 morpholino (5′-
TGTCAGGATACTAAACTTACCAGTC-3′, targeting exon1-intron 1 splicing site, 
Gene tools) or the same volume and concentration of a standard control morpholino (5′-
CCTCTTACCTCAGTTACAATTTATA-3′, Gene tools) were injected at 1 cell stage in 




Cloning of cxcl18b promoter and construction of Tg(cxcl18b:eGFP) reporter line – 
3.04 kb of cxcl18b promoter immediately proximal to the transcriptional start were 
amplified from genomic DNA derived from a pool of AB/TL embryos, using the following 
amplification primers: XhoI-Cxcl18bFw: 5′-
GGGCCCCTCGAGGTCTCCTCATGCATTGACTAC-3′ and BamHI-Cxcl18bRv: 5′-
GGGCCCGGATCCAATTGCTGCAAACTATATGTAGG-3′. The PCR resulted in a 
single band on gel electrophoresis at the expected molecular weight. The primers 
supplemented the sequence with a unique XhoI site at the 5’ end, a unique BamHI site at 
the 3’ end and with exceeding 5′-GGGCCC-3′ extremities preceding both restriction sites 
to facilitate digestion. XhoI and BamHI extremities were activated by double enzymatic 
digestion to permit cloning into a custom-adapted pTol2+ destination vector, upstream of 
the eGFP coding sequence. Briefly, the destination vector was derived from pTol2+/coro-
1a:eGFP-SV40pA vector, previously described and kindly provided by the Wen lab49. The 
7.03 kb coro-1a promoter sequence was fully removed by double restriction and gel 
extraction and replaced by a multiple cloning site, containing a BamHI proximal to the 
eGFP transcription start and an XhoI site more distally. Both vector and XhoI-cxcl18b-
BamHI constructs where BamHI/XhoI digested and ligated together to obtain 
pTol2+/cxcl18b:eGFP-SV40pA. The plasmid was purified and injected into zebrafish 
fertilised eggs together with the Tol2-transposase mRNA, according to previous reports3. 
Several founders were identified and appeared very similar in basal eGFP expression. One 
eGFP-positive founder was selected, outcrossed to AB/TL and the positive F1 offspring 
was raised to adulthood. Further single crosses of the F1 founders to AB/TL produced 
significantly >25% positive animals, suggesting the presence of multiple integrations. 
 
Mycobacterial infection and image acquisition – Tg(cxcl18b:eGFP) embryos were 
injected with 200 CFU of mCrimson-labeled M. marinum strain M by the caudal vein 
injection route (Figure 4) or with 50 CFU via the trunk injection route (Figure 5). Bacteria 
were handled, prepared and injected as previously described23,50. Stereo-fluorescence 
images in Figure 4 were taken with a Leica MZ16FA fluorescence stereomicroscope 
connected to a Leica DFC420C camera (Leica Microsystems). Confocal images were 
acquired with a Leica TCS SPE microscope equipped with a HCX APO L U-V-I 
40x/WATER objective (Leica Microsystems). 
 
Statistical analysis – All data were analysed using GraphPad Prism 5 (GraphPad 
Software). For comparison between two groups (Figure 2), a Mann-Whitney test was used. 
For comparisons between more than two groups (Figure 3) a Kruskal-Wallis test was used, 
followed by Sidak’s multiple comparisons post-hoc test for selected groups. Significance 
(P-value) is indicated as: ns (non-significant); * (P<0.05); ** (P<0.01); *** (P<0.001); 
**** (P<0.0001). Error bars in all the graphs are mean±s.e.m. 
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Rationale of using a non-mammalian host to model mycobacterial diseases 
In this thesis we applied the Danio rerio (zebrafish)-Mycobacterium marinum (Mm) 
infection model to obtain novel insights into how chemokines orchestrate the response of 
immune cells to mycobacterial infection. Mm is a natural pathogen of zebrafish and is 
phylogenetically very close to Mycobacterium tuberculosis (Mtb)1, the causative agent of 
human tuberculosis (TB). The Mtb bacillus is carried by one third of the world population 
and remains the most severe global health problem of bacterial entity since its emergency 
and adaptation to humans in prehistorical eras, before the out-of-Africa emigration of the 
Homo sapiens species (~70.000 years ago)2,3,4. Mtb mainly provokes a lung disease5, 
although it is able to colonise extrapulmonary tissues of the host (including the central 
nervous system and meninges6,7, the eye8, the breast9, the liver10, the kidney11, the 
gastrointestinal tract12, the genitourinary tract13, the skin14, the bones15 and the lymph 
nodes16). In all these tissues Mtb infection can lead to the formation of granulomas, a 
hallmark of local inflammation. Granuloma formation is initiated by infected macrophages 
that subsequently attract new macrophages and other immune cells that confine the 
pathogen and the necrotising tissue17. Since Mtb can persist in granulomas for many years, 
the host-pathogen interplay that drives granuloma formation is key for our understanding 
of TB pathogenesis. 
 
In comparison to Mtb, Mm represents a less host-specialised pathogen that can infect an 
expanded niche of ectothermic species, including fresh- and salt-water fish, amphibians, 
but also invertebrates and protists18,19,20,21,22,23,24,25,26. Furthermore, in sporadic cases, Mm 
can infect endothermic animals, including humans, where it is generally restricted to the 
dermis, since it grows very poorly at human internal body temperature27,28. Mm, in its 
multicellular hosts can induce formation of granulomatous aggregates, similar to human-
Mtb granulomas27,28. Almost two decades of use of the zebrafish model have proven that 
the two pathogens in their respective natural hosts rely on the activation of specific and 
evolutionary conserved disease-causing programmes, in order to induce granuloma 
aggregation20,29,30,31,32. This is also illustrated by the fact that in the rare cases of Mm 
infection in humans, this pathogen can still induce formation of dermal granulomas, that 
are phenotypically indistinguishable from those that Mtb would form in the same tissue27,33. 
 
The ability to grow within host macrophages is the key virulence attribute of pathogenic 
mycobacteria. This is well exemplified by studies in macrophage-like models, such 
Dictyostelium discoideum amoebas, where Mm can establish lasting intracellular 
parasitosis, similarly to those evoked in vivo in vertebrates and in macrophage cell 
cultures25,34,35. Interestingly, the pathogenesis in the monocellular models (including 
macrophage cultures) substantially relies on the capability to escape to the cytosol and on 
non-lytic ejection, which are important virulence traits that pathogenic mycobacteria 
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maintain also when infecting vertebrate host macrophages in vivo25,36,37,38,39,40. Despite this, 
in complex animal models, additional mechanisms of pathogenesis add to these core 
mechanisms of disease. These include, for example, the formation of distinct cell 
aggregates (the granulomas)17, the manipulation of host angiogenesis41 (Chapter 6) and the 
control of the inflammatory process via intricate cross talks that can solely occur in 
multicellular hosts42. Notably both aspects of mycobacterial pathogenesis that act at 
cellular and multicellular level are largely driven by virulence factors encoded by the RD1 
(Region of Difference 1) locus, a genomic region conserved among tubercular bacilli 
(including Mm) and remarkably absent in environmental mycobacteria (e.g. M. smegmatis) 
and in the non-pathogenic BCG (bacillus of Calmette–Guérin) M. bovis strain, used to 
provide immunisation against Mtb. 
 
Rodents and lagomorphs have been largely applied as in vivo models to study the 
histological aspects of mycobacterial disease. However, mice granulomas generally do not 
caseate43 (necrotising granulomas, a typical characteristic of tuberculosis granulomas in 
humans) and the limited genetic tools available for the other rodents and lagomorphs that 
do form caseating granulomas (e.g. guinea pigs and rabbits44) make these models less 
attractive, due to restricted research opportunities. To date, the animal model that most 
closely resembles human tuberculosis is the macaque-Mtb model, that in terms of 
histopathology, physiopathology and disease progression/manifestation (including the 
existence of active and latent forms of TB) is near-identical to the human disease45,46. 
However, for obvious ethical, economical and practical restrictions, the use of this model is 
very limited. In contrast to the mice-Mtb model, caseating granulomas, wasting syndrome 
effects (another common symptom of TB displayed in primates) and latency have been 
observed when fish are infected with Mm19,20,21,47. 
 
Evolutionary, Mtb and Mm are very close and share about 85% of genome identity1. The 
genome of Mm is ~1.5 fold larger than the Mtb genome, which is likely related with the 
ubiquitous distribution of Mm in waters of different ecological niches and to the capability 
of Mm to infect a larger spectrum of hosts1,28,48. However, there is also a 14% of Mtb-
specific genome sequence, which does not have orthologues in Mm, and which has likely 
arisen after their evolutionary divergence. About 8% of this Mtb-specific genetic material 
was estimated to have derived from horizontal gene transfer from other microbes that share 
a similar niche (e.g. respiratory microflora)1,49,50,51,52 and is essentially related to niche 
adaptation (differences in temperature, organ-specificity, host-to-host transmission 
mechanisms), rather than to the central mechanisms of virulence. 
 
Taken together, the Mm and Mtb species have most likely diverged from an Mm-like 
common ancestor, which was already adapted to the intra-macrophage life in vertebrate 
animals, was able to induce granuloma aggregation with a wide tissue tropism, and was 
able to alternate phases of life inside the host with phases of environmental life. This 
hypothesis is also justified by the fact that intramacrophage-specific and granuloma-
specific genes exist in both Mm and Mtb, which are activated when the pathogens resides 
in phagocytic cells and when the granuloma aggregation is initiated53,54. 
 
Leprosy, the disease caused by Mycobacterium leprae, represents a severe cause of 
deformity and life-long disability in developing countries55. Unfortunately, the pathology 
of leprosy remains still poorly characterised, partly because culturing this pathogen 
axenically is near-impossible56,57,58, and partly because there is a limited availability of 
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animal models59,60,61. The main experimental model for leprosy consists of the murine 
footpad infection59 where the temperature of approximately 30°C mirrors the cooler tissues 
(skin and peripheral nerves) preferentially infected in humans. However, immunologically 
competent mice develop a poor infection with M. leprae and, apart from humans, 
armadillos are the only other known hosts of M. leprae, which represents the sole animal 
model to study the pathology of M. leprae infection in a natural host60. 
 
The evidence that leprosy predominantly affects peripheral tissues reflects the fact that, 
similarly to Mycobacterium marinum, the optimal growth temperature of this pathogen is 
lower than the human body temperature. Noteworthy, it has been described that M. leprae 
can infect and replicate in a variety of cold-blooded experimentally-injected species, 
including several fish, such as goldfish (Carassius auratus), spots (Leiostomus xanthurus), 
spotted sea-trout (Cynoscion nebulosus) and croakers (Micropogon undulates)62,63. Not 
only could M. leprae persist and replicate in these heterologous hosts, but the bacilli could 
also establish a distinctive type of intracellular parasitism of M. leprae infections, referred 
to as “lepra cells”, large foamy macrophages containing numerous intracellular bacilli. 
These evidences suggest that the zebrafish model might be explored also as an 
experimental model to study M. leprae infection and, in particular, its use might help to 
elucidate the function of the innate immune cells and of immune signalling pathways in the 
onset of different manifestations of leprosy. 
 
Function of chemotactic cues in driving granuloma aggregation 
Mtb strongly induces chemokine expression and both TB patients and cell/animal models 
infected with Mtb exhibit a rapid induction of many of these chemotactic peptides64. We 
and others have found that also zebrafish infected with Mm displays large induction of 
chemokines, which include the mammalian counterparts of CXCL9-10-11 (CXCL11aa-ae-
af-ag, Chapter 3-4), CXCL1-2-3-5-6-7-8 (Cxcl8a-8bb-18b65,66,67 Chapter 7) and CCL268 
(Figure 1). Since mycobacteria mostly reside in macrophages, these cells experience 
profound transcriptomic changes and represent a primary source of chemokine 
ligands69,70,71,72,73,74,75,76 (Chapter 1). In agreement with this, we have found here that 
infected macrophages inside the zebrafish host largely upregulate cxcl11aa, the ligand of 
Cxcr3.2 (Chapters 3-4). However, also non-infected cells participate in the production of 
chemokines. Our studies, for example, show that Cxcl18b, a neutrophil-specific zebrafish 
chemokine, functionally similar to the ELR+ chemokines of mammals (Chapters 1,7), 
does not derive from infected or uninfected phagocytic cells (macrophages and 
neutrophils), but from stromal cells that reside within the granuloma microenvironment 
(Figure 1D). Similarly, it was suggested that one of the putative zebrafish orthologues of 
CCL2, which is able to induce macrophage chemotaxis, is mostly expressed by epithelial 
cells (Figure 1A)68. 
 
The initial stages of granulomas are characterised by a continuous, bidirectional trafficking 
of innate immune cells22,41 (Figure 1, Chapter 2). We and others have shown that, since 
most macrophages are unable to readily eradicate the intracellular mycobacterial infection, 
the pathogen can take advantage of this in/out trafficking that guarantees a continuous 
supply of the mycobacterial infection niche (Figure 1B) and generates a mechanism for 






macrophages	 to	 invading	mycobacteria	 (e.g.	 injected	 in	 the	 hindbrain	 cavity)	 can	 be	 guided	 by	 several	
bacterial	molecules.	Additionally,	 it	has	been	proposed	 that	 recognition	of	phenolic	glycolipids	 (PGL)	by	
the	epithelium	mediates	induction	of	the	macrophage	chemokine	CCL2.	However,	mycobacteria	are	also	
phagocytosed	 by	 tissue-resident	macrophages	 and	 active	 chemotaxis	may	 not	 be	 essential	 to	 establish	
the	 initial	 intracellular	 parasitosis.	 B.	 When	 resident	 in	 macrophages,	 mycobacteria	 produce	 ESAT-6,	
which	induces	expression	of	Mmp9	by	the	epithelium.	By	digesting	the	extracellular	matrix	(ECM),	Mmp9	
facilitates	 macrophage	 infiltration	 into	 the	 infected	 focus.	 Once	 the	 intramacrophage	 infection	 is	
established,	 this	 triggers	 expression	 of	 chemokines	 in	 the	 host	 macrophages.	 In	 particular,	 the	
macrophage	 chemokine	 Cxcl11aa	 is	 highly	 induced	 in	 infected	 macrophages,	 with	 a	 mechanism	 that	
requires	Myd88-dependent	pathogen	sensing.	Signalling	of	Cxcl11aa	via	 its	receptor	Cxcr3.2	can	control	
lysosomal	 function,	 for	 example	 via	 induction	 of	 exocytosis,	 therefore,	 this	 signalling	 not	 only	 controls	
macrophage	 recruitment,	 it	 might	 also	 contribute	 to	 generate	 and	 maintain	 an	 infection-permissive	
phenotype.	 Already	 from	 these	 very	 initial	 stages,	 some	 infected	 macrophages	 are	 seen	 to	 mediate	
mycobacterial	dissemination	to	other	tissues.	C.	The	Mmp9	and	Cxcl11aa	signalling	mechanisms	continue	
to	 sustain	 macrophage	 recruitment	 and	 the	 aggregation	 of	 macrophages	 indicates	 the	 initiation	 of	
granulomas.	Although	mechanistically	still	unclear,	the	atypical	Cxcr3.3	receptor	exerts	a	host	protective	
function	 and	 limits	 infection,	most	 likely	 by	 antagonising	 Cxcr3.2.	D.	Macrophages	 that	 do	 not	 contain	
infection	die	releasing	the	bacteria,	most	of	which	will	be	re-phagocytosed	when	still	encapsulated	in	cell	
debris.	 The	 inflammatory	 properties	 of	 the	 granuloma	 progressively	 increase.	 Neutrophil	 chemokines,	
including	 Cxcl8a	 and	 Cxcl18b,	 are	 also	 locally	 released.	 Induction	 of	 local	 hypoxia	 determines	 the	
production	 of	 Vegf	 and	 primes	 neutrophil	 protective	 functions.	 Cxcr4b,	 which	 can	 control	 the	 level	 of	
inflammation	 by	 modulating	 production	 of	 Il1β,	 cooperates	 with	 the	 Vegfaa	 signalling	 to	 support	




Despite their capability to persist in macrophages, pathogenic mycobacteria grow very 
slowly in their host, when compared to non-pathogenic environmental mycobacterial 
strains, such as M. smegmatis78,79. These two opposing forces, together with the capability 
of macrophages to contain the infection to a certain extent in healthy situations, generate a 
balanced dynamic equilibrium. This equilibrium is characterised by granuloma lesions that 
expand slowly or do not expand at all, and by a disease that develops into its active form 
only in about 10% of cases80,81. This balance of host and pathogen responses probably 
emerged from host-pathogen reciprocal adaptations and likely represents an important 
aspect of evolutionary fitness, as both the host and the pathogen survive when the infection 
is contained by granulomas80,81,82. The zebrafish model has been used to show that bacterial 
persistence in granulomas is accomplished by the spread of bacteria from dying 
macrophages to newly arriving ones22. When a macrophage can no more contain the 
intracellular bacterial replication, it undergoes cell death and leaves viable bacteria still 
encapsulated within the cell debris. Simultaneously, new uninfected macrophages are 
recruited to the granuloma, which engulf the bacteria and the remains of dead macrophages 
(Figure 1D). 
 
The concomitant activity and the integration of host and pathogen factors plays an 
important role in the process of granuloma formation. Previous studies implicated the ESX-
1 secretion system (one of the virulence determinants encoded by the RD1 locus) into 
driving macrophage aggregation during the initial stages of granuloma formation, most 
likely via the release of the virulence factor ESAT-6 (Figure 1B)83. However, the ESAT-6 
virulence factor requires the response of the host to mediate this mechanism. A study in 
zebrafish showed that ESAT-6 induces the production of the matrix metalloproteinase 9 
(Mmp9) in epithelial cells surrounding the nascent infectious lesion, which in turn 
facilitates macrophage infiltration and formation of granulomatous cell aggregates (Figure 
1B)83. 
 
Here we have found that the induction of the macrophage chemokine Cxcl11aa is also 
important to sustain the granuloma aggregation and to maintain a proper macrophage 
trafficking via its receptor Cxcr3.2 (Figure 1B, Chapters 3-4). In fact, cxcr3.2 mutant 
macrophages were recruited to a reduced extent to the infectious foci, which resulted in 
delayed granuloma expansion and reduced bacterial dissemination (Chapter 3). Sorting of 
macrophages from infected larvae followed by transcriptional quantification, showed that 
macrophages themselves are the main responsible cell type for the production of Cxcl11aa. 
These findings suggest a macrophage-autonomous mechanism by which mycobacterial 
infection induces production of the macrophage chemoattractant Cxcl11aa, to support 
further macrophage aggregation (Figure 1B, Chapters 3-4). Notably, Cxcl11aa induction 
does not require the presence of the RD1 locus while it requires active Myd88 (Myeloid 
differentiation factor 88)-dependent immune signalling (Chapter 4). Myd88 is a central 
adaptor that links innate pathogen recognition via most of the Toll-like receptors (Tlr) to a 
downstream machinery that modulates transcription of immune and inflammatory genes. 
Signalling via Tlr/Myd88 has been shown to be fundamental for the induction of 
inflammatory genes in the zebrafish-Mm model and to drive host protection, for example 
by activating bacterial clearance via autophagy84. Notably, Myd88-deficient larvae develop 





The studies presented above indicate that the ESX-1/ESAT-6/Mmp9 and the 
Myd88/Cxcl11aa/Cxcr3.2 mechanisms of recruitment represent two distinct, but 
synergistic, systems (Figure 1B). However, differently from the Myd88/Cxcl11aa/Cxcr3.2 
axis, the ESX-1/ESAT-6/Mmp9 pathway is not likely to induce active recruitment, rather it 
would facilitate macrophage infiltration by generating local inflammation and by loosening 
the matrix resistance (Figure 1B). It is however also possible that local activity of Mmp9 
might facilitate recruitment directly by mediating release of matrix-derived chemotactic 
peptides or by processing chemotactic mediators85. On the other hand, it must be noted that 
in mammals, MMP9 processing has been shown to exclusively activate neutrophil 
chemokines (and not macrophage chemokines) and to produce matrix debris that are solely 
able to activate neutrophil recruitment85. Therefore, the indirect macrophage recruitment 
model is the most likely mechanism of action of Mmp9. In contrast to the passive Mmp9-
mediated recruitment, the Myd88/Cxcl11aa/Cxcr3.2 signalling can induce direct 
macrophage recruitment to the infection focus, since the Cxcl11aa/Cxcr3.2 signalling can 
mediate directional cell migration, sustain cell anteroposterior polarisation and increase 
basal motility (Figure 1B, Chapters 3-4). 
 
The zebrafish model has helped to clarify that granuloma aggregation, which was 
historically regarded as a host-protective mechanism, can benefit the bacteria in many 
different ways: recruitment and coalescence of macrophages fuel the infectious focus with 
novel cells to be infected and to replace the dying ones, which is an advantage for a 
pathogen that essentially is adapted for an intracellular life (Figure 1)22. Additionally, by 
curtailing tissue necrosis with efferocytosis (collection and clearance of cell debris), newly 
recruited macrophages also moderate tissue inflammation to a level that is suitable to 
maintain the parasitic relationship (Figure 1D)42,86. Furthermore, departure of infected 
macrophages from a mature granuloma can seed new granulomas in healthy tissues of the 
host (Figure 1E, Chapters 2-3)41,77. Finally, establishment of an intra-macrophage niche 
permits host signalling subversion and the initiation of specific pathogen-beneficial 
programmes, which include the induction of angiogenesis (Figure 1D-E, Chapter 5) 41. 
Taken together, it is not surprising that attenuation of macrophage trafficking can benefit 
the host and, in agreement with this, the knockdown of mmp9 and the null mutation cxcr3.2 
confer resistance to the host, reducing infection burden and granuloma formation (Chapter 
3)83. Host-beneficial effects from disrupting CXCL9-10-11/CXCR3 signalling and Mmp9 
function have also been observed in murine animal models for TB and have been suggested 
by human clinical and genetic association studies. CXCR3 knockout BALB/c mice 
developed a limited disease upon exposure to Mtb87 and a study performed on the Chinese 
population revealed a host-beneficial association between TB and a -135G>A proximal 
promoter polymorphism of CXCL10. This replacement, which is in the proximity of a 
putative NFκB binding site, was suggested to impair the infection-dependent inducibility of 
this gene88. Similarly, increased MMP9 secretion is associated with increased severity and 
mortality in TB meningitis89,90 and increased expression of all CXCR3 ligands (CXCL9-
10-11) is correlated with active TB91. 
 
Initial macrophage recruitment to mycobacteria: insights into a “chicken and egg”-
like paradox 
Intriguingly, both the Cxcl11aa/Cxcr3.2 and the ESAT-6/Mmp9 pathways that drive 
macrophage recruitment to mycobacterial infectious foci substantially require a pre-
existing intramacrophage infection (Figure 1B). Infection-dependent induction of cxcl11aa 
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occurs in macrophages and requires Myd88-signalling and active pathogen recognition 
(Chapter 4). Similarly, the ESAT-6 secretion by mycobacteria requires pathogen 
adaptation to the intramacrophage life style83. Therefore, these two recruitment axes seem 
to be predominantly exploited to maintain an appropriate macrophage supply once the 
lesion has been established, rather than mediate its very initial onset (Figure 1A-B). 
Another zebrafish study has suggested that an additional chemokine axis, an orthologue of 
the mammalian CCL2/CCR2, might be important for the initial recruitment of 
macrophages to the invading bacteria, via a mechanism that does not require Myd88 
signalling and intramacrophage infection (Figure 1A)68. This axis was shown to rely on 
recognition of extracellular mycobacteria via specific mycobacterial wall lipids by the 
neighbouring epithelial cells. This recognition would, in turn, activate production of the 
macrophage chemokine Ccl2 and therefore macrophage recruitment. However, evidence 
from the murine model and from human disease-polymorphism association studies are 
contradictory on the function of CCL2/CCR2. In mice, this axis seemed to permit better 
containment of high doses of bacteria but did not abolish granuloma aggregation neither 
reduced infection susceptibility to low doses92,93, which is in contrast with the hypothesis 
that the Ccl2/Ccr2 pathway would not require Myd88 signalling and classical Tlr-mediated 
pathogen recognition. On the contrary, these data suggest that CCL2/CCR2 may not be 
crucial to establish the initial parasitism (considering that CCR2-deficient mice have the 
same susceptibility to low-dose infection as wt), rather to contain the effects provoked by a 
larger and more inflammatory inoculum. Human polymorphism studies also fuel the debate 
on the real significance of CCL2, since some studies indicate that higher expression levels 
of CCL2 increase susceptibility to infection in some populations, although the same 
correlation could not be replicated in other populations94,95. A similar indication in this 
direction also comes from the fact that PGL (the mycobacterial lipid that has been 
proposed to mediate CCL2 release in Myd88-independent conditions68) is not essential for 
the virulence of Mtb strains and many clinical Mtb isolates exist that do not express PGL96. 
An alternative to the CCL2-mediated mechanism could be that the initial establishment of 
intramacrophage parasitosis may depend on direct chemotaxis to bacterial components or 
may simply not require active recruitment, since the tissues, including the human alveoli, 
contain resident macrophages that can readily engulf invading pathogens when these are 
presented in a limited number (Figure 1A). 
 
Function of chemokines and cell motility in controlling macrophage intrinsic immune 
competence 
We have found that in uninfected conditions, macrophages express basal levels of cxcl11aa 
and that the Cxcr3.2-dependent signalling can facilitate macrophage basal patrolling under 
physiological conditions, presumably by activating an autocrine loop (Chapters 3-4). This 
mechanism possibly generates continuous adjustments of macrophage anteroposterior 
polarity that leads to random walks. The capability to random patrol might be intrinsic to 
macrophages and might influence the ability of these cells to exert a sentinel function into 
tissues. In this perspective, the establishment of initial parasitism could be impacted by 
Cxcl11aa/Cxcr3.2 signalling, with mechanisms that not necessarily require Myd88-
dependent upregulation of cxcl11aa. Our own evidence is that macrophages use the 
Cxcl11aa/Cxcr3.2 signalling pathway to maintain their capability to random patrol and that 
in the absence of this signalling axis, macrophages upregulate lysosomal genes and become 
more microbicidal (Chapters 3-4). Thus, our data indicate that Cxcl11aa/Cxcr3.2 
signalling directly correlates chemotaxis/motility to intrinsic immune competence, 
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although the molecular mechanism that triggers this phenotype still remains to be 
elucidated. A known connection between motility and lysosome function is that chemokine 
signals lead to the fusion of lysosomes to the plasma membrane to sustain cell movement97. 
Therefore, one hypothesis to explain why lysosomal genes are upregulated in a situation of 
deficient motility is that the cell is alerted and promotes lysosomal biogenesis, in the 
attempt to restore normal motility dynamics. There is evidence that, if the flux of 
lysosomes to the plasma membrane is compromised, this leads to the CLEAR (Coordinated 
Lysosomal Expression and Regulation) response and production of more lysosomes98,99,100. 
In addition, macrophage motility seems to be severely affected by excessive phagocytosis 
and by the inability to digest phagocytosed debris101. In lysosomal storage disorders (LSD), 
macrophages are amply vacuolated and the presence of these large intracellular 
compartments severely perturbs their motility101. Activation of the lysosome pathway can 
rescue the LSD disease by facilitating elimination of the undigested inclusions98,99,102, 
which in turn would restore motility too. Therefore, the reduction of motility below certain 
levels might function as an alarm signal that suggests a post-phagocytosis phenotype and 
therefore increased need of digestive lysosomal contents. 
 
Several genetic diseases associated with LSD are associated with impaired lysosomal 
function and increased susceptibility to infections103,104,105. Also in zebrafish the 
knockdown of the orthologues of three genes linked with LSD in human 
(glucocerebrosidase 1, hexosaminidase A, and arylsulfatase A) resulted in LSD and 
hypersusceptibility to Mm infection101. In this respect, our study indicates an important 
complementary aspect: if the content of functional lysosomes is increased without leading 
to the LSD phenotype, this benefits the host, by boosting the intrinsic capability of 
macrophages to counteract infection, with beneficial rather than detrimental effects. This 
hypothesis is in line with the proposed idea that genetic conditions that in homozygosis 
associate with LSD and increased susceptibility to TB, might provide resistance to TB 
when carried in heterozygosis. 
 
To discuss the hypothetical links between LSD-associated genetic conditions and 
susceptibility to TB, the Ashkenazi Jewish (AJ) population (and their descendants) 
represents an interesting case, since 6 independent mutated alleles for four LSD diseases (2 
mutations leading to Tay-Sachs disease, 2 mutations leading to Gaucher disease, 1 
mutation leading to Niemann-Pick disease and 1 mutation leading to mucolipidosis type 
IV) are fixed in this population with anomalously increased frequencies106,107. The selection 
of these four genetic disorders is unlikely derived from stochastic genetic drifting events 
and might be explained if these disorders provide a selective advantage to the heterozygote 
carriers. Notably, among the AJ population, the frequency of TB-associated deaths is 
reduced, when compared to ethnically-separated populations residing in similar 
areas108,109.110,111. Additionally, dividing the AJ population based on their geographical 
origin, it was shown that the AJ groups with ancestry in areas of higher incidence of TB 
have also increased prevalence of the Tay-Sachs allele, compared with the AJ groups that 
were originally from areas with reduced TB prevalence112,110,111. 
 
The heterozygote advantage hypothesis for the Tay-Sachs mutations in TB has been 
debated106,113,114, since the proportion of the LSD-allele carriers does not occur at such high 
frequency (3 to 6% of AJ population107,112) to provide a substantial population protection, 
differently, for example, from the well-known associations of sickle-cell anaemia and other 
haemoglobinopathies with malarial endemic areas (3 to 40% of endemic populations115). 
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However, recent studies have elucidated how the Tay-Sachs allele could provide carrier 
advantage against TB. The Tay-Sachs alleles consist of genetic mutations of the gene 
coding for the alpha subunit of hexosaminidase A (HEXA), an important enzyme that 
mediates lipid degradation (especially neuronal gangliosides). Hexosaminidase A is a two-
subunit enzyme and its beta-subunit is encoded by a different gene (HEXB). A second 
functional isoenzyme, hexosaminidase B, exists which is instead composed of two beta-
subunits. In Tay-Sachs patients, the disease is caused by the homozygote mutation of the 
HEXA gene (and concomitant complete absence of functional hexosaminidase A isoform). 
Mutations of HEXB gene are very rare (Sandhoff disease), and lead to more severe 
dysfunctions and LSD. The main consequence of the Tay-Sachs disease is a deficient 
digestion of gangliosides, which accumulate into cells and provoke vacuolation. 
Interestingly, it has been found that Tay-Sachs heterozygotes express higher levels of 
hexosaminidase genes and have increased enzymatic activity of the hexosaminidase B 
isoenzyme than healthy individuals109,116,117, which permits normal processing of 
accumulating lipids and, prevents the onset of Tay-Sachs disease. Of note, 
hexosaminidases are target of the CLEAR response and can be induced in lysosomal stress 
conditions via the CLEAR transcriptional programme99,102. Therefore, a possible 
explanation of why Tay-Sachs carriers are less susceptible to TB might be that this 
deficiency in heterozygosis induces lysosomal stress and the CLEAR response, in the 
attempt to restore normal hexosaminidase activity. However, if lysosomal stress and the 
CLEAR response are activated, this will lead to increased expression, not only of 
hexosaminidases, but also of many other lysosomal genes, and therefore to a better intrinsic 
microbicidal function. That dysfunction of one lysosomal component is accompanied by 
upregulation of many other lysosomal-related genes is a recurrent observation in LSD 
patients and in LSD in vitro models99,102,118. Additionally, most of LSD syndromes can be, 
at least partly, restored by transcriptional stimulation of CLEAR in vitro99,102,119. Therefore, 
these observations suggest that genetic manipulation of the lysosomal function at 
transcriptional level might be explored for therapeutic purposes also against bacterial 
infections. 
 
It is well known that mycobacteria can counteract phagosome maturation and can mount 
countermeasures to persist in acidified compartments. On the other hand, it has been shown 
that they are susceptible to anti-bacterial autophagy and degradation via 
autophagolysosomes84. Intriguingly, among the mechanisms by which mycobacteria hijack 
the host macrophage, there is the promotion of lipid inclusions formation, which results in 
the “foamy cell” macrophage phenotype. It has been hypothesised that the fatty acids 
derived from lipid bodies might be an important energy source for the pathogen, or that 
they provide to the mycobacteria a mechanism to interfere with the eicosanoid biosynthesis 
and therefore with the production of pro- or anti-inflammatory components120. Given the 
fact that lipid bodies can be counteracted via induction of CLEAR activation, triggering 
lysosomal stress might contribute to fight this peculiar mechanism of virulence. 
 
In mammals, the CLEAR pathway is controlled by a group of factors, including MITF 
(microphthalmia-associated transcription factor), TFEB, TFEC and TFE3 (transcription 
factor EB, EC, E3). These genes are conserved in zebrafish (Figure 2A), which has a 
single orthologue for TFEB and TFEC (Tfeb, Tfec) and 2 orthologues for MITF and TFE3 
(Mitfa, Mitfb, Tfe3a, Tfe3b)121. Additionally, there is evidence that the genetic control of 
the CLEAR response is similar in humans and in zebrafish122. Our transcriptome data 
suggest that the increased lysosomal function of cxcr3.2 mutant macrophages derives from 
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activation of the CLEAR response. While expression of Mitf, Tfeb and Tfe3 genes did not 
significantly differ between cxcr3.2 mutants and wt, Tfec was approximately 1.8 fold 
downregulated in cxcr3.2 mutants (Chapter 4). 
 
TFEB is currently the most studied inducer of the lysosomal stress response123. However, 
while TFEB and TFE3 are ubiquitously expressed123, TFEC expression is restricted to 
myeloid cells124, indicating a specific function of this gene in innate immune cells. TFEC 
function has not been characterised to the same extent as that of the other members of this 
transcription factor family and its function needs further elucidation. It is known that in 
physiological conditions TFEC mutation does not generate any apparent phenotype in 
mice125. Interestingly, TFEC could be induced in macrophages by stimulation with T-
helper 2 cytokines (IL4 and IL13) or lipopolysaccharide treatment125. However, even after 
its upregulation, TFEC did not evoke major transcriptional changes in murine 
macrophages. It should be noted that TFEC diverges significantly, in terms of structure, 
from the other TFEs (Figure 2). In the study that initially identified TFEC, it was found 
that this factor can act a negative regulator of the other members of the TFE family, by 
formation of non-functional heterodimers and by DNA binding competition126. Both TFEB 
and TFE3 possess an important MITF/TFEB N-terminal homology domain and a 
conserved bridging sequence between the N-terminal domain and the basic helix-loop-
helix (bHLH) DNA-binding domain (Figure 2B). This linking sequence was shown to be 
important to activate transcription of the canonical TFE target genes, although not required 
for the DNA binding per se126,127. Notably, the MITF/TFEB N-terminal homology domain 
of TFEC is truncated when compared to those of TFEB and TFE3 (Figure 2B), and the 
region immediately upstream of the bHLH domain is also specifically divergent in TFEC. 
On the other hand, TFEC maintains highly conserved bHLH and basic Leucine zipper 
(bZip) domains, which are required to bind the DNA and to form homo/heterodimers 
within the TFE family members. The alterations in the N-terminal and in the bridging 
region involved in transcription regulation justify why induction of TFEC alone or its 
knockout, did not provoke large transcriptional consequences, as this factor, that 
antagonises TFEB and TFE3, would display transcriptional effects only in situations where 
TFEB and TFE3 are activated, such as during the CLEAR response. Structurally, zebrafish 
Tfec resembles closely the human TFEC and displays similar aberration in the 
MITF/TFEB N-terminal homology domain and in the region that supports target 
transcription in TFEB and TFE3 (Figure 2B). Therefore, this suggests a conserved 
function of Tfec and indicates that the zebrafish model could contribute substantially to 
understand the importance of this factor.  
 
Reduced expression of tfec in cxcr3.2 mutant macrophages indicates that cxcr3.2 mutation 
might lead to the CLEAR response by suppressing a negative regulator of Tfeb/Tfe3. In 
future work, this hypothesis could be tested by overexpressing tfec in the cxcr3.2 mutant 
background, which is predicted to prevent the induction of the CLEAR programme and 
thereby revert the increased microbicidal capacity of cxcr3.2 mutant macrophages. 
 
Concluding, our results indicate that the CXCR3-CXCL11 axis exerts different functions 
on macrophages, and that disruption of this axis reduces macrophage recruitment to 
infection, while enhancing the macrophage intrinsic microbicidal capability via induction 
of a lysosomal stress response (Chapters 3-4). In response to these functions, 
mycobacteria seem to have evolved several mechanisms for manipulating this axis to 
regulate macrophage trafficking during granuloma aggregation, drive macrophage-
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mediated dissemination and suppress the basal bactericidal property of the host cell. 
Therefore, use of CXCR3 antagonists may represent a therapeutic regime that, by acting on 
a single target, could counteract mycobacterial infection at multiple levels. Additionally, 
considering the work performed in the murine model, CXCR3 blockade might be 
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Atypical CXCR3 receptors and emerging functions of ACKRs in inflammatory 
diseases 
Atypical chemokine receptors (ACKRs) are 7-loop transmembrane proteins, evolutionary 
close to the classical chemokine receptors. However, because of a modified or missing 
canonical E/DRY motif and altered micro-switch elements, ACKRs are unable to interact 
with G-proteins and are therefore unable to induce G-protein coupled receptor (GPCR) 
signalling (Chapters 1,5)128. 
 
The most obvious consequence of the altered sequence in ACKRs is that these molecules 
are unable to directly mediate cell migration128. However, ACKRs are not silent molecules 
and can activate GPCR-independent signalling and exert important regulatory functions129. 
An important feature of the ACKR class is for example the capability to efficiently mediate 
ligand internalisation130. Because ACKRs are generally not very specific in terms of ligand 
binding, these receptors can intercept a wide range of chemokine ligands and mediate their 
transport to the lysosomes for degradation128,130. In some circumstances the ACKR/ligand 
recycling has also been seen to mediate the transcytosis of chemokines and therefore their 
transport across biological barriers131. Several ACKRs have shown to play an important 
function to control speed and directionality of chemotactic movements, by tightly titrating 
the chemokine ligand concentration and by shaping the chemokine gradients132. Since 
binding of excessive amounts of chemokine ligands to their classical receptors can induce 
desensitisation via receptor internalisation, the expression of ACKRs can also help to 
maintain appropriate signalling by avoiding complete downregulation of classical 
chemokine receptors133. 
 
There is increasing evidence that ACKRs also control the overall inflammatory response, 
by preventing exceeding chemokine-derived inflammatory signals. This condition has been 
recently demonstrated by using a murine knockout for the wide spectrum chemokine 
scavenger D6/ACKR2. The mutant animals are basically indistinguishable from wt 
littermates in physiological conditions. However, when challenged by wounding, 
chemicals, cancer or infections, these animals develop a higher inflammatory 
status134,135,136,137138. In infections with Mtb, the uncontrolled inflammation occurring in 
D6/ACKR2 knockouts is lethal and D6/ACKR2 expression is essential to prevent the 
inflammatory storm and to attenuate excessive infiltration of leukocytes into the lungs137. 
Similar anti-inflammatory functions have been demonstrated also for other ACKRs that 
scavenge inflammatory chemokines, for example DARC/ACKR1139,140, which can 
sequester large amounts of circulating chemokines and dampen leukocyte activity. 
However, the function of DARC/ACKR1 is multifaceted, given the fact that this receptor 
can also sustain the transport of chemokines through physical barriers and function as a 
chemokine reservoir which can in some circumstances generate opposing pro-
inflammatory phenotypes141,142,143. In fact, during inflammatory disorders of the brain, 
binding of chemokines to DARC can facilitate their shuttling through the blood brain 
barrier via transcytosis. Additionally, binding of chemokines to DARC expressed by 
erythrocytes can reduce exaggerated levels of freely circulating chemokines during acute 
inflammatory responses but also help to maintain a steadier concentration of them in the 





In Chapter 5 we have identified and characterised a novel chemokine receptor, Cxcr3.3, 
which, based on its altered E/DRY motif (Glu/Asp-Arg-Tyr) and on altered micro-switch 
elements, likely represents an ACKR. Similarly to the results found in D6/ACKR2 
mutants, cxcr3.3 mutants displayed an increased infection burden, and intriguingly an 
opposing phenotype as mutants for the canonical chemokine receptor cxcr3.2 (Chapter 3-
5). This phenotype suggests that cxcr3.3 may antagonise cxcr3.2 function, for example by 
attenuating the inflammatory response or moderating leukocyte infiltration to the infected 
tissues (Figure 1C)138. Based on sequence and synteny reconstruction, we have found that 
atypical Cxcr3-like receptors exist in a large number of fish species, although not in 
tetrapods (Chapter 5). Due to high sequence similarity with classical Cxcr3 genes and due 
to its close synteny to the other cxcr3 genes throughout fish species, it is likely that the 
atypical cxcr3 products have originated from an ancestral cxcr3 gene which encoded a 
functional chemokine receptor, able to bind CXCL9-10-11-like ligands. To our knowledge, 
in sharks (Callorhinchus milii) there is also only one copy of Cxcr3, which contains a 
normal E/DRY sequence, while in ray-fish that have diverged before the teleost-specific 
whole genome duplication such as the spotted gar (Lepisosteus oculatus), there is already 
existence of E/DRY-depleted Cxcr3 genes (Figure 1, Chapter 5). Therefore, the origin of 
atypical cxcr3 genes may have occurred before the teleosts whole genome duplication, but 
after the divergence of bony fishes from cartilaginous fishes. 
 
We currently do not know whether Cxcr3.3 acts as a scavenger of Cxcl11-like chemokines, 
the classical ligands of the Cxcr3.2 receptor (Chapter 3-4). However, since Cxcr3.3 forms 
a homophyletic group and is in a synteny cluster with Cxcr3.1 and Cxcr3.2 throughout fish 
species (Figure 3, Chapter 5), this is a plausible hypothesis. In this case, the cxcr3.3 genes 
may have differentiated in the attempt to more strictly regulate the activity of the CXCR3 
axis and its central role in adaptive and innate immunity. We also currently do not know 
whether this CXCR3 atypical axis, that appears a fish-specific system, has parallels in 
mammals. Intriguingly, despite the lack of atypical CXCR3 receptors, mammalian 
CXCL9-10-11 ligands can be still scavenged by two other ACKRs, CXCR7/ACKR3, and 
DARC/ACKR1130,144,145 (Chapter 1).  
 
In Actinopterygii, which includes the zebrafish, an orthologue for every human ACKR can 
be found, with the exception of DARC/ACKR1, which can be first found in coelacanths 
(Latimeria chalumnae), a rare group of fish regarded as living fossils that are directly 
related to the last fully-aquatic ancestor of tetrapods (Figure 3). The coelacanth does not 
possess an atypical Cxcr3, as its three copies of the Cxcr3 gene all contain intact E/DRY 
motifs. This suggests that the evolution of ACKR1 has occurred during speciation of 
Sarcopterygii (lobe-finned fish and tetrapods) and coincided with the loss of atypical 
CXCR3 isoforms. It is possible that the emergence of a novel wide spectrum chemokine 
scavenger (DARC/ACKR1) determined the loss of the atypical CXCR3, due to redundant 
function. It should also be mentioned that ACKR3/CXCR7, which is also able to scavenge 
CXCL11, is not redundant with DARC/ACKR1, since it is best known for its scavenging 
activity against CXCL12132,144. This receptor is the sole ACKR able to bind CXCL12 and, 
similarly to the classical receptor of CXCL12 (CXCR4), exerts a unique function in 
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According to alignment-based phylogenetic reconstruction, it is unlikely that ACKR1 had 
radiated directly from a CXCR3-like ancestor, due to large sequence differences. However, 
by blasting the lchDARC/ACKR1 protein to the coelacanth protein database, its closest 
intraspecific orthologue is in fact the lchCxcr3.1. Unfortunately, the coelacanth genome 
has not been assembled, which makes it impossible to support phylogenetic reconstructions 
with synteny studies. However, a hypothesis that could explain the large divergence of 
ACKR1 from the other chemokine receptors (including CXCR3) could be that stringent 
selective pressures have acted on this atypical receptor and mediated its diversification. 
This idea is supported by that fact that we have examples of large diversification of 
DARC/ACKR1 sequences in primates, due to selective advantages provided by 
DARC/ACKR1 variants against Plasmodium infections146,147,148. DARC/ACKR1 can in 
fact also act as a parasite receptor and facilitate entry of certain Plasmodium species into 
the erythrocytes. 
 
Concluding, in vivo studies during the course of inflammatory processes have been crucial 
to demonstrate that ACKRs play a fundamental role, not only in the trafficking of the 
immune cells, but also in the regulation of the inflammatory process itself. The use of 
zebrafish Cxcr7/Ackr3 mutants (and the remarkable conservation of specificity for Cxcl12) 
has already provided fundamental insight into the function of ACKRs in homoeostatic 
contexts149,150,151. With the exception of DARC/ACKR1, all the other mammalian atypical 
chemokine receptors are present in zebrafish too, which is both striking and valuable in 
scientific terms, as it suggests high functional conservation throughout vertebrates and the 
possibility to use zebrafish to obtain a better understanding of the origin of ACKRs and 
their function in inflammatory diseases. 
 
Function of chemokine signals as modulators of inflammation and angiogenesis in 
mature granulomas 
As illustrated by studies in cancer treatment, targeting pathological angiogenesis has 
potential therapeutic applications. Inhibition of tumour-associated vessel formation has 
long been known to have anti-neoplastic properties, as the microvasculature contributes to 
the growth and dissemination of cancer cells. However, in vivo results suggest that, 
depending on the stage and nature of the tumour, in some circumstances a pro-angiogenetic 
therapy, rather than an anti-angiogenic one, may benefit the patient. It has been proven, for 
example, that improving the angiogenetic response can lead to a better delivery of 
chemotherapeutics and promote healing and inflammation resolution by preventing 
hypoxia152. Reasoning on TB, similar conclusions can be drawn. An anti-angiogenic 
treatment might help restrict bacterial dissemination and granuloma formation, while a pro-
angiogenic treatment might be beneficial as adjuvant therapy to a better delivery of first 
line antibiotics, by promoting tissue repair, remodelling, resolution of inflammation, and by 
preventing granuloma caseation153. 
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Studies on TB patients corroborate the hypotheses that the function of angiogenesis in 
either limiting or sustaining development of the disease is not univocal and that in different 
situations, an anti- or pro-angiogenetic therapy might be advisable to counteract the 
diseases. In general, vascular endothelial growth factor (VEGF), an important angiogenesis 
promoter, has been shown to increase in the circulation of individuals with active TB at a 
greater extent, compared to both uninfected subjects and infected patients that do not 
display active TB154,155. A study also correlated increased levels of VEGF with the lack of 
lung cavitation in TB patients, suggesting that high levels of VEGF are at least protective 
against induction of central necrotisation of the granuloma and the formation of caseating 
lesions. This seems to indicate that, in an active TB state, a pro-angiogenic host-targeted 
therapy might be beneficial156. On the other hand, there is also evidence that in TB patients 
treated with anti-VEGF compounds, the vascular integrity was normalised, which led to 
beneficial effects by promoting small molecule delivery157. Evidence for a host beneficial 
effect of anti-VEGF treatment also comes from the Mm zebrafish infection model, where it 
was shown that innate immune cells, most likely macrophages, were required for the 
induction of granuloma angiogenesis (Figure 1D-E)41. In this model, inhibiting VEGF 
proved to be beneficial by reducing vascular leakage, and by reducing the oxygen 
availability for mycobacteria. A VEGF receptor inhibitor, Pazopanib, which is currently in 
clinical trials, was tested in the zebrafish-Mm model where it reduced bacterial burden, 
vascular leakiness and bacterial dissemination41. Additionally, this treatment increased also 
the effectiveness of rifampicin, a first line anti-tubercular antibiotic41. 
 
In Chapter 6 we found that under knockout condition of the chemokine receptor Cxcr4b, 
the induction of angiogenesis to the granuloma aggregates was largely suppressed, which 
also reduced bacterial burden (Chapter 6). However, macrophage and neutrophil 
recruitment to mycobacteria and macrophage basal motility are unaffected in cxcr4b 
mutants (Chapter 6)158, suggesting that no major mechanistic alterations are evoked in the 
initiation of granuloma formation. There are several hypotheses that could explain the 
cxcr4b phenotype in the regulation of angiogenesis. One possibility is that cxcr4b is 
important to complete myeloid differentiation in the haematopoietic tissues, since the 
Cxcr4b/Cxcl12a signalling axis is important to establish the definitive haematopoietic 
niches159. However, the number of macrophages was not largely altered in cxcr4b mutants 
in the developmental window used in our study and these cells did not display difference in 
basal microbicidal capability (Chapter 6), which indicates both quantitative and qualitative 
normal macrophage competence. Another hypothesis relates to the fact that Cxcr4b, like 
CXCR4 in mammals, is an M2-type macrophage marker that is upregulated in 
macrophages engaged in inflammation resolution160. It is possible that absence of cxcr4b 
may lead to incomplete polarisation, since M2 macrophages are also the cells that in cancer 
promote angiogenesis via induction of VEGF161. However, our study seems to indicate that 
vegfaa is induced at comparable levels in cxcr4b mutants and wt (Chapter 6), suggesting 
that aberration of Vegfaa signalling is not the main phenotype cause. 
 
A more mechanistic explanation of the cxcr4b mutant phenotype in granuloma-
angiogenesis could be that macrophages are also required to promote infiltration of 
endothelial cells and vessels sprouting162 and that this mechanism would require a 
Cxcr4b/Cxcl12a crosstalk between the endothelium and the macrophages. Finally, although 
more highly expressed by macrophages, cxcr4b is expressed to some extent by endothelial 
cells too (Chapter 6), which would suggest that this signalling may be required for the 
directed recruitment of the endothelium, with a mechanism that not necessarily requires a 
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macrophage function163. Despite these considerations, our study seems to indicate that 
cxcr4b deficiency in granuloma-associated angiogenesis is related to the modulatory 
function that cxcr4b exerts on the inflammatory mediators (Figure 1D-E, Chapter 6). In 
TB patients and in other inflammatory disorders, the presence of inflammatory mediators 
such as CXCL8/IL8, IL1β and TNFα has also been correlated with the level of angiogenic 
activity, suggesting that, synergistically to VEGF, these mediators play a role in 
inflammation-associated angiogenesis164,165,166,167,168. Notably, the level of il1b, a key factor 
to propagate inflammation that also promotes proliferation and migration of endothelial 
cells, 165,166,169,170, was induced to a lower extent in cxcr4b mutants (Chapter 6), which 
suggests that Cxcr4b can control the induction of the local inflammation. Since il1b is 
largely induced in infected cells (Chapter 6), it is likely that this mechanism is 
macrophage dependent (Figure 1D-E). Studies in vitro have shown that mammalian 
CXCR4 is an important co-receptor to mediate activation of Tlr signalling, for example by 
contributing to Lipopolysaccharide recognition171,172. Therefore, deficiency of cxcr4b 
might reduce the capability of immune cells to upregulate inflammatory genes via 
Tlr/My88/Nfκb pathway. Therefore, we propose a model where Cxcr4b deficiency, by 
limiting the induction of inflammation, especially via suppression of il1b, can reduce the 
levels of pro-angiogenetic signals and restrict vascularisation and bacterial growth (Figure 
1D-E). 
 
Overall, angiogenesis represents a promising target for granuloma-suppressive therapy, 
although more research is needed to determine under which circumstances its inhibition or 
promotion is more desirable in TB patients. In cases when anti-angiogenesis therapy can be 
applied, it should be considered that its direct blockade via VEGF-signalling inhibitors 
could have several contraindications, since this leads to risks of vascular disruption also in 
healthy tissues173. Therefore, in this respect an indirect antagonism via curtailing 
inflammation or CXCR4 signalling (which seems only implicated into inflammation-
dependent vascularisation) might represent a better alternative. Additionally, since CXCR4 
represents an important co-receptor for HIV entry into macrophages, use of CXCR4 
antagonists might benefit especially patients that are both TB and HIV positive174. 
 
Chemotaxis of neutrophils to the granulomas and its protective function 
Neutrophils can be recruited to mycobacterial infection and play an important protective 
role. However, when bacteria are systemically injected, macrophages are the main cell type 
that phagocytoses Mm and neutrophils are not actively engaged with mycobacteria175. It 
might be pointed that systemic injections in zebrafish are mostly started at 1 day post 
fertilisation, when neutrophils are not fully functional. However, the predominant 
macrophage phagocytosis can be reproduced also when bacteria are injected at later times, 
such as at 2 or 5 dpf175. In part, the poor phagocytosis of Mm by neutrophils could be 
explained by the fact that zebrafish neutrophils do not phagocytose well bacteria dispersed 
in solution and scavenge efficiently only pathogens that are associated to surfaces176 
(Chapter 2). In agreement with this hypothesis, Mm can be readily phagocytosed by both 
neutrophils and macrophages when infections are performed in the fin tissue177. It is likely 
that increased phagocytosis of bacteria by neutrophils in this tissue can be due to the fact 
that in the thin tissue, most bacteria are presented in association to surfaces176. 
 
When injections are performed locally in the hindbrain (at developmental stages where 
fully-competent neutrophils are already present), not only does Mm appear to essentially 
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reside into macrophages, it also seems to not induce neutrophil recruitment. Injection of 
other pathogens in this ventricle (such as Pseudomonas aeruginosa175) is able to induce 
comparable macrophage and neutrophil recruitment. In contrast with this phenotype, 
injections of Mm in the fin tissue seem to initially induce a comparable level of both 
macrophages and neutrophils177. It is, however, possible that injection of the pathogen in 
this tissue inevitably induces a significant wound response and that neutrophils may be 
recruited via wound-induced signals (e.g. H2O2)178. Furthermore, in the hindbrain it is 
possible to induce recruitment of neutrophils to Mm by providing additional signals, such 
as co-injection with P. aeruginosa175. In this case, the level of neutrophil infiltration is 
comparable to that of P. aeruginosa injection alone, which indicates that Mm does not 
chemoattract, but also does not chemorepel neutrophils175. Despite this scarce recruitment 
of neutrophils in the hindbrain model, in vitro mammalian cell models and in vivo zebrafish 
studies have demonstrated that neutrophil-chemotactic chemokines are induced as early as 
a few hours post-infection67 (Chapter 1). In zebrafish systemic injections, a first wave of 
the neutrophil chemoattractants cxcl8a and cxcl18b is induced in the acute phase response 
and peaks at 4 hpi67 (Chapter 7). In situ detection of cxcl18b also showed local induction 
to Mm at the injection point, as early as 3 hpi66. Additionally, our transgenic reporter 
Tg(cxcl18b:eGFP) is similarly upregulated in the tissue surrounding the infection, and 
notably not in infected or uninfected phagocytes (Chapter 7). However, systemic injection 
studies suggest that induction of neutrophil chemoattractants is transient and drops between 
8 and 24 hours67. From 24 hpi, a second induction wave starts, which is characterised by a 
continuous increase of cxcl8a and cxcl18b mediators. In agreement with this, while 
neutrophils associate poorly to the initial mycobacterial infection, their presence in the 
granuloma increases over time (Figure 1D-E)175. Importantly, neutrophils that have 
engulfed mycobacteria can be more recurrently seen in mature granulomas, although it 
seems that the increased predisposition of neutrophils to get infected in mature granulomas 
is due to their “accidental” ingestion via efferocytosis of cell debris, which mostly derives 
from dying macrophages and can contain viable bacteria (Figure 1E)175,177. Engulfment of 
mycobacteria by neutrophils at this stage also leads to a better bacterial containment, since 
neutrophils can counteract the infection by induction of respiratory stress175. A recent study 
also showed that early after Mm infection, when the pathogen essentially resides in 
macrophages, uninfected neutrophils appear responsive to mycobacterial infection and 
increase their immune competence by activating a nitrosative stress response. This 
indicates that neutrophils do not exert exclusively a passive scavenging function within the 
granuloma, but that they possess (direct or indirect) mechanisms of mycobacterial sensing 
that contribute to their priming against the infection179. 
 
Concluding, the involvement of neutrophils increases (both quantitatively and 
qualitatively) with the increase of the inflammatory nature of the granulomatous lesion. 
Interestingly, the augmented competence and presence of neutrophils in the granuloma 
recapitulates the progressively increased expression of the neutrophil chemoattractant 
cxcl18b and cxcl8a (Figure 1D-E). It is possible that these molecules not only participate 
in the neutrophil recruitment to the granuloma, but they might be important also to activate 
specific antibacterial neutrophil responses. CXCL8 and other mammalian neutrophil 
chemokines are able to induce neutrophil degranulation180,181, netosis182 (a particular kind 
of neutrophil death that leads to release of traps composed of decondensed chromatine) and 
participate in the activation of the neutrophil respiratory burst183,184 (production of reactive 
oxygen and nitrogen species) in vitro. The zebrafish model has already contributed 
relevantly to elucidate all these aspects of neutrophil biology upon bacterial and 
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inflammatory insults175,178,179,185,186. Therefore, further use of the zebrafish model may help 
to elucidate the mechanistic implication of chemokines into orchestrating not only 




In summary, the work discussed in this thesis has contributed to elucidate novel 
mechanisms by which mycobacterial infection can benefit from chemotactic cues to initiate 
bacterial-beneficial programmes and to facilitate persistence of the infection. We have 
shown that Cxcr3.2 signalling is involved in the granuloma formation and can additionally 
support infection dissemination and dampen the basal microbicidal capability of immune 
cells. In contrast, the atypical Cxcr3.3 receptor seems to antagonise the pro-granuloma 
programme and exerts therefore a host protective function. We have additionally found that 
Cxcr4b-dependent signalling can affect the activation of the pro-granuloma angiogenesis, 
leading to a better infection control. Finally, we have characterised Cxcl18b and show that 
this novel neutrophilic cue is locally induced during the formation of granulomas. 
 
We believe that our work has helped to shed light on the fact that chemokine signals 
occupy a very central position in the control of immunity. These signals, which are mostly 
regarded as a class of cytokines dedicated to cell migration, exert in fact extremely 
diversified functions, which include control of gene transcription, cell-autonomous immune 
functions and inflammation. The chemokine network displays an intricate texture, 
composed of receptors, their ligand partners and receptors that have evolved to act as 
ligand scavengers. Despite responding to general rules of signalling architecture, the 
affinity of some receptors to one specific ligand or more ligands is strikingly diversified. 
Additionally, the preferential activation of specific pathways of the downstream machinery 
can be also a prerogative of each chemokine receptor. Therefore, the application of the 
zebrafish model, which can be used for intravital imaging, has been crucial to obtain new 
insight on these highly dynamic signalling mediators and to comprehend new functions 
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The main objective of the work enclosed in this thesis has been to analyse the functions 
exerted by chemokines in shaping the host-pathogen interface at play between the cells of 
the innate immune system and mycobacterial pathogens. Chemokines are small 
chemotactic cytokines, which are host signalling molecules that occupy a central position 
in immunity and inflammation. There is a large body of evidence that several chemokine 
mediators are activated in response to mycobacterial infections. These chemokines can 
have host protective functions, but may also contribute to disease pathology, as 
exemplified by the work in this thesis. 
 
Human tuberculosis (TB) is a global health concern caused by Mycobacterium 
tuberculosis. This human-adapted mycobacterial pathogen has been parasitising the 
mankind since prehistorical eras, provoking debilitation, illness and death worldwide. In 
the 21st century and more than 130 years after the discovery of its infectious agent, we are 
still far from eradicating TB, since it is estimated that about one third of the global 
population is chronically infected by M. tuberculosis and may therefore develop an active 
disease. A major complication of modern days’ TB control is the emergency of drug-
resistant strains that do not respond to the conventional therapeutic regimen, which consists 
of prolonged treatment with a cocktail of antibiotics disrupting different processes essential 
for bacterial growth, such as cell wall synthesis or DNA and protein synthesis. The 
problem of multi-drug resistances emphasises the need of novel strategies to counteract the 
disease. Establishment of M. tuberculosis infections is intimately connected with the 
capability of the pathogen to manipulate the host signalling machinery. Therefore, it is an 
attractive hypothesis that drugs for TB treatment might be identified that act on the host 
rather than on the pathogen itself. Identifying the host targets for development of such 
drugs would not only largely expand the therapeutic opportunities, but also provide a more 
difficult system for the pathogen to develop new drug resistances. 
 
The chemokine signalling system, by exerting a crucial function in immunity, may be 
involved in relevant aspects of TB. On one hand this signalling might function in host 
defence; on the other hand it might also be exploited by mycobacteria, similarly to other 
immune-related pathways that are subverted by these pathogens.  Chemokines act via a 
class of G-protein coupled receptors, which are currently the most successful drug targets 
in practice for a number of diseases. Therefore, the chemokine axes may represent easily 
druggable therapeutic targets that could be used to develop novel host-directed therapies to 
combat TB. 
 
As we further elaborate on in Chapter 1 and Chapter 2, the zebrafish (Danio rerio) has 
proved to be an excellent animal model to study both the biology of innate immune cells 
(macrophages and neutrophils) and the molecular and cellular basis of infectious diseases. 
This is especially true for the embryonic and larval stages of zebrafish, which are optically 
transparent as well as chemically and genetically tractable. The zebrafish is naturally 
susceptible to Mycobacterium marinum, a bacterium that is closely related to M. 
tuberculosis. The zebrafish-M. marinum model is characterised by a disease that faithfully 
recapitulates the main molecular, cellular and histopathological aspects of human TB. The 
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striking similarity of fish TB with the human disease is not only interesting from an 
evolutionary point of view, but also scientifically attractive for the study of TB. This is 
particularly significant if we consider that M. tuberculosis does not fully reproduce the 
human disease in the murine model and there are severe restrictions to work with this 
human pathogen. In recent years, it additionally became clear that several human 
chemotactic signalling axes maintain remarkable molecular and functional conservation in 
zebrafish, suggesting that their role in limiting or driving susceptibility to mycobacterial 
infection might have homologies in the two infectious systems. Therefore, the 
embryonic/larval zebrafish platform represented for us an insightful system to model and 
challenge mycobacterial disease, and led to the discovery of new virulence mechanisms 
that involve chemokine signalling. 
 
In Chapter 3 we found that zebrafish conserves a Cxcr3.2/Cxcl11aa-11af signalling axis 
that exerts important functions in macrophages, as its orthologous CXCR3/CXCL9-10-11 
axis does in mammals. Homozygote cxcr3.2 mutants displayed deficiency in macrophage 
recruitment to recombinant Cxcl11aa-11af and to bacterial infections (including M. 
marinum), which promptly induce the Cxcr3.2 ligands. Strikingly, cxcr3.2 mutation 
conferred resistance against mycobacterial infection, since this mutation, by attenuating 
macrophage trafficking, reduced mycobacterial dissemination and delayed the expansion of 
the so-called granulomas. Granulomas are infectious and inflammatory lesions consisting 
of immune cells (especially macrophages) that collect the pathogen and the necrotising 
tissue debris. Tuberculous granulomas are the disease-causing hallmark of mycobacterial 
infection and represent the natural niche of pathogenic mycobacteria. Within the 
granuloma, mycobacteria essentially persist intracellularly in the macrophages and 
extracellularly in the necrotic centre that results from the death of infected macrophages. 
Therefore, the Cxcr3.2 receptor, by increasing the engagement of macrophages with 
mycobacteria, represents a pro-granuloma determinant. The small CXCR3 inhibitor 
NBI74330 could phenocopy the deficient macrophage mobilisation to mycobacteria in 
zebrafish, therefore suggesting that CXCR3 antagonistic therapy might be used to curtail 
TB infection. 
 
In Chapter 4 we further analysed the downstream signalling dependent on Cxcr3.2. 
Therefore, we sorted macrophages from cxcr3.2 mutants and we profiled their 
transcriptome by RNA-sequencing. Intriguingly, we discovered that cxcr3.2 mutation leads 
to a lysosome stress signature and to a coordinated upregulation of several lysosomal 
genes, including acid hydrolases and lysosomal proton pump subunits. To corroborate 
these results, we demonstrated that this macrophage signature goes together with an 
increased acidification of bacteria-containing compartments and increased microbicidal 
activity against mycobacteria in vivo. To obtain more mechanistic insight on how lysosome 
stress is evoked in macrophages by deficient sensing of chemotactic cues, we tracked 
macrophages with stained lysosomes. Surprisingly, we found that cxcr3.2 mutation 
attenuated the recruitment of lysosomes to the leading edge in moving cells. The 
accumulation of lysosomes at the leading edge of wildtype macrophages is possibly 
indicating local lysosome exocytosis, which can be triggered by chemokines and is 
important to provide new membrane to the protruding lamellipodia. Remarkably, we show 
that macrophages themselves upregulate Cxcl11aa during mycobacterial parasitosis and 
that active Myd88-mediated immune recognition of the pathogen is essential to Cxcl11aa 
synthesis. We therefore hypothesise that the existence of this immune 
recognition/chemokine signalling/lysosome function circuit might benefit the pathogen in 
Summary	
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two ways: induction of Cxcr3.2-dependent signalling not only would fuel the granuloma 
with new macrophages to be infected, it would also generate a more permissive intra-
macrophage phenotype by hijacking lysosome function. 
 
In Chapter 5 we preliminarily characterised the function of Cxcr3.3, another zebrafish 
orthologue of CXCR3, and we describe the CRISPR/Cas9 genome editing pipeline that we 
optimised to obtain a cxcr3.3 mutant. Besides the technical improvements of the 
CRISPR/Cas9 mutagenesis method in zebrafish that we propose (as further detailed in the 
chapter), we found that the cxcr3.3 mutants are more susceptible to mycobacterial 
infection, which is diametrically opposite to the cxcr3.2 mutant phenotype. A 
cxcr3.2/cxcr3.3 double mutant line will be necessary to shed light on this controversy. 
However, we found that treatment with the NBI74330 inhibitor, which is predicted to 
equally antagonise Cxcr3.3 and Cxcr3.2, still attenuated susceptibility to infection and 
evoked a more cxcr3.2-like phenotype. This suggested that Cxcr3.3 requires Cxcr3.2 to 
exert its function. In support of this hypothesis we discovered that Cxcr3.3 displays 
significant sequence modification, the most remarkable of which is the replacement of an 
Arginine residue within the Aspartic acid-Arginine-Tyrosine (DRY) motif, the most 
conserved motif within functional G-protein coupled receptors. The Arginine residue in the 
DRY motif is 100% conserved in fully functional human CXCR receptors, as it serves to 
interact with the heterotrimeric G-proteins and activate the downstream signalling. The 
DRY motif is instead recurrently modified (or absent) in atypical chemokine receptors that 
essentially function as ligand scavengers and tight regulators of chemokine concentrations 
and gradients. Notably, the existence of one atypical CXCR3 isoform is recurrent in bony 
fish, although lost in tetrapods and tetrapodomorph lobe-finned fish (fully aquatic species 
directly related to tetrapods). Therefore, atypical Cxcr3.3 receptors do not exclusively exist 
in zebrafish and might have important conserved function in fish immunology and could 
additionally help to reconstruct the evolutionary history of chemokine receptors. 
 
In Chapter 6 we have analysed the function of the chemokine receptor Cxcr4b and 
observed that Cxcr4b mutation can limit expansion of granulomas forming in the poorly 
vascularised tissues of the trunk. This phenotype correlated with a concomitant deficiency 
in triggering angiogenesis, a process that promotes the growth of granulomas in the 
wildtype situation. In the attempt to elucidate the mechanistic pathway that leads to 
granuloma vascularisation via Cxcr4b, we found that cxcr4b mutants had a limited 
induction of inflammatory mediators, especially the master regulator of inflammation, il1b. 
This pleiotropic molecule, which is also well known to exert proliferative and pro-
angiogenic functions on endothelial cells, is largely expressed by infected cells in the 
granulomas and might represent the main connector between Cxcr4b and the induction of 
granuloma-associated inflammation. 
 
In Chapter 7 we characterised the function of the fish-specific chemokine Cxcl18b and by 
injection of recombinant chemokine we demonstrate that this molecule serves as a potent 
chemoattractant of neutrophils, while it does not affect macrophage recruitment. We 
additionally show that, at least partly, Cxcl18b exerts its function via the chemokine 
receptor Cxcr2, which was previously described as being the receptor partner of other two 
CXCL8/IL8-like chemokines in zebrafish, Cxcl8a and Cxcl8bb. Similarly to these 
CXCL8/IL8-like chemokines, Cxcl18b did not require the chemokine receptor Cxcr1, the 
zebrafish counterpart of mammalian CXCR1 that is redundant with CXCR2. Expression of 
cxcl18b is significantly and reliably induced by mycobacterial infection and by other 
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inflammatory conditions. Therefore cxcl18b expression may represent an important marker 
to longitudinally track the development of inflammation. We constructed a cxcl18b 
reporter and show that, in this line, the reporter reproduces the endogenous induction of 
cxcl18b during mycobacterial infection. Intriguingly, it seems that within the granuloma 
aggregate, the infected cells are not the main source of Cxcl18b. Instead, uninfected cells, 
that participated in the lesion but did not represent phagocytes, highly expressed the 
transgene. This observation suggests that further use of this reporter could permit to 
distinguish responses that are activated in defined subsets of non-phagocytic cells in the 
granuloma microenvironment, which might be important for the recruitment of neutrophils. 
This transgenic line could therefore be useful to study the function exerted by neutrophils 
in mycobacterial diseases, which remains poorly understood. 
 
This dissertation is concluded by a general discussion in Chapter 8, which relates our 
findings with recently emerged concepts in innate immunity and mycobacterial disease. 
We discuss the dual function of macrophages in restricting and sustaining mycobacterial 
disease and the effects of macrophage-recruitment axes to establish, maintain and 
disseminate the infection. We elaborate on how the lysosome stress response and 
lysosomal storage diseases are emerging as opposing forces driving resistance or 
susceptibility to TB and discuss how this knowledge could be translated into novel 
therapeutic strategies. We try to explain our results on the atypical Cxcr3.3 receptor, of 
which mutation causes increased infection susceptibility, by comparing our findings to a 
study carried in a mice mutant of another atypical chemokine receptor, which essentially 
led to a comparable phenotype when infected with M. tuberculosis. We corroborate our 
findings on Cxcr4b/inflammation/angiogenesis with the complementary literature, which 
confirms a function of CXCR4 in induction of pathological angiogenesis and in modulating 
inflammation. We continue with a section discussing how the zebrafish model might help 
to clarify the function of chemokines in controlling neutrophilic involvement in 
mycobacterial diseases. Finally, we conclude with some general reflections on the 
pleiotropic functions and complexity behind the chemokine signalling network and on how 
the zebrafish model is contributing to our understanding of this and other multidimensional 
biological processes. 
 
Concluding, the work described here has contributed to clarify how the chemokine network 
is implicated into different aspects of mycobacterial disease. We have emphasised how this 
intricate network can drive pathogen or host beneficial responses and we have shown that 
chemokine signalling not only controls recruitment of immune cells, but also their 
expression profile and their immune competence against the invading bacteria. More 
importantly, using the zebrafish model, we were able to follow longitudinally both the 
cellular dynamics and the molecular pathways that activate (or are activated by) the 
chemokine signalling in vivo. Finally the use of intravital imaging in this genetically 
tractable host model permitted to directly relate these new findings to pathological 
consequences at the level of the entire host during the course of the mycobacterial disease. 
This approach has helped us to comprehend to a deeper level the complexity behind the 
mycobacterial disease and how different cell types (e.g. neutrophils, macrophages, 
endothelium) and different host factors (e.g. chemokines, inflammatory mediators, 
angiogenesis factors) interact with each other and ultimately work together as a whole, in a 
system that eventually leads to the establishment of the disease. 
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Het belangrijkste doel van het werk beschreven in dit proefschrift was om de functie van 
chemokinen bij de interactie tussen het aangeboren immuunsysteem en mycobacteriële 
pathogenen te onderzoeken. Chemokinen (chemotactische cytokinen) zijn kleine 
signaaleiwitten die een centrale rol spelen bij immuniteit en ontstekingsreacties. De 
verschillende chemokinen die door een gastheer geproduceerd worden als reactie op een 
mycobacteriële infectie kunnen beschermende functies hebben, maar kunnen ook bijdragen 
aan de pathologie van de ziekte, zoals geïllustreerd wordt door het werk in dit proefschrift. 
 
Tuberculose (TBC) vormt een wereldwijd gezondheidsprobleem. Deze ziekte wordt 
veroorzaakt door infectie met Mycobacterium tuberculosis, een bacterie die zich al sinds 
prehistorische tijden aan de mens heeft aangepast en door de eeuwen heen veel dodelijke 
slachtoffers heeft gemaakt. In de 21e eeuw, meer dan 130 jaar na de ontdekking van deze 
besmettelijke ziekteverwekker, zijn we nog ver verwijderd van het uitbannen van TBC. Er 
wordt geschat dat ongeveer een derde van de wereldbevolking chronisch is geïnfecteerd 
met M. tuberculosis en daarom de kans heeft om TBC te ontwikkelen. TBC kan genezen 
worden door langdurige behandeling met een cocktail van antibiotica die verschillende 
essentiële processen van de bacteriegroei verstoren, zoals celwandsynthese of DNA- en 
eiwitsynthese. Een belangrijke complicatie bij de hedendaagse TBC-bestrijding is de 
opkomst van resistente stammen die niet meer reageren op de conventionele 
antibioticatherapie. Het probleem van multiresistentie benadrukt de noodzaak tot het 
ontwikkelen van nieuwe strategieën om de ziekte tegen te gaan. M. tuberculosis heeft het 
vermogen om immuuncellen van de gastheer te parasiteren. Om dat te bewerkstelligen 
manipuleert de bacterie verschillende signaleringssystemen van de gastheercellen. Het is 
daarom een aantrekkelijke hypothese dat TBC mogelijk behandeld zou kunnen worden met 
geneesmiddelen die op de gastheer werken in plaats van op de ziekteverwekker zelf. Met 
de ontwikkeling van geneesmiddelen voor zulke gastheerdoelwitten zouden niet alleen de 
behandelingsmogelijkheden voor TBC uitgebreid kunnen worden, maar zou ook de kans 
dat de bacteriën resistenties ontwikkelen verkleind kunnen worden. 
 
Omdat het chemokinennetwerk cruciaal is voor de communicatie tussen cellen van het 
immuunsysteem, kan dit netwerk betrokken zijn bij verschillende aspecten van TBC. 
Enerzijds kunnen chemokinen de afweer van de gastheer stimuleren, maar anderzijds 
kunnen de processen die door chemokinen worden aangestuurd ook omzeild of zelfs benut 
worden door mycobacteriën. Chemokinen werken via de klasse van zogenoemde G-eiwit-
gekoppelde receptoren. Deze receptoren zijn in de praktijk zeer succesvolle doelwitten 
gebleken voor de ontwikkeling van geneesmiddelen tegen verschillende ziekten. Daarom 
zijn de chemokinereceptoren mogelijk ook geschikte therapeutische doelwitten voor 
nieuwe gastheer-gerichte therapieën tegen TBC. 
 
Zoals wordt uitgewerkt in Hoofdstuk 1 en Hoofdstuk 2 is de zebravis (Danio rerio) een 
uitstekend diermodel voor het bestuderen van de biologie van aangeboren immuuncellen 
(macrofagen en neutrofielen) en de moleculaire en cellulaire basis van infectieziekten. Dit 
geldt vooral voor de embryonale en larvale stadia, die behalve optisch transparant, ook 
chemisch en genetisch traceerbaar zijn. De zebravis is een natuurlijke gastheer voor 
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Mycobacterium marinum, een bacterie die nauw verwant is aan M. tuberculosis. Het 
zebravis-M. marinum-model recapituleert de belangrijkste moleculaire, cellulaire en 
histopathologische aspecten van humane TBC. De treffende gelijkenis tussen vissen-TBC 
en de humane ziekte is niet alleen interessant vanuit een evolutionair oogpunt, maar ook 
wetenschappelijk aantrekkelijk voor onderzoek naar TBC. Dit is niet alleen vanwege de 
strenge restricties om te werken met de humane pathogeen, maar ook omdat M. 
tuberculosis in muizen de humane ziekte niet volledig kan reproduceren. De laatste jaren is 
bovendien gebleken dat verscheidene humane chemotactische signalen moleculair en 
functioneel geconserveerd zijn in de zebravis, wat suggereert dat deze signalen mogelijk 
ook een overeenkomstige rol bij mycobacteriële infecties zouden kunnen spelen. Daarom 
biedt het embryonale/larvale zebravisplatform een inzichtelijk systeem om mycobacteriële 
infecties te modelleren. De toepassing van dit model heeft geleid tot de ontdekking van 
nieuwe virulentiemechanismen waarbij chemokinensignalering een rol speelt. 
 
In Hoofdstuk 3 hebben wij gevonden dat de zebravis een geconserveerde 
Cxcr3.2/Cxcl11aa-11af-signalering heeft met een belangrijke functie in macrofagen, net 
zoals de homologe CXCR3/CXCL9-10-11-signalering in zoogdieren. Homozygote 
cxcr3.2-mutanten lieten een deficiëntie zien in het rekruteren van macrofagen naar 
recombinante Cxcl11aa-11af-eiwitten en naar infecties met bacteriën (waaronder M. 
marinum) die de productie van Cxcr3.2-liganden opwekken. Opvallend was dat de cxcr3.2-
mutatie tot resistentie tegen mycobacteriële infectie leidt, doordat deze mutatie de 
verspreiding van de bacteriën vermindert en de ontwikkeling van de zogenoemde 
granulomen vertraagt. Granulomen zijn besmettelijke ontstekingshaarden die bestaan uit 
geïnfecteerde immuuncellen (vooral macrofagen) die worden ingesloten door andere 
ongeïnfecteerde immuuncellen. Het ontstaan van tuberculeuze granulomen is een 
belangrijk kenmerk van de mycobacteriële infectie en deze structuren vormen de 
natuurlijke niche van mycobacteriën. Binnen het granuloom verblijven de mycobacteriën 
voornamelijk intracellulair in de macrofagen en extracellulair in het necrotisch centrum dat 
ontstaat door de dood van geïnfecteerde macrofagen. De Cxcr3.2-receptor bevordert de 
migratie van macrofagen en is daarom een belangrijke factor in de granuloomvorming. De 
migratie van macrofagen naar mycobacteriën in de zebravis kon behalve door mutatie van 
cxcr3.2 ook geremd worden met behulp van een CXCR3-antagonist (NBI74330). Deze 
resultaten suggereren dat behandeling met CXCR3-remmers mogelijk zou kunnen worden 
toegepast om TBC-infectie te beperken. 
 
In Hoofdstuk 4 hebben wij verder onderzoek gedaan naar de signaleringsprocessen die 
afhankelijk zijn van Cxcr3.2. Hiertoe hebben we macrofagen gesorteerd uit cxcr3.2-
mutanten en hun transcriptoom geprofileerd met RNA-sequentieanalyse. Verrassend 
genoeg ontdekten we dat de cxcr3.2-mutatie tot kenmerken van lysosomale stress leidt en 
zorgt voor een gecoördineerde inductie van verschillende lysosomale genen, waaronder 
genen die coderen voor hydrolytische enzymen en onderdelen van de lysosomale 
protonpompen. Om deze resultaten te bevestigen hebben we aangetoond dat deze 
kenmerken samengaan met een verhoogde verzuring van de bacterie-bevattende 
compartimenten en met een versterkte microbicide activiteit. Om meer inzicht te krijgen in 
hoe lysosomale stress in macrofagen wordt opgewekt door een tekort aan chemotactische 
signalen, hebben we de migratie van macrofagen gevolgd na toepassing van een 
lysosoomkleuring. Opvallend was dat de lysosomen zich tijdens het migratieproces 
verplaatsen naar de voorkant van de bewegende cel en dat cxcr3.2-mutatie hier een 
remmend effect op heeft. De ophoping van lysosomen aan de voorkant van migrerende 
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cellen is mogelijk een teken van de exocytose van lysosomen, een proces dat kan worden 
geïnduceerd door chemokinen en belangrijk is voor membraanvoorziening aan de 
uitgestrekte lamellipodia. Een interessante waarneming was dat macrofagen zelf de 
expressie van cxcl11aa induceren tijdens de mycobacteriële infectie. De Myd88-
signaalroute, die betrokken is bij de herkenning van pathogenen door het immuunsysteem, 
bleek essentieel te zijn voor de expressie van cxcl11aa. Daarom veronderstellen we dat het 
circuit van immuunherkenning, chemokinesignalering en lysosoomfunctie mogelijk de 
pathogeen op twee manieren kan bevoordelen. Ten eerste kan de inductie van Cxcr3.2-
afhankelijke signalering het granuloom voeden met nieuwe macrofagen die vervolgens 
besmet kunnen worden en ten tweede kan deze signalering voor een meer toegankelijke 
intracellulaire niche zorgen, omdat de lysosomale functies onderdrukt worden. 
 
Hoofdstuk 5 rapporteert over een voorlopige karakterisering van de functie van Cxcr3.3, 
een andere homoloog van de humane CXCR3-receptor in de zebravis. In dit hoofdstuk 
wordt allereerst beschreven hoe we de CRISPR/Cas9-methode hebben toegepast om een 
cxcr3.3-mutant te verkrijgen, waarbij we een aantal verbeteringen in het protocol hebben 
ingevoerd om de mutagenese te optimaliseren. De analyse van cxcr3.3-mutanten liet 
vervolgens zien dat deze gevoeliger zijn voor mycobacteriële infecties, wat 
tegenovergesteld is aan het fenotype van de cxcr3.2-mutant. Een dubbelmutant van cxcr3.2 
en cxcr3.3 zal nodig zijn om deze tegenstelling verder te onderzoeken, maar als alternatief 
hebben we gekeken naar het effect van behandeling met de NBI74330-remmer, die even 
goed tegen Cxcr3.2 als tegen Cxcr3.3 zou moeten werken vanwege de overeenkomstige 
structuur van de receptoren. Deze receptorantagonist had een positief effect op de 
resistentie van zebravisembryo’s tegen mycobacteriële infectie, overeenkomstig met het 
fenotype van de enkele cxcr3.2-mutant. Dit resultaat suggereert dat de functie van de 
Cxcr3.3-receptor afhankelijk is van die van de Cxcr3.2-receptor. Ter ondersteuning van 
deze hypothese ontdekten wij dat de sequentie van Cxcr3.3 een aantal belangrijke 
verschillen vertoont in vergelijking met andere G-eiwit-gekoppelde chemokinereceptoren. 
Het meest opmerkelijke verschil is de vervanging van een Arginine-residu in het 
Asparaginezuur-Arginine-Tyrosine-motief (DRY-motief), het meest geconserveerde motief 
van de functionele G-eiwit-gekoppelde receptoren. Het Arginine-residu is 100% 
geconserveerd in de functionele humane CXCR-receptoren en is noodzakelijk voor de 
interactie met heterotrimere G-eiwitten en voor de activering van de onderliggende 
signaalroute. Het DRY-motief is daarentegen vaak afwijkend (of geheel afwezig) in 
atypische chemokinereceptoren. Deze atypische receptoren competeren met de functionele 
receptoren voor de binding van chemokinen en kunnen op die manier chemokine-
concentratiegradiënten reguleren. Het voorkomen van atypische CXCR3-isovormen is een 
terugkerend fenomeen in beenvissen, terwijl het verloren lijkt te zijn gegaan tijdens de 
evolutie van tetrapoden en kwastvinnige vissen, die nauw verwant zijn aan tetrapoden. 
Atypische Cxcr3.3-receptoren zijn daarom niet uniek voor de zebravis en hebben mogelijk 
een belangrijke geconserveerde functie in het immuunsysteem van vissen. Verder 
onderzoek hiernaar kan helpen om de evolutionaire geschiedenis van chemokinereceptoren 
te reconstrueren. 
 
In Hoofdstuk 6 hebben wij de functie van de chemokinereceptor Cxcr4b geanalyseerd en 
geconstateerd dat mutatie van deze receptor de groei van granulomen in de weefsels van de 
romp van zebravisembryo’s beperkt. Een kenmerk van de weefsels in de romp is dat hier 
weinig bloedvaten doorheen lopen. Om in grootte te kunnen toenemen, moeten de 
granulomen in deze weefsels daarom nieuwe bloedvaten aantrekken (angiogenese). De 
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beperkte groei van granulomen in cxcr4b-mutanten bleek een correlatie te vertonen met 
verminderde angiogenese. In een poging om te ontrafelen hoe Cxcr4b de 
bloedvatvoorziening van granulomen bevordert, vonden we dat cxcr4b-mutanten een 
verminderde inductie vertonen van genen betrokken bij ontstekingsreacties, in het 
bijzonder het gen dat codeert voor het ontstekingsbevorderende cytokine Il1b. Dit cytokine 
is een pleiotroop molecuul dat ook bekend staat om zijn proliferatieve en pro-angiogene 
effecten op de cellen van de wand van bloedvaten (endotheelcellen). Het il1b-gen komt 
grotendeels tot expressie in de geïnfecteerde cellen in de granulomen en vormt mogelijk 
een belangrijke verbinding tussen Cxcr4b en de activering van de ontstekingsreactie in 
deze structuren. 
 
In Hoofdstuk 7 karakteriseren wij de functie van Cxcl18b, een chemokine dat specifiek is 
voor de zebravis. Door middel van injectie van recombinant Cxcl18b-eiwit laten we zien 
dat dit chemokine een krachtige chemoattractant van neutrofielen is, terwijl het geen 
invloed heeft op het aantrekken van macrofagen. We hebben bovendien aangetoond dat 
Cxcl18b zijn functie in ieder geval gedeeltelijk uitoefent via de chemokinereceptor Cxcr2, 
die eerder werd beschreven als de receptor voor twee CXCL8/IL8-achtige chemokinen. De 
expressie van cxcl18b is sterk induceerbaar door mycobacteriële infecties en andere 
ontstekingscondities. Daarom kan cxcl18b een bruikbare marker zijn om de ontwikkeling 
van ontstekingsreacties te volgen. We hebben een cxcl18b-reporter geconstrueerd en zagen 
dat deze reporter de endogene inductie van cxcl18b reproduceert tijdens mycobacteriële 
infectie. Interessant genoeg bleek dat de geïnfecteerde cellen niet de belangrijkste bron van 
expressie van de cxcl18b-reporter zijn, maar dat ongeïnfecteerde cellen in de granulomen 
het transgen sterk tot expressie brengen. Deze observatie suggereert dat de reporter kan 
worden gebruikt om reacties te onderscheiden die worden geactiveerd in specifieke 
subpopulaties van cellen waaruit granulomen bestaan en die belangrijk zouden kunnen zijn 
voor de rekrutering van neutrofielen. Deze transgene lijn lijkt daarom nuttig voor 
toekomstig onderzoek naar de functie van neutrofielen in mycobacteriële ziekten, waarover 
nu nog weinig bekend is. 
 
Dit proefschrift wordt afgesloten met een algemene discussie in Hoofdstuk 8, waarin onze 
resultaten worden besproken in relatie tot recente inzichten in aangeboren immuniteit en 
mycobacteriële ziekten. We bediscussiëren de dubbele functie van macrofagen, die aan de 
ene kant noodzakelijk zijn om een mycobacteriële infectie in te perken, maar aan de andere 
kant juist kunnen bijdragen aan de verspreiding van de bacteriën in de weefsels van de 
gastheer. Tevens gaan we erop in op hoe de lysosomale stressreactie bij kan dragen aan 
resistentie tegen infecties, terwijl lysosomale stapelingsziekten juist geassocieerd zijn met 
een grotere vatbaarheid voor infecties. Hierbij bespreken we hoe deze kennis benut zou 
kunnen worden voor nieuwe therapeutische strategieën. Daarnaast hebben we getracht om 
een verklaring te vinden voor onze resultaten met betrekking tot de atypische Cxcr3.3-
receptor, waarvan mutatie tot verhoogde vatbaarheid voor infectie leidt. Hiertoe hebben we 
onze bevindingen vergeleken met een studie in muizen die een mutatie hebben in een 
andere atypische chemokinereceptor en die een vergelijkbaar fenotype vertonen na infectie 
met M. tuberculosis. Voorts plaatsen we onze resultaten over het effect van Cxcr4b op 
angiogenese en de ontstekingsreactie in granulomen in de context van literatuur waarmee 
de functie van CXCR4 bij inductie van pathologische angiogenese en modulatie van 
ontstekingsreacties wordt ondersteund. Vervolgens wordt besproken hoe het zebravismodel 
kan helpen om meer inzicht te verkrijgen in de functie van chemokinen bij het reguleren 
van de betrokkenheid van neutrofielen in mycobacteriële ziekten. Het hoofdstuk wordt 
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besloten met enkele algemene reflecties over de pleiotropische functies en complexiteit 
achter het chemokine-signaleringsnetwerk en over hoe het zebravismodel kan bijdragen 
aan ons begrip van deze en andere multidimensionale biologische processen.  
 
Concluderend, het onderzoek dat in dit proefschrift wordt beschreven heeft bijgedragen aan 
het verduidelijken van de betrokkenheid van het chemokinennetwerk bij verschillende 
aspecten van mycobacteriële infectie. Onze resultaten benadrukken hoe dit intrigerende 
netwerk kan leiden tot verschillende uitkomsten die gunstig kunnen zijn voor de gastheer 
of juist voor de pathogeen. Daarnaast hebben we laten zien dat signalering door 
chemokinen niet alleen de rekrutering van immuuncellen reguleert, maar ook het 
expressieprofiel van deze cellen en hun immuuncompetentie tegen de binnendringende 
bacteriën. Bovendien heeft het zebravismodel longitudinaal in vivo onderzoek mogelijk 
gemaakt om de cellulaire dynamica en moleculaire routes te volgen die de 
chemokinensignalering activeren (of hierdoor worden geactiveerd). Ten slotte heeft het 
gebruik van dit gastheermodel het mogelijk gemaakt om deze nieuwe bevindingen over 
chemokinensignalering rechtstreeks te relateren aan pathologische consequenties op het 
niveau van de gastheer tijdens de mycobacteriële ziekte. Deze aanpak heeft ons geholpen 
om op een dieper niveau inzicht te krijgen in de complexiteit achter de mycobacteriële 
ziekte en om te begrijpen hoe verschillende celtypen (zoals neutrofielen, macrofagen, en 
endotheelcellen) en verschillende gastheerfactoren (zoals chemokinen, 
ontstekingsmoleculen en angiogenesefactoren) een interactie met elkaar aan gaan en als 








AB/TL AB/Tupfel long fin 
AC Adenylyl cyclase 
Ackr Atypical chemokine receptor 
AGM Aorta, gonads and mesonephros 
AJ Ashkenazi Jewish 
ASMase Acid sphingomyelinase 
BALB/c Bagg Albino/c 
BCA Bicinchoninic acid 
Bcc Burkholderia cenocepacia 
BCG Bacillus of Calmette–Guérin 
bHLH Basic helix-loop-helix 
BLT1 Leukotriene B4 receptor 1 
bZip Basic Leucine zipper 
C/ebpβ  CCAAT enhancer-binding protein β  
cAMP Cyclic adenosine monophosphate 
Cas9 CRISPR-associated protein 9 
Ccl1 Cys-Cys motif chemokine ligand 
Ccr1 Cys-Cys motif chemokine receptor 
Cdc42 Cell division control protein 42 
homologue 
CFU Colony forming unit 
CHT Caudal haematopoietic tissue 
CLEAR Coordinated lysosomal expression 
and regulation 
Coro-1a Coronin 1a 
COX Cycloxygenase 
CRISPR Clustered regularly interspaced short 
palindromic repeats 
CV Caudal vein 
Cx3cl Cys-X3-Cys motif chemokine ligand 
Cx3cr Cys-X3-Cys motif chemokine 
receptor 
Cxcl Cys-X-Cys motif chemokine ligand 
Cxcr Cys-X-Cys motif chemokine 
receptor 
Cxl Cys-X motif chemokine ligand 
Cxr Cys-X motif chemokine receptor 
CYPD Cyclophilin D 
DAG Diacylglycerol 
DARC Duffy antigen chemokine receptor 
DC Denditic cell 
DMSO Dimethyl sulfoxide  
Dpf Days post fertilisation 
Dpi Days post infection\injection 
DRY Asp-Arg-Tyr 
dsDNA Double-stranded DNA 
DUOX Dual oxidase 
Ec Escherichia coli 
ECM Extracellular matrix 
eGFP Enhanced Green fluorescent protein 
Eif Eukariotic initiation factor 
ELR Glu-Leu-Arg 
ENA78 Epithelial-derived neutrophil-
activating peptide 78 
ER Endoplasmic reticulum 
ERP Exported repeated protein 
ESAT-6 Early secretory antigenic target 6 
kDa 
ESX-1 ESAT-6 secretion system 1 
FACS Fluorescence-activated cell sorting 
Fli1a Friend leukemia integration 1a 
GCP2 Granulocyte chemotactic protein 2 
Gcsf  Granulocyte colony stimulating 
factor 
GDP, GTP Guanosine 5'-diphosphate, 
triphosphate 
GEF Guanine nucleotide exchange factor 
GPCR G-protein-coupled receptor 
GPR35 G-protein-coupled receptor 35 
GR Glucocorticoid receptor 
Grb2 Growth factor receptor-bound 
protein 2 
GROα, 
GROβ, GROγ  
Growth-regulated protein alpha, 
beta, gamma 




Hexosaminidase A, B 
Hif-1α, Hif-
2α 
Hypoxia-inducible factor 1 alpha, 2 
alpha 
Hpf Hours post fertilisation 
Hpi Hours post infection/injection 
Hpw Hours post wounding 
HSPC Haematopoietic stem and progenitor 
cell 
I-TAC Interferon-inducible T-cell alpha 
chemoattractant 
Ifnγ Interferon gamma 
Il1β, Il8, Il13 Interleukin 1 beta, 8, 13 
iNOS Inducible nitric oxide synthase 
IP-10 Interferon gamma-inducible protein 
10 
IP3 inositol 1,4,5-trisphosphate 
Irf8 Interferon regulatory factor 8 
Irg1 Immunoresponsive gene 1 
JAK Janus kinase 
kDa kilo Dalton 
Kdrl Kinase insert domain receptor-like 
KO Knockout 
Lamp3 Lysosomal associated membrane 
protein 3 
Lc3 Microtubule-associated protein 
1A/1B-light chain 3 
Lck Lymphocyte cell-specific protein-
tyrosine kinase 
Lp/Lcp1 Leukocyte plastin/ Lymphocyte 
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cytosolic protein 1 
LSD Lysosomal storage disorder 
Lta4h Leukotriene A4 hydrolase 
LTB4 Leukotriene B4 
Lyz Lysozyme 
M(Φ) Monocyte/macrophage 
MAPK Mitogen-activated protein kinases 
MIF Macrophage migration inhibitory 
factor 
MIG monokine induced by interferon γ 
miRNA Micro RNA 
Mitf Microphthalmia-associated 
transcription factor 
MLCK Myosin light-chain kinase 
Mm Mycobacterium marinum 
Mmp 9 Matrix metalloproteinase 9 
Mpeg1 Macrophage expressed gene 1 
mPTPC Mitochondrial permeability 
transition pore complex 
Mpx Myeloperoxidase 
Mtb Mycobacterium tuberculosis 
Myd88 Myeloid differentiation primary 
response gene 88 
MΦ Macrophage 
NADPH Nicotinamide adenine dinucleotide 
phosphate 
NAI Nfκb activation inhibitor 
NAP2 Neutrophil-activating peptide 2 
Nfκb Nuclear factor kappa-light-chain-
enhancer of activated B cells 
NK Natural killer cell 
Nlr Nod-like receptor 
NSAID Non-steroid antinflammatory drug  
NΦ Neutrophil 
P/DAMP Pathogen and Damage-associated 
molecular pattern 
PAM Protospacer adjacent motif 
PBS, PBSTx Phosphate buffer saline, triton x 
pC3 Previously chromosome 3 
PCR Polymerase chain reaction 
PDIM Phthiocerol dimycocerosate 
PGL Phenolic glycolipid 
PGP Pro-Gly-Pro 
PH Plekstrin homology 







PITPNM3 Phosphatidylinositol transfer protein, 
membrane-associated 3 
PKC Protein kinase C 
PLA, PLC Phospholipase A, C 
Ppiab Peptidylprolyl isomerase ab 
PRR Pattern recognition receptor 
PTK Protein tyrosine kinase 
Ptpn6/Shp1 Protein tyrosine phosphatase, non-
receptor type 6/ Src homology region 
2 domain-containing phosphatase 1 
Ptprc/Cd45 Protein tyrosine phosphatase 
receptor type C/Cd45 
PTU Phenylthiourea 
PVP Polyvinylpyrrolidone 
qRT-PCR Quantitative real time polymerase 
chain reaction 
Rac1 Ras-related C3 botulinum toxin 
substrate 
RD1 Region of difference 1 
RhoA Ras homologue gene family member 
A 
RNS Reactive nitrogen species 
ROCK Rho-associated protein kinase 
ROS Reactive oxygen species 
shgRNA Short guide RNA 
SNARE Soluble NSF attachment protein 
receptor 
Spi1/Pu.1 Spleen Focus Forming Virus (SFFV) 
Proviral Integration Oncogene 1/Pu.1 
Sqstm1/p62 Sequestosome 1/Ubiquitin-binding 
protein of 62 kDa 
ssDNA Single-stranded DNA 
St Salmonella enterica Serovar 
Typhimurium 
STAT Signal transducer and activator of 
transcription 
SV40pA Simian virus 40 polyadenylation 
signal 
T3SS Type III secretion system 
T7SS Type VII secretion system 





Transcription factor E, C, 3 
Tg Transgenic 
Tiam1 T-lymphoma invasion and 
metastasis-inducing protein 1 
Tlr Toll-like receptor 
TM Transmembrane 
TMT Trasmembrane transporter 
Tnfα Tumour necrosis factor alpha 
Traf6 TNF receptor-associated factor 6 
UAS Upstream activating sequence 
Vegf Vascular endothelial growth factor 
Vegfr Vascular endothelial growth factor 
receptor 
WGD Whole genome duplication 
WHO World health organisation 
Wt Wildtype 
Xcl X- Cysteine motif chemokine ligand 
Xcr X- Cysteine motif chemokine 
receptor 
YPD Yeast extract peptone dextrose 
ZFN Zinc finger nuclease 
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Name in this 
thesis Ensembl gene name 
zfin gene 
name 
Ensembl gene ID/Alignment 
position Ensembl protein ID 
Previous /synonymous names 
and notes 
ccl18ab CR762483.1 - ENSDARG00000074487 ENSDARP00000101228 - 
ccl19aa ccl19a.1 ccl19a.1 ENSDARG00000058389 ENSDARP00000090385 ccl-c5a, dr-scNA10579-CCL19-34.3%-DN, si:ch211-89f7.4 









ccl20aa - - unmappable no protein assigned - 
ccl20ab ENSDARG00000100432 - ENSDARG00000100432 ENSDARP00000138620 - 




ccl20ad - - 2:45319950-45317434 (-) no protein assigned Incomplete sequence/pseudogene 





ccl25a CU693369.1 - ENSDARG00000089534 ENSDARP00000111107 - 




ccl27a ccl27a ccl27a ENSDARG00000058570 ENSDARP00000075898 ENSDARP00000137864 
ccl1, Dr8_WGA606_1_66363, 
wu:fa96a04 





ccl32ab ccl32a.2 ccl32a.2 ENSDARG00000095049 ENSDARP00000122846 ENSDARP00000141410 
ccl-c2c, Dr7_WGA489_1_245599, 
si:ch211-122l24.2 
ccl32ac - - 2:40365520-40370475 (+) no protein assigned - 
ccl32ad - - 2:40387422-40388412  (+) no protein assigned - 
ccl32ae - - unmappable no protein assigned - 
ccl32bc CT574575.1 - ENSDARG00000098656 ENSDARP00000137910 ENSDARP00000140796 - 
ccl32ca - - KN149905:570-1 (-) no protein assigned - 
ccl32cb - - KN149905:2766-1821 (-) no protein assigned - 
ccl32d - - KN150005:21462-23168 (+) no protein assigned - 
ccl33aa - - 25:25106427-25106501 (+) no protein assigned Incomplete sequence/pseudogene 













ccl34aa - - unmappable no protein assigned - 
ccl34ab - - unmappable no protein assigned - 






ccl34ad ccl34a.4 ccl34a.4 ENSDARG00000090873 no protein assigned 









ccl34bb - - 24:27327959-27327535 (-) no protein assigned - 
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thesis Ensembl gene name 
zfin gene 
name 
Ensembl gene ID/Alignment 
position Ensembl protein ID 
Previous /synonymous names 
and notes 









ccl34be CR383669.1 - ENSDARG00000099782 ENSDARP00000137755 - 
ccl34bf CR383669.2 - ENSDARG00000100520 ENSDARP00000137901 - 
ccl34bg - - KN150005:21462-21536 (+) no protein assigned - 
ccl34bh ccl34b.8 ccl34b.8 ENSDARG00000093098 ENSDARP00000121266 ccl-c24c, si:dkey-25o1.4 
ccl34bi ccl34b.9 ccl34b.9 ENSDARG00000078205 ENSDARP00000098604 ccl-c24b, si:dkey-25o1.3 
ccl34bl - - 24:27403153-27402859 (-) no protein assigned Incomplete sequence/pseudogene 
ccl34bm - - 24:27411537-27411245 (-) no protein assigned Incomplete sequence/pseudogene 





ccl34ea CABZ01001434.1 - ENSDARG00000098602 ENSDARP00000133785 ENSDARP00000133418 - 
ccl34eb - - unmappable no protein assigned - 









ccl36aa - - 7:39442461-39442771 (+) no protein assigned Incomplete sequence/pseudogene 
ccl36ab BX908792.2 - ENSDARG00000105263 ENSDARP00000138949 - 
































ccl39aa ccl39.1 ccl39.1 ENSDARG00000101041 ENSDARP00000130968 ccl-c25q, dr-chr25-CCL13-38.9%-DN, si:dkeyp-55h4.5 
ccl39ab ccl39.2 ccl39.2 ENSDARG00000102945 ENSDARP00000138051 ENSDARP00000141835 
ccl-c25p, dr-chr25-CCL2-37.5%-
DN, si:ch211-149o7.5 
ccl39ac ccl39.3 (ch. 25) ccl39.3 ENSDARG00000100295 ENSDARP00000141922 ENSDARP00000138620 
ccl-c25o, dr-chr25-CCL13-35.9%-
DN, si:dkeyp-55h4.6 









ccl39af ccl39.6 ccl39.6 ENSDARG00000105089 ENSDARP00000132580 ccl-c25l, si:dkeyp-55h4.9 




ccl39ah CR450808.1 - ENSDARG00000100484 ENSDARP00000135517 - 
ccl39ai - - 25:12816818-12816285 (-) no protein assigned Incomplete sequence/pseudogene 
ccl39aj* ccl39a.10 ccl39a.10 ENSDARG00000096060 ENSDARP00000125562 ccl-c25z, si:ch211-202c4.2 Incomplete sequence/pseudogene 
ccl39ba* ccl39.3 (ch. 6) - ENSDARG00000101499 ENSDARP00000130440 - 
ccl44 ccl44 ccl44 ENSDARG00000074772 ENSDARP00000101027 ccl-c11b, Dr11_WGA839_1_233313 
cxcl8a CT826376.2 cxcl8a ENSDARG00000104795 ENSDARP00000137520 
cxcl8, il8, cxcl-c1a, 
CXCL8_L1_chr1, dr-chr1-
CXCL8, si:dkey-151b16.2 
cxcl8ba - - 7:7671156-7665921 (-) no protein assigned - 
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thesis Ensembl gene name 
zfin gene 
name 
Ensembl gene ID/Alignment 
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cxcl8bb cxcl8b.1 cxcl8b.1 ENSDARG00000102299 ENSDARP00000131403 ENSDARP00000136965 il8l2, cxcl8_l2_chr17 
cxcl8bc cxcl8b.3 cxcl8b.3 ENSDARG00000099169 ENSDARP00000136707 cxcl-c13d, CXCL8_L2_chr7, dr-scNA16716-CXCL8 
cxcl11aa  CXCL11 (1 of many) cxcl11.1 ENSDARG00000100662 ENSDARP00000135444 
cxcl11l, cxcl-c5d, dr-chr5-
CXCL11, vig7, SCYB9B, b-R1, 
IP-9, H174, SCYB11, I-TAC 
cxcl11ab - cxcl11.2 5:42290344-42290046 (-) no protein assigned dr-chr5-CXCL11-27.4-DN Incomplete sequence/pseudogene 
cxcl11ac ENSDARG00000102514 cxcl11.3 ENSDARG00000102514 ENSDARP00000136965 cxc-66, cxcl-c5e, dr-chr5-CXCL11-37.2-EK12810 
cxcl11ad CXCL11 (1 of many) cxcl11.4 ENSDARG00000101138 ENSDARP00000133434 
cxcl11l2, cxc-56, cxcl-c5f, dr-
chr5-CXCL9-35.1-EK43819, 
SCYB9B, b-R1, IP-9, H174, 
SCYB11, I-TAC 
cxcl11ae cxcl11.5 cxcl11.5 ENSDARG00000092423 ENSDARP00000115162 ENSDARP00000136838 
cxcl-c5g, dr-chr1-CXCL11-37.1-
DN, si:ch211-202a12.7 
cxcl11af cxcl11.6 cxcl11.6 ENSDARG00000094706 ENSDARP00000112794 cxcl-c5h, si:ch211-202a12.8 
cxcl11ag cxcl11.7 cxcl11.7 ENSDARG00000093779 ENSDARP00000116772 cxcl-c5i, dr-chr1-CXCL9-37.2-EK42273, si:ch211-202a12.9,  




cxcl12a cxcl12a cxcl12a ENSDARG00000037116 ENSDARP00000053945 
cxcl12, sdf1, sdf1a, unm t30516, 
unm_t30516, wu:fa55e10, 
wu:fc16h12, wu:fj84c02 
cxcl12b cxcl12b cxcl12b ENSDARG00000055100 ENSDARP00000071878 sdf1b, zgc:136720 
cxcl13 si:dkey-58f10.3 - ENSDARG00000095112 no protein assigned - 
cxcl14 cxcl14 cxcl14 ENSDARG00000056627 ENSDARP00000109550 scyba, fb67g04, wu:fb67g04 
cxcl18aa - - 13:30566063-30568522 (+) no protein assigned Incomplete sequence/pseudogene 
cxcl18b cxcl18b cxcl18b ENSDARG00000075045 ENSDARP00000102296 cxcl-c1c, dr-chr25-CXCL11-28.0-EP27297, si:ch73-6k14.1GN 
cxcl19 cxcl19 cxcl19 ENSDARG00000102776 ENSDARP00000135787 cxcl-c13d, dr-scNA11550-CXCL2-36.0%-DN 
cxcl20b cxcl20 cxcl20 ENSDARG00000075163 ENSDARP00000102486 cxcl-c5c, dareCXCc, dr-chr5-CXCL10-28.6%-DN 
cxcl32ba cxcl32b.1 cxcl32b.1 ENSDARG00000071499 ENSDARP00000096549 cxcl-c24e, si:ch211-260d11.1, scNA16670-CCL8-33.3-DN 
cxcl32bb CT574575.2 - ENSDARG00000099822 ENSDARP00000131333 - 
cxl34bj - - 24:27385246-27384292 (-) no protein assigned   
cxl34bk cxl34b.11 cxl34b.11 ENSDARG00000092283 ENSDARP00000115786 cxl-c24a, cxl1, si:dkey-25o1.2 
cxl34c cxl34c cxl34c ENSDARG00000096664 ENSDARP00000126667 cxl-c12a, wu:fb09d09, si:ch211-125g7.3 
cxl34d - - 7:57100469-57102607 (+) no protein assigned - 
xcl32aa xcl32a.1 xcl32a.1 ENSDARG00000093906 ENSDARP00000118951 cxl-c2a, si:ch211-122l24.3 
 
Notes: Comparison of the nomenclature applied in this work (column 1) with the nomenclature used in Ensembl 
and zfin databases or elsewhere in literature (columns 2-6). The nomenclature adopted here essentially reflects the 
systematic classification suggested by Nomiyama et al., Genes Cells. 2013. Exceptions are made for genes where 
other names are largely in use (for these cases the name according to Nomiyama et al., 2013 is reported in 
brackets in column 1). Names followed by asterisks (*) indicate sequences which were not annotated in 
Nomiyama et al., 2013. Rows highlighted in grey represent either incomplete sequences or previously reported 
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ackr2/d6* CU633991.1 - ENSDARG00000086314 ENSDARP00000108059 - 




ackr3b/cxcr7b ackr3b ackr3b ENSDARG00000058179 ENSDARP00000063664 drRDC1b, sb:cb900, si:dkey-96h14.2 
ackr4a/ccrl1a ackr4a ackr4a ENSDARG00000078729 ENSDARP00000116973 zfCCRL1-1 
ackr4b/ccrl1b ackr4b ackr4b ENSDARG00000040133 ENSDARP00000058702 drCCRL1b, zfCCRL1-2, sb:eu250 
ackr6/pitpnm3* pitpnm3 pitpnm3 ENSDARG00000055255 ENSDARP00000072049 wu:fk08b02, fk08b02 




ccr4lab CABZ01093075.1 CABZ01093075.1 ENSDARG00000086616 ENSDARP00000105159 zfCCR8-2 
ccr4lac ccr8 si:cabz01093077.1 ENSDARG00000105467 ENSDARP00000142256 
GPR-CY6, CMKBR8, 
TER1, CY6, CKR-L1, 
CDw198, CMKBRL2 





ccr6b ccr6b ccr6b ENSDARG00000038968 ENSDARP00000128924 ENSDARP00000056883 zfCCR6-1, wu:fk31f08 
ccr7 ccr7 ccr7 ENSDARG00000044561 ENSDARP00000118528 zfCCR7, zgc:165629 








ccr10 ccr10 ccr10 ENSDARG00000040643 ENSDARP00000099267 zgc:91924 




ccr2 (ccr11ab) si:ch211-207g17.2 si:ch211-207g17.2 ENSDARG00000079829 ENSDARP00000142081 ENSDARP00000094958 - 
ccr11ac si:ch211-207g17.3 si:ch211-207g17.3 ENSDARG00000105363 ENSDARP00000142057 - 
ccr12a ccr12a ccr12a ENSDARG00000038541 ENSDARP00000122747  ccr12.3, zfCCR3-3, si:ch211-106n13.2 
ccr12ba ccr12b.1 ccr12b.1 ENSDARG00000059410 ENSDARP00000126464 ccr12.1, zfCCR3-1, si:dkey-225n22.5 




cxcr1 (cxcr1ba) si:ch73-54b5.2 si:ch73-54b5.2 ENSDARG00000052088 ENSDARP00000068360 zmp:0000001086 
cxcr2 (cxcr1bb) cxcr2 cxcr2 ENSDARG00000054975 ENSDARP00000071727 si:ch73-54b5.1 
cxcr3.1 (cxcr3ab) cxcr3.1 cxcr3.1 ENSDARG00000007358 ENSDARP00000137552 dr-chr16-CXCR3-41.8-EK27498, sb:eu378 
cxcr3.2 (cxcr3l) cxcr3.2 cxcr3.2 ENSDARG00000041041 ENSDARP00000122984 dr-chr16-CXCR3-37.5-EK27053, zgc:92301 
cxcr3.3 (cxcr3aa) cxcr3.3 cxcr3.3 ENSDARG00000070669 ENSDARP00000119122 si:dkey-269d20.3 
cxcr4a cxcr4a cxcr4a ENSDARG00000057633 ENSDARP00000074800 ENSDARP00000123851 cb824 
cxcr4b cxcr4b cxcr4b ENSDARG00000041959 ENSDARP00000061498 
cxcr4, odysseus, ody, 
cb403, drCXCR4b1, 
zgc:109863 
cxcr5 cxcr5 cxcr5 ENSDARG00000010514 ENSDARP00000010091 MDR15, BLR1, CD185 
cxcr8a/gpr35a* ENSDARG00000075877 - ENSDARG00000075877 ENSDARP00000103013 - 
cxcr8ba/gpr35ba* gpr35.1 gpr35.1 ENSDARG00000074633 ENSDARP00000133176 ENSDARP00000103106 zgc:171586 
cxcr8bb/gpr35bb* ENSDARG00000086776 gpr35.2 ENSDARG00000086776 ENSDARP00000111768 zmp:0000001226 
xcr1aa xcr1a.1 xcr1a.1 ENSDARG00000054847 ENSDARP00000071590 ENSDARP00000103498 xcr1, xcr1a 
xcr1ab si:ch73-217b7.4 xcr1a.2 ENSDARG00000054846 no protein assigned Incomplete sequence/pseudogene 
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xcr1ac si:ch73-217b7.3 xcr1a.3 ENSDARG00000087978 no protein assigned Incomplete sequence/pseudogene 
xcr1ba CABZ01053221.1 xcr1b.2 ENSDARG00000058774 ENSDARP00000076150 drXCR1b 
xcr1bc XCR1 (1 of many) xcr1b.1 ENSDARG00000052988 ENSDARP00000069429 xcr1b, GPR5, CCXCR1, zmp:0000001090 
xcr1bd CABZ01053219.1 xcr1b.3 ENSDARG00000089840 ENSDARP00000110709 ccr8.3, zfCCR8-3 
 
Notes: Comparison of the nomenclature applied in this work (column 1) with the nomenclature used in Ensembl 
and zfin databases or elsewhere in literature (columns 2-6). The nomenclature adopted here essentially reflects the 
systematic classification suggested by Nomiyama et al., Genes Cells. 2013. Exceptions are made for genes where 
other names are largely in use (for these cases the name according to Nomiyama et al., 2013 is reported in 
brackets in column 1). Names followed by asterisks (*) indicate sequences which were not annotated in 
Nomiyama et al., 2013. Rows highlighted in grey represent either incomplete sequences or previously reported 
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